<!DOCTYPE html> <html lang=en class="js webfonts-loaded" style><!--
 Page saved with SingleFile 
 url: https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3 
 saved date: Mon May 22 2023 21:35:26 GMT+0800 (中国标准时间)
--><meta charset=utf-8>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=applicable-device content=pc,mobile>
<meta name=viewport content="width=device-width, initial-scale=1">
<title>Current controversies in radiotherapy for breast cancer | Radiation Oncology | Full Text</title>
<meta name=citation_abstract content="Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).">
<meta name=journal_id content=13014>
<meta name=dc.title content="Current controversies in radiotherapy for breast cancer">
<meta name=dc.source content="Radiation Oncology 2017 12:1">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="BioMed Central">
<meta name=dc.date content=2017-01-23>
<meta name=dc.type content=ReviewPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2017 The Author(s).">
<meta name=dc.rights content="2017 The Author(s).">
<meta name=dc.rightsAgent content=reprints@biomedcentral.com>
<meta name=dc.description content="Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).">
<meta name=prism.issn content=1748-717X>
<meta name=prism.publicationName content="Radiation Oncology">
<meta name=prism.publicationDate content=2017-01-23>
<meta name=prism.volume content=12>
<meta name=prism.number content=1>
<meta name=prism.section content=ReviewPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=10>
<meta name=prism.copyright content="2017 The Author(s).">
<meta name=prism.rightsAgent content=reprints@biomedcentral.com>
<meta name=prism.url content=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3>
<meta name=prism.doi content=doi:10.1186/s13014-017-0766-3>
<meta name=citation_pdf_url content=https://ro-journal.biomedcentral.com/counter/pdf/10.1186/s13014-017-0766-3>
<meta name=citation_fulltext_html_url content=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3>
<meta name=citation_journal_title content="Radiation Oncology">
<meta name=citation_journal_abbrev content="Radiat Oncol">
<meta name=citation_publisher content="BioMed Central">
<meta name=citation_issn content=1748-717X>
<meta name=citation_title content="Current controversies in radiotherapy for breast cancer">
<meta name=citation_volume content=12>
<meta name=citation_issue content=1>
<meta name=citation_publication_date content=2017/12>
<meta name=citation_online_date content=2017/01/23>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=10>
<meta name=citation_article_type content=Review>
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1186/s13014-017-0766-3>
<meta name=DOI content=10.1186/s13014-017-0766-3>
<meta name=size content=206930>
<meta name=citation_doi content=10.1186/s13014-017-0766-3>
<meta name=citation_springer_api_url content="http://api.springer.com/xmldata/jats?q=doi:10.1186/s13014-017-0766-3&amp;api_key=">
<meta name=description content="Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).">
<meta name=dc.creator content="Krug, David">
<meta name=dc.creator content="Baumann, René">
<meta name=dc.creator content="Budach, Wilfried">
<meta name=dc.creator content="Dunst, Jürgen">
<meta name=dc.creator content="Feyer, Petra">
<meta name=dc.creator content="Fietkau, Rainer">
<meta name=dc.creator content="Haase, Wulf">
<meta name=dc.creator content="Harms, Wolfgang">
<meta name=dc.creator content="Piroth, Marc D.">
<meta name=dc.creator content="Sautter-Bihl, Marie-Luise">
<meta name=dc.creator content="Sedlmayer, Felix">
<meta name=dc.creator content="Souchon, Rainer">
<meta name=dc.creator content="Wenz, Frederik">
<meta name=dc.creator content="Sauer, Rolf">
<meta name=dc.subject content="Cancer Research">
<meta name=dc.subject content=Oncology>
<meta name=dc.subject content=Radiotherapy>
<meta name=dc.subject content="Imaging / Radiology">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases; citation_author=W Budach, C Matuschek, E Bölke, J Dunst, P Feyer, R Fietkau; citation_volume=191; citation_publication_date=2015; citation_pages=623-33; citation_doi=10.1007/s00066-015-0843-1; citation_id=CR1">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences; citation_author=W Harms, W Budach, J Dunst, P Feyer, R Fietkau, W Haase; citation_volume=192; citation_publication_date=2016; citation_pages=199-208; citation_doi=10.1007/s00066-015-0939-7; citation_id=CR2">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways; citation_author=ML Sautter-Bihl, F Sedlmayer, W Budach, J Dunst, P Feyer, R Fietkau; citation_volume=190; citation_publication_date=2014; citation_pages=342-51; citation_doi=10.1007/s00066-013-0543-7; citation_id=CR3">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer; citation_author=F Sedlmayer, ML Sautter-Bihl, W Budach, J Dunst, G Fastner, P Feyer; citation_volume=189; citation_publication_date=2013; citation_pages=825-33; citation_doi=10.1007/s00066-013-0437-8; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast; citation_author=R Souchon, ML Sautter-Bihl, F Sedlmayer, W Budach, J Dunst, P Feyer; citation_volume=190; citation_publication_date=2014; citation_pages=8-16; citation_doi=10.1007/s00066-013-0502-3; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer; citation_author=F Wenz, E Sperk, W Budach, J Dunst, P Feyer, R Fietkau; citation_volume=190; citation_publication_date=2014; citation_pages=705-14; citation_doi=10.1007/s00066-014-0687-0; citation_id=CR6">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Letters Regarding the TARGIT-A Trial: The Editor’s Introduction; citation_author=A Zietman; citation_volume=92; citation_publication_date=2015; citation_pages=951-2; citation_doi=10.1016/j.ijrobp.2015.05.048; citation_id=CR7">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer; citation_author=JS Vaidya, M Bulsara, F Wenz, D Joseph, C Saunders, S Massarut; citation_volume=92; citation_publication_date=2015; citation_pages=491-7; citation_doi=10.1016/j.ijrobp.2015.03.022; citation_id=CR8">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer; citation_author=PM Poortmans, S Collette, C Kirkove, E Limbergen, V Budach, H Struikmans; citation_volume=373; citation_publication_date=2015; citation_pages=317-27; citation_doi=10.1056/NEJMoa1415369; citation_id=CR9">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Regional Nodal Irradiation in Early-Stage Breast Cancer; citation_author=TJ Whelan, IA Olivotto, WR Parulekar, I Ackerman, BH Chua, A Nabid; citation_volume=373; citation_publication_date=2015; citation_pages=307-16; citation_doi=10.1056/NEJMoa1415340; citation_id=CR10">
<meta name=citation_reference content="citation_journal_title=Int J Breast Cancer; citation_title=Boost IORT in Breast Cancer: Body of Evidence; citation_author=F Sedlmayer, R Reitsamer, C Fussl, I Ziegler, F Zehentmayr, H Deutschmann; citation_volume=2014; citation_publication_date=2014; citation_pages=472516; citation_doi=10.1155/2014/472516; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=Breast Care; citation_title=Accelerated Partial Breast Irradiation in Clinical Practice; citation_author=F Wenz, F Sedlmayer, C Herskind, G Welzel, E Sperk, C Neumaier; citation_volume=10; citation_publication_date=2015; citation_pages=247-52; citation_doi=10.1159/000437194; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=Radiother Oncol; citation_title=Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial; citation_author=C Polgár, J Fodor, T Major, Z Sulyok, M Kásler; citation_volume=108; citation_publication_date=2013; citation_pages=197-202; citation_doi=10.1016/j.radonc.2013.05.008; citation_id=CR13">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial; citation_author=V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major; citation_volume=387; citation_publication_date=2016; citation_pages=229-38; citation_doi=10.1016/S0140-6736(15)00471-7; citation_id=CR14">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial; citation_author=JS Vaidya, F Wenz, M Bulsara, JS Tobias, DJ Joseph, M Keshtgar; citation_volume=383; citation_publication_date=2014; citation_pages=603-13; citation_doi=10.1016/S0140-6736(13)61950-9; citation_id=CR15">
<meta name=citation_reference content="citation_journal_title=Lancet; citation_title=Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial; citation_author=JS Vaidya, DJ Joseph, JS Tobias, M Bulsara, F Wenz, C Saunders; citation_volume=376; citation_publication_date=2010; citation_pages=91-102; citation_doi=10.1016/S0140-6736(10)60837-9; citation_id=CR16">
<meta name=citation_reference content="citation_journal_title=Health Technol Assess; citation_title=An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial); citation_author=JS Vaidya, F Wenz, M Bulsara, JS Tobias, DJ Joseph, C Saunders; citation_volume=20; citation_publication_date=2016; citation_pages=1-188; citation_doi=10.3310/hta20730; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=Lancet Oncol; citation_title=Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial; citation_author=U Veronesi, R Orecchia, P Maisonneuve, G Viale, N Rotmensz, C Sangalli; citation_volume=14; citation_publication_date=2013; citation_pages=1269-77; citation_doi=10.1016/S1470-2045(13)70497-2; citation_id=CR18">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy; citation_author=IA Olivotto, TJ Whelan, S Parpia, D-H Kim, T Berrang, PT Truong; citation_volume=31; citation_publication_date=2013; citation_pages=4038-45; citation_doi=10.1200/JCO.2013.50.5511; citation_id=CR19">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis; citation_author=D Peterson, PT Truong, S Parpia, IA Olivotto, T Berrang, D-H Kim; citation_volume=91; citation_publication_date=2015; citation_pages=968-76; citation_doi=10.1016/j.ijrobp.2014.12.040; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=Eur J Cancer; citation_title=Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial; citation_author=L Livi, I Meattini, L Marrazzo, G Simontacchi, S Pallotta, C Saieva; citation_volume=51; citation_publication_date=2015; citation_pages=451-63; citation_doi=10.1016/j.ejca.2014.12.013; citation_id=CR21">
<meta name=citation_reference content="Coles C, Agrawal R, Ah-See ML, Algurafi H. Partial breast radiotherapy for women with early breast cancer: First results of local recurrence data for IMPORT LOW (CRUK/06/003). Eur J Cancer. 2016;57 Supplement 2:S1–S8.">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials; citation_author=JS Vaidya, M Bulsara, F Wenz, N Coombs, J Singer, S Ebbs; citation_volume=96; citation_publication_date=2016; citation_pages=259-65; citation_doi=10.1016/j.ijrobp.2016.05.008; citation_id=CR23">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update; citation_author=GH Lyman, S Temin, SB Edge, LA Newman, RR Turner, DL Weaver; citation_volume=32; citation_publication_date=2014; citation_pages=1365-83; citation_doi=10.1200/JCO.2013.54.1177; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Ann Surg; citation_title=Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial; citation_author=AE Giuliano, L McCall, P Beitsch, PW Whitworth, P Blumencranz, AM Leitch; citation_volume=252; citation_publication_date=2010; citation_pages=426-32; citation_id=CR25">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial; citation_author=AE Giuliano, KK Hunt, KV Ballman, PD Beitsch, PW Whitworth, PW Blumencranz; citation_volume=305; citation_publication_date=2011; citation_pages=569-75; citation_doi=10.1001/jama.2011.90; citation_id=CR26">
<meta name=citation_reference content="citation_journal_title=Ann Surg; citation_title=Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial; citation_author=AE Giuliano, K Ballman, L McCall, P Beitsch, PW Whitworth, P Blumencranz; citation_volume=264; citation_publication_date=2016; citation_pages=413-20; citation_doi=10.1097/SLA.0000000000001863; citation_id=CR27">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Radiation field design in the ACOSOG Z0011 (Alliance) Trial; citation_author=R Jagsi, M Chadha, J Moni, K Ballman, F Laurie, TA Buchholz; citation_volume=32; citation_publication_date=2014; citation_pages=3600-6; citation_doi=10.1200/JCO.2014.56.5838; citation_id=CR28">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study; citation_author=M Nitsche, N Temme, M Förster, M Reible, RM Hermann; citation_volume=190; citation_publication_date=2014; citation_pages=715-21; citation_doi=10.1007/s00066-014-0681-6; citation_id=CR29">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=How nescience may obscure evidence; citation_author=ML Sautter-Bihl, F Sedlmayer, W Budach, J Dunst, P Feyer, R Fietkau; citation_volume=190; citation_publication_date=2014; citation_pages=861-3; citation_doi=10.1007/s00066-014-0755-5; citation_id=CR30">
<meta name=citation_reference content="citation_journal_title=Lancet Oncol; citation_title=Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial; citation_author=M Donker, G Tienhoven, ME Straver, P Meijnen, CJH Velde, RE Mansel; citation_volume=15; citation_publication_date=2014; citation_pages=1303-10; citation_doi=10.1016/S1470-2045(14)70460-7; citation_id=CR31">
<meta name=citation_reference content="citation_journal_title=Breast Care; citation_title=Radiotherapy of the Lymphatic Pathways in Early Breast Cancer; citation_author=M-L Sautter-Bihl, F Sedlmayer; citation_volume=10; citation_publication_date=2015; citation_pages=254-8; citation_doi=10.1159/000438662; citation_id=CR32">
<meta name=citation_reference content="citation_journal_title=Radiat Oncol; citation_title=Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials; citation_author=W Budach, K Kammers, E Boelke, C Matuschek; citation_volume=8; citation_publication_date=2013; citation_pages=267; citation_doi=10.1186/1748-717X-8-267; citation_id=CR33">
<meta name=citation_reference content="citation_journal_title=Radiat Oncol; citation_title=Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta- analysis of randomized trials- an update; citation_author=W Budach, E Bölke, K Kammers, PA Gerber, C Nestle-Krämling, C Matuschek; citation_volume=10; citation_publication_date=2015; citation_pages=1-7; citation_doi=10.1186/s13014-015-0568-4; citation_id=CR34">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer; citation_author=LBJ Thorsen, BV Offersen, H Danø, M Berg, I Jensen, AN Pedersen; citation_volume=34; citation_publication_date=2016; citation_pages=314-20; citation_doi=10.1200/JCO.2015.63.6456; citation_id=CR35">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy; citation_author=C Hennequin, N Bossard, S Servagi-Vernat, P Maingon, J-B Dubois, J Datchary; citation_volume=86; citation_publication_date=2013; citation_pages=860-6; citation_doi=10.1016/j.ijrobp.2013.03.021; citation_id=CR36">
<meta name=citation_reference content="citation_journal_title=JNCI Monographs; citation_title=Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast; citation_author=; citation_volume=2010; citation_publication_date=2010; citation_pages=162-77; citation_doi=10.1093/jncimonographs/lgq039; citation_id=CR37">
<meta name=citation_reference content="citation_journal_title=JAMA Oncol; citation_title=Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ; citation_author=SA Narod, J Iqbal, V Giannakeas, V Sopik, P Sun; citation_volume=1; citation_publication_date=2015; citation_pages=888-9; citation_doi=10.1001/jamaoncol.2015.2510; citation_id=CR38">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast; citation_author=GL Smith, BD Smith, BG Haffty; citation_volume=65; citation_publication_date=2006; citation_pages=1397-403; citation_doi=10.1016/j.ijrobp.2006.03.009; citation_id=CR39">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study; citation_author=Y Sagara, RA Freedman, I Vaz-Luis, MA Mallory, SM Wong, F Aydogan; citation_volume=34; citation_publication_date=2016; citation_pages=1190-6; citation_doi=10.1200/JCO.2015.65.1869; citation_id=CR40">
<meta name=citation_reference content="citation_journal_title=Ann Surg Oncol; citation_title=Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years; citation_author=P Subhedar, C Olcese, S Patil, M Morrow, KJ Zee; citation_volume=22; citation_publication_date=2015; citation_pages=3273-81; citation_doi=10.1245/s10434-015-4740-8; citation_id=CR41">
<meta name=citation_reference content="citation_journal_title=Breast Care; citation_title=Radiotherapy of Ductal Carcinoma In Situ; citation_author=D Krug, R Souchon; citation_volume=10; citation_publication_date=2015; citation_pages=259-64; citation_doi=10.1159/000437452; citation_id=CR42">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study; citation_author=LJ Solin, R Gray, LL Hughes, WC Wood, MA Lowen, SS Badve; citation_volume=33; citation_publication_date=2015; citation_pages=3938-44; citation_doi=10.1200/JCO.2015.60.8588; citation_id=CR43">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation; citation_author=B McCormick, K Winter, C Hudis, HM Kuerer, E Rakovitch, BL Smith; citation_volume=33; citation_publication_date=2015; citation_pages=709-15; citation_doi=10.1200/JCO.2014.57.9029; citation_id=CR44">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=Adjuvant radiotherapy significantly also reduces local recurrence rate for prognostically favorable DCIS; citation_author=R Pahl, J Dunst; citation_volume=191; citation_publication_date=2015; citation_pages=997-1000; citation_doi=10.1007/s00066-015-0906-3; citation_id=CR45">
<meta name=citation_reference content="citation_journal_title=Eur J Cancer; citation_title=Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study; citation_author=LE Elshof, K Tryfonidis, L Slaets, AE Leeuwen-Stok, VP Skinner, N Dif; citation_volume=51; citation_publication_date=2015; citation_pages=1497-510; citation_doi=10.1016/j.ejca.2015.05.008; citation_id=CR46">
<meta name=citation_reference content="citation_journal_title=Eur J Cancer; citation_title=Addressing overtreatment of screen detected DCIS; the LORIS trial; citation_author=A Francis, J Thomas, L Fallowfield, M Wallis, JMS Bartlett, C Brookes; citation_volume=51; citation_publication_date=2015; citation_pages=2296-303; citation_doi=10.1016/j.ejca.2015.07.017; citation_id=CR47">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Ductal Carcinoma In Situ; citation_author=AL Merrill, L Esserman, MCLINICALDECISIONS Morrow; citation_volume=374; citation_publication_date=2016; citation_pages=390-2; citation_doi=10.1056/NEJMclde1512213; citation_id=CR48">
<meta name=citation_reference content="citation_journal_title=Ann Surg Oncol; citation_title=Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?; citation_author=M Pilewskie, M Stempel, H Rosenfeld, A Eaton, KJ Zee, M Morrow; citation_volume=23; citation_publication_date=2016; citation_pages=3487-93; citation_doi=10.1245/s10434-016-5268-2; citation_id=CR49">
<meta name=citation_reference content="citation_journal_title=Radiother Oncol; citation_title=The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies; citation_author=C Nilsson, A Valachis; citation_volume=114; citation_publication_date=2015; citation_pages=50-5; citation_doi=10.1016/j.radonc.2015.01.001; citation_id=CR50">
<meta name=citation_reference content="citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions; citation_author=MS Moran, S Zhao, S Ma, YM Kirova; citation_volume=96; citation_publication_date=2016; citation_pages=S144; citation_doi=10.1016/j.ijrobp.2016.06.349; citation_id=CR51">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy; citation_author=MN Duma, M Molls, KR Trott; citation_volume=190; citation_publication_date=2014; citation_pages=5-7; citation_doi=10.1007/s00066-013-0465-4; citation_id=CR52">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer; citation_author=SC Darby, M Ewertz, P McGale, AM Bennet, U Blom-Goldman, D Brønnum; citation_volume=368; citation_publication_date=2013; citation_pages=987-98; citation_doi=10.1056/NEJMoa1209825; citation_id=CR53">
<meta name=citation_reference content="citation_journal_title=Strahlenther Onkol; citation_title=Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients; citation_author=R Hepp, M Ammerpohl, C Morgenstern, L Nielinger, P Erichsen, A Abdallah; citation_volume=191; citation_publication_date=2015; citation_pages=710-6; citation_doi=10.1007/s00066-015-0838-y; citation_id=CR54">
<meta name=citation_reference content="citation_journal_title=Radiother Oncol; citation_title=Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients; citation_author=T Grantzau, J Overgaard; citation_volume=114; citation_publication_date=2015; citation_pages=56-65; citation_doi=10.1016/j.radonc.2014.10.004; citation_id=CR55">
<meta name=citation_reference content="citation_journal_title=J Clin Oncol; citation_title=Improvement in breast cancer outcomes over time: are older women missing out?; citation_author=BD Smith, J Jiang, SS McLaughlin, A Hurria, GL Smith, SH Giordano; citation_volume=29; citation_publication_date=2011; citation_pages=4647-53; citation_doi=10.1200/JCO.2011.35.8408; citation_id=CR56">
<meta name=citation_author content="Krug, David">
<meta name=citation_author_institution content="Department of Radiation Oncology, University Hospital Heidelberg and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany">
<meta name=citation_author content="Baumann, René">
<meta name=citation_author_institution content="University Hospital Schleswig-Holstein, Kiel, Germany">
<meta name=citation_author content="Budach, Wilfried">
<meta name=citation_author_institution content="Heinrich-Heine-University, Duesseldorf, Germany">
<meta name=citation_author content="Dunst, Jürgen">
<meta name=citation_author_institution content="University Hospital Schleswig-Holstein, Kiel, Germany">
<meta name=citation_author content="Feyer, Petra">
<meta name=citation_author_institution content="Vivantes Hospital Neukoelln, Berlin, Germany">
<meta name=citation_author content="Fietkau, Rainer">
<meta name=citation_author_institution content="University Hospital Erlangen, Erlangen, Germany">
<meta name=citation_author content="Haase, Wulf">
<meta name=citation_author_institution content="Formerly St.-Vincentius-Hospital, Karlsruhe, Germany">
<meta name=citation_author content="Harms, Wolfgang">
<meta name=citation_author_institution content="St. Claraspital, Basel, Switzerland">
<meta name=citation_author content="Piroth, Marc D.">
<meta name=citation_author_institution content="HELIOS-Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany">
<meta name=citation_author content="Sautter-Bihl, Marie-Luise">
<meta name=citation_author_institution content="Municipal Hospital, Karlsruhe, Germany">
<meta name=citation_author content="Sedlmayer, Felix">
<meta name=citation_author_institution content="Paracelsus Medical University Hospital, Salzburg, Austria">
<meta name=citation_author content="Souchon, Rainer">
<meta name=citation_author_institution content="Formerly University Hospital Tuebingen, Tuebingen, Germany">
<meta name=citation_author content="Wenz, Frederik">
<meta name=citation_author_institution content="University Hospital Mannheim, Mannheim, Germany">
<meta name=citation_author content="Sauer, Rolf">
<meta name=citation_author_institution content="University Hospital Erlangen, Erlangen, Germany">
<meta name=format-detection content="telephone=no">
<meta name=msapplication-config content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name=msapplication-TileColor content=#1b3051>
<meta name=msapplication-TileImage content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name=theme-color content=#1b3051>
<style media=screen>.u-h3{font-weight:700}.u-h3{font-size:1.25rem}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0;line-height:1.5}main{display:block}h1{font-size:2em;margin:.67em 0}a{background-color:transparent}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-.5em}img{border:0;max-width:100%;height:auto;vertical-align:middle}button{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}[type=button],button{-webkit-appearance:button}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}template{display:none}button{cursor:pointer}.c-article-author-affiliation__list,.c-article-author-institutional-author,.c-article-references{list-style:none;padding:0}.js .u-js-hide:first-child+*,.u-hide:first-child+*{-webkit-margin-before:0;margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:1024px){.js .u-js-hide-at-lg:first-child+*,.u-hide-at-lg:first-child+*{-webkit-margin-before:0;margin-block-start:0}}.u-float-left{float:left}.u-list-style-bullet{list-style-type:disc}.u-list-reset{list-style:none;margin:0;padding:0}.u-sans-serif{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.u-text-right{text-align:right}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0;line-height:1.5;font-size:.813rem}main{display:block}h1{margin:.67em 0;font-size:1.875rem}a{background-color:transparent;color:#069}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-.5em}img{border:0;max-width:100%;height:auto;vertical-align:middle}button{font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}[type=button],button{-webkit-appearance:button}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}template{display:none}button{cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;border-radius:0}*{margin:0}h2{font-size:1.5rem}h3{font-size:1.0625rem}h4{font-size:.875rem}</style>
<style>@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){button{line-height:inherit}html{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,p{margin:0;padding:0}body{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.61803;padding:16px 0}.c-navbar--with-submit-button{padding-bottom:24px}@media only screen and (min-width:540px){.c-navbar--with-submit-button{padding-bottom:16px}}.c-navbar__container{display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{display:flex;flex:0 1 auto}.c-navbar__nav{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;list-style:none;margin:0;padding:0}.c-navbar__item{flex:0 0 auto}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}.c-skip-link:link{color:#004b83}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{text-decoration:none}.c-header__link{color:#fff}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-title{color:#1b3051;display:flex;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-logo{display:block}html.webfonts-loaded .u-h3{font-family:Europa,Trebuchet MS}.u-button{align-items:center;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary svg,.u-button--tertiary svg{fill:currentcolor}.u-button--primary,.u-button--tertiary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--tertiary{font-weight:400}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3{line-height:1.4}.u-h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.u-vh-full{min-height:100vh}.u-hide:first-child+*{margin-block-start:0}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}.u-hide-at-lt-lg:first-child+*{margin-block-start:0}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-button--tertiary{font-size:.875rem;padding:8px 16px}@media only screen and (max-width:539px){.u-button--alt-colour-on-mobile{background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;color:#004b83}}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem .5rem}}@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){button{line-height:inherit}html{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,p{margin:0;padding:0}body{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}p{overflow-wrap:break-word;word-break:break-word}.u-h3{font-size:1.5rem}.u-h3{font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}}.c-article-author-list__button svg{margin:1px 4px 0 0}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;margin-top:0;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:24px 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-article-associated-content__container a{text-decoration:underline}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label{display:block}.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}}</style>
<style media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">@-webkit-keyframes slide-from-bottom{0%{max-height:0}to{max-height:200px}}@keyframes slide-from-bottom{0%{max-height:0}to{max-height:200px}}button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;font-size:100%;box-sizing:border-box;color:#333;line-height:1.6180339888;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased}*,:after,:before{box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff}body,figure{margin:0}button,div,dl,dt,p{margin:0;padding:0}body,dd{padding:0}abbr[title]{text-decoration:none}a{color:#004b83;text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a.visited,a:visited{color:#8e2555}a.hover,a:hover{color:#0061a9}a.active,a:active{color:#003b84;text-decoration:none}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2{font-style:normal;font-weight:700;color:#1b3051}h1{font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h2{font-size:26px;margin-bottom:.5em}h2,h3,h4{line-height:1.4}h3{font-size:18px;color:#1b3051;font-style:normal;margin-bottom:.7em}h3 a:hover{color:#004b83}h3 a:visited{color:#8e2555}h3 a:hover{text-decoration:underline}h3 a:active{color:#0061a9;text-decoration:none}h4{font-weight:700}h4{font-size:18px;color:#1b3051;font-style:italic;margin-bottom:.7em}ol:not([class]),ul:not([class]){padding-left:.9em}dd{margin:0}@font-face{font-family:"Europa";font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,d09GMgABAAAAAHfYABEAAAABgDgAAHd3AAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGhAbuR4cCgZgAI0OCIEYCZoWEQgKhMYgg9VEATYCJAOPIAuHUgAEIAWhMAeaUQyBI1vdQnEEPe2WAPG7bQALVt180uY1bJtJ87sdU16e81EBOzYa6A5C7j0tSNn///8LkoqMmXaYtGwiwFBV1f//fUoIkDlm1FFoCQVICLUxcEzITBROs0ksOU5YhTbPsdEGKyaZ6Mp9PKPWi3eVnC0inIhbONEG2O5L8GHyEOVxlbmb58HFOY2wC3LEcrJURzlC4BoMVMsXqtmu78zdtOLVn+iqvPUnupUTJqwsLWlGZJ8fbkUdopqNT+9Tm1M9jaZ5I2hHfy5/fbWX80m309Ahu8uhKx6nbxs9KWcN28Ek+VNE2ks3WpbCfHJzhPevbGqvzTIJ2l8oB7+V3q7yBB7mw/79e8HBtuIVNmXsFnMh9di+P89v7s+99/Heg9Fj4cTJikVaG9JDRJy478fIXKWR9SNiUWXPqBm1MoHneZ2+5z6Q2LYMpDgoEwYAnD8V31Zatm4dyz//7Pf/m2uf+8UkiiWD5NK8kTx7SJRCSOYVGoPs9YVC5QzQ3ErnJGrAGKvbLYtYsLGxSMaAY5RkSqhgICmi/QIiWIWYMYzEAkTfCqzAwPg33VAYIOCs9ym0YLJcf4IhjEJZft628o0rI4b4YLIDLB+x40S1TFMkXXWatKHn2/X6zQQSW8YHBke28P+p9ktFR0hqrnjkHbkjm6RNkP2XJBHl/bGClqJ2Vx2ZbKVNi6b2pKm4yvRMBq4CAGcivc1rIuWtaBSCALi0pZJOZ8/sPthNHaCKuLJZKx38+57vYdIaKEnrbwPUAVMFeAHCChIg4J+Q5cyxf0S3sUKft7k+iAg2lEAIoZrSyCjT6s5mSz/u4XT6z88fl23/t0edwGjNEKOhVKbcSkgcolaqVGbdiy6QH+LSirep0RdFFr0Xw19ck0rr+L1O6575HoQ05MFIIjhkbO+y7OVQXtGlomm2IyAA4se/PfVOq6pe6P4ga2wNCGODcQzYkwOoJ6UT+52+2NOe9jwZ/jO17d4RUl6NL8yrUc+Xe2IY26AeipqKrkNFW0aSKfcEBdr6LU+LI2DimqD8VlF3mZvAhCL31dRvpw1jT+cYm8l1Zee0+xwp1waRkASHIlgQtKq0/9BgW7tcgCYqLy77+XMX8Nz/7FM99B2iFsbkdUN0tmnriNSVYYSguT2yEOr48MIwW8qFEiY6tPr/u1l/39nu3fM7CCTZdfAxw8csOhCa4netWTVmjhCAObUntJ0UCJUO+YUa2NwoSaIFDv4om27TNK9wIO+0fN/cdJl7KlYwV4J8snAzvKnra99oDNjwg9kUCeefYtGY+GPuLqTySr33ZkbzZkaSR8H2SLZBEgYnwJIMRpbZnWQsydpdYJPxRrMhJQUva9nsX8veBD9tTr8HLrEXYmoq9qofUnnllVfUV6VQlNURVatmJwO1EiFHIk9IFNJeNG9p1MUqJIFauY7H4izhR568OIVyYHFYi3bsN/dlj7ru1Em18Pyek5Ok7Yf2CDHTSdP5f2f7DxCFAlQopFuC75/79PiA5FKeYWIBCfmfbJ2uu+64+7Z6TwUKXi9WoYIV5PYimSyQyuvnPu3NjT99wtbJ1uiOBwxP8l+6B5n8EjgA+Pxgsxv6JVYAoIh8haxQVbJTP3/l9KRCVqg6jCZYNUzPl8nqzfTQzYdbcf+9Ts/hTLOKICQK5dASid//9fOdO/0JEpxUt7V59KUSWG6PhzewBAPpT1+FeMD1Oh5fi2MRQuieeuzJ7bd9lfvsOZK7h6HpOZDGFdOIFJWKGCmM6eT+200gVZjl2u0B7aQwAQ3+pv1CbdZuJ9p2K54QIQpRZPc+9fLnepaiZ8kDW4mNktA0NDtWJDDvK4dMraKkO5G50v+98ZomWjUIqc9AR0AA+EY/BvbEeDyFQQ89YpsELAoAOFZnZ/TG6xvWABvWjNGEtZWFyOZ8xKHDWsREB3T06CoUZ1tDRDKKMckcy2yQiqBY6oTYFjedEJ0iYndXlrJ3EQQnIJ8kdH8CX+pbTsi6y/aCvTJTszF7czFS74xPIs9/4QER5LDChnIsghEn8OMO+hPTLdeD62X2FutteVzY/57Xru0Vv5/HYnIYzFgmcipnsptW3pB4h49E89/+yyDxZBGkZGUoTyWq1Ey1yKoLJfXcrMDb4ba53LO8wBves9fX/Vp4q0vpeS87o5ua3hO196redrZroqaikKKACGJOXuqzkaME05nes+z9iec1L7OwmRSRKCVmFiWmapdLmiSdO0Zu08XNwMzSbGrvml7MXK+vu4GyNjZD4owkcZOkxpY+wM0JmCG8Y6obJrxRwhsIq6qOqpjukalUXFYkEpJLz7AnO3jFmBtPp0vATWwchDHTWXRZA7s5+3OYXF1eVz5TMFKoSLESpcqUq1CpSrUaterUa9CoSbMWrdq063A117mp0x1dnnrupde69epv76Yiqahp6RmZmFmK15L0riOGSSNO96JSnEgNMmQ/k+e8oKQoCYp7cS6uxbG4FafiUhyerV1SPZElFCktbQOv1B3hWMxKYouzM9PDOBFJdiONW2Y4ZF0pI6EKsQUSjHPYDEJCcBFUYzM/K2Kj2J8/NxlMkzULNwdJlJNMk8YoU3K6da5fHsmXAgpTJMUjJUqVKVehUpVqNWrVqdegUZNmLVq1adfxeIW7xg233E5Xl6c899Jr3Xr1e9ffcx+bYwp1rkPlREBEwpkLNx7rEeVFlopqVEZS09DS0TMwimYyitlollj1mCKb2D6n2eZZYJEllllhlTXWJbFLqpZ+jy2c3woJYkYSQiItE/uYUguEzoiNkbSxszmT2E0XhuoxAtW/IBVkgGy4fvoX3Q890ynfkundq5hiUk8JlypDdhW/z62t935GeCPlTJeSLIJpdCR5KnHy+UyS5E7CA+I4YXgCcWIBZoqFYi3VnTKnJU0yS89V8hQoVKxEmXKVqtSoVa9Bk2at2nS46rqbOt3R5annXnqtW6/+9m4qkoqalp6RiZmlaK+pUoxYOKGrpic4P0ByHioriKBDDHKMNDlCflGkVIVqdRq1tPYzTS013cy+vlobW9wD1H397qFZwBhgBTHADiaBKaQ5IA8KoQTKoQpqoQGaoQ2uwnW4CZ1wB7rgKTyHl/AauqEX+uEdikRFTUvPyMTMwtonVGY3qSj9wYRHwm65GRgZ43i6rBmoqXVnCPrW/TU2UGpjMySujXwYVUH2+M45e5yTH4t3iihRqlyFKtVq1WnQqFmLNu3JmjKSpYT6lujOSDkmtX5qf6KJdV/sKmxykwpnQX9b0OoLLEHvOyYdpfMwqfWLnaLOTB2Cbq5ih9LWZ8wFlezGHT3duAgvsQ1gneWYCqENBk3/iacfVOz/FC22LPB28e+Bb3LrjnEhnje2QBuOjtmqMYyvOz6WnX0HDgXx43nl2TcX06RKJ7xa3o3l9WJ35mfgcDAlxBCxX6Sr/7PtgB2XWm6ueI6DMP5anFEvKs672xevMISHY5Mmnvr/7bw+6z9/PbGeRt9LpPe+wvnqd77GYAd1VNVC9D7oO4HFKKRIlS5Dluy6WgE98QJPqiChwg03gspIaho6BkYmo4xmYTVWLLuJJptiqulmmGWOBEnxSFqiMv+93SFHnnyFipQoVa5ClWq16jRo1KxFm6uuu6nTHfc91OWp5156rVuvfu8iKMThAZBEoYWEhonEEmm4TB6hiDaNMo+2WGNssRPsk6ZMnT5z/YaNm+LiExJTUtPSMxC4Bkg4Z+ZQr6bjOnKOfEVKVahWp1ELwenpy7lCZTrqMo416TKcflp16kmi6aqTbFc34/Cjw/toZuHmJwv2V3fIladAoWIlypSrVKVGrXoNmjRr1aZDohvkGRx+G5kqddr0GYtMLcB05cf9emo1zWwWzE9oBhkONmKaPDVA1CA6KEY4TNBGwbgP8rCFGlRwikLydo0vi5IlgGWEgooqqJEFpSkoXUEZCiq6oEYV1OiCmlqopltmsqxXOG20xLEkKHQpljSWDIUpq3ECErTJbQ8AGSd4HmzhHxAAFAAWAA+AE9MjNss3/6KFBABEADgAaABc+HwGizt9jPDO15i3OWEeZWGCK8NbxLgmL/eE/hC+oFPYLWhjMCqDO6JNcHYpNAbzwBxjI1gymBViLJRYOOzQJsOYAWsWXHNAdkDJAykEKQEpB6kCqQVpAGkGaQO5CnYd7CZYJ9gdsC6IpxDPIV5CvIbohuiF6Id4N0MUaBknHUWiU0XXqFm0LHoWI4uJxcxiYbGyxChMNkssywaFbZMlniVR4ZZqSddYhfUq0HUQc0SEHActXowpEQtYtii5EUGUAoh4UYohEkYpgwgZpRIiZ5QaiKhR6iHSRmmCCBylFSJzlA6I2NDiiCOOOOKIFi1atGjRokXP0kaMGDFixIgRI0bMFtOEWNjsrpnEMoVlqlVIfYVmkfzCwo9xrX5PxrkDONjZNYkAxs2X0GuUc/kM8RRvEQDgAvj5Oeh83zwok5+cGgtG8H7jLHQoA/JvMgCHAQD6bXIAKD5UImcvPpqwVY5A9o1H1w/A1afyphRAdPq55/05F4WVYqNNvvcLMWcCq7lxN4CHgeQG8TSY4vkLlfjHn/7FRQsSLESoMOEiDDHUsK5hUaSofolok6g/itHH/OutscEPZI4w91DimONoMcaxGS/WZyb4vKeyTzqK045kZso3W5y14klBH7I9tzwpLF0LFchVrFKZGp2e6uoLsuaGuEiARCg8VW+6Ov1zZF5pZZXjJz+aZ76lttjuoOWWWeGwQ/7SnsE3fvWf/y1wyRe+8qXLvrXSKhd1FO4XHr7zvrbY3wCSJBPBcpSmaUx6Llx9nsR95QP9u++aVW1nLZQg0U57/WyzNJk4ijyT74XH8RAfCRHbR92vAN1qbpmlNh6OOuOc40446ZSzTjuG2iQD2CYTnf+9BAhnNA9AOscwo6l87biliRmHZO/U59TvdNfpgXO781bnk7gm3BjgBwQBOAAEKAAPkABqoByYBswFthMCCCABIqQR2gj7CAdAJ9AL9AWDQBzIBPVgBphLvkTxpeSaSOX89/ufoH77sPFl/Lee3up7+dcBAChEiDbfhWBIiKTJC2hoYzJX0DQKFeenAw+ne/nqcZ8BBBAIYADggRbvOxmof30cIYWwpLIPlTPFm/46I/5b5k+H/j8dRvnvcKGm6346Hm/K7uQf7W/A76HfJ36f/O3+678Pd598ejL7sdNDlkevH914LB+pHwnNHXmPDj0+8kj/dkyPiY85zfvhpZvHAG5+cnPXzfSHax9O8TLvdhb8hdG7Lfl4PpAr1FZhgC0uKQrQvUMB4INFujhcML42NuMVxg+MdozOlfeOdkzWcbuPceNLJ1Ed/+/xGvdj/Ap95yUWWGepQ5lXSnK+p5Y758fwRvW01eHC2212qi1WSebNT0BPs2kZut0tjz3xzIvYOjsd3C3sreyPJM6uuLub3bRmOyhXgWJlKtXo0LnhCDYBOamKDPeSbbsh+73zpZWhLdmbXkuz1KnX6P/wF6FWV1x1zXW33XHDTW9069GrT7+33nmlmCqYF6jEFUk4dP3Ah9cwRkmbN2bjVv7f/3FgCBShNmKa7ry4QJL4yc+28OHPiy+lwDXVUnOtvvKbPQ50rrLKq6iyqqqrqba6/steX8c63olOVlhRxXYo1lnaZZ+RTMogtqjpA/jX6oDj9L71v44r1u5J/mp1LQQX8jmJ1w2HIsO6ag6Pz5m+WhX/Bm3rzd9Y9yGpgHtpnqVn/5CvnuHdfEic7FN7Kgca7j2irP8fpPw86nZt7bwHHsHGZiNYUokBDJI4COBoT/x/iak+jKM8p/nuHK9OHsLy6mPy5t3w8ISbl9MR6MmJ6bVt+pRVAwP9HqPIWoro3rjoBoH/iS4k5h88gb9MZUZI3AJ/tYzBuKrkt2IcmOdswM20n3OAQIcogrR+T1DqErZEvBI/QmxGIkBilxSpvWrbKCciK7nkaIpFx3wXPfb0FdRKg8O/v/fanTQGi9hJpXP9KifLPgt0k/IFxxaLe6gABYwmI+BCIvTl9pRoAoqxR7UHSIcEdhxgEJldBO3+M6lV6yAPkYvdZZbdFsvIzCfN4zUv9o1wqEHiEYyEuQEbjBXNh6NGJVhULvDFuZL9fZCAOqDN+hn8dISmMkWL9fDZ0jwCETETGOO5vqS315nP13xAouK9mn+aWUAGLCREPW0Kf7aUmEmvqNuUFB1QECo/iHpPOpwPGSUVDS9PkEu0gMqzN6maz1m+gPRlPwIaz3bSs9c3ZOcfaOMNdSooesuX58hIEyl7hg3KYk2+UmkzsmXqg69LlXPNGIuDalGXq429gTVnyZWh6m5lzyT3gixpJ8scHTmZkd4wFShshgguR0xYTS8Ag40avH6TKJeoOXGJRAUiogrS/M5WN9NSuojDH//VKefvz/vnc8CkgjEJWFTsB7AtOMhZCOBYSOBaKOBZaOBbGBBYWBBauIY6JnIFL4QbYWrA3gZH/0CjYEqz5Ltyc8qg5OdqHbHB8FS4UTEVUQlqJA8hBQgpQkgJQsoQUoGQKoTUIKEUtfjoKGiFF7LQ1C7FqRyDEszM9BdMG1pOaxzoIC2lwKD1t8wZmi8VXM+dXblmky0640rlzXmyYoi5pJ5QDIpCfXSd1iswYAN1ByeNeMcoLwj2L3jt8vt9u1X7eZOxK2WIWi2J/cUEm/5WYERzug2MqwUQ7VYdYULF09ZFNVpCcUg0PRn+3xQrvZJ/KC4jJY5nOW+euBaYAtioVWRjnzHISqjJ/rAoUjugSnFR7FZzUAT5DtYaVry8TAJdpZ/qZPvEzVGq7b0cowlWGoo1L6ctCkZjsa0IzENGFlxlzyDU7xUFlHp3FooV060f25sEWdlCksSQBxYo+44xHGvRVjJ7qZAqPwJQ1n/RrQCRod6IRgD8JnV2UoVnaQ5kIuCleqgKdLL2VmB22w1bxi9AHSLFOee8Q4ywwo3lbmrUmnfvuAcIUcV/2bOrpCeBnZGcoU6zSoK09g8sqHBITlWFTHnALifblktMjQDDF1SUOucvd1ptbmo7b0wCy5KPXbmub9TOdO0LvYKpdxa2hgsf6EKmBRkyl+WBVEPbAxt2kVly6kA6uaqpVWO3EK6+pbITFiutKw3+mliaLOoBsk9yaw5IbRxen+kDuwaYTkRA9leNFxNvR7YXNoapg2QNbtfIOL5RjjcMx4FjXuyJCtjGcUbnwBWYfAfnWLDnpkaLgQZ277qK/spsT2HXGBWOvD8pzQLoU4kycMcsgDkd+YjFAtgigTgwwl1+IrluiTegAV+i1yTAAIR7IUiEBmKJQBIMhDQd9VgydBFyIAgFEEA5HfmpygLUU4lq8EJsKVE33UFXsQsEsQcEsQ8EcQAEcQgEcQSElWMq1k+eOLFkmLuSKcUKs484NhTXOKeSX1oMCPRyEoFVDbaI4trCkDY3BGkL9I7asY9Ke4MgHYAAjjXYY4knC0M63xCkCxCoK/uodDMI0h0I4FGDI5b4tDCk1w1BegOB+rCPSl+DIP2AsNofm/x+LvgL1S1EBn9/uZ9p0nM1LbiZDQj6VUYo70X0c2uZ/F7W/gIY/oDx/7xuM4LJH/9lRQxgHAycRTIhoEEkxolMIp7RWSSrEqnv8RMqGazRrOYiG7hUUzLymwhmqOkc0CKZCjWZxFRcA3K6Ps2sm6Jv4kwkcnEUTZwqU5rBjqG66kIV4CRnRohkglTIr4qnYa7zJhHnxonFTYVDDderHIYsdW0uXfrE9JAkF88EERPhuiWhKu49fmkiad9UuTsJO+c+MJYb0leBxprwjltAMqOhNQtlfw7/07FKBuYrmCUkA8g9jGJsFe7e6+C0qWmTybJG2O+IC3WAcMS48PXYT0iPw02ElMdSBYvIDGnK+p4hhlhbayLnJHqrPBmO1Clz5dkVO9OcC8/g3ODkrbjCgWpytfl2e+XKMQx36nf98HLT2p+FtQcrSah4lwrDeHOlyvJ2pcrYFhYrMm3xCtv8Vd5P4687ZoBImEi2nTwcBcFYu40orVZlsaE2DQXYLwXQaLGsVqFkhD50DnDK4MopIECAQAc60KH9bcd8ypj/KaFkfWHrQIAAmcAq+Jo9llnw2pQYcKaBBnA+HHjgc1nuS0pTh+IQvS7A2JlhOTEJbLALvAXuCwbryLR9b+iezoXcS5TzPZffA9DaCi9YwyDUw/ErowOkEIHSjuEMbgnkJBQPSHER+swA2uYTFA2vDItOd540eXh7gLUhyQiQlSrpsALpWBccdJSWTau1GRAgApaglqNOr5WBRKiUKtAEFP4WE72lSROglSs4OJSzjZdCPchPnmpmz1x3vlurFS9YAULw1wH15QGmR5GMaAMcKBSRAxI5q4IyxRRdntS4oraL1A3x0uWbkuH99tmMRRb2o2/vOZMfr5YhNXaGNCMyphsDJQQiCsJgBPN5Bq7qVgnH99ffGPwpnrOmG6+OqCgMcy7PUlFVDSiCIDEMBMIKjp+HifxNsjNU5gjPo85C4WaxGkxjOG2JKeVI0bb2TX96bvp2HAAb3lC500LCnnGPKd0grOkeXbUQqBrWzHvNnb4S66mqJKkS+AOyeTyiklTfEuF04j2NNXaCGJR9KpL72eySqOwp8rKuLVGDZTXrqwBz2utkXWkMTbOoeoyciRsmVCLbj4ALv/BQwyGdz6N6h0LlABx6BEML0cLRobbAUZbd5X42T6To08N+Fq7qa4T/z8fCvgab8Lre79K9ULVV8A8vHNhE1o8sUldFllUPdHP833j+ykTQ9qzhJbllQBH+AIaDf6ayR6Ub8uRwuE9c2wtuWm2fYf7IOuR/bSI6v8/FSPYY9RAcUDkinZHIa2N7LDFA7TPyRPZLVzWVROsj/OE75iIvZcDA7CbDzCgHqz8KkJiNz8gS3wXZtyc+cD+xIFe+1pin04BBYVKalERxl79v0IdGnk1xH4uq81yiZEImJ3EDp5ley7zgF8tg7mZs+IvXJTGImorlO7WltLS1bIRSuhwmnDTYCRXfVFKB+kF0KMFWXeG4qJXLnoaQm6G8xph1IBqU5iZhgQFoA39LGZ3bgl2W8L4N64ZCa/AnrjIFZq3Zn6mSgobqGcv346bIsW55ZBUFMjQIsbzl/PB3ar1abwhEhN1Ofb6kkB80b0Pq0UpkqRyPGnTgixSTkakN+vjyPLd793XqQRg8vBnBFbCqarfYwHr+NU2/oy5e1rXYl0qrhq7WmDB3orV1je19gwbnyundIrOK9oGjYY5g35oW9hCiPNKiGuDiSoHB6tJjo0Soz5qbdhy9AuTkuZ92CeurCUFuY/g7uABLzfnlsP+CBUFeJcz2qbihvvtkZUk7lQhT2O1H40NzVjd2vBLbIDBcQWXdZllsjMTbFoaR68VuSDWGGD13PkeVUdFhCbj2yePROV3/GK0R3vWftFDBES8sVOQ6Qgd8XJ7mBMGKUkkYR9nF1D/Hi4eo9lB8sjAC2l8sfWRHe4mG9Mc7/1qfFV/KadVdA26vdWbQmEnkXcUK6JgCH73gOA5bYBhmn3yYtUC5h6JfH+BLKbLooLpcyA7DWqVtbjH01B7f3rl6z7S6rO+8MXDUFyEA1Vubop2up16UunYXSidDGWoYnV0D8OvyL8bF9qj/Ak3qFIw5xlQZxfpQgtXMhyLueHw1lERDjzCylm4ZMmqjQSjEQhFKFeAeovc517dSsuN9VYKKfSbVX8Ev8eMpoZt2n0SYE0sUa14YYS2LKAoe2UV74oclnadjjdLepyH5QNTDtXebwxKzNwPzYHVljUvc3lSm7SmIIPvSRQNNTbFNxZnAp05O4DyqtZYS2r+QeKhq9vEABzyORCEJ3gvSsUwGLzP11KL21ZPpKqZpXtqTqiIv4ENL6IDv/XyN4xYhoK8cZxOrMf6hMrsKG3IKUQQCurKVjBR1RGbRb+YOEi6T7XY2IuepeVTx0uAh0tCwE88tAQl1zjZY1HOIkpCZByJ7RmQa7JGFRV5g+QP40FZOpMAcV1ALfS3RsSWEZEPoq/4sTGaX4pISFH5g3dLGWE1wbz3B2QJDjse44+KKWSOuqsHbfqm+jwG38KxfstBLFngaT6ygbxRBMHyZBxDW4ABYkN+uVHcECVueRXGxPPRAU0O9GSglgwRAWoXbsAYhYHsBe4lN9dy7ZA8rYXlQEAVck0lECqcS3VSW2xK1bpPiXItBRaDn0h94l/lGpY7hf7mR+Xefo2WFbIQZlaJc9dDU8Lwm1xeAbE8i1U5SWR5gurklia4UxXB7gU+WgbWWU30A2RBRxFRmPVsgWgwjE2TLTQYpQhGjvVsP2OSvuygPDBoBGDf5rBqNc2TWoLk6bBTiOaLF+bUCRMU3cxdfMcFfjLkIpNkezzd56wkeROJppFZgNG1JiuqWv1DmHxx/EuzpaViHknnyEK3TGQAPhd7pMseZqffeUFzib0fdMQzWl4cEWUqvl0gIyz4XV4ZRG4KVTz/J4RdYfVdI1TvZNFN4oxGOJtpR7GxXMll4SZWlcnPx64fLdT68O8WejXUq4KMHWbLLypPRnVBM5vbtSdzcFJUZRuCTYp4qG1+yCP+Xw1Dc+znTscwxHMH8A4XrvnPzohEMAnDU0HeSSrnnXeAGsN+F16jNh2qJO1viDtUox9WEucz1IHQOdTRuGsetQWulfL/hAT8x74FkN3KqoJRg6qX2qJBtJ8DB/+Be5O1iPeMHjRk0D15aRJYFiqZE+AAV+OYQTnWqC6Db1oJrO1MEXeYi4T6yO0riuHQKPuWoLUmK5Ba7GjKHuGAlbcnrZgUeIhdFWWw1WsNvyIZdjldHkOHgLtPa2z2T2GGhmkhVHtlapXtziXpldHzKU1Z5bYjKL1Mh6cvG6wcP1+FH3GzyKOhOFMozcEGXlDIX4GUbz/Hs9G0mKVZHnInJ+FR040S/D2k1tjYjEJgGhuE6YYosALQOQEgmeiL6a5cXhgOBsD0KbdV0wu9cdaHf8DYLDHNanYqR1PgRUdcXNQNmsTPtxPGES4/ip1ZtFWaQkOAkonAnhygwAyrABghQAPsyk5DhqOKA51jZbrpfSwiHw2HhfLQzAILBIHgQpoRrdtJbioKA2WXA/xnGGAhCb25DKtTgV7PKomUdd7UJrNC4LQoJXR5Y4UVoA6w7xa0aGtlow2iMyJVGGUPoVS1scjsUjWlV1GLajG6nM/7myqu3opsnBKTCL5PChteaH5pJlauwLBSwKywSLu4IKp2C7BiZdvMl2CDBei9M/1Q53wvrN0AjeCL0pQ9e5Dhn/1wdVB7fV4/aUwtxtepxXmMHIMzfoNJflgKaS/YlmgBfVOujAOT6IcugqwWupIyjMI03jcaQoyEzhJ7Ooscww9m+QxVm25tB0Ti+TfRHfHE2FCpe6y1IH7CtQxF2SxeFureSA2y5zqQ/nRczfuI0d+SAWnRtnlYLTKAXkpkfjJY8up/PInbjigLnz5q2sZVlzkDdZVmMfoXZGf+lyVmIazvmqMxAJw3Ryl8YhsobYYuX8RaFeQopt/1OTOEwQoqUvWhQMoUIEYgYmN0hJQXwRK3S9OZxweCNWhTPxsZRA+PIEIa+Jh2+AsFgAHPkq5vFRLBNMhu3pJDwtCXO0FyF6PORn3z1zdgFijW2tBiOtg2GUfDp2GDGMoF1aIyNr5hkvpRk3nwhwu1+iv0ecHSfKMZFUOPWXemdA7VIopFg7Oaq9pHUvs57RzgXltA1y49wMIFqSY24oCNjH9ScQ8RKnX9LoiKJgY/JsAH84ZTheHGtKKBZJJhDkdMIFFn41B3cBc8BZ1sb82Fy4D6SczIn3MvRgvwvyE0jI3PM2TzLslvgi/3U9SYi0zl5MYF0np6fbSP0pycBSyIzVkeTNaSMNYUs/7RrS+KmpnZXw4Oy39APWNxj7YMMz+d49qq1ZPpH73aKGI8PGbZPE1Rz2YtoFgLt6spGbc0PZuypbpu1y17cA9CuNhfgWLaO+KYn0RFb1kZH8SC3VCGuU42UxBDVlBfy32ZyroqcaiV0i1DVFiS5lHPmpJepVg0LZVDqjSFYTGYAfEM1RmHa6XXrCoMWGa6iashyoVEj87gXeGWMKQ+y85HgO02PSY2XXwRVFnj8jYzgoXSNchFRabLj8ABfzgRQEFrOn3uHYW9ZVODoKKtTPdW40GrYohfdaa6aLSUPLbfc0nWG9IwKZIWJcicMeOoygbGMN2HfhXJVq4WrcU2u4dHYrCVtTaLVVosxxtWh7RdimRbBJx2iZI19Nm9JQya25g2L1vpZz3we1hKo04CHadxCY/HNFmRfUID5gaNO1qgoCKcAfbGA7RGGzA7VfONVh/tM7RmurNEym+JjZpGh4UqhtPmqkOa6l6bJj8Y4CqYg8fiuZRw/FY2YcJ/4qeQoumgSnN42xW+alRBtwH6EqexTMR8aXr/wRN9Ua20c2W1vBqrExQtsdq6wqrpU1I2aTyPN8gHz9IcsM/P7/OmrD+lZcuVEduWzCnZJ2It8hmFXelrVmPbzJAtuNTZ454BoFu/stR49q4zVgzVGK1GwvlZTuKav7dNKaUM1UtodAFJFuNOOvoU98pBsdch8/RbjNy3YRnEe03rJLZEmnff2DHaEDNTH1RKCvw2OOp0Bo7QcEitauZxaTbUe9k9ruDMJz39+FwIGdaa7kNBz0xCjpGws4d8mZG7xdWQ5BSGuR/fmSkNebskS7qzx0nH8OPdSXFhjEguSeFVDK93QlUx3aSsXs6BW79ofmftsHxzQhlxfmfr/OYPI4v5cH2dez+IF2LHMLIe/zRqZc5dKeDSyhd4xcCE8eV2YFFNWm/lKql2q/AswokMR8zNe42ZNCYs8bMy7DA0QeuJgXsmV7vmASYmTLHPaCHmV8TLwHn0yZNgIyaaHqgWZNNG9vKHP4sbFFxkVg+5IT0gJn7VG3naMr+SvhAFSzZ6EJC2CZ10ap9Ci8v5WbcUSjJQqJBLsVEsjFP6UqvHCXxDOBgWCRTWl27Lx/Elh2V/8L2oPb2On4F28YjHfV7xw6bL+tiVbT7nn9pXT7gbg4KkUqNnNGF+rl91ioWZx7vSKs6ZNs0B55tRJs6fDv8mEzI6VLK/A2taEbm7WB2vsxFJsfhTt+iUPb9OsgAu3GHKDa7kTlSAH6rTiK7szBcpLtOyK05LvZsR7FCrbm2c4IKhLvSk8BS1qVRWIaZVpRXgnsFUo40bmZwxMb54WSv1Wb4EmCC0QTmT4lfnp0s1XgK47YhiIatzAKImDNM2yKCKgyM2/xcil47AsRgw4bsAzCA0uEbJEMOZCnpJY/JdRDJNQ0XYjZCXaWEQVkzsfhK0kTiLqPLBmywjwDVEip61ZyMQVU8K0pOdB1sFlUoV+I8gMwt1RFEgjiZkjbi4N1RLBfzdEvqDTOKBgAtt3nwXzwhuARzZry55CjEG5rRCj+AWCI5jTdt8PfoYaWvPSKEu4x8L6YWcQzEtFg1ykBL8YjRUrERXNpTRx0Iub8pLipZ1Ao+hkJ8ycJh/7dJgmY/t0HGal41JLwQVLRwyQWS0MAr+HIkNaehU23YVAZgIDcOLAjShfjFAcZ66hBccc6t6XsZfKb9+CWH3oKSBVHVMkTFtoQX7WBUR+a94gfCY3+ci8c6oUtNUo9v7UOp491oNOnWyB2eI0P8KY5bi5I/VYeZOULKqDXkUXEIT7w0+dwDGlaV8rJKWa/bmQ2WflH37HSQojnss2gk18dAYs/3pZlL5p+SZV/z/+GCg87B8mgAwnrTTzNpRSaTJBfQmesvq4z5nmPFmY00mnXCRH+QPPjGNMcReXQ6xt5RuVgzo7cIJT1PM0IJ6WRln4/5e7sV/oDV3VT0/Rmo4CMGNYF8WXo15gWQnN//DCHJ6DFvjVgidNC//JwggveKXEfe2MZ7SvRSfRbuG/WBgkrHJ97SGZ7T02vsBvvjGU5P6Pt4kr51LMpYtK5zrXXj/7/r6/FW55Aa+YS7pTp01Eiud3qmZ6I5nuOl2m6c26tX2SflJOxHNcBfLZDi1r0nRmct1kpyxuh83qFiwMkjJhknZi0qkIGsnfJGYLf+Mijmkt/HV/flLr1K77LuN5dtwywn5TCGZcrnnZhu6ThBJJq5DP+GFR6UJ4Ygh7kqlewsDKaPqrQAE1UJl0zSJ/WOwoFbrCUncx7PSTgfFjUPCtyPPNDrjSIr6uKyh0BpwXLpENr6p0Gll/E4T/Vh+HK/yj6v5i/yPoNFc1dqrF36Cf+UETbEB//7OnfELRPAY8flT7m743k7sru90uqtCklO2psf93FgOs37+DQebX9GhDqA+BQUBPpPgcUW+550twdeQLJO7uEg/3aUbb+3r8gwvYf1txD27PYaoV9X6LaxQNwLsL+KetAW7D1XaIxdXrFrdyj1qVrKHtl84PzuzrVD9QKB6oOwFg9psx4+/Px+j0Y8eYjGODNNrgMUbpKhvuZCa991BtX63rKcOJUrXhw5YngcLMIImxKczHJ6zJaKwqH5/Lc8toqA358IhXq6uNV4spi33U1Wfm4QNHgHYxOo3Hi8FRE14P4MJeZlKYREbnWdP9qThjTJSqA9nmhw8Zy5ZS83W2PIZMVsLu6mKXbGuzYu2/ucjSdZTW6r8PsnAFbjAP0ncseJqQ6fVNrxb6IJ1Iiz43N6nNY3Siz6TnyxmTCqeVcZSqKp7dzp0cqawqe1+/HKosM31Jq+//UsHL6rL8DevXTytlVheyfyuwuuzP598AuEff3yVqNhbm8rHT4sFoeiQ635aPRXacOTO6dOeqV6Xh4oRZq4fv9sR7Wk4ssPl6P7T3Uum9NeDS5xmMMye3gVpx4sgjX/6FvDBLRhje61SgYh/pmI6AjzYzW2QMA+bIEatMm/6tfJHOFyGxSDDK1NTty3657VjP33HGEYn0SeB9bgc3LnceVnjHJ5QXn69cjxjSEf6XTmmRUynbenEA+K1cbcdfo/+djObu3w+Nhzw2EYfwp+c66HAl4Ij0WGQWwotVPhru90eEH8ISUxsb4MvtHCdDQGdn0AUpJlT8K20gTEXHQ1JvGRMKETbp3ULQ1y35wy1PsnlHxFTc7+v7Eji0n3HTg5y6Qy4C0G5Wt0B6x1rrWgDzxfolEPPK+iqwoD9D/OUqtkGvr6qrX/4yKBSZkrGruEadjqqrY4xJwZyt5BrJpimhvjkUg5LLSmAlHWpzQ0L+/8cSyk62sYbtpj7IMrvIC03XLGYQunDBX8hyTQdygS7o3vq9glcSbjTObscamZK3F5aCR77DLT2UZhT6rzl0RK3TVh3+a1guJGGYMZcu43V07drg4gqc4m8Yl2D68SYWzZuktgy/NxC49ac4yhZvGSrcoDQSovwjShdKZWV248EES8Lh2MO5OVGht0PYnpP0Cvd4LGdSpPEDWk9ZUH6KpZpzz2C6u0wt1VF2fl+0xhJ9MiVlYxAzGnNfpagIe3iIss7qWajQDGFj2Gxs7NBIPCUkpD8Hh4dwMSysr/JdQt2tm+E0VUhyaJKK2SzM8yPpcPgwkn8BQbmIFIbH6fxIeYCJbb9WNaAlhyZZAkv6581FqYhMhpXkGjJRysSbrzyIAfj8+NIeXMGbmdKQia4khpUJBqnmzUvkMUcduFyH53z+ZFvDk6b5clFo0LdQLi/0BdEoru80mTpifIfzsGtIPClIHa0sFi52aDiI4xwZwsayhEduD0XTNWWHVcwmQT7JTxO4WQuVhATyk6oh+SUQaDPv7Lh9dxBv5y0TGYsS4P9sRHz47o+ZId5+nRAszJFI1ZEhhOvbxTMw/t8/IMLQO+JQqDgMZvRu4ImtePxWItGd2kllskvTzF6Bc6h2Uaoo9fq1kI3lG2I9eSq2/MwCaDO2l91Eu5VQRFoFn2a/cvOncyMQVMwtk6jr/Oa/uPHENYg0gtdZAoN9yIOEGOITNKPI0YnRt+9wph3Pnxz8YHSt+Xtsp2Z5KHLj/u5eNEBLpAIXdpDuStOEMqNODkSuMs+y/NcWKwtvNkqEaa/2Irua8ZSpPVQmlkpZJr34/L/gk+ldTz65ohzEW1SzPIM0rWbe8TGcD8kJ+nR2JEkdMXj0Gtm7kQ1HEnqvqvTbP1vI+yi31vzYaR2ofXeYGVKC7BZve6K+j5P3UfIp94/VoeQY++HiKblJMvHI5pfe+WFz/jgKJ964UXDv3MLwSKlQWPc6vPJhi0yX7S0M9o7Vz/koUpBnqpEsviiVRQ0g5YpEURVAvYxNFK1hn5o5d00y8ElurAsduSpoNpmoujrCGI258SHkQWqQPbpB+PA4p85s5sw6/iiGib7Yd6ZYnkXzdwYyxWKqnP0Zg7wcw960iGalfdBau/varQr6+zYQrcQIqG++NYy4tM6Jd9FAknE0xlmhnx4L6Vt77eNPsxhTZQxfW3i0VRNo4onSWFQkOUckoigkNY0lir29NfrIrhAXO9QHRaRHjILsdEI6VoUQss2OSfHVGYbhg8yzU88XYxXfVvOATZVB+mJqvD63MjjKYqUUH/OFlkisi1Cb7B9bPrTE9EGk0ebRJiLUR+mxT+XyoL4EGIh0sX+vdZkghzWFS4IxTIABDKcDyUCChDVZMfYDk+rKcnJqzUmZAdCuXGO8UlaWGSfCGC7vygZ9ZnF6eFnmRFNtK1/R4ewkvjEtjJSLbOglz31kUwZnJohj7AeFNuwbhSjVVHFmHO1a8ClSbh9WiYOOlmqNKqm0nuPa/D+CtieZ9zb/qYJdy22LAVCKuStTYyMFN6VPbn3txYc53KDzl8CtxDP/aq5GM/Da27ejg9iFav0DhoY+mnzyJCPUVCdg3Cy+aH1hvVgCoX/aoaPhhExnvzSKVBrjdHHyzgo/Cu1JqTyckHC4MgVNRRCHJv63tfsqAbEBcYFykeI+lLb72bZnsq3P9j5LCiSS95HTRwqHY7I3eW30ShuOuWTMwX/3fduTZk84nJC0MyAgLN3eWjzVOm48h8qs5IQ7OdXzCbwo1c+p96jAjewSXaS5KjKAKgDn9aPkfcNMjvO986DGteQ8jbpiqfypco29OSjkD5kOO8OqLbgTQ3o8QkgUCOr+fDwSQ+LoYJnnVFFfoPQNU+6S2nXzqAuI6t0LteDEEG0rQXxLcLbsktkA5g+fSoGN5OhwmCAUgIkOaApJYLyzJKHx4dpqnGZXyEQQTA7drRadxIxRZXfA9OF06EuU6nLePQYnhjTy2KuykceR7avenV8Bqq3L2oXq/XGL8Lws9E4s+OgxkBzmMYGKQy2JvK2QDFtPatN1mCh2cALRx79LE4VCIOHxCEQSLrrkLHWcp4hc4ShByBADGWs0r/k+qMC7u3DqQ7alrgQd2F1jrmmEGjP47eLxTy6JPN92LTLzrCrqapVW4ZGAFcZGMp8kcr5NPUo0xVmj1BdfrgD3RTSH60+k+Dz+26ToOy+mtKBVdDqEFv0+KuTm+W6QQ1+gtJTUuUJ+RM3d02V5tkGDENayWqT+vxL3gEs4NhMSGjfhdvgxgumbHj12mnXs3JWyW3dej02hx4wt7z6i/I4tJZ4OYUQ6DuvZ8QORs5/fQYu6+NYMovqNT88s1AJqkiww+Qctymr9NkpMxB0byYFVbjAhhrgYo4QUhKk6d4cmgzG73i4Nun6sBQOqNwl2JiddZBP3On/FQ/vjwudR4wulCGIm+UkR3yL8W/BqYD+E/zrG2uvWIBVfVbAlb88zcWTC8wLKnSlknOnbcIY3m/K5LbjPd93ClyVgXsq8fsoKkPLwIwrrkGL22PNFhlocS9NH7t3jsKx3cXUg8xQq6MSaFWaviV8UER1LFN5grJJ7Q8JADiQvhBYuMS/5H/QjeIsOqHBqN25Y1jn972ThRjePiFjmdBH3C/jxPm0Kj9Y8MW4lNSpzYKHI5bYXIxmCsgZmMKYxxNMZMcN2baQz2Tofe3zDwOStVVtTux9tep89a//M/Wlb3q96RJHP9yBXuQVd/UpMvjWUvq5kbknKZAp2jWrbMEfNppHw8C2U4wPwuj+WpeMOf1rIrwYGo1Tvcu8x2DGkYcYcbCWxdedefOfWCsIRA9PYgwlHuKa5KLQnXDSMbN8lwp/718fHWXDFSdIYWJwQ0sJrK+lPLdUpVR+zvM9I/8eKAltVuGxImKa9Br9zDk36LHT+PrI8jylwMk9QYDwa44Tx54y0XSJVKhsbs3atiXYgQRivcbFNCmkUr8uv1F9fjT0BkBWJxaoZbz2ktN0v32+J6lXMy6/FEJ+mTZ9aKHDr8yWvOTHpbrX5BBXYM0lw9oiX//Cjkxl3x2V6tSatjUH6Hl06SWHs27OLBAQoZ4gi801K/k1D54Xn8wnywKFb3tHEk9VzfiQfgPZByS0/ahTdZM1JxY2f0M8bihNkTVe+R06jCLq+1Df6leKLGxLp9kXxroiu/n7ThKSJniHNndHyQnJWrN5rslVhMPsXw6CIRVVa9ZBxuuJ2s8/JgtuSjPUbislyWyR+Ou2pKWla/JfhwBizIsnfw8OFqwADYx59iZcXh7F7ULMjrQ02Q6wGO7VAkeriLvV1GzcbFkD0TClIjiNZQJFDYlN4ss3NYMOsdjfE6bW4+9f7ceqkfcMwg7sB3VXjZqgJXvH3D6v+rkqVl6Edev2Oqe5axp6Mzvj4eQTCPEjTM194PfHq+QBhejx0GDAkTwA57JSX9eWSg0Bo0sp1P/mGEIJ9CsusaK0fv2kSV4discFAkCNPXnU3LaUHH5o048wvvjaUYJ/MNkcWNIzfFJ0uMr+raXOTosPZuC3chZGBlRKO94X73IVs7pYncvSE3uQY1mwwlMMRR0/smbZzyrq6yjgyWSlnl3LKmjml3V2lMijjuy/Dyi40wD5NA2la7LYujI5Or6ruXoajCb2ZiKbW3zCkTGOJkDMGGZl2qDXPYbS/FG+0bzPi6fSostupotPxHLXjZduOZuFOVavzAcUV9dThjCsKIF99X1kzU7AItP+kEL5GRFd4KXmmAlxgIA7Ds1W35IQ4huTJwpAVtYN+g7DKMLfaq7zb6TkHv9XPdmPtVRCRP16gyP2vGfR/ONhLN+K8kRPpAfiUylu3UnuhQN9n6csSkbdz93oiHiMQw4imkF9dQi1W0tsrweYIu6RYjVAIYR+Cl8Acjki8DIKXidKkZhU28HpDb4BNeD8LS3pqvWRFjJQW6/HBlrHtGyoj+y71RVZiN6yTM9xdFTWZkEqrqK/Huq2XNS+JuLZfxPTa2jYcNlZTCENXagpwcWDGzJmR2Z2bEHYpuhpIppY1NUUVkMzzDIZa4Qq+BzlXtLxlIy4jy3jaK1xgFHTV+2nIHxX35S8u+gdIOBkvZPeleTkSPx72qZ8kJ096X/YigyMJ8L/4Qn4/QqnT+uldwVGA68LMqY4uKJ5wXFzTlefxZfeLbf8c9ZJtsAqPab/dL2Bbqse9mNXAwXb1wQFbBeBUu3ZUi5Da9aP6+e+HCpKauSIFbmJ3TM5MxNpRz9cXT7723ReB9VNYDt4C1B4HQKMEoENRIF8o5COoc4CoK1dMeCYjCr/fAB/FYOJNpVFAqQm4bwETE4akYNRdXSo0BdYHlaWVQVqKCtPVhVFRYLl2aDXPRnQAUjyPR7LFTttIPFgNxEgjHhs4ng94r/UTyPHBSdjMtnxCIUVVApmykMlYGEaal2/Ot1IwzZzWoh/5ZI76dNXg6tPq019rJjQIhTAack1KdZ9Pb0Uio00FTwqz6fP14EJfIinMvbAVu7zn5UY5PMpGHzZqe5xP2Ayc3pDj3+ssJp9P+p0m6VYxmMViwsIcc440cM63HDrmfR8YgujeSNEbnYlOsA8VKaB+PqNO1jRw9d3/GzGgQ+jkfu3P43SM4mJjsHMJxOTW0j1OxRylomFKWqbRmAFq/c5pQjIiR336infnFURMvp/73UpBc3EWVMLfXq32bnSaMSqkj0sr+6GMuN8iJUK53Puz9fcHLGUif21dthjX3g7T9A0ed24Hmya4UZ3idjc21cCujm+1nTPS+J3shNXa2S9/ARhKRWWACfXrW68qjWogwGPkZS/xvgzAfdH40VG2f/37h3B/9uhoeQDn0W+O9i8S2X9RMbb8jkbKDprhsC+OATG8vf7cw0xm+tvCKMf5A/4BFwJ8GttikVHuR8JBTAiL7oqGzw9v/718IoCn8KO+jg+iFVpE53bUbN1QtWOEOi4SPi6To+EA/mOJLPNDd9y6sVVj4QeMvuzKvzsToqf+S9MxDQnPbZ8fYppp2ufV1o9WC1Jo4RpSH6S4B6uJpfIMgihLoPUjTDkAISWXBEKtz8ac25+ti7TbqYIpHyEbySWY4bfDc7/Jua4eqk+zvLcU/GTjLgW4l8D+92tVmb/YKMI86K8/kgmzrNTtNW3gN0Kf7xcbHBvKMYrTm7bevDdV4AXPi87cv7HQei/Yure2oeXW/zB1uIYf1m4YccPJaETblauLE4xzlwTByBEOcVpQi+s1GDvVq8WBulyHsQaHxbr1Uu2UQperlsb1CD90j0Ye5PLwwIPFIjyvcCZzD24fIgFQuf5I19zmg/JerojG1BdSbnvY8/4H2Q8qPL100asxfoJ/dzfkfzIUmgo/m/JmUAKn05rDm8fPcyDm9Zh6oCOlnb2MnUS4PbW7hWvF4ZYn6LrjuThGNHzBPsu+RcZFXhavBQSM+A7g7E/XAuMC3wW8t5dPXzFfOW08fdZ89rSSZdy72Lh4r3Zvh7Fj76md6p3xLOROy07YxVe8l76yfqdx58r0tQAl6c5WI4XDMBwWmtNt7IYGYwdDZ4wu9bvY/KPCuJwZd9b4dj78Te37SmP31V9OzsPCRPTXxUSEychfbXMlJU1TFLHOlxD9mSlZ27WuYFKNAizaOSzchz9w1lLaVdptGTgH+/q2Wxvf/W4l01mYz8oBu6WovagtuthdBs2D8K/RIKPT24ra18DRVdNeE7fNUl3SUaPPNPPq1atMR0/ryaJpKD2peVCUX+mKEVYvItqq0So1ulZe5fL4RtyV6WnrnEiK24BfzHS0e0HK3q3+OZP5aQCz7Sxor30IKiYspK12Y0CAzqAtcW1Nkjku0+moWtTeURzFllaZXLNarndTNx2dbm6tcMLKDYqJO6dGuI4GlqR72mpzIR4eC9M4nM5rfpOGES/vjs40t7duw6zb0pUxrduBBj6Q6+UUjoZTntSIiFvNa5keZVY0Wjw7NW1W6Siq9PJZIH3oqobKZ67cJaUwfR6prrnnGDvaKe9rMN9Qv4vLmcLuUSTyoqTjaiSg/Y4yWQ8eHNMcaIAnM3beoKPz79KkgYg3zQXebXwhbsTseTfC4u+r+d/KeEVzxOyOXUN+Gb7GvsIa+MDB6vACZ6089qu0L/W8e8ZAunL9HVmkTDXpreafvNLldmQujm4gzwoJzBWGyXPDHq1Ml8gJp7MqN4PmvT3KJRNE5aYw1mQ/utK05xZBlcroeG5jBLdednZ/VaSIWOAodVp/eTOe5IXxXRvwOITbJWeB18rwqbgmTkO/oNltMc0ubktKtnS6iXcNG0QEr/H051pyBe6eTYLseHmQcmvfyeEMmIjTUgd+ajqiiBwP31Di25Yi6PeRZUmPNzQkySPa4jQL+vH+FcjzB2sYkP30q4TF/1l2Z94JU53w4UNBPc1PqHs4WhdsPKGNR3wVpdLIfqTMIPxTM/3IqTRR8ePL2svfQrOsGaxtahJBYWNo+bWSR6lMi55m5qeVLlLpI9RF6sALuf+hfpOgnOim8GuDGsBputWrtc+pJOz1YBGc3uxm6yHEC3HjnBHtqLbrH1dEf1tq+Qjax6CaeG18aBGWPABXX7dBu0FB41keoqvs8tIfOM29MXyFof2MRyRRoRBrgXIQnaE7VWDkcPtGAIMQG+XJ8AD4++5gBtrToJ4Gfl0oklccLAYnmiy5MLjPKRZMxCmlEK/XKZiwOrDUbCN2k9AgY1tYRsKp/J7hRGZm1ToPIdeXsb/Ym+uObM4M/SPFFRI9iauOIt3ekJbLa8kgitq/qTvqY+1o1VhB5mXvPigKlCkGkjfiAq9NfBpNOXkSD3Gz6szLd8/jXbO23P//h82HsSSek+MaI3iGMGV53FFOd5AdmfjM9U2uxupq3zO9y7PHrXLmhafHAjOmoaLqKr9xwWO1l1CJuDeKmA9TqzWoBiSFANkcN5Gg7v7DfOBuadZMxp/BjRN5512kxhq6z1PDVeS1l57ml4uT7VBNeg1UE6eN+5PS+jN7btz+9EnpoePrUiZDk68w22xuJvcSQQbzbHXjgjxi46skKWLVADQIIVya+E1oOurxNCr06v+FkYObE5S385YRFY8Sd2SriPKdCCCcZ0pIf6A30WTLpfW/Xg/tqFq9Q9Ncy/UIgTVh83zm501wVAnMnKHGSmGYELwqfGQwcmhecMOSJLsRFrnQhsWlm6qxzvtmVThpyI45Tjk/wtL3jlL23mMqwX3oJxznHYD6nPQFBdQ2qQAjAhFn7ocGT2eNQ6SOcduzVRwsTqfj1udWDbSg5XZ3jV7U1i87FUIA1RAdhh3Q+EtVKZwYn7QtFReUwNt2j/52JMiCV2e2Djlt22YchC6euVD676oKvHfc9GnUjwKKVuG9q7ZdWm+ceiiYkXfg5OCADx544QWG2Ee9TA7hbC//z8OfZbS12xxiWMuPH38fdvy7otiZkGRj3fLBtbfDrPNfKPjkCZjyhDpIHhW+vHpiKoTWhuLxZyon40aBTXMLa8+/gnT+DqxoLYdCxV7X26VrOhhDYAYinLfN7Uz4uJWjktni1ckWf+QWS1Hp2rIxiUUu3s0uZcEDfoYsP5A0muzT2shSt9A4v3/EbZo6jc2B+qA/PcLY8fmd4C36QWA18azJ56C1/LxPGzNYWYJoO3BiPXsYTyYE55Yv8h2nUS8rBXhhQ6/zur4rhV8nXB97AmD2XctqGA5OCJHHyflPg/ohHnE2WNYjkvLhLdkjnHytpcxIi6cSwUqtLS9OMn37IveaU9b3SH73p+gNCQdMSWs5dfoqvLEqUaG2HlDHfOY3ms9v+LuakPli4kq1JEndj8NQ/3xHjjg6uftzvCH1Tk/dxvqruFhe8fsal5VuLH0E2Hgvm3dxfl75ouOcowcbS/Mcyd0rY2SOwbMt9yrJ+jihc5xQzYb8QmZLVIciEF+sT89UyFx9nLeTXx4p4xkadNVKhyuv5WeLtco9uPQZPztup3pjXfDoQ0Gdn9vXP3xYJzTNM0U+a3GxKJ1GJpEzRaKas+Zcrk+Ew0S8tkneaFawl+eiEFmeS6SPf83zYXqITNr5ILjQgSn6RBcDZRKDGuOvWQNHYbhCBPBds/g7NrD3SVheMSVzi+0mDGEoVt8Kg3IfTT9r7uYsQXLSAmCO2EaTKhRi82ANHUYTC0Eyob+kQUOu4WGE+E/WqftLAsFthP4fQXC88dWifVefDYILEI13xaYNMH3Oy6nrlGB0OjCIf5DFsHEPJfd2CyBZRW9deCpy6CoyHvqedpLoOXa3hvsWdt6oiBjoXB3xhas7tZ2tUGsnEzkAvbzKuCRxiXZJMqgj+MR+My/Iif9Smw5poURI5VTHS47C2gXhiOSFwPWAbRMIR1wGMkSNZuHOGfeYnfdJiq8CxiK+934AxG1qKSLjeoC0uTlh8a1zM8bRK7Z/RENpQfVzXbPlfnxQcmF4WZILGuEVXGBjlpvHEq9MYhyRy7g1IkSXHpHubWrEq4YYmrP3b7UISX8B2Wo8Pcj4x/Nzy8Tt9icjGEuKLVYgmzZyPGF8LiqJwacRL0cyhIRNdsp7B/PLx8kNct2UDF69BzqamdhiRfnL9cf9rJIdOGj1I3BLbsLxvL//e0QOiRzVNj/LEWPzj5MInNh/YFg/hG9PyOTs+7ECTjyRyH2+EZsszgRoKu5S7p69PQAgiF8YfD4EMdW9tEpW9r4WQdy6fAzlXEUH2MesIKFCbexMvdCtMZy3KpUApqn8Cr05aJI3aZuVCWEOanLgY7auFkGWOGbpYpHp6fs84uAgQwXsGd37M82c2voFM0Z3G5zO9HIeawQB8ZSICveQTRVgbdFTLv0tJ4GknqjA/srXADyE9t9/AjvGDtUVFn+IDM7MihRcLSncA/U5WAtXKJQrEg2F7zib2uen9kpLjsz6LpTdWVJm52MKoOYMdmZ/quz57qB6tSZo1u4Xl3dERKTJXuxG16lV6Po9z+MZEcw5z9jjvebz+cUznWU86ykLYmQEeGWh6KwARhYEjyhB/EMcacPBpB9wj/AjD5v3/mAlH064+0ce9vG18JjvMdh06SPqGhcDV99JJAE+pExi7dm8fZJIAkEiycebjM8gJ3l7J76A1Z2PtTMIhJnaR1pij9Y2AyTMsNm2gvDhAdMglNtS/BOmXK95uNmSeeLclS8T8eRrNB7lc7YWc3ofkSjQ4XJXkuT/wirMf3E8WQmxWgNgdAYaJGLoMFuLj/+/BMqSxwf7n2wfEDAA3Z07ZgxTFMPYs9tNh98ZtHYJXapRCsUKaQTdTJZGhoXA0gbM9QaL4Xzs+aTEKMdTDvB3VBLk/jMGzS5QmYbctIS5ipM0nFrQqVJZo5UyDXnnwZrZlpAdxeicALYFfe8+AQqDPUjUGeiBUylrfjwcUwYr6p8/r5QpKQtlfuYQ5pQgfgzx0XFcFJ3eVww+shL5ynhQPb2Hat8SI9N2a6iNuOk6sURHdgvRScS66TJ4XGLSmtIdCxaw/mtxtrSwnb4GPkmVUr7WpkvvmZgMHm8ojXKsr4FK7XEYeRPZQI3EYLdnxNCUel5pu1EmM7bz+ZNGo6uzosz7KUH/ZmgnHfljkFv8g2vCbybd4zrQPMVs9UCZ+Yc5ZWl75jCMoCFqRSLd/AhAR9SJyLv1ucq4sJQdaftGiMRnFMpTEnGEYnDMBnjPzwmsJ5HSjCs57+e01AWA+wbjonm6AtAStR0k795Oiwy27Ujc6t2pxn0oZ3ADa41I/VD+qE5Vyo+XHPkDiO+KtJPLVQey99XLn346QpbuqKf7i9TTInBErn6a1OfZnzbaw1P7wtfYPxXYx/OnKuxHUQoeAHbXDp8yXF346YAt5e0L97d/JmAjpz5Nrud3u+GB1T+cirCHK6J4SseCrT1a1al4QNj9DlgIqoXjOqXjPbNiYc0bjzj2ghJfGJaCxaaEFSrxdOsE3eLcugnW026f+OKDlc7VLFY1gzEabuVMiVHiEX7ymmT1dugZzDy0B0tgaPTyRz0atnyuBYZEv9H42O2rNTBew2ALzGqH80jtxrUuNrXu7I7LWiMsxt7T12PU+nJ84fMdDhqNab6VEPvPklyr685hn2/v89p9bOdxr95j2485/Bx47Y+usi2hTT6OjVysINRrDOVy9TWGOeIZ9BJmQXV+PlMqLesuZRZY8eRXK9YG4RiGO7/PlwbFEREkLIYkFEZisJF8QQgaS/YlxGJdEXZSH+kfCVGsI0a+XfRWm+66T1gpzAy1syIiihxab/j6VkbL0JD7jPQM173N9s+8g1NxUOdMeKcALOBpZ+tnhkWxSbnwjuo9HVNm05xdHXmon3JSQvTizBUdaQxXvrwjGtWRgXowMYh3KIBl/tD2BPFnE4DZSrukGJVKGIxBBwuFykhQ4lV6nmAwatWHUdi1/pnBJ09yWqwuoFOhkRE3bhfBP0W7BmZtCXP6JGw0GnlNw9dmhZoPcrFzcmZHomim6Jwt7F3+mkklPu4OSf9OOYl439NnnYj1mSaI8qdvNb55k+5a9RMuC7oB8Kq2qRPzCsXDeGAf+JePNI9N8HXzl4yEraUB3yjCuJM5bIgGeYT/MinOY+cXhcc3e1HftQ0sCgiH9z7b5bL5BxjR6EUtEsgSuUdiH2jliw5Pn+5DZrMuKMV77MvUN3NrCYns/T6/sl3XZvbt7oYYoukQ3aXrYpfT5r/txZGCbqhyPbQYsXZRHyoldJpHE/Zxdt57Hpb2eildh/7XcHwv344Ouq/dl/SufdW+XMxwWY69wReUIMM833kSYm3x53+GRI52MioaRXjGHmNUfLRPZipGdUV7XmUPHZmuQw+gx/dzFf76/MuHd08f18rGjNo6nvIpbP74pxwk7oznEUbbvjcbZWLOqiDcmgcbKm8tN/nvjMFEfeGeMu52gNfbu1urJSwd3OtdQnK3lCsJbH+7qBX2O4Cc6jFRxxTtwYhlzquWWohy4kONC4BVQLKnL3FXYu/VtGQgRwAgO8gJLKADpGVYpQCzKM8XsU0hoHZgfnBmSDZZ7bLURR7kcW23kBmmM6oHS29RyoIOSR3qbNQBvcayOC+0Cw5yrrOtbM8YNwg4qMV8o1++oJYCgq0E2xBjBZiR3566aMH2kLRHUt8VVSm2Yd9ofI6sh3rilz6uBL/JVFTm8ucP5vLEutbSZinFTKEjOk5Ae0auBAtaNCfxPsKh3Y27WwH1LZBTDaOuKG9krZJxQLLdKXoaO/NHy8Nf/YyfCszF4vYtkFsjcAvfGwYny1wX48f785XkVsbw3Q1BgDO8LPoSowYScMZH4g9MzgFXlmjHqMMoZMzHMkoNOxmw4hGl6EnMupJKe7RoSBshyZjv+RUY2/P3f+hjA7JJQcCKSDyMqTTnyARuY7mpbi12SLpQ3At/nk7j3ZLbdQSlDdQO1KUa2OrKZejG5jN4mCMQPe4fxooYd7/PecDmtb+dZ/yW3zgbHLC/XEvh85SjHowNyQCNFyQsXoTeU/Tj8cFZJ07jfcyP1QyXqyDCqGJNYMtipegMnSJHYeuWV4rowfTLOR2N43b1xrfR8v11fBjvr8/bj9ntgEC0NULhAD1aOBZIaOMJsUEMGVkOA4egypK9pIY1YkcU3zTEV0ay4hF167xottJ1UidylAFoKcq9B+Bp9Ai0Msz+ukx7FhmFYj8k7AmY3s8HRTMZBdEqF82HGMDxSIFjsbh+CaqcXONLZ8xxtu33tYqLnYKFl/B9oqBaqXsG6nAcKdVhNO5Ghpl90mXjcfY0p8UI1lWzOY+/GIfyiaSlxcYGB6cVphXkZMWmxk5MtAXHBFtVStqJlyZi7lqU5czYA5dW8SXSOAysMXCOGqKjjB7tvwy4MNk3gyqUkhijALjdv2KMcUHqYKxaPnzGAcRVYCB1JXSy8MclEBK20aMB2/nTncOhXv//+Z1njx4cbh9uXTvX9/XddCwhUlrTj4R/gGy2U0h37gDwulT36SNe693kYmnZ0Q9L13qopQun2Amfa9JhC897VneO4xaH5P8/OCoYftRtcsnVFB/1YvzCr1F+hJZN6zYQsMT+gcoIal3+AqiCwizy+sOUOtDsdlx239yJ9+64mL+/QVioUEy7ApAfYjucqnhX6wOxwVsw/E0PQrAs+mRo7WZ5/evD59uLvbd302lzm96fFNtus+YLPBxBE1A8bekhWGb4KmbeMsuIhhCuGLYs/BDD3YPCWuPajyts9XGkY9/ioRrKgq6czNJSvUT2HosVLBhvhYjyT6ruye0bCF2k3WEU6R5WFGDRPbys9ekKhzzMMmm+Yq7XmfAd9omnQK9CprU1Pqmksd7rT0OfyvtONYrdD/RQA1gHe5g6ZdHhkXXOpE6opFD6I7DuSRqIVXOK7bQP1bvtFwpLUj0UBIelbKGAUEALXBI1ukm4X88hdxz2c7X+Qz7TJqLIZtJ3/U3ULgcgxniyni9rnHGehvaHhuiOzAfx77ckk+SkegqBMr5yFhSDnMnsaG17mp/WJY0R/kqOezdNYqZRFUwthA2OBNjmBCznggVtWtMl/O4dCXI2j0kiSbOdsKLO3TDbGnVlB2FHE/G8YbV7jYpIjuaZtbFA5Nnw5MwUSWITB0fqxxgME/fh2zjHltx5bJ1FqASwwYqW8K1rCVEU66JjgoFvefRCkW/AhRnoUtC3EIBGCZvxHtcCE9iE0OAjbicWNNlt6CpLIiMpxUd5wqBosxjKr6LNue63RBnett+RLXyHBBQiFVsf897nvuqsTPQYCSflo1JxCECjjioeGZdVswGjc/t0ex0MGQytLNekdxW3uN3bP2jAMB0ighnofI+YhPUeM4heew7qMinJ5QY4Uy7CduRHSAVGg6EL2rQy5BI2j1iq4XIhsY2YpJXOtNaqTkYE7UCk2939lcLvQiC9piMMtsybyBEBdS7Ha1TOmQwm6FXD/t4FRNkzIwcAmy+AL0kDApV1a1eUAoqFczgbHHE4lGbVsLzNY5QxITUIgdpPhvw7QqIYTEyzMX4FhVZZkheb17IRLSJA5JUzYDA5c2xAjEi5IogekcHMdrCcRcHj+GZYRXGID2whhZzoKqxthfCzx25qkN5b7Wgbww7Xn3wAOrQzJHFsyqyVlfYdMaOJmym1VYLQlNQLVlw25paiLXClvm/KCVlEhXUYqnlIMQiN54TZ0CmBieqQYG3r2tzlId4ZSKHcBZsAGX1Q0yJmnQzSe5cH16iEymXKXG2xlJGWQwnzwkKRUnbw/DaYGBikXQ0QWm+T+uDFnaQcSypBsbkwpdcTk8rGzmP1/abEcXob4sN+KI8pmHN8ADbQ01HTTM43SX12Cg3ZTYMIdg5gUKzZHNyuOwlx/ATVwt3I2Mu4vNJoYcBngw6oQp/stdleEwkZpLstrs1kBJuibY6kyzqeuPJIHUD1BrN9FkJDObLhagXQvRlk8GZeh8QlUKeWoUe3GFd1QvLxPhhbKnfBRh/Ry9iL6iRAWVdxnbVvgeA/DDHmjdnC07wOy9z1spgUHvFi+6HHJGgGbDWbMbimMWNz4KVq412mja9JQ7cwaMyRkOcArS4ALOIoKn3LAVfFGdgQgVbCR3YfbXgvuchnqoA/lxYMMRgoRaFOEXOC2onhHLsQUjfUEQdUoWb+Zl/qXGnzmOvmO9nr/R2jXVuhzQw/BB8geNdG0L+G3Npp4zLrxSjlqhbHoanLPLExPHMjIL8kqa2Cb0Jr9D4UV3dbfKme300l3iG3NsK0wTK5/e5BMI27jldLz5bFIkvWr+NqOXl6fFDmBMds5LzNJMNlRKmhChyiMkvkEIqTeEcb3DKtxqwQQN5mA35alSmGm1a7RAV8DeYw264R3o78zBif5z4XYbiWN1lYma5uFcQ93/GicyTuIhm4E1MLsFRyVH8PC87QqKGNul6sQ3rn7EZrtEdREE0Q0Dpl4FIhKGUCPTt0n1GoYYR5TMFaBC8Y0rV4eUJnuhEQMT63/Z3fe7SZYd7YpssmG/u1U9ZyitgaErlZpmgk9dtIWix+t6O4++7O6hNbrqvEP7x+ubhtm33FXp0GMr1IwIaWfl5lUzpUZZSTqRPJFO2pOSUQAjU3ebncC1dxXE1F1Y1OgiQZTYYwhNbzAIsafkOpjAU/l3ZIP6dGV73bRyoyag677NfZzz+9+RnSNKwMwknb0J9dzXXMInJxKL+ENuW6fQsi7uUM1fbNkqvcH3YM4PWBzM3dDasCHhP8vZoIYQc94ggLpwezN/L2fNWkJFpPlP++H7E4rBQUtnADO4thB3RQ+Ox8URQb2/0rj0ZEzZjlROVC8NtteRUQ/IOch8kEb77PzJgS56mv3VtsdQx2ALVRFVyWAJoYVkRZ4L6wGKfqemstkPCg/04Bm1Ngi9jxCruLHmqEjRVNNjq0wFKU3wEekasTcmofocC63zfOMQN9F4p4ykiEzUIJ6sc0Ptf36npZSeYzCbz34HYcK6bWM41aG731ezhOzDzCrR05uGawmSfC/ttCD4GuJ+Qzdi146rjou6jotcB8m4BPQBxO/E4A/mNXR9kk2d3cNm5R31C8O/OEdyLCMQVqHxS5Y8d5Djcj2Vxr2TKKHiFMOvGfQOL64IMolCLly6TnPLsgi5x1jr9rGZQLLZv4kNjsH5CDrDgbLVbSfrd8zJJe9mEQoHfpvFqg8cuT7pWrixfL7bqZ7FoQac3RyNkBtMzdAadqPWh7J7BTBTxASHBZ2xLGXr/HTk3KANNtJfMlg7av4stQ6+7VqKTgSCKMVOq7FDLxKiVCtlSiua+3R4sDzECux76q6/Xs+ioUDm5O+yJvs9q7OTl83VlbEyySnDpDVpfo3+je8d2fDpBbYsYyO64TqDNqqJy/Z6T5HVKg9X9AyZDyqKcI+j5Hudsb5T9bJm0Ctb0KJGx21Ywx2sqc8UcPeptlRXkU5NqIuzXE7yJBSAt2zTaIRCbRATWV8fRIsAlYINrr5V3Goz96IRfUyS15e+WzpbANPhCZIq7KP0kYtf4AJMoHEf/lFCoECgL7N8stYTNphHgv5uzckYWVTsRENDtIzCWEsrHdhR0S89w58pNCwpYtaXaI27jK8OqR7yJT84KNTRthEWmJV2JjvmaPI82Brl0Wah3IhDC6d+XNQVdLhpt4gE202fDtYQbmtkmBDQUE/0Ty/1WG1FKlxEJO+FYgEL8LLGx26yjCgaA5bGABENsc2+pXWwsHusKhA14Y6THQrLa8dE2Hr0JmL3z/fR8DnZuCjtYZhnHDRv06eVx0Crml6oxp3EdMEh591WWX4CWGpZdOeNKHfYNDAkXIgbB/lossgoK50J0H4fHiAzqhMMXFyhLpemnFa+k2H1kmqtO8vD8eOIjxN+/MeTH2R5yvyXCwJf9pbZdmaTSqVw3lN9GWXOun26Ug1Oh7y7cLQgXSU2T3P57eHu+j7/R1Z6n/2fvVWOENYTRPFac1VDxs0owjjcuCOnWbWu395HnKNNvTjjHtKY6Hn6ePv36q/JYfQLez0w3Z+ShrGbEQ0y3l5hBVbpCNo5hIWDxdLGf9PVYCso/COmRLCYSJlT6WWj8S5U0zTz5KxNIlPKZPSV2klnoni26U3Z4ttY/Vuuqi0WjSC6anNEfD6gTq4TbclHtkh9zdLgz/uLu7c/1quA036kKE5kpz0b42lx3Rpf3+BdcthOVsCox0sJdCEUoxKGjOwqzvivLYzM+f495xS6dSA4Wl9qxP6bcrGvamAEKO42+g66eDsySfdwIhCIFsnv/yyg1FmvSHaeOGyseeadDFFgy5DKA21KfUOx/99baa1EV06lVRaiarG4JRjsck+fvB8f6tG8kh2bMIiWPAu3y/6eu23Gt2KiPFOMzwwi399CBOVsa4D3OYlZcRvFkNPW+yWEp3FdW1MEbVXJLt2xmleiFbIvtQ5qrz+5B6bY395OYorUagHNfllhUGdijnNAQ880+84O7cc6QoJgV7bYm7giiH/iuxpTkqcumYyX9fjBaHbACZtEpNKlwiKY3a7L43J2HWN0V5YObH9/4QUx2XquzYnqqPo2wY/tonw5VC6uOjOIiNT3NKkYX5B0IBSKdsu405Q2/3t87S9zxsFal91Fc26ma/JRTKCqHjopgdkv4KVdL0rfOEwDzsFELUC0cSLlVbplVmFCbCni0wi/e1v5GvCfvyNU9kXs5UOTL0KqA0Blks9wABX2CPPhCx6pwfdFxPa8DTrfXN8wn+8KvWrsy0sRW1oLO0AKgxSROOdluwKhtCFek1B6AAho0xQ8NX1C/PcikGpu2iH7cwz9cXwOJ47SDCWmmUj0eSzzGUpi771OjcpsxFTkmwHPZ5M50GPN/b3L1+5XScrp3pch6cczaQVqoQsqm/pNGqiYfwQgWabR2qJaZD2tQLKeJx4tZ1QttQ2mmbTJntyySlx4PTdtcyUU3Sr3X34Kg7mC/CvAm48TI76p6k+lkDuCHNuZNC7RGj8doAEq4NPPG1ADRIV9Ly37X69pCzhbujgzVdJK2cSdBtu4m8fEADRRT1JryRXpYW3zINXTe0xDx0KBRS0LHM9/byJvmQZCuK6yrpxq511iO98GXd0bN6mk5Dl2fLnDTfF2xM+NpHbVpJXD0rBRYFjM/1/FArRrLaw+OVSqo3SalXTeWBj2paH6jr+lv8a2k0wlWeNtW9aSXSBKZjThc81ttmWfdCO72jeKTiyflKXLW7NRkwqQB/2dQz96v9Clbe664I0TKrjqm67QFQAxSRmwLNDslPH0Na7aRG4/GpGNtDrAKNTodyNpjZPXErRoxqkd1+AeRYHN3SO/TVK6wwR1vg7SGl8aC164BloCe03aQRx91XbnczxZ/lA/qcOBK6PIZmWX5d3eTVibZXc1QQ+iyblcdmA7igSJVusQ4enTsVzhMpZWVvb3czJ+TjT3ddI2dG3ox0bMSdh/SVV2tnV27hFNJVt+SOJldyIg5yGqzstzGsXsG2PIQKZEUDTf6oXst0+1iwI9kzb3LNe7d4SzXd8afLUcoLOD2L2uaQAyCxtbKOZeu/V60MWjNAFVfsyZf3NBJTUN/NNe5wMUUogJPeCnpGTycnWN9mmZS25gLu9ykke584WpB9u1V3t15/cMTTw+5//jd+BPY4mr/kAI1IqB1ilIGww0klvHCAJdhN2KGWQhAbVYXph7S5re/N6QbCrTFymf/uS8hSA0bf+dL1T3JWZl7jLyZWc1pXEqJ1q1nUg2FPBnpoah5PbaFQNG5zUcdbeEdg8iwyGM/eExEK9EjEA79hVj5u4tWpTcySRF4gxymWz7lY4ze2zE89i4rJLnhaLWa311Z3zcPL064vaoulm7DRG69AuYnhVHDCdNt10XuTA0nfiDi6O7P6ShXDNbHrmrMk6fF8VxzygO1pjbLp7bUblairkll2eeclARhvrzCLRqzkY31FSZUB9yot+DKj8OCB5cb6y9P2o2RR5YCqDxYgZNoWlnBqtrjjkZIVRFpmhMtbfSVrW6wwhN2tnERkGLXOIXGI7VpTT5oA9Nybrk9yHaD0wu3LM1lENPx542pc/sPU9E4bZ0W+MocQpPEOjP0QfmxQIrEJqA1PS1mVV6C7CQ44ieMqH9EHPsgY5aAKYHUStHCqzavYjZNtzCJ9wVMN2asY5W4OPN50bCpNKDMFlmAsa68KpmwV1MZuG/bUEMdU5tX5aq2T2E6nC9U0tX19Lq3EyASE+TBTG4dx1ELv5jxmjr4ZLQ2Z0NQZYrPZukgwj5nGCasPQtTcmNuMWek26tM2BlW5NpcjjzYtqG5gXI56a0Wk2jci2b01R1Veg4gr4uCwNmcO54eOJid6knPRwGesHWzJwuyAcqlCBMvkJZJn0ZbdgL400LG5TVb+UA7lYBu7jswstTu0ZmG3r9ggfqzRZtF/ZgfxHZSGlebBal/ddrdDs/a8emXovsnpecpaBmgM1oft0ti6EsIogCzIBi9K8pVAUTRPjjy690KU5uIG4utowt+g+fHCBgMnBjFZhKnRLZ35pkIN00g162w4OobU+Vyq0MZg4zqL8cVXD31XHQGeRi8J1/2OADCghbTapvr1TcDA6LbPtboopHZ6hzdUX7bjWtdVkNYlw1l2F9kq4Lbykm8aCEsE7tHd0Ku/qMq7KrQRbIHSvBF/xsuO1vESxRamuiFsotmlPKXMfzwtfOsQg3ySskzPQDf2Cnj7QqczcYPgTlCwiv8Eej4YG8CiY7W0nZlrJ8B9C92CKvdJp/kH3xOvDVnFeBbsF9tLspnkSz3h5QEL/3D4V+dWbNslFXOiypZJlD4cVMqs0xbM1FUPA7oVBYnah2c2luKQFjTfU//YtugTG+3618VUzXT7nvfEv+J+R+vksUz3dbbuPvIrvdT/ehv+Efl9igmaESMxtEdGj0XvF+FcORN3cn53E94+/Nn7Fm42fJFDyhQTKk0R2a8mIJWoGYOajzzR5iteWWsAZBfGK0Ni9XxIX5Cgk50h6PDRciV3Zy2zrL8bwA8OHjnwhE0Y1rvd5RGSl0Cfo3U+4ZJiEjtmTINDCkuCIDJIWmv0lB6fEN3Y81j9MJ92k5Z7XPbJfaOmAQ2PojguvR648C49finPG1lsuDOXC07w/Z8PN1ZL53uqLxdKLMFpq+LCQs59Np2O+v5xdjuvluFDfz/dH0fTPKN5rH6Qv0eH5UKabMVUmKlCjlWXkJu/uvt5dvhEOptwzKSax+oH+a27zqa/F/YEieunxyGPwnRulTBrCreVfSmaTsVHIPJs7C2nQU531n8Mk3d8sBj6yE1H89acqx2oVAIGSz2x44NjcMjRZgISFyI896kz2YQ2R/ucpZjHyjbhWMLIjO9dZS2B2k8MW74yf7ocVVj50WykXx2HgvSEUMDsOV1Px+gKOTpoxo51YmegzzJZzLli33+I+9Pn08ONNmAiTMwZE54kq7r8lr7fiVq9Da9bOTFKMY/V939J75z1zOFQXeMQFlnGGb2qDjt2bc7j5MJx/bBSRGlZJOPdjhjjWK5T0rbrNWym68elZqQiGOQYWJneR1lL/AZC9fus8bhK04DHs7MddilKl8+PwZRCqbxCTPfeAc3hMonJ/VDv1HGOPaE1tUhmDc6lbK2mEWxeTLJsmyPjGyCdyC29gLrnk2rPpzvoV2l4XOti2o8ANru2mFyTtD0BctsmhldS7bEAfKXXdwe4J0YZOS5vMnin3GPHhre8st7bhmsxSC1kZzqt74hwokAvUL6o9kJ5gH4/Qmd4T6pIHHjjY21dr6Y3U9+iPJp4PxmtICTfOAZDcvtpD0DQprU3fmzqzG1ajiElNxVLhI49RqSsE01769TIQaelrD/PdjDvIt3OADf78xLTHRwX4XQAtDnE8Qqo/pUYClO22TmYMDpKcnHseMA3O0qqfZK3IVsav+PCCCMmMmXmr8H4u3EgLhChnTGV3E2DoHdZmXMGnOU1AqTqxSxiElkZvMNZ6ytIRPmg0i95uUmgwHtJuh6qQlasV8u+KshipGGaGh6jpKV/usi1rN44SMNDiocD2r7ycmT7zQRlyKYHWyoVvZErT1JaaoDVBlWGDIqwh4CbVtBbbMJATyufnJrN4cspwhSwa1OisK8mNQuDG1Xqk6tTihNvVXtnb3i2tUjFYK1N274MK4dtYIhUfy4S1twPmqWRzscx0S9xOiaGUbn5TspjN4HT6nwOfg9JUHKqkXseBpCFlq72hOEsmLVgkh87sVa8sNEt1TEE25c4tQsf4HEq00eqFC5GJpsjT1m/wzbTfKbKoqd/G/vOOw12t+0acx0i/Z80GwOOQlopEsbUbTpFp6Ej2E6TdZwn8kycwOgH9a2zIlvKE3zNxESFP4Zh0+G97859FsnMxr2ODSPgV/K/XL3ItNAzDHZ2d2ji5KXt3pmvbNZ6o8MrKb3qgG4L0CXNRugEEWoEffuL9KfyfvHUlKghOZufpSmJexXgG7MpLjHzxmDsfBkI5jl6lGVuwIrl0CGBnpot/mViK44ZvOp0JRVMziPNxzVKHPKk+EO7j3bk3nbuCC9/g+VZLYiuHSUzeC+9wajQ4GnxZ+3eILKS8KnZLuI6HPR0+YZ1ZS1w6cAdkCH3I232JFqkEDlJ9tJYhxpdTW9qe3qluvEbIHq8zFrUkkUUcPVaRWnkaaEooIswzkfsUK9IgcVj6WpPyG7P258l9vL0cyGk69DXB6+vFSUzrnSAN+LH9p9bL2Vda/M5c6ZFpoL22Pmu/SmCT4TqiHBBFOg+51bne+ZsfC8zDjFs82fsP7deyQYW53MW3wRBOGN4KNjQvJKobBXlfufwsFZDzTRUECsjSOBuB1hMIK7ExsD+4b0Whj8HMZ9++mhUAcDVpKEqQe/W6r33AXPBbmy8P+5COaKS0CyMcqvLC7Bl6Ybu7cR8ZZPlh2GNA2vL/rDhnLgx1cb7JOaD9vGPpdR3qeT77zsu9TEMCUJG7S2zj+Ig8ArabTgyIWR5hHQbBzT7mMLlCxrUJ/GsWQzHqvgBgNn6wyjAuHFTooMBGsIXBOgNtpOcb+EII9y/+ghReUqXV2/t8TgSi8unQJ/2UaCT/Cp+LIaDfqD0hTI0wU8hEPwOcdX7nBkWzwv1kuFMn+IDoGaZeLj38ZBcGNh3Fez3ZrLvqFhoaKJipMhVtSTwMPi/u7buMkRPW0UZjqI0vqi5jP6CP1CsaiQdDF9OKPH0yldJtbiQrNrLGD+qIzp5bbWZnS4QEXIzO1V6V6/hhiFgcvqbVM5hHKzkQY+d+TpD+FO/+YrGEFOmAfq33yNdGqWYo02nObW/hllVM0OlNVjrpra5VdloS98B5fVFjSvr6lxfaKA5TlFUzXWsW5XdlHX949BphaqSFPvZRmeRj37Cfasp7qQWqubo25KfLVrkvP26XVxXY4fSAXJfrHT0Exo8Vv+lrkrq6JGl5suqtIb+mUo4oWQMugDW6jiD/mw6B4sLkYXex9NTc7PPijzZzm4PfEj7JW1zgdojXAr3/JOFpI1K+UlTxtF7kaAZgdsWnGmXN74vqc4oe7URt8y1Nou2u9AJINiHLdH2JY5q8jIVaVckp0PXEIzybL/uajgxol7GyncJwhDPOt6Xad4rtUUqvxK2XVYxB1RXPIwg+HfPae6B8P8YWR4BgPKfguY5AEDreekVh56T3ZdbAJgn3e9H4DmEK0A9tQLIdZ8dfw60NWoBcwfnDPg9EVVQPBHhoBss4p3KZe0J11lhc2Ev6AG1p3T3yHr3uU9md99PZBvPa91BCCxWAD832tajpMlEpODXUHgM9HkK2buwAkSG8oDTq01iyEy5U0MKWaYRO8PYp5Oy04EAKLemAcq+lyU/87qLmvGjplfsC0PZnJ/pAMrEFBIEZhmcoWEQziXbakUtf6EmliQz/mhJAwhKw94DCuWK2LBNJStQdjm714w5Oh71PMT2sy9wMI5racZQFMgqt2KTGOvnvUTu7jF0Fz0PsD3mum5ebQHHUszGRGoaZaKcm726S9qEgHsR+2BbhCJWzDUH1Ged5W3ce3WezYuCGdPFxs0cuuFMM+VT8ZjpuSGEStQeNfDoXRwTMBstB2RzQDkNrDtLbUDB3qAVfJtblYfS8yxt4Po32KZ2UqezqZiaI2IshHquS/eNsF0SvFOGecHgNUEa01zDbxv3pZNOjZ6vuJ4ZtchEJGYag6B8eVZsxjzh3noBZ6HcJfxqsO0jzz0g/o2xMAGUvHIoFUhFUcGUipI6A2ZUQn6AIOn35HvpxZUtw/3HKUupR/PMC/ijQKVtn2NTNkpxTMMNqpN0AwGvoaIHuV6bXOyEY11nzo9MJ2JGlPsGvNH6LHD8MeudnvXhgbmuj5Uxn64JqxkfA9fvb8TDW+LRP5/d5nWZsS9UfMeD+oTXjtz92cgXtPro6xU2i58nVf26K6TcwhaLV8e4xkzNDWbSO673UyanMCJbaun5+lrNlLetpgV7PbMzZwsDdQTVuJmh1SsMwvrX4FCK10t0C0PJwz7VrzcfYA3rGWtNOmNaUh2KhcnZ9S80kUUK03H6RMFL6EhLerLDbB9S8txq0jWJOOx132QA31w0LBe8dvJ8DY+nacvQQnNprapi0Xgy0GrSrOHMTeE7BX5zyDcvMP8HjAIiNoP39Fw3hXKU6BkyadCC4PmWny2y1zNtzGNjX15xLTPl9bvOcm8avwNPTutyPb8Kk/SUjIqmQpWJs6j5WAhvnUiPA5k97phxVQTQlnX/XYutYL5G2A1g174AaJBvSkv3oE+D8URkE8yhAmP6q4JQLpdQu026W8EhyFFBGxi/giXJv4JLmsrPo/uqGo3LnQxou6ngG9yFCsHoJv/2hbyfDwTacAHIQ9tw9wok4LOgAhPu3FVB2HYur6CoPvcqODxeeQUt8o2sYHm/qyq4fN99FTzJu/ZWOBn6Dang03/nVAg2ybtXPtlC5gMBT7YkaVbuB4MPq49wfnp2BmtsGSPcUqHYkvakgNFDVVQS1nOiBSxDgBVPaAalTHokv4B64AxriQb30tmESjDiDFEMWgKlpOKLI/8FRvHc8bVIz9kFyeRBFEwx5o5Uo70sNLENUgxsIKDfCUPWDJOyGUXABOcyjxhAOopyVc1+93MJnAGfLoenEfW1Au4F2mBqWnrORphiOIIjNfzxk38oytmzM5aYGYJviDA+BEcMgGqTdNBTnm2hHgg8Ze4jfsjEmTZy9sg0HjN8ZxnJryiaYthTXwLq2eJUwsX/LoV0UUO7tX8Fho3tsAs8kGYMIiAx255hTL016KnaiCa5gdsZGpnQnDUGs/Tt5GSSe0EUCMat/k7Gm2IHp3LI4Ibtrr5aX62Ws/1uC7s13F6qqm22h+VmX1V3X7lreJYCAx4JpOXsGZAHk+eu86zkLMzQqYzyMlQ9MkiofaGCbVDfxZFIbdYAXxODJjtmmqopmt9wJoCQEznu2MFtVFHMGMBeiUZ6jusVo3Hs2wXRe9YOB3JS+HKrRaFkIqJvo3kGh0A9pgdB4MYmcWrzgehQvGKm3BajxqdbwFVHchzGGX4VyhqKxlE9qqfLqXQHjHQ8BVIg3EcpHZkmzhkwhqCuouSIjyMf3zsz3uCGImmtFi5mYkXJ2JMxRTqM0BJ0cgXIAxo8eU5C8/SyxtnI9DL6B96tJM3K/WDwYfURzk/P8vdhjS1jhFsqFFvSfgJ4Jh4qaMzPsZ4TLWAZujKkQbaM8urwSL2HC6gH9ri1REJD99LZhOHDMOIMUbxoHU4ppXa+uHj4EsiLS+74yG9uZxckvfMgPMyUi+WOlqpnP7E9m5R0fOe3Y/ptlCljYmhmEp0DJkJ2RAE+Kp1Mrmr2/1uKzRJkCJCSeWL+cX2N4uVjJpMnD/qIMGZyAJOEW2wMDzjENM5CHXHGy5hyypJ4VbK+4cgfmAST02PxBwqNSYHyS2TcR4qRQLJhRpwKESCS3OC7E2MkrChLvizsBbcSOLuzxenp7kVz87gdROKkPNR9RS7J6+CIB4aaeZSBTgEUIllLccic1xR6dJxDm8OMyXJTHR6uW/p2kkcTFhFnMgRWXHBypAgud4ROEg67Yburr9bFVsv7freFirU07LJqa+7CcrOvMu4cX9XwLAUG5HAJ0hatlHN3q1DzfHXOgrDoOHcZKyyX2p/ppKgfijzlUIOa6u0/zSqgTQZEletnqaSYYzRwY6K2yDHUNQ04CjwzeAoBn01JjyUOYAG8hxyTl9LQizxTj3osyuBLoFMo5TkToy+TGlzwO+qVViSakYhtnepqbtb+pDHCaKFtdX1QcreAK6oJQhO6GX7lsZxVdNaSDDVtRLImlVzypaNYSDwVhfqt0pFpKrrMWZuRlSrYECuD1/a9WE2ZMzZRAlLblIS9bCwLYCnH6pO6ste2aoSNUAFSzaxQr08Cgb6zylFh4FZyVtAoF8RtHb9QMprRFoCvaA8q0FhlfEaAy9sllMskBvmeiKf5xEx+8ztnMmGzqAV5UngU9DQO0dDdeMRCb+8CfobhR8lfgECBnqxrwZ1sY67A2GKrY7khPnwl1za77bLHWedgdIO5HtEzcsI3xzzhCI3tW9/h4Sjxl7+V+sOfihkiDySEHXlBgWBMPAqbee20z16jdLgtUhPxhlCAOl5xy1VfCM7kq9JpJ5xy0pcOOeNfAtE2y1ZE6LAX/vGSwn5fG8zLEUf9aEUolZYXpNzK0H6yOowFVoW10BohDBGvJvFpEr/m3z5/B1zw0adoBXIEWGRtjII91lVIoYWFoNp6i61TYYMqG+MW0ZCGNqzhohxCgkDRFefQPdCuXpwam9SKV2d4fQIeInzzCxFJeXdDodLoDCaLzeGKfGgMgTB33r15/yKWSLMkHplMrlCqIGmWrEGSRil+lmapVAddLLscsaNs3i9+FT3KzlRU6b0P7rkvTCJZG8xska710pfJqpKANwETqYSU8sLE4AgkCo3B5uPbND6XnAQiiZy7h59/i1QancFksTlcHl8gFIklUplcIQiW37dKlVqj1ekNRpPZYrXZHaJNOXYkBJUXdixXNwmMJiklLSMrJ68AikrKKqpq6hqaWto6urgnuh7hmfzvqNcbF+N+f/eAtsWkM4lET6RCs3Ht4yGMbRBaX9G5jvsFu/OtnTP1lF1TdCFiUhXhaoiwKNuWlIh2jkVCwSDYNrB41HXj5OMSDu4Evm83WwZpkokZsLrT+GTafQT3e7HkU3uKsoi+6HzIFboovrxfiT6bD7aY6hwL9JGEutg1ImaoMQd1CLMc0Qtng5OXqmu378KyFeoJcAzbOViSwJn+OkVdC+RW/pNzi+t25VnRe8pqnTqEHw6FM/jx4IcTRoVKd4JiqtCBMlQhAu1VNMeUTaUvDLHbBMj2ZjPuz1UbR3VMCat+yu6S1Az9yWWLMhmGCa7YnIDHxVyFVxlXwsVchQx8cnR1PeKDu3bfHGp1ExJ9fTZ/7YUoJ8x19HAb9wnCuFa3FjVkuGWkhP7k1rNOwjDDlgRxtB1FbCX+6CK23Klw29C4imFMMZjdHqpgJ/LXYjeUHFDKO2HRhWAZ9v5CR/uRYh90HO5tSmZ3zyKT1yfF9pA62RjVDt3GcVLHUmNoULTRgkZKnDbHSJyW0eGiOZSVUkwTmygJHk/MDNPYH/UEE5B71MlNiwzPFn1W2D3bsHN4cUfeyL6k3fHbC9MgOXTLNxLeplzePzo8XkgkjG3a7quzW5UMvbTspMjyRdyTDc/8wcsex/EcyB0Oj5wpRDO4r2UYQAoxpIiAtwEYGQADAoYTMIcIbJlBf+2vA+kAOoD214F0IB1AAfDasnZfcrlPLvv5cZKfzHKHKKKMKupZM7slQqSRRR5FlFFFnU2EGfUwElQWYBhACjGkiIC3ARgZAAMChhMwhwgptNchOrymzO+YdUAWDohDtkEctdfIbgPi0Foh3s42yEKEOLTXiLfp3iFD1K69/cvkm9cZqvB/opfaGb4fb5uOpKe0O/gaKTvd6p6WDkUiBhLSIpvqr5DJJHRXWrH4RHO1w5NVqfbNKyN3fNNasWuwa0OdgVDUfgFhc0niUyl83K9lIolcbxV/S8I4W5rQE8ZYtGordncY9x0VLyT+Ko77XvxFBMCS891fYR746n1Y7AxB8+7fXrHKndKdhG292QvN2y7f3oX3wE+lk7sKNsJvIlwEBFjsV5IRrCOT+fMC7Xh+2i8PO37/ATmWgfJfUP+d1Hrv+3vStN3kRaOYv2/YgJ2ynYQf9B3/bsULP1fBtVqbs30KDwE=)format("woff2")}@font-face{font-family:"Europa";font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,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)format("woff2")}.c-navbar{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:#f2f2f2;border-top:1px solid #d9d9d9;border-bottom:1px solid #d9d9d9;line-height:1.6180339888;padding:16px 0}.c-navbar--with-submit-button{padding-bottom:24px}@media only screen and (min-width:540px){.c-navbar--with-submit-button{padding-bottom:16px}}.c-navbar__container{margin:0 auto;max-width:1280px;padding:0 16px;display:flex;justify-content:space-between;flex-wrap:wrap}.c-navbar__content{flex:0 1 auto;display:flex}.c-navbar__nav{list-style:none;margin:0;padding:0;display:flex;flex-wrap:wrap;align-items:center;gap:16px}.c-navbar__item{flex:0 0 auto}.c-navbar__link{display:block;text-decoration:none;background:0 0;border:0;text-transform:capitalize}.c-navbar__link,.c-navbar__link:active,.c-navbar__link:hover,.c-navbar__link:visited{color:currentColor}.c-navbar__link--is-shown,.c-navbar__link:hover{text-decoration:underline}.c-navbar__link:active{outline:0}.c-corporate-footer{background-color:#f2f2f2;border-top:1px solid #ccc;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;padding-top:16px;padding-bottom:24px}.c-corporate-footer__legal{color:#666;font-size:1rem;margin-bottom:0;padding-top:4px}.c-corporate-footer__link,.c-corporate-footer__link:hover,.c-corporate-footer__link:visited{color:inherit}.c-list-group{list-style:none;margin:0;padding:0;line-height:1.4}.c-list-group__item>a.active,.c-list-group__item>a.hover,.c-list-group__item>a:active,.c-list-group__item>a:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-list-group--sm .c-list-group__item{padding:8px 0}.c-skip-link{background:#dceaf6;color:#004b83;font-size:.875rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-align:center;padding:8px;position:absolute;inset:0;bottom:auto;z-index:9999;transform:translateY(-100%)}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#004b83}.c-skip-link:focus{transform:translateY(0)}@supports (gap:1em){.c-listing__view-options{gap:.5em}}@supports not (gap:1em){.c-listing__view-options li{margin:.25em}}@supports (-webkit-line-clamp:3){.c-listing__intro--truncated{overflow:hidden;display:-webkit-box;-webkit-line-clamp:var(--listing-lines);-webkit-box-orient:vertical}}.c-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background-color:#1b3051;padding:16px 0;border-bottom:4px solid #1b3051}.c-header__container>*+*,.c-header__menu>*+*{margin-left:2em}@supports (gap:2em){.c-header__container>*+*,.c-header__menu>*+*,.c-header__nav-menu>*+*{margin-left:0}}.c-header__container,.c-header__menu{display:flex;align-items:center;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu,.c-header__nav-menu{gap:2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px;justify-content:space-between}.c-header__brand a{text-decoration:none}.c-header__brand img{width:auto}.c-header__link.active,.c-header__link.hover,.c-header__link:active,.c-header__link:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-header__link,.c-header__link:hover,.c-header__link:visited{color:#fff}html.webfonts-loaded .c-journal-title{font-family:"Europa","Trebuchet MS"}.c-publisher-footer{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:0 0;padding:16px;border-top:1px solid #ccc}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-top:8px;padding-bottom:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:left center}}.c-journal-header__identity--sky-dark-blue{background-color:#1e9cc3}.c-journal-header__identity--sky-dark-blue{background-image:url(data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" viewBox="352 376.9 1300 89" enable-background="new 352 376.9 1300 89"><filter width="155.5%" height="156.6%" id="d" filterUnits="objectBoundingBox" y="-39.6%" x="-35.2%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="c" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="b" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="132.6%" height="132%" id="o" filterUnits="objectBoundingBox" y="-22.4%" x="-20.6%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="n" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="170%" height="171.1%" id="m" filterUnits="objectBoundingBox" y="-49.8%" x="-44.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="149.5%" height="150.3%" id="l" filterUnits="objectBoundingBox" y="-35.2%" x="-31.4%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.9%" height="175%" id="k" filterUnits="objectBoundingBox" y="-52.5%" x="-50%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="j" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="135.2%" height="134.9%" id="a" filterUnits="objectBoundingBox" y="-24.4%" x="-22.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="175%" height="175%" id="i" filterUnits="objectBoundingBox" y="-52.5%" x="-47.5%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="h" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="171.3%" height="173.7%" id="g" filterUnits="objectBoundingBox" y="-51.6%" x="-45.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="150.5%" height="151.4%" id="f" filterUnits="objectBoundingBox" y="-36%" x="-32%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.5%" height="180%" id="e" filterUnits="objectBoundingBox" y="-56%" x="-49.7%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><title>identity BMC series</title><g opacity=".756"><path d="M416.6-308.9l42.5 43h-42.6" filter="url(#a)" transform="rotate(180 772.3 55.5)"/><path fill="#FFF" fill-opacity=".107" d="M1128 419.9l-42.5-43h42.6"/></g><path d="M273.8-280.8l59.1 59.9h-59.1" filter="url(#b)" transform="rotate(180 637.825 92.033)"/><path fill="#FFF" fill-opacity=".107" d="M1001.85 464.866l-59.1-59.9h59.1"/><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M943 405.3l59.4.1-29.6 29.8"/><path d="M-213.5-308.4l59.1 60h-59.1" filter="url(#c)" transform="rotate(180 150.533 64.5)"/><path fill="#FFF" fill-opacity=".09" d="M514.566 437.4l-59.1-60h59.1"/><path opacity=".242" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1085.5 377.3h42.5l-21.2 21.3"/><path fill="#1b3051" d="M1085.6 377.3l42.3 42.8h-42.3"/><path fill="#1b3051" d="M1127.7 419.9l20 20h-20"/><path d="M-154.1-248.5l27 26.5h-27" filter="url(#d)" transform="rotate(180 193.907 107.683)"/><path fill="#FFF" fill-opacity=".253" d="M541.914 463.866l-27-26.5h27"/><g opacity=".313"><path d="M178.4 564l19.1 18.8h-19.1" filter="url(#e)" transform="rotate(-45 193.913 94.39)"/><path fill="#FFF" fill-opacity=".53" d="M515.008 437.424l26.8-.212-13.506 13.505"/></g><path opacity=".16" fill="#FFF" enable-background="new" d="M455.6 377.6l59.4.1-29.6 29.8"/><path d="M137.5-281.1l29.7 29.2h-29.7" filter="url(#f)" transform="rotate(180 486.862 76.365)"/><path fill="#FFF" fill-opacity=".073" d="M836.224 433.83l-29.7-29.2h29.7"/><g opacity=".359"><path d="M470.4 530.6l21 20.3h-21" filter="url(#g)" transform="rotate(-45 486.862 61.764)"/><path fill="#FFF" fill-opacity=".53" d="M806.74 404.922l29.202-.495-14.85 14.85"/></g><path fill="#E4002B" d="M-333.5-327.9l28 28h-28" filter="url(#h)" transform="rotate(180 193.5 38.5)"/><path fill="#FFF" fill-opacity=".276" d="M720.5 404.9l-28-28h28"/><g opacity=".488"><path d="M-.9 484l20 20h-20" filter="url(#i)" transform="rotate(-45 216.435 -406.437)"/><path fill="#FFF" fill-opacity=".43" d="M692.39 376.876h28.284l-14.142 14.142"/></g><path d="M-305.5-298.9l28 28h-28" filter="url(#j)" transform="rotate(180 221.5 67.5)"/><path fill="#FFF" fill-opacity=".073" d="M748.5 433.9l-28-28h28"/><g opacity=".548"><path d="M27.1 513l19 20h-19" filter="url(#k)" transform="rotate(-45 243.935 -377.437)"/><path fill="#FFF" fill-opacity=".43" d="M720.244 405.523l27.577.707-13.434 13.435"/></g><path fill="#1b3051" d="M692.5 376.9l29 29h-29"/><g><path d="M167.8-249.7l30.3 29.8h-30.3" filter="url(#l)" transform="rotate(180 517.48 108.09)"/><path fill="#FFF" fill-opacity=".073" d="M867.16 465.88l-30.3-29.8h30.3"/></g><g opacity=".453"><path d="M500.8 561.5l21.5 21.1h-21.5" filter="url(#m)" transform="rotate(-45 517.492 93.077)"/><path fill="#FFF" fill-opacity=".43" d="M836.914 436.105l30.123-.283-15.203 15.203"/></g><g><path d="M-153.6-308.4l59.1 60h-59.1" filter="url(#n)" transform="rotate(180 210.467 64.5)"/><path fill="#FFF" fill-opacity=".107" d="M574.534 437.4l-59.1-60h59.1"/></g><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M514.6 377.8l59.5.1-29.7 29.8"/><g><path d="M612.6-285.8l46 46.9h-46" filter="url(#o)" transform="rotate(180 970.07 80.547)"/><path fill="#FFF" fill-opacity=".107" d="M1327.54 446.894l-46-46.9h46"/></g><path opacity=".137" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1280.7 400.1l47.1.1-23.5 23.6"/><path fill="#1b3051" d="M942.8 405l59.1 59.9h-59.1M514.6 377.4l59 60h-59"/></svg>)}.c-journal-header__identity--gold-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--gold-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-green .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--ocean-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-red .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-red .c-journal-header__submit-button:visited,.c-journal-title a:hover{color:#004b83}.c-journal-title{font-size:26px;font-weight:700;color:#1b3051;line-height:1.4;display:flex;font-style:normal;margin-bottom:0}.c-journal-title a:visited{color:#8e2555}.c-journal-title a:hover{text-decoration:underline}.c-journal-title a:active,.c-journal-title>a{color:#0061a9;text-decoration:none}.c-journal-title>a{color:#1b3051;display:flex}.c-journal-title>a:active,.c-journal-title>a:hover,.c-journal-title>a:visited{color:#1b3051}.c-journal-title--footer{font-size:24px;margin-bottom:8px}.c-journal-title__text{display:block;flex:0 1 auto;align-self:center}.c-logo,.c-logo>a{display:flex;align-items:baseline}.c-logo>a:active,.c-logo>a:focus,.c-logo>a:hover,.c-logo>a:visited{text-decoration:none}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-journal-footer{font-size:18px;border-top:1px solid #ccc;padding-top:16px;padding-bottom:16px}.c-journal-footer__inner{margin:0 auto;max-width:1280px;padding:0 16px}@media only screen and (min-width:768px){.c-journal-footer__inner{display:flex;justify-content:space-between}}.c-journal-footer__summary{margin-bottom:16px}@media only screen and (min-width:768px){.c-journal-footer__summary{display:flex;flex-direction:column;justify-content:space-between;margin-bottom:0}}.c-journal-footer__issn{color:#1b3051;margin-bottom:0}.c-journal-footer__contact-title{font-size:18px;font-style:normal}@media only screen and (min-width:768px){.c-journal-footer__contact-title{margin-bottom:16px}}.c-journal-footer__contact-list{list-style:none;margin:0;padding:0;color:#1b3051}.c-logo{display:block}html.webfonts-loaded .u-h3{font-family:"Europa","Trebuchet MS"}.u-button{align-items:center;cursor:pointer;display:inline-flex;margin:0;position:relative;text-decoration:none;width:auto;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;line-height:1.3;justify-content:center;padding:8px;transition:.25s ease,color .25s ease,border-color .25s ease;border-radius:2px}.u-button--primary svg,.u-button--tertiary svg{fill:currentColor}.u-button,.u-button:visited{color:#004b83}.u-button:hover{border:1px solid #666;text-decoration:none}.u-button:focus{border:1px solid #666;text-decoration:none}.u-button:focus,.u-button:hover{color:#fff;background-color:#666;background-image:none}.u-button--primary{color:#fff;background-color:#33629d;background-image:linear-gradient(to bottom,#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5)}.u-button--primary:visited{color:#fff}.u-button--primary:hover{border:1px solid #0061a9}.u-button--primary:focus{border:1px solid #0061a9}.u-button--primary:focus,.u-button--primary:hover{color:#fff;background-color:#0061a9;background-image:none}.u-button--tertiary{color:#fff;background-color:#33629d;background-image:linear-gradient(to bottom,#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);font-weight:400}.u-button--tertiary:visited{color:#fff}.u-button--tertiary:hover{border:1px solid #0061a9}.u-button--tertiary:focus{border:1px solid #0061a9}.u-button--tertiary:focus,.u-button--tertiary:hover{color:#fff;background-color:#0061a9;background-image:none}.u-button--disabled,.u-button:disabled{color:#333;background-color:transparent;background-image:none;border:1px solid #ccc;opacity:.67;cursor:default}.u-button--disabled svg,.u-button:disabled svg{fill:currentColor}.u-button--disabled:visited,.u-button:disabled:visited{color:#333}.u-button--disabled:hover,.u-button:disabled:hover{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button:disabled:focus{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button--disabled:hover,.u-button:disabled:focus,.u-button:disabled:hover{color:#333;background-color:transparent;background-image:none}.u-button--full-width{display:flex;width:100%}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-color-open-access{color:#b74616}.u-color-inherit{color:inherit}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-block{display:block}.u-display-flex{display:flex;width:100%}.u-flex-wrap{flex-wrap:wrap}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.js .u-js-hide:first-child+*{-webkit-margin-before:0;margin-block-start:0}@media only screen and (min-width:1024px){.js .u-js-hide-at-lg:first-child+*,.u-hide-at-lg:first-child+*{-webkit-margin-before:0;margin-block-start:0}}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-style-bullet{list-style-type:disc}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-8{margin-top:8px}.u-mt-32{margin-top:32px}.u-mr-8{margin-right:8px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-pr-16{padding-right:16px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-sans-serif{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}.u-h3 a{text-decoration:none}.u-text-sm{font-size:14px}.u-text-lg{font-size:24px}.u-text-right{text-align:right}.u-h3{line-height:1.4}.u-h3{font-size:18px;color:#1b3051;font-style:normal;margin-bottom:.7em}.u-h3 a:hover{color:#004b83}.u-h3 a:visited{color:#8e2555}.u-h3 a:hover{text-decoration:underline}.u-h3 a:active{color:#0061a9;text-decoration:none}.u-vh-full{min-height:100vh}.u-hide:first-child+*{-webkit-margin-before:0;margin-block-start:0}@media only screen and (min-width:1024px){.u-hide-at-lg:first-child+*{-webkit-margin-before:0;margin-block-start:0}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}.u-hide-at-lt-lg:first-child+*{-webkit-margin-before:0;margin-block-start:0}}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-gray-link,.u-gray-link:hover,.u-gray-link:visited{color:#666}.u-link-inherit,.u-link-inherit:hover,.u-link-inherit:visited{color:inherit}.u-button--tertiary{font-size:.875rem;padding:8px 16px}@media only screen and (max-width:539px){.u-button--alt-colour-on-mobile{background-color:#f2f2f2;background-image:linear-gradient(to bottom,#fff,#f2f2f2);border:1px solid #ccc;color:#004b83}.u-button--alt-colour-on-mobile:visited{color:#004b83}.u-button--alt-colour-on-mobile:hover{color:#fff;background-color:#0061a9}}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem}.c-header__brand img{height:16px}@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;box-sizing:border-box;color:#333;line-height:1.6180339888;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased;font-size:100%}*,:after,:before{box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff}body,figure{margin:0}button,div,dl,dt,p{margin:0;padding:0}body,dd{padding:0}abbr[title]{text-decoration:none}a{color:#004b83;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word;text-decoration:underline;text-decoration-thickness:.0625rem;text-underline-offset:.08em}a.visited,a:visited{color:#8e2555}a.hover,a:hover{color:#0061a9}a.active,a:active{color:#003b84;text-decoration:none}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2{font-style:normal;font-weight:700;color:#1b3051}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h2{font-size:26px;margin-bottom:.5em}h2,h3,h4{line-height:1.4}h3{font-size:18px;color:#1b3051;font-style:normal;margin-bottom:.7em}h3 a:hover{color:#004b83}h3 a:visited{color:#8e2555}h3 a:hover{text-decoration:underline}h3 a:active{color:#0061a9;text-decoration:none}h4{font-weight:700}h4{font-size:18px;color:#1b3051;font-style:italic;margin-bottom:.7em}ol:not([class]),ul:not([class]){padding-left:.9em}dd{margin:0}@font-face{font-family:"Europa";font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,d09GMgABAAAAAHfYABEAAAABgDgAAHd3AAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGhAbuR4cCgZgAI0OCIEYCZoWEQgKhMYgg9VEATYCJAOPIAuHUgAEIAWhMAeaUQyBI1vdQnEEPe2WAPG7bQALVt180uY1bJtJ87sdU16e81EBOzYa6A5C7j0tSNn///8LkoqMmXaYtGwiwFBV1f//fUoIkDlm1FFoCQVICLUxcEzITBROs0ksOU5YhTbPsdEGKyaZ6Mp9PKPWi3eVnC0inIhbONEG2O5L8GHyEOVxlbmb58HFOY2wC3LEcrJURzlC4BoMVMsXqtmu78zdtOLVn+iqvPUnupUTJqwsLWlGZJ8fbkUdopqNT+9Tm1M9jaZ5I2hHfy5/fbWX80m309Ahu8uhKx6nbxs9KWcN28Ek+VNE2ks3WpbCfHJzhPevbGqvzTIJ2l8oB7+V3q7yBB7mw/79e8HBtuIVNmXsFnMh9di+P89v7s+99/Heg9Fj4cTJikVaG9JDRJy478fIXKWR9SNiUWXPqBm1MoHneZ2+5z6Q2LYMpDgoEwYAnD8V31Zatm4dyz//7Pf/m2uf+8UkiiWD5NK8kTx7SJRCSOYVGoPs9YVC5QzQ3ErnJGrAGKvbLYtYsLGxSMaAY5RkSqhgICmi/QIiWIWYMYzEAkTfCqzAwPg33VAYIOCs9ym0YLJcf4IhjEJZft628o0rI4b4YLIDLB+x40S1TFMkXXWatKHn2/X6zQQSW8YHBke28P+p9ktFR0hqrnjkHbkjm6RNkP2XJBHl/bGClqJ2Vx2ZbKVNi6b2pKm4yvRMBq4CAGcivc1rIuWtaBSCALi0pZJOZ8/sPthNHaCKuLJZKx38+57vYdIaKEnrbwPUAVMFeAHCChIg4J+Q5cyxf0S3sUKft7k+iAg2lEAIoZrSyCjT6s5mSz/u4XT6z88fl23/t0edwGjNEKOhVKbcSkgcolaqVGbdiy6QH+LSirep0RdFFr0Xw19ck0rr+L1O6575HoQ05MFIIjhkbO+y7OVQXtGlomm2IyAA4se/PfVOq6pe6P4ga2wNCGODcQzYkwOoJ6UT+52+2NOe9jwZ/jO17d4RUl6NL8yrUc+Xe2IY26AeipqKrkNFW0aSKfcEBdr6LU+LI2DimqD8VlF3mZvAhCL31dRvpw1jT+cYm8l1Zee0+xwp1waRkASHIlgQtKq0/9BgW7tcgCYqLy77+XMX8Nz/7FM99B2iFsbkdUN0tmnriNSVYYSguT2yEOr48MIwW8qFEiY6tPr/u1l/39nu3fM7CCTZdfAxw8csOhCa4netWTVmjhCAObUntJ0UCJUO+YUa2NwoSaIFDv4om27TNK9wIO+0fN/cdJl7KlYwV4J8snAzvKnra99oDNjwg9kUCeefYtGY+GPuLqTySr33ZkbzZkaSR8H2SLZBEgYnwJIMRpbZnWQsydpdYJPxRrMhJQUva9nsX8veBD9tTr8HLrEXYmoq9qofUnnllVfUV6VQlNURVatmJwO1EiFHIk9IFNJeNG9p1MUqJIFauY7H4izhR568OIVyYHFYi3bsN/dlj7ru1Em18Pyek5Ok7Yf2CDHTSdP5f2f7DxCFAlQopFuC75/79PiA5FKeYWIBCfmfbJ2uu+64+7Z6TwUKXi9WoYIV5PYimSyQyuvnPu3NjT99wtbJ1uiOBwxP8l+6B5n8EjgA+Pxgsxv6JVYAoIh8haxQVbJTP3/l9KRCVqg6jCZYNUzPl8nqzfTQzYdbcf+9Ts/hTLOKICQK5dASid//9fOdO/0JEpxUt7V59KUSWG6PhzewBAPpT1+FeMD1Oh5fi2MRQuieeuzJ7bd9lfvsOZK7h6HpOZDGFdOIFJWKGCmM6eT+200gVZjl2u0B7aQwAQ3+pv1CbdZuJ9p2K54QIQpRZPc+9fLnepaiZ8kDW4mNktA0NDtWJDDvK4dMraKkO5G50v+98ZomWjUIqc9AR0AA+EY/BvbEeDyFQQ89YpsELAoAOFZnZ/TG6xvWABvWjNGEtZWFyOZ8xKHDWsREB3T06CoUZ1tDRDKKMckcy2yQiqBY6oTYFjedEJ0iYndXlrJ3EQQnIJ8kdH8CX+pbTsi6y/aCvTJTszF7czFS74xPIs9/4QER5LDChnIsghEn8OMO+hPTLdeD62X2FutteVzY/57Xru0Vv5/HYnIYzFgmcipnsptW3pB4h49E89/+yyDxZBGkZGUoTyWq1Ey1yKoLJfXcrMDb4ba53LO8wBves9fX/Vp4q0vpeS87o5ua3hO196redrZroqaikKKACGJOXuqzkaME05nes+z9iec1L7OwmRSRKCVmFiWmapdLmiSdO0Zu08XNwMzSbGrvml7MXK+vu4GyNjZD4owkcZOkxpY+wM0JmCG8Y6obJrxRwhsIq6qOqpjukalUXFYkEpJLz7AnO3jFmBtPp0vATWwchDHTWXRZA7s5+3OYXF1eVz5TMFKoSLESpcqUq1CpSrUaterUa9CoSbMWrdq063A117mp0x1dnnrupde69epv76Yiqahp6RmZmFmK15L0riOGSSNO96JSnEgNMmQ/k+e8oKQoCYp7cS6uxbG4FafiUhyerV1SPZElFCktbQOv1B3hWMxKYouzM9PDOBFJdiONW2Y4ZF0pI6EKsQUSjHPYDEJCcBFUYzM/K2Kj2J8/NxlMkzULNwdJlJNMk8YoU3K6da5fHsmXAgpTJMUjJUqVKVehUpVqNWrVqdegUZNmLVq1adfxeIW7xg233E5Xl6c899Jr3Xr1e9ffcx+bYwp1rkPlREBEwpkLNx7rEeVFlopqVEZS09DS0TMwimYyitlollj1mCKb2D6n2eZZYJEllllhlTXWJbFLqpZ+jy2c3woJYkYSQiItE/uYUguEzoiNkbSxszmT2E0XhuoxAtW/IBVkgGy4fvoX3Q890ynfkundq5hiUk8JlypDdhW/z62t935GeCPlTJeSLIJpdCR5KnHy+UyS5E7CA+I4YXgCcWIBZoqFYi3VnTKnJU0yS89V8hQoVKxEmXKVqtSoVa9Bk2at2nS46rqbOt3R5annXnqtW6/+9m4qkoqalp6RiZmlaK+pUoxYOKGrpic4P0ByHioriKBDDHKMNDlCflGkVIVqdRq1tPYzTS013cy+vlobW9wD1H397qFZwBhgBTHADiaBKaQ5IA8KoQTKoQpqoQGaoQ2uwnW4CZ1wB7rgKTyHl/AauqEX+uEdikRFTUvPyMTMwtonVGY3qSj9wYRHwm65GRgZ43i6rBmoqXVnCPrW/TU2UGpjMySujXwYVUH2+M45e5yTH4t3iihRqlyFKtVq1WnQqFmLNu3JmjKSpYT6lujOSDkmtX5qf6KJdV/sKmxykwpnQX9b0OoLLEHvOyYdpfMwqfWLnaLOTB2Cbq5ih9LWZ8wFlezGHT3duAgvsQ1gneWYCqENBk3/iacfVOz/FC22LPB28e+Bb3LrjnEhnje2QBuOjtmqMYyvOz6WnX0HDgXx43nl2TcX06RKJ7xa3o3l9WJ35mfgcDAlxBCxX6Sr/7PtgB2XWm6ueI6DMP5anFEvKs672xevMISHY5Mmnvr/7bw+6z9/PbGeRt9LpPe+wvnqd77GYAd1VNVC9D7oO4HFKKRIlS5Dluy6WgE98QJPqiChwg03gspIaho6BkYmo4xmYTVWLLuJJptiqulmmGWOBEnxSFqiMv+93SFHnnyFipQoVa5ClWq16jRo1KxFm6uuu6nTHfc91OWp5156rVuvfu8iKMThAZBEoYWEhonEEmm4TB6hiDaNMo+2WGNssRPsk6ZMnT5z/YaNm+LiExJTUtPSMxC4Bkg4Z+ZQr6bjOnKOfEVKVahWp1ELwenpy7lCZTrqMo416TKcflp16kmi6aqTbFc34/Cjw/toZuHmJwv2V3fIladAoWIlypSrVKVGrXoNmjRr1aZDohvkGRx+G5kqddr0GYtMLcB05cf9emo1zWwWzE9oBhkONmKaPDVA1CA6KEY4TNBGwbgP8rCFGlRwikLydo0vi5IlgGWEgooqqJEFpSkoXUEZCiq6oEYV1OiCmlqopltmsqxXOG20xLEkKHQpljSWDIUpq3ECErTJbQ8AGSd4HmzhHxAAFAAWAA+AE9MjNss3/6KFBABEADgAaABc+HwGizt9jPDO15i3OWEeZWGCK8NbxLgmL/eE/hC+oFPYLWhjMCqDO6JNcHYpNAbzwBxjI1gymBViLJRYOOzQJsOYAWsWXHNAdkDJAykEKQEpB6kCqQVpAGkGaQO5CnYd7CZYJ9gdsC6IpxDPIV5CvIbohuiF6Id4N0MUaBknHUWiU0XXqFm0LHoWI4uJxcxiYbGyxChMNkssywaFbZMlniVR4ZZqSddYhfUq0HUQc0SEHActXowpEQtYtii5EUGUAoh4UYohEkYpgwgZpRIiZ5QaiKhR6iHSRmmCCBylFSJzlA6I2NDiiCOOOOKIFi1atGjRokXP0kaMGDFixIgRI0bMFtOEWNjsrpnEMoVlqlVIfYVmkfzCwo9xrX5PxrkDONjZNYkAxs2X0GuUc/kM8RRvEQDgAvj5Oeh83zwok5+cGgtG8H7jLHQoA/JvMgCHAQD6bXIAKD5UImcvPpqwVY5A9o1H1w/A1afyphRAdPq55/05F4WVYqNNvvcLMWcCq7lxN4CHgeQG8TSY4vkLlfjHn/7FRQsSLESoMOEiDDHUsK5hUaSofolok6g/itHH/OutscEPZI4w91DimONoMcaxGS/WZyb4vKeyTzqK045kZso3W5y14klBH7I9tzwpLF0LFchVrFKZGp2e6uoLsuaGuEiARCg8VW+6Ov1zZF5pZZXjJz+aZ76lttjuoOWWWeGwQ/7SnsE3fvWf/y1wyRe+8qXLvrXSKhd1FO4XHr7zvrbY3wCSJBPBcpSmaUx6Llx9nsR95QP9u++aVW1nLZQg0U57/WyzNJk4ijyT74XH8RAfCRHbR92vAN1qbpmlNh6OOuOc40446ZSzTjuG2iQD2CYTnf+9BAhnNA9AOscwo6l87biliRmHZO/U59TvdNfpgXO781bnk7gm3BjgBwQBOAAEKAAPkABqoByYBswFthMCCCABIqQR2gj7CAdAJ9AL9AWDQBzIBPVgBphLvkTxpeSaSOX89/ufoH77sPFl/Lee3up7+dcBAChEiDbfhWBIiKTJC2hoYzJX0DQKFeenAw+ne/nqcZ8BBBAIYADggRbvOxmof30cIYWwpLIPlTPFm/46I/5b5k+H/j8dRvnvcKGm6346Hm/K7uQf7W/A76HfJ36f/O3+678Pd598ejL7sdNDlkevH914LB+pHwnNHXmPDj0+8kj/dkyPiY85zfvhpZvHAG5+cnPXzfSHax9O8TLvdhb8hdG7Lfl4PpAr1FZhgC0uKQrQvUMB4INFujhcML42NuMVxg+MdozOlfeOdkzWcbuPceNLJ1Ed/+/xGvdj/Ap95yUWWGepQ5lXSnK+p5Y758fwRvW01eHC2212qi1WSebNT0BPs2kZut0tjz3xzIvYOjsd3C3sreyPJM6uuLub3bRmOyhXgWJlKtXo0LnhCDYBOamKDPeSbbsh+73zpZWhLdmbXkuz1KnX6P/wF6FWV1x1zXW33XHDTW9069GrT7+33nmlmCqYF6jEFUk4dP3Ah9cwRkmbN2bjVv7f/3FgCBShNmKa7ry4QJL4yc+28OHPiy+lwDXVUnOtvvKbPQ50rrLKq6iyqqqrqba6/steX8c63olOVlhRxXYo1lnaZZ+RTMogtqjpA/jX6oDj9L71v44r1u5J/mp1LQQX8jmJ1w2HIsO6ag6Pz5m+WhX/Bm3rzd9Y9yGpgHtpnqVn/5CvnuHdfEic7FN7Kgca7j2irP8fpPw86nZt7bwHHsHGZiNYUokBDJI4COBoT/x/iak+jKM8p/nuHK9OHsLy6mPy5t3w8ISbl9MR6MmJ6bVt+pRVAwP9HqPIWoro3rjoBoH/iS4k5h88gb9MZUZI3AJ/tYzBuKrkt2IcmOdswM20n3OAQIcogrR+T1DqErZEvBI/QmxGIkBilxSpvWrbKCciK7nkaIpFx3wXPfb0FdRKg8O/v/fanTQGi9hJpXP9KifLPgt0k/IFxxaLe6gABYwmI+BCIvTl9pRoAoqxR7UHSIcEdhxgEJldBO3+M6lV6yAPkYvdZZbdFsvIzCfN4zUv9o1wqEHiEYyEuQEbjBXNh6NGJVhULvDFuZL9fZCAOqDN+hn8dISmMkWL9fDZ0jwCETETGOO5vqS315nP13xAouK9mn+aWUAGLCREPW0Kf7aUmEmvqNuUFB1QECo/iHpPOpwPGSUVDS9PkEu0gMqzN6maz1m+gPRlPwIaz3bSs9c3ZOcfaOMNdSooesuX58hIEyl7hg3KYk2+UmkzsmXqg69LlXPNGIuDalGXq429gTVnyZWh6m5lzyT3gixpJ8scHTmZkd4wFShshgguR0xYTS8Ag40avH6TKJeoOXGJRAUiogrS/M5WN9NSuojDH//VKefvz/vnc8CkgjEJWFTsB7AtOMhZCOBYSOBaKOBZaOBbGBBYWBBauIY6JnIFL4QbYWrA3gZH/0CjYEqz5Ltyc8qg5OdqHbHB8FS4UTEVUQlqJA8hBQgpQkgJQsoQUoGQKoTUIKEUtfjoKGiFF7LQ1C7FqRyDEszM9BdMG1pOaxzoIC2lwKD1t8wZmi8VXM+dXblmky0640rlzXmyYoi5pJ5QDIpCfXSd1iswYAN1ByeNeMcoLwj2L3jt8vt9u1X7eZOxK2WIWi2J/cUEm/5WYERzug2MqwUQ7VYdYULF09ZFNVpCcUg0PRn+3xQrvZJ/KC4jJY5nOW+euBaYAtioVWRjnzHISqjJ/rAoUjugSnFR7FZzUAT5DtYaVry8TAJdpZ/qZPvEzVGq7b0cowlWGoo1L6ctCkZjsa0IzENGFlxlzyDU7xUFlHp3FooV060f25sEWdlCksSQBxYo+44xHGvRVjJ7qZAqPwJQ1n/RrQCRod6IRgD8JnV2UoVnaQ5kIuCleqgKdLL2VmB22w1bxi9AHSLFOee8Q4ywwo3lbmrUmnfvuAcIUcV/2bOrpCeBnZGcoU6zSoK09g8sqHBITlWFTHnALifblktMjQDDF1SUOucvd1ptbmo7b0wCy5KPXbmub9TOdO0LvYKpdxa2hgsf6EKmBRkyl+WBVEPbAxt2kVly6kA6uaqpVWO3EK6+pbITFiutKw3+mliaLOoBsk9yaw5IbRxen+kDuwaYTkRA9leNFxNvR7YXNoapg2QNbtfIOL5RjjcMx4FjXuyJCtjGcUbnwBWYfAfnWLDnpkaLgQZ277qK/spsT2HXGBWOvD8pzQLoU4kycMcsgDkd+YjFAtgigTgwwl1+IrluiTegAV+i1yTAAIR7IUiEBmKJQBIMhDQd9VgydBFyIAgFEEA5HfmpygLUU4lq8EJsKVE33UFXsQsEsQcEsQ8EcQAEcQgEcQSElWMq1k+eOLFkmLuSKcUKs484NhTXOKeSX1oMCPRyEoFVDbaI4trCkDY3BGkL9I7asY9Ke4MgHYAAjjXYY4knC0M63xCkCxCoK/uodDMI0h0I4FGDI5b4tDCk1w1BegOB+rCPSl+DIP2AsNofm/x+LvgL1S1EBn9/uZ9p0nM1LbiZDQj6VUYo70X0c2uZ/F7W/gIY/oDx/7xuM4LJH/9lRQxgHAycRTIhoEEkxolMIp7RWSSrEqnv8RMqGazRrOYiG7hUUzLymwhmqOkc0CKZCjWZxFRcA3K6Ps2sm6Jv4kwkcnEUTZwqU5rBjqG66kIV4CRnRohkglTIr4qnYa7zJhHnxonFTYVDDderHIYsdW0uXfrE9JAkF88EERPhuiWhKu49fmkiad9UuTsJO+c+MJYb0leBxprwjltAMqOhNQtlfw7/07FKBuYrmCUkA8g9jGJsFe7e6+C0qWmTybJG2O+IC3WAcMS48PXYT0iPw02ElMdSBYvIDGnK+p4hhlhbayLnJHqrPBmO1Clz5dkVO9OcC8/g3ODkrbjCgWpytfl2e+XKMQx36nf98HLT2p+FtQcrSah4lwrDeHOlyvJ2pcrYFhYrMm3xCtv8Vd5P4687ZoBImEi2nTwcBcFYu40orVZlsaE2DQXYLwXQaLGsVqFkhD50DnDK4MopIECAQAc60KH9bcd8ypj/KaFkfWHrQIAAmcAq+Jo9llnw2pQYcKaBBnA+HHjgc1nuS0pTh+IQvS7A2JlhOTEJbLALvAXuCwbryLR9b+iezoXcS5TzPZffA9DaCi9YwyDUw/ErowOkEIHSjuEMbgnkJBQPSHER+swA2uYTFA2vDItOd540eXh7gLUhyQiQlSrpsALpWBccdJSWTau1GRAgApaglqNOr5WBRKiUKtAEFP4WE72lSROglSs4OJSzjZdCPchPnmpmz1x3vlurFS9YAULw1wH15QGmR5GMaAMcKBSRAxI5q4IyxRRdntS4oraL1A3x0uWbkuH99tmMRRb2o2/vOZMfr5YhNXaGNCMyphsDJQQiCsJgBPN5Bq7qVgnH99ffGPwpnrOmG6+OqCgMcy7PUlFVDSiCIDEMBMIKjp+HifxNsjNU5gjPo85C4WaxGkxjOG2JKeVI0bb2TX96bvp2HAAb3lC500LCnnGPKd0grOkeXbUQqBrWzHvNnb4S66mqJKkS+AOyeTyiklTfEuF04j2NNXaCGJR9KpL72eySqOwp8rKuLVGDZTXrqwBz2utkXWkMTbOoeoyciRsmVCLbj4ALv/BQwyGdz6N6h0LlABx6BEML0cLRobbAUZbd5X42T6To08N+Fq7qa4T/z8fCvgab8Lre79K9ULVV8A8vHNhE1o8sUldFllUPdHP833j+ykTQ9qzhJbllQBH+AIaDf6ayR6Ub8uRwuE9c2wtuWm2fYf7IOuR/bSI6v8/FSPYY9RAcUDkinZHIa2N7LDFA7TPyRPZLVzWVROsj/OE75iIvZcDA7CbDzCgHqz8KkJiNz8gS3wXZtyc+cD+xIFe+1pin04BBYVKalERxl79v0IdGnk1xH4uq81yiZEImJ3EDp5ley7zgF8tg7mZs+IvXJTGImorlO7WltLS1bIRSuhwmnDTYCRXfVFKB+kF0KMFWXeG4qJXLnoaQm6G8xph1IBqU5iZhgQFoA39LGZ3bgl2W8L4N64ZCa/AnrjIFZq3Zn6mSgobqGcv346bIsW55ZBUFMjQIsbzl/PB3ar1abwhEhN1Ofb6kkB80b0Pq0UpkqRyPGnTgixSTkakN+vjyPLd793XqQRg8vBnBFbCqarfYwHr+NU2/oy5e1rXYl0qrhq7WmDB3orV1je19gwbnyundIrOK9oGjYY5g35oW9hCiPNKiGuDiSoHB6tJjo0Soz5qbdhy9AuTkuZ92CeurCUFuY/g7uABLzfnlsP+CBUFeJcz2qbihvvtkZUk7lQhT2O1H40NzVjd2vBLbIDBcQWXdZllsjMTbFoaR68VuSDWGGD13PkeVUdFhCbj2yePROV3/GK0R3vWftFDBES8sVOQ6Qgd8XJ7mBMGKUkkYR9nF1D/Hi4eo9lB8sjAC2l8sfWRHe4mG9Mc7/1qfFV/KadVdA26vdWbQmEnkXcUK6JgCH73gOA5bYBhmn3yYtUC5h6JfH+BLKbLooLpcyA7DWqVtbjH01B7f3rl6z7S6rO+8MXDUFyEA1Vubop2up16UunYXSidDGWoYnV0D8OvyL8bF9qj/Ak3qFIw5xlQZxfpQgtXMhyLueHw1lERDjzCylm4ZMmqjQSjEQhFKFeAeovc517dSsuN9VYKKfSbVX8Ev8eMpoZt2n0SYE0sUa14YYS2LKAoe2UV74oclnadjjdLepyH5QNTDtXebwxKzNwPzYHVljUvc3lSm7SmIIPvSRQNNTbFNxZnAp05O4DyqtZYS2r+QeKhq9vEABzyORCEJ3gvSsUwGLzP11KL21ZPpKqZpXtqTqiIv4ENL6IDv/XyN4xYhoK8cZxOrMf6hMrsKG3IKUQQCurKVjBR1RGbRb+YOEi6T7XY2IuepeVTx0uAh0tCwE88tAQl1zjZY1HOIkpCZByJ7RmQa7JGFRV5g+QP40FZOpMAcV1ALfS3RsSWEZEPoq/4sTGaX4pISFH5g3dLGWE1wbz3B2QJDjse44+KKWSOuqsHbfqm+jwG38KxfstBLFngaT6ygbxRBMHyZBxDW4ABYkN+uVHcECVueRXGxPPRAU0O9GSglgwRAWoXbsAYhYHsBe4lN9dy7ZA8rYXlQEAVck0lECqcS3VSW2xK1bpPiXItBRaDn0h94l/lGpY7hf7mR+Xefo2WFbIQZlaJc9dDU8Lwm1xeAbE8i1U5SWR5gurklia4UxXB7gU+WgbWWU30A2RBRxFRmPVsgWgwjE2TLTQYpQhGjvVsP2OSvuygPDBoBGDf5rBqNc2TWoLk6bBTiOaLF+bUCRMU3cxdfMcFfjLkIpNkezzd56wkeROJppFZgNG1JiuqWv1DmHxx/EuzpaViHknnyEK3TGQAPhd7pMseZqffeUFzib0fdMQzWl4cEWUqvl0gIyz4XV4ZRG4KVTz/J4RdYfVdI1TvZNFN4oxGOJtpR7GxXMll4SZWlcnPx64fLdT68O8WejXUq4KMHWbLLypPRnVBM5vbtSdzcFJUZRuCTYp4qG1+yCP+Xw1Dc+znTscwxHMH8A4XrvnPzohEMAnDU0HeSSrnnXeAGsN+F16jNh2qJO1viDtUox9WEucz1IHQOdTRuGsetQWulfL/hAT8x74FkN3KqoJRg6qX2qJBtJ8DB/+Be5O1iPeMHjRk0D15aRJYFiqZE+AAV+OYQTnWqC6Db1oJrO1MEXeYi4T6yO0riuHQKPuWoLUmK5Ba7GjKHuGAlbcnrZgUeIhdFWWw1WsNvyIZdjldHkOHgLtPa2z2T2GGhmkhVHtlapXtziXpldHzKU1Z5bYjKL1Mh6cvG6wcP1+FH3GzyKOhOFMozcEGXlDIX4GUbz/Hs9G0mKVZHnInJ+FR040S/D2k1tjYjEJgGhuE6YYosALQOQEgmeiL6a5cXhgOBsD0KbdV0wu9cdaHf8DYLDHNanYqR1PgRUdcXNQNmsTPtxPGES4/ip1ZtFWaQkOAkonAnhygwAyrABghQAPsyk5DhqOKA51jZbrpfSwiHw2HhfLQzAILBIHgQpoRrdtJbioKA2WXA/xnGGAhCb25DKtTgV7PKomUdd7UJrNC4LQoJXR5Y4UVoA6w7xa0aGtlow2iMyJVGGUPoVS1scjsUjWlV1GLajG6nM/7myqu3opsnBKTCL5PChteaH5pJlauwLBSwKywSLu4IKp2C7BiZdvMl2CDBei9M/1Q53wvrN0AjeCL0pQ9e5Dhn/1wdVB7fV4/aUwtxtepxXmMHIMzfoNJflgKaS/YlmgBfVOujAOT6IcugqwWupIyjMI03jcaQoyEzhJ7Ooscww9m+QxVm25tB0Ti+TfRHfHE2FCpe6y1IH7CtQxF2SxeFureSA2y5zqQ/nRczfuI0d+SAWnRtnlYLTKAXkpkfjJY8up/PInbjigLnz5q2sZVlzkDdZVmMfoXZGf+lyVmIazvmqMxAJw3Ryl8YhsobYYuX8RaFeQopt/1OTOEwQoqUvWhQMoUIEYgYmN0hJQXwRK3S9OZxweCNWhTPxsZRA+PIEIa+Jh2+AsFgAHPkq5vFRLBNMhu3pJDwtCXO0FyF6PORn3z1zdgFijW2tBiOtg2GUfDp2GDGMoF1aIyNr5hkvpRk3nwhwu1+iv0ecHSfKMZFUOPWXemdA7VIopFg7Oaq9pHUvs57RzgXltA1y49wMIFqSY24oCNjH9ScQ8RKnX9LoiKJgY/JsAH84ZTheHGtKKBZJJhDkdMIFFn41B3cBc8BZ1sb82Fy4D6SczIn3MvRgvwvyE0jI3PM2TzLslvgi/3U9SYi0zl5MYF0np6fbSP0pycBSyIzVkeTNaSMNYUs/7RrS+KmpnZXw4Oy39APWNxj7YMMz+d49qq1ZPpH73aKGI8PGbZPE1Rz2YtoFgLt6spGbc0PZuypbpu1y17cA9CuNhfgWLaO+KYn0RFb1kZH8SC3VCGuU42UxBDVlBfy32ZyroqcaiV0i1DVFiS5lHPmpJepVg0LZVDqjSFYTGYAfEM1RmHa6XXrCoMWGa6iashyoVEj87gXeGWMKQ+y85HgO02PSY2XXwRVFnj8jYzgoXSNchFRabLj8ABfzgRQEFrOn3uHYW9ZVODoKKtTPdW40GrYohfdaa6aLSUPLbfc0nWG9IwKZIWJcicMeOoygbGMN2HfhXJVq4WrcU2u4dHYrCVtTaLVVosxxtWh7RdimRbBJx2iZI19Nm9JQya25g2L1vpZz3we1hKo04CHadxCY/HNFmRfUID5gaNO1qgoCKcAfbGA7RGGzA7VfONVh/tM7RmurNEym+JjZpGh4UqhtPmqkOa6l6bJj8Y4CqYg8fiuZRw/FY2YcJ/4qeQoumgSnN42xW+alRBtwH6EqexTMR8aXr/wRN9Ua20c2W1vBqrExQtsdq6wqrpU1I2aTyPN8gHz9IcsM/P7/OmrD+lZcuVEduWzCnZJ2It8hmFXelrVmPbzJAtuNTZ454BoFu/stR49q4zVgzVGK1GwvlZTuKav7dNKaUM1UtodAFJFuNOOvoU98pBsdch8/RbjNy3YRnEe03rJLZEmnff2DHaEDNTH1RKCvw2OOp0Bo7QcEitauZxaTbUe9k9ruDMJz39+FwIGdaa7kNBz0xCjpGws4d8mZG7xdWQ5BSGuR/fmSkNebskS7qzx0nH8OPdSXFhjEguSeFVDK93QlUx3aSsXs6BW79ofmftsHxzQhlxfmfr/OYPI4v5cH2dez+IF2LHMLIe/zRqZc5dKeDSyhd4xcCE8eV2YFFNWm/lKql2q/AswokMR8zNe42ZNCYs8bMy7DA0QeuJgXsmV7vmASYmTLHPaCHmV8TLwHn0yZNgIyaaHqgWZNNG9vKHP4sbFFxkVg+5IT0gJn7VG3naMr+SvhAFSzZ6EJC2CZ10ap9Ci8v5WbcUSjJQqJBLsVEsjFP6UqvHCXxDOBgWCRTWl27Lx/Elh2V/8L2oPb2On4F28YjHfV7xw6bL+tiVbT7nn9pXT7gbg4KkUqNnNGF+rl91ioWZx7vSKs6ZNs0B55tRJs6fDv8mEzI6VLK/A2taEbm7WB2vsxFJsfhTt+iUPb9OsgAu3GHKDa7kTlSAH6rTiK7szBcpLtOyK05LvZsR7FCrbm2c4IKhLvSk8BS1qVRWIaZVpRXgnsFUo40bmZwxMb54WSv1Wb4EmCC0QTmT4lfnp0s1XgK47YhiIatzAKImDNM2yKCKgyM2/xcil47AsRgw4bsAzCA0uEbJEMOZCnpJY/JdRDJNQ0XYjZCXaWEQVkzsfhK0kTiLqPLBmywjwDVEip61ZyMQVU8K0pOdB1sFlUoV+I8gMwt1RFEgjiZkjbi4N1RLBfzdEvqDTOKBgAtt3nwXzwhuARzZry55CjEG5rRCj+AWCI5jTdt8PfoYaWvPSKEu4x8L6YWcQzEtFg1ykBL8YjRUrERXNpTRx0Iub8pLipZ1Ao+hkJ8ycJh/7dJgmY/t0HGal41JLwQVLRwyQWS0MAr+HIkNaehU23YVAZgIDcOLAjShfjFAcZ66hBccc6t6XsZfKb9+CWH3oKSBVHVMkTFtoQX7WBUR+a94gfCY3+ci8c6oUtNUo9v7UOp491oNOnWyB2eI0P8KY5bi5I/VYeZOULKqDXkUXEIT7w0+dwDGlaV8rJKWa/bmQ2WflH37HSQojnss2gk18dAYs/3pZlL5p+SZV/z/+GCg87B8mgAwnrTTzNpRSaTJBfQmesvq4z5nmPFmY00mnXCRH+QPPjGNMcReXQ6xt5RuVgzo7cIJT1PM0IJ6WRln4/5e7sV/oDV3VT0/Rmo4CMGNYF8WXo15gWQnN//DCHJ6DFvjVgidNC//JwggveKXEfe2MZ7SvRSfRbuG/WBgkrHJ97SGZ7T02vsBvvjGU5P6Pt4kr51LMpYtK5zrXXj/7/r6/FW55Aa+YS7pTp01Eiud3qmZ6I5nuOl2m6c26tX2SflJOxHNcBfLZDi1r0nRmct1kpyxuh83qFiwMkjJhknZi0qkIGsnfJGYLf+Mijmkt/HV/flLr1K77LuN5dtwywn5TCGZcrnnZhu6ThBJJq5DP+GFR6UJ4Ygh7kqlewsDKaPqrQAE1UJl0zSJ/WOwoFbrCUncx7PSTgfFjUPCtyPPNDrjSIr6uKyh0BpwXLpENr6p0Gll/E4T/Vh+HK/yj6v5i/yPoNFc1dqrF36Cf+UETbEB//7OnfELRPAY8flT7m743k7sru90uqtCklO2psf93FgOs37+DQebX9GhDqA+BQUBPpPgcUW+550twdeQLJO7uEg/3aUbb+3r8gwvYf1txD27PYaoV9X6LaxQNwLsL+KetAW7D1XaIxdXrFrdyj1qVrKHtl84PzuzrVD9QKB6oOwFg9psx4+/Px+j0Y8eYjGODNNrgMUbpKhvuZCa991BtX63rKcOJUrXhw5YngcLMIImxKczHJ6zJaKwqH5/Lc8toqA358IhXq6uNV4spi33U1Wfm4QNHgHYxOo3Hi8FRE14P4MJeZlKYREbnWdP9qThjTJSqA9nmhw8Zy5ZS83W2PIZMVsLu6mKXbGuzYu2/ucjSdZTW6r8PsnAFbjAP0ncseJqQ6fVNrxb6IJ1Iiz43N6nNY3Siz6TnyxmTCqeVcZSqKp7dzp0cqawqe1+/HKosM31Jq+//UsHL6rL8DevXTytlVheyfyuwuuzP598AuEff3yVqNhbm8rHT4sFoeiQ635aPRXacOTO6dOeqV6Xh4oRZq4fv9sR7Wk4ssPl6P7T3Uum9NeDS5xmMMye3gVpx4sgjX/6FvDBLRhje61SgYh/pmI6AjzYzW2QMA+bIEatMm/6tfJHOFyGxSDDK1NTty3657VjP33HGEYn0SeB9bgc3LnceVnjHJ5QXn69cjxjSEf6XTmmRUynbenEA+K1cbcdfo/+djObu3w+Nhzw2EYfwp+c66HAl4Ij0WGQWwotVPhru90eEH8ISUxsb4MvtHCdDQGdn0AUpJlT8K20gTEXHQ1JvGRMKETbp3ULQ1y35wy1PsnlHxFTc7+v7Eji0n3HTg5y6Qy4C0G5Wt0B6x1rrWgDzxfolEPPK+iqwoD9D/OUqtkGvr6qrX/4yKBSZkrGruEadjqqrY4xJwZyt5BrJpimhvjkUg5LLSmAlHWpzQ0L+/8cSyk62sYbtpj7IMrvIC03XLGYQunDBX8hyTQdygS7o3vq9glcSbjTObscamZK3F5aCR77DLT2UZhT6rzl0RK3TVh3+a1guJGGYMZcu43V07drg4gqc4m8Yl2D68SYWzZuktgy/NxC49ac4yhZvGSrcoDQSovwjShdKZWV248EES8Lh2MO5OVGht0PYnpP0Cvd4LGdSpPEDWk9ZUH6KpZpzz2C6u0wt1VF2fl+0xhJ9MiVlYxAzGnNfpagIe3iIss7qWajQDGFj2Gxs7NBIPCUkpD8Hh4dwMSysr/JdQt2tm+E0VUhyaJKK2SzM8yPpcPgwkn8BQbmIFIbH6fxIeYCJbb9WNaAlhyZZAkv6581FqYhMhpXkGjJRysSbrzyIAfj8+NIeXMGbmdKQia4khpUJBqnmzUvkMUcduFyH53z+ZFvDk6b5clFo0LdQLi/0BdEoru80mTpifIfzsGtIPClIHa0sFi52aDiI4xwZwsayhEduD0XTNWWHVcwmQT7JTxO4WQuVhATyk6oh+SUQaDPv7Lh9dxBv5y0TGYsS4P9sRHz47o+ZId5+nRAszJFI1ZEhhOvbxTMw/t8/IMLQO+JQqDgMZvRu4ImtePxWItGd2kllskvTzF6Bc6h2Uaoo9fq1kI3lG2I9eSq2/MwCaDO2l91Eu5VQRFoFn2a/cvOncyMQVMwtk6jr/Oa/uPHENYg0gtdZAoN9yIOEGOITNKPI0YnRt+9wph3Pnxz8YHSt+Xtsp2Z5KHLj/u5eNEBLpAIXdpDuStOEMqNODkSuMs+y/NcWKwtvNkqEaa/2Irua8ZSpPVQmlkpZJr34/L/gk+ldTz65ohzEW1SzPIM0rWbe8TGcD8kJ+nR2JEkdMXj0Gtm7kQ1HEnqvqvTbP1vI+yi31vzYaR2ofXeYGVKC7BZve6K+j5P3UfIp94/VoeQY++HiKblJMvHI5pfe+WFz/jgKJ964UXDv3MLwSKlQWPc6vPJhi0yX7S0M9o7Vz/koUpBnqpEsviiVRQ0g5YpEURVAvYxNFK1hn5o5d00y8ElurAsduSpoNpmoujrCGI258SHkQWqQPbpB+PA4p85s5sw6/iiGib7Yd6ZYnkXzdwYyxWKqnP0Zg7wcw960iGalfdBau/varQr6+zYQrcQIqG++NYy4tM6Jd9FAknE0xlmhnx4L6Vt77eNPsxhTZQxfW3i0VRNo4onSWFQkOUckoigkNY0lir29NfrIrhAXO9QHRaRHjILsdEI6VoUQss2OSfHVGYbhg8yzU88XYxXfVvOATZVB+mJqvD63MjjKYqUUH/OFlkisi1Cb7B9bPrTE9EGk0ebRJiLUR+mxT+XyoL4EGIh0sX+vdZkghzWFS4IxTIABDKcDyUCChDVZMfYDk+rKcnJqzUmZAdCuXGO8UlaWGSfCGC7vygZ9ZnF6eFnmRFNtK1/R4ewkvjEtjJSLbOglz31kUwZnJohj7AeFNuwbhSjVVHFmHO1a8ClSbh9WiYOOlmqNKqm0nuPa/D+CtieZ9zb/qYJdy22LAVCKuStTYyMFN6VPbn3txYc53KDzl8CtxDP/aq5GM/Da27ejg9iFav0DhoY+mnzyJCPUVCdg3Cy+aH1hvVgCoX/aoaPhhExnvzSKVBrjdHHyzgo/Cu1JqTyckHC4MgVNRRCHJv63tfsqAbEBcYFykeI+lLb72bZnsq3P9j5LCiSS95HTRwqHY7I3eW30ShuOuWTMwX/3fduTZk84nJC0MyAgLN3eWjzVOm48h8qs5IQ7OdXzCbwo1c+p96jAjewSXaS5KjKAKgDn9aPkfcNMjvO986DGteQ8jbpiqfypco29OSjkD5kOO8OqLbgTQ3o8QkgUCOr+fDwSQ+LoYJnnVFFfoPQNU+6S2nXzqAuI6t0LteDEEG0rQXxLcLbsktkA5g+fSoGN5OhwmCAUgIkOaApJYLyzJKHx4dpqnGZXyEQQTA7drRadxIxRZXfA9OF06EuU6nLePQYnhjTy2KuykceR7avenV8Bqq3L2oXq/XGL8Lws9E4s+OgxkBzmMYGKQy2JvK2QDFtPatN1mCh2cALRx79LE4VCIOHxCEQSLrrkLHWcp4hc4ShByBADGWs0r/k+qMC7u3DqQ7alrgQd2F1jrmmEGjP47eLxTy6JPN92LTLzrCrqapVW4ZGAFcZGMp8kcr5NPUo0xVmj1BdfrgD3RTSH60+k+Dz+26ToOy+mtKBVdDqEFv0+KuTm+W6QQ1+gtJTUuUJ+RM3d02V5tkGDENayWqT+vxL3gEs4NhMSGjfhdvgxgumbHj12mnXs3JWyW3dej02hx4wt7z6i/I4tJZ4OYUQ6DuvZ8QORs5/fQYu6+NYMovqNT88s1AJqkiww+Qctymr9NkpMxB0byYFVbjAhhrgYo4QUhKk6d4cmgzG73i4Nun6sBQOqNwl2JiddZBP3On/FQ/vjwudR4wulCGIm+UkR3yL8W/BqYD+E/zrG2uvWIBVfVbAlb88zcWTC8wLKnSlknOnbcIY3m/K5LbjPd93ClyVgXsq8fsoKkPLwIwrrkGL22PNFhlocS9NH7t3jsKx3cXUg8xQq6MSaFWaviV8UER1LFN5grJJ7Q8JADiQvhBYuMS/5H/QjeIsOqHBqN25Y1jn972ThRjePiFjmdBH3C/jxPm0Kj9Y8MW4lNSpzYKHI5bYXIxmCsgZmMKYxxNMZMcN2baQz2Tofe3zDwOStVVtTux9tep89a//M/Wlb3q96RJHP9yBXuQVd/UpMvjWUvq5kbknKZAp2jWrbMEfNppHw8C2U4wPwuj+WpeMOf1rIrwYGo1Tvcu8x2DGkYcYcbCWxdedefOfWCsIRA9PYgwlHuKa5KLQnXDSMbN8lwp/718fHWXDFSdIYWJwQ0sJrK+lPLdUpVR+zvM9I/8eKAltVuGxImKa9Br9zDk36LHT+PrI8jylwMk9QYDwa44Tx54y0XSJVKhsbs3atiXYgQRivcbFNCmkUr8uv1F9fjT0BkBWJxaoZbz2ktN0v32+J6lXMy6/FEJ+mTZ9aKHDr8yWvOTHpbrX5BBXYM0lw9oiX//Cjkxl3x2V6tSatjUH6Hl06SWHs27OLBAQoZ4gi801K/k1D54Xn8wnywKFb3tHEk9VzfiQfgPZByS0/ahTdZM1JxY2f0M8bihNkTVe+R06jCLq+1Df6leKLGxLp9kXxroiu/n7ThKSJniHNndHyQnJWrN5rslVhMPsXw6CIRVVa9ZBxuuJ2s8/JgtuSjPUbislyWyR+Ou2pKWla/JfhwBizIsnfw8OFqwADYx59iZcXh7F7ULMjrQ02Q6wGO7VAkeriLvV1GzcbFkD0TClIjiNZQJFDYlN4ss3NYMOsdjfE6bW4+9f7ceqkfcMwg7sB3VXjZqgJXvH3D6v+rkqVl6Edev2Oqe5axp6Mzvj4eQTCPEjTM194PfHq+QBhejx0GDAkTwA57JSX9eWSg0Bo0sp1P/mGEIJ9CsusaK0fv2kSV4discFAkCNPXnU3LaUHH5o048wvvjaUYJ/MNkcWNIzfFJ0uMr+raXOTosPZuC3chZGBlRKO94X73IVs7pYncvSE3uQY1mwwlMMRR0/smbZzyrq6yjgyWSlnl3LKmjml3V2lMijjuy/Dyi40wD5NA2la7LYujI5Or6ruXoajCb2ZiKbW3zCkTGOJkDMGGZl2qDXPYbS/FG+0bzPi6fSostupotPxHLXjZduOZuFOVavzAcUV9dThjCsKIF99X1kzU7AItP+kEL5GRFd4KXmmAlxgIA7Ds1W35IQ4huTJwpAVtYN+g7DKMLfaq7zb6TkHv9XPdmPtVRCRP16gyP2vGfR/ONhLN+K8kRPpAfiUylu3UnuhQN9n6csSkbdz93oiHiMQw4imkF9dQi1W0tsrweYIu6RYjVAIYR+Cl8Acjki8DIKXidKkZhU28HpDb4BNeD8LS3pqvWRFjJQW6/HBlrHtGyoj+y71RVZiN6yTM9xdFTWZkEqrqK/Huq2XNS+JuLZfxPTa2jYcNlZTCENXagpwcWDGzJmR2Z2bEHYpuhpIppY1NUUVkMzzDIZa4Qq+BzlXtLxlIy4jy3jaK1xgFHTV+2nIHxX35S8u+gdIOBkvZPeleTkSPx72qZ8kJ096X/YigyMJ8L/4Qn4/QqnT+uldwVGA68LMqY4uKJ5wXFzTlefxZfeLbf8c9ZJtsAqPab/dL2Bbqse9mNXAwXb1wQFbBeBUu3ZUi5Da9aP6+e+HCpKauSIFbmJ3TM5MxNpRz9cXT7723ReB9VNYDt4C1B4HQKMEoENRIF8o5COoc4CoK1dMeCYjCr/fAB/FYOJNpVFAqQm4bwETE4akYNRdXSo0BdYHlaWVQVqKCtPVhVFRYLl2aDXPRnQAUjyPR7LFTttIPFgNxEgjHhs4ng94r/UTyPHBSdjMtnxCIUVVApmykMlYGEaal2/Ot1IwzZzWoh/5ZI76dNXg6tPq019rJjQIhTAack1KdZ9Pb0Uio00FTwqz6fP14EJfIinMvbAVu7zn5UY5PMpGHzZqe5xP2Ayc3pDj3+ssJp9P+p0m6VYxmMViwsIcc440cM63HDrmfR8YgujeSNEbnYlOsA8VKaB+PqNO1jRw9d3/GzGgQ+jkfu3P43SM4mJjsHMJxOTW0j1OxRylomFKWqbRmAFq/c5pQjIiR336infnFURMvp/73UpBc3EWVMLfXq32bnSaMSqkj0sr+6GMuN8iJUK53Puz9fcHLGUif21dthjX3g7T9A0ed24Hmya4UZ3idjc21cCujm+1nTPS+J3shNXa2S9/ARhKRWWACfXrW68qjWogwGPkZS/xvgzAfdH40VG2f/37h3B/9uhoeQDn0W+O9i8S2X9RMbb8jkbKDprhsC+OATG8vf7cw0xm+tvCKMf5A/4BFwJ8GttikVHuR8JBTAiL7oqGzw9v/718IoCn8KO+jg+iFVpE53bUbN1QtWOEOi4SPi6To+EA/mOJLPNDd9y6sVVj4QeMvuzKvzsToqf+S9MxDQnPbZ8fYppp2ufV1o9WC1Jo4RpSH6S4B6uJpfIMgihLoPUjTDkAISWXBEKtz8ac25+ti7TbqYIpHyEbySWY4bfDc7/Jua4eqk+zvLcU/GTjLgW4l8D+92tVmb/YKMI86K8/kgmzrNTtNW3gN0Kf7xcbHBvKMYrTm7bevDdV4AXPi87cv7HQei/Yure2oeXW/zB1uIYf1m4YccPJaETblauLE4xzlwTByBEOcVpQi+s1GDvVq8WBulyHsQaHxbr1Uu2UQperlsb1CD90j0Ye5PLwwIPFIjyvcCZzD24fIgFQuf5I19zmg/JerojG1BdSbnvY8/4H2Q8qPL100asxfoJ/dzfkfzIUmgo/m/JmUAKn05rDm8fPcyDm9Zh6oCOlnb2MnUS4PbW7hWvF4ZYn6LrjuThGNHzBPsu+RcZFXhavBQSM+A7g7E/XAuMC3wW8t5dPXzFfOW08fdZ89rSSZdy72Lh4r3Zvh7Fj76md6p3xLOROy07YxVe8l76yfqdx58r0tQAl6c5WI4XDMBwWmtNt7IYGYwdDZ4wu9bvY/KPCuJwZd9b4dj78Te37SmP31V9OzsPCRPTXxUSEychfbXMlJU1TFLHOlxD9mSlZ27WuYFKNAizaOSzchz9w1lLaVdptGTgH+/q2Wxvf/W4l01mYz8oBu6WovagtuthdBs2D8K/RIKPT24ra18DRVdNeE7fNUl3SUaPPNPPq1atMR0/ryaJpKD2peVCUX+mKEVYvItqq0So1ulZe5fL4RtyV6WnrnEiK24BfzHS0e0HK3q3+OZP5aQCz7Sxor30IKiYspK12Y0CAzqAtcW1Nkjku0+moWtTeURzFllaZXLNarndTNx2dbm6tcMLKDYqJO6dGuI4GlqR72mpzIR4eC9M4nM5rfpOGES/vjs40t7duw6zb0pUxrduBBj6Q6+UUjoZTntSIiFvNa5keZVY0Wjw7NW1W6Siq9PJZIH3oqobKZ67cJaUwfR6prrnnGDvaKe9rMN9Qv4vLmcLuUSTyoqTjaiSg/Y4yWQ8eHNMcaIAnM3beoKPz79KkgYg3zQXebXwhbsTseTfC4u+r+d/KeEVzxOyOXUN+Gb7GvsIa+MDB6vACZ6089qu0L/W8e8ZAunL9HVmkTDXpreafvNLldmQujm4gzwoJzBWGyXPDHq1Ml8gJp7MqN4PmvT3KJRNE5aYw1mQ/utK05xZBlcroeG5jBLdednZ/VaSIWOAodVp/eTOe5IXxXRvwOITbJWeB18rwqbgmTkO/oNltMc0ubktKtnS6iXcNG0QEr/H051pyBe6eTYLseHmQcmvfyeEMmIjTUgd+ajqiiBwP31Di25Yi6PeRZUmPNzQkySPa4jQL+vH+FcjzB2sYkP30q4TF/1l2Z94JU53w4UNBPc1PqHs4WhdsPKGNR3wVpdLIfqTMIPxTM/3IqTRR8ePL2svfQrOsGaxtahJBYWNo+bWSR6lMi55m5qeVLlLpI9RF6sALuf+hfpOgnOim8GuDGsBputWrtc+pJOz1YBGc3uxm6yHEC3HjnBHtqLbrH1dEf1tq+Qjax6CaeG18aBGWPABXX7dBu0FB41keoqvs8tIfOM29MXyFof2MRyRRoRBrgXIQnaE7VWDkcPtGAIMQG+XJ8AD4++5gBtrToJ4Gfl0oklccLAYnmiy5MLjPKRZMxCmlEK/XKZiwOrDUbCN2k9AgY1tYRsKp/J7hRGZm1ToPIdeXsb/Ym+uObM4M/SPFFRI9iauOIt3ekJbLa8kgitq/qTvqY+1o1VhB5mXvPigKlCkGkjfiAq9NfBpNOXkSD3Gz6szLd8/jXbO23P//h82HsSSek+MaI3iGMGV53FFOd5AdmfjM9U2uxupq3zO9y7PHrXLmhafHAjOmoaLqKr9xwWO1l1CJuDeKmA9TqzWoBiSFANkcN5Gg7v7DfOBuadZMxp/BjRN5512kxhq6z1PDVeS1l57ml4uT7VBNeg1UE6eN+5PS+jN7btz+9EnpoePrUiZDk68w22xuJvcSQQbzbHXjgjxi46skKWLVADQIIVya+E1oOurxNCr06v+FkYObE5S385YRFY8Sd2SriPKdCCCcZ0pIf6A30WTLpfW/Xg/tqFq9Q9Ncy/UIgTVh83zm501wVAnMnKHGSmGYELwqfGQwcmhecMOSJLsRFrnQhsWlm6qxzvtmVThpyI45Tjk/wtL3jlL23mMqwX3oJxznHYD6nPQFBdQ2qQAjAhFn7ocGT2eNQ6SOcduzVRwsTqfj1udWDbSg5XZ3jV7U1i87FUIA1RAdhh3Q+EtVKZwYn7QtFReUwNt2j/52JMiCV2e2Djlt22YchC6euVD676oKvHfc9GnUjwKKVuG9q7ZdWm+ceiiYkXfg5OCADx544QWG2Ee9TA7hbC//z8OfZbS12xxiWMuPH38fdvy7otiZkGRj3fLBtbfDrPNfKPjkCZjyhDpIHhW+vHpiKoTWhuLxZyon40aBTXMLa8+/gnT+DqxoLYdCxV7X26VrOhhDYAYinLfN7Uz4uJWjktni1ckWf+QWS1Hp2rIxiUUu3s0uZcEDfoYsP5A0muzT2shSt9A4v3/EbZo6jc2B+qA/PcLY8fmd4C36QWA18azJ56C1/LxPGzNYWYJoO3BiPXsYTyYE55Yv8h2nUS8rBXhhQ6/zur4rhV8nXB97AmD2XctqGA5OCJHHyflPg/ohHnE2WNYjkvLhLdkjnHytpcxIi6cSwUqtLS9OMn37IveaU9b3SH73p+gNCQdMSWs5dfoqvLEqUaG2HlDHfOY3ms9v+LuakPli4kq1JEndj8NQ/3xHjjg6uftzvCH1Tk/dxvqruFhe8fsal5VuLH0E2Hgvm3dxfl75ouOcowcbS/Mcyd0rY2SOwbMt9yrJ+jihc5xQzYb8QmZLVIciEF+sT89UyFx9nLeTXx4p4xkadNVKhyuv5WeLtco9uPQZPztup3pjXfDoQ0Gdn9vXP3xYJzTNM0U+a3GxKJ1GJpEzRaKas+Zcrk+Ew0S8tkneaFawl+eiEFmeS6SPf83zYXqITNr5ILjQgSn6RBcDZRKDGuOvWQNHYbhCBPBds/g7NrD3SVheMSVzi+0mDGEoVt8Kg3IfTT9r7uYsQXLSAmCO2EaTKhRi82ANHUYTC0Eyob+kQUOu4WGE+E/WqftLAsFthP4fQXC88dWifVefDYILEI13xaYNMH3Oy6nrlGB0OjCIf5DFsHEPJfd2CyBZRW9deCpy6CoyHvqedpLoOXa3hvsWdt6oiBjoXB3xhas7tZ2tUGsnEzkAvbzKuCRxiXZJMqgj+MR+My/Iif9Smw5poURI5VTHS47C2gXhiOSFwPWAbRMIR1wGMkSNZuHOGfeYnfdJiq8CxiK+934AxG1qKSLjeoC0uTlh8a1zM8bRK7Z/RENpQfVzXbPlfnxQcmF4WZILGuEVXGBjlpvHEq9MYhyRy7g1IkSXHpHubWrEq4YYmrP3b7UISX8B2Wo8Pcj4x/Nzy8Tt9icjGEuKLVYgmzZyPGF8LiqJwacRL0cyhIRNdsp7B/PLx8kNct2UDF69BzqamdhiRfnL9cf9rJIdOGj1I3BLbsLxvL//e0QOiRzVNj/LEWPzj5MInNh/YFg/hG9PyOTs+7ECTjyRyH2+EZsszgRoKu5S7p69PQAgiF8YfD4EMdW9tEpW9r4WQdy6fAzlXEUH2MesIKFCbexMvdCtMZy3KpUApqn8Cr05aJI3aZuVCWEOanLgY7auFkGWOGbpYpHp6fs84uAgQwXsGd37M82c2voFM0Z3G5zO9HIeawQB8ZSICveQTRVgbdFTLv0tJ4GknqjA/srXADyE9t9/AjvGDtUVFn+IDM7MihRcLSncA/U5WAtXKJQrEg2F7zib2uen9kpLjsz6LpTdWVJm52MKoOYMdmZ/quz57qB6tSZo1u4Xl3dERKTJXuxG16lV6Po9z+MZEcw5z9jjvebz+cUznWU86ykLYmQEeGWh6KwARhYEjyhB/EMcacPBpB9wj/AjD5v3/mAlH064+0ce9vG18JjvMdh06SPqGhcDV99JJAE+pExi7dm8fZJIAkEiycebjM8gJ3l7J76A1Z2PtTMIhJnaR1pij9Y2AyTMsNm2gvDhAdMglNtS/BOmXK95uNmSeeLclS8T8eRrNB7lc7YWc3ofkSjQ4XJXkuT/wirMf3E8WQmxWgNgdAYaJGLoMFuLj/+/BMqSxwf7n2wfEDAA3Z07ZgxTFMPYs9tNh98ZtHYJXapRCsUKaQTdTJZGhoXA0gbM9QaL4Xzs+aTEKMdTDvB3VBLk/jMGzS5QmYbctIS5ipM0nFrQqVJZo5UyDXnnwZrZlpAdxeicALYFfe8+AQqDPUjUGeiBUylrfjwcUwYr6p8/r5QpKQtlfuYQ5pQgfgzx0XFcFJ3eVww+shL5ynhQPb2Hat8SI9N2a6iNuOk6sURHdgvRScS66TJ4XGLSmtIdCxaw/mtxtrSwnb4GPkmVUr7WpkvvmZgMHm8ojXKsr4FK7XEYeRPZQI3EYLdnxNCUel5pu1EmM7bz+ZNGo6uzosz7KUH/ZmgnHfljkFv8g2vCbybd4zrQPMVs9UCZ+Yc5ZWl75jCMoCFqRSLd/AhAR9SJyLv1ucq4sJQdaftGiMRnFMpTEnGEYnDMBnjPzwmsJ5HSjCs57+e01AWA+wbjonm6AtAStR0k795Oiwy27Ujc6t2pxn0oZ3ADa41I/VD+qE5Vyo+XHPkDiO+KtJPLVQey99XLn346QpbuqKf7i9TTInBErn6a1OfZnzbaw1P7wtfYPxXYx/OnKuxHUQoeAHbXDp8yXF346YAt5e0L97d/JmAjpz5Nrud3u+GB1T+cirCHK6J4SseCrT1a1al4QNj9DlgIqoXjOqXjPbNiYc0bjzj2ghJfGJaCxaaEFSrxdOsE3eLcugnW026f+OKDlc7VLFY1gzEabuVMiVHiEX7ymmT1dugZzDy0B0tgaPTyRz0atnyuBYZEv9H42O2rNTBew2ALzGqH80jtxrUuNrXu7I7LWiMsxt7T12PU+nJ84fMdDhqNab6VEPvPklyr685hn2/v89p9bOdxr95j2485/Bx47Y+usi2hTT6OjVysINRrDOVy9TWGOeIZ9BJmQXV+PlMqLesuZRZY8eRXK9YG4RiGO7/PlwbFEREkLIYkFEZisJF8QQgaS/YlxGJdEXZSH+kfCVGsI0a+XfRWm+66T1gpzAy1syIiihxab/j6VkbL0JD7jPQM173N9s+8g1NxUOdMeKcALOBpZ+tnhkWxSbnwjuo9HVNm05xdHXmon3JSQvTizBUdaQxXvrwjGtWRgXowMYh3KIBl/tD2BPFnE4DZSrukGJVKGIxBBwuFykhQ4lV6nmAwatWHUdi1/pnBJ09yWqwuoFOhkRE3bhfBP0W7BmZtCXP6JGw0GnlNw9dmhZoPcrFzcmZHomim6Jwt7F3+mkklPu4OSf9OOYl439NnnYj1mSaI8qdvNb55k+5a9RMuC7oB8Kq2qRPzCsXDeGAf+JePNI9N8HXzl4yEraUB3yjCuJM5bIgGeYT/MinOY+cXhcc3e1HftQ0sCgiH9z7b5bL5BxjR6EUtEsgSuUdiH2jliw5Pn+5DZrMuKMV77MvUN3NrCYns/T6/sl3XZvbt7oYYoukQ3aXrYpfT5r/txZGCbqhyPbQYsXZRHyoldJpHE/Zxdt57Hpb2eildh/7XcHwv344Ouq/dl/SufdW+XMxwWY69wReUIMM833kSYm3x53+GRI52MioaRXjGHmNUfLRPZipGdUV7XmUPHZmuQw+gx/dzFf76/MuHd08f18rGjNo6nvIpbP74pxwk7oznEUbbvjcbZWLOqiDcmgcbKm8tN/nvjMFEfeGeMu52gNfbu1urJSwd3OtdQnK3lCsJbH+7qBX2O4Cc6jFRxxTtwYhlzquWWohy4kONC4BVQLKnL3FXYu/VtGQgRwAgO8gJLKADpGVYpQCzKM8XsU0hoHZgfnBmSDZZ7bLURR7kcW23kBmmM6oHS29RyoIOSR3qbNQBvcayOC+0Cw5yrrOtbM8YNwg4qMV8o1++oJYCgq0E2xBjBZiR3566aMH2kLRHUt8VVSm2Yd9ofI6sh3rilz6uBL/JVFTm8ucP5vLEutbSZinFTKEjOk5Ae0auBAtaNCfxPsKh3Y27WwH1LZBTDaOuKG9krZJxQLLdKXoaO/NHy8Nf/YyfCszF4vYtkFsjcAvfGwYny1wX48f785XkVsbw3Q1BgDO8LPoSowYScMZH4g9MzgFXlmjHqMMoZMzHMkoNOxmw4hGl6EnMupJKe7RoSBshyZjv+RUY2/P3f+hjA7JJQcCKSDyMqTTnyARuY7mpbi12SLpQ3At/nk7j3ZLbdQSlDdQO1KUa2OrKZejG5jN4mCMQPe4fxooYd7/PecDmtb+dZ/yW3zgbHLC/XEvh85SjHowNyQCNFyQsXoTeU/Tj8cFZJ07jfcyP1QyXqyDCqGJNYMtipegMnSJHYeuWV4rowfTLOR2N43b1xrfR8v11fBjvr8/bj9ntgEC0NULhAD1aOBZIaOMJsUEMGVkOA4egypK9pIY1YkcU3zTEV0ay4hF167xottJ1UidylAFoKcq9B+Bp9Ai0Msz+ukx7FhmFYj8k7AmY3s8HRTMZBdEqF82HGMDxSIFjsbh+CaqcXONLZ8xxtu33tYqLnYKFl/B9oqBaqXsG6nAcKdVhNO5Ghpl90mXjcfY0p8UI1lWzOY+/GIfyiaSlxcYGB6cVphXkZMWmxk5MtAXHBFtVStqJlyZi7lqU5czYA5dW8SXSOAysMXCOGqKjjB7tvwy4MNk3gyqUkhijALjdv2KMcUHqYKxaPnzGAcRVYCB1JXSy8MclEBK20aMB2/nTncOhXv//+Z1njx4cbh9uXTvX9/XddCwhUlrTj4R/gGy2U0h37gDwulT36SNe693kYmnZ0Q9L13qopQun2Amfa9JhC897VneO4xaH5P8/OCoYftRtcsnVFB/1YvzCr1F+hJZN6zYQsMT+gcoIal3+AqiCwizy+sOUOtDsdlx239yJ9+64mL+/QVioUEy7ApAfYjucqnhX6wOxwVsw/E0PQrAs+mRo7WZ5/evD59uLvbd302lzm96fFNtus+YLPBxBE1A8bekhWGb4KmbeMsuIhhCuGLYs/BDD3YPCWuPajyts9XGkY9/ioRrKgq6czNJSvUT2HosVLBhvhYjyT6ruye0bCF2k3WEU6R5WFGDRPbys9ekKhzzMMmm+Yq7XmfAd9omnQK9CprU1Pqmksd7rT0OfyvtONYrdD/RQA1gHe5g6ZdHhkXXOpE6opFD6I7DuSRqIVXOK7bQP1bvtFwpLUj0UBIelbKGAUEALXBI1ukm4X88hdxz2c7X+Qz7TJqLIZtJ3/U3ULgcgxniyni9rnHGehvaHhuiOzAfx77ckk+SkegqBMr5yFhSDnMnsaG17mp/WJY0R/kqOezdNYqZRFUwthA2OBNjmBCznggVtWtMl/O4dCXI2j0kiSbOdsKLO3TDbGnVlB2FHE/G8YbV7jYpIjuaZtbFA5Nnw5MwUSWITB0fqxxgME/fh2zjHltx5bJ1FqASwwYqW8K1rCVEU66JjgoFvefRCkW/AhRnoUtC3EIBGCZvxHtcCE9iE0OAjbicWNNlt6CpLIiMpxUd5wqBosxjKr6LNue63RBnett+RLXyHBBQiFVsf897nvuqsTPQYCSflo1JxCECjjioeGZdVswGjc/t0ex0MGQytLNekdxW3uN3bP2jAMB0ighnofI+YhPUeM4heew7qMinJ5QY4Uy7CduRHSAVGg6EL2rQy5BI2j1iq4XIhsY2YpJXOtNaqTkYE7UCk2939lcLvQiC9piMMtsybyBEBdS7Ha1TOmQwm6FXD/t4FRNkzIwcAmy+AL0kDApV1a1eUAoqFczgbHHE4lGbVsLzNY5QxITUIgdpPhvw7QqIYTEyzMX4FhVZZkheb17IRLSJA5JUzYDA5c2xAjEi5IogekcHMdrCcRcHj+GZYRXGID2whhZzoKqxthfCzx25qkN5b7Wgbww7Xn3wAOrQzJHFsyqyVlfYdMaOJmym1VYLQlNQLVlw25paiLXClvm/KCVlEhXUYqnlIMQiN54TZ0CmBieqQYG3r2tzlId4ZSKHcBZsAGX1Q0yJmnQzSe5cH16iEymXKXG2xlJGWQwnzwkKRUnbw/DaYGBikXQ0QWm+T+uDFnaQcSypBsbkwpdcTk8rGzmP1/abEcXob4sN+KI8pmHN8ADbQ01HTTM43SX12Cg3ZTYMIdg5gUKzZHNyuOwlx/ATVwt3I2Mu4vNJoYcBngw6oQp/stdleEwkZpLstrs1kBJuibY6kyzqeuPJIHUD1BrN9FkJDObLhagXQvRlk8GZeh8QlUKeWoUe3GFd1QvLxPhhbKnfBRh/Ry9iL6iRAWVdxnbVvgeA/DDHmjdnC07wOy9z1spgUHvFi+6HHJGgGbDWbMbimMWNz4KVq412mja9JQ7cwaMyRkOcArS4ALOIoKn3LAVfFGdgQgVbCR3YfbXgvuchnqoA/lxYMMRgoRaFOEXOC2onhHLsQUjfUEQdUoWb+Zl/qXGnzmOvmO9nr/R2jXVuhzQw/BB8geNdG0L+G3Npp4zLrxSjlqhbHoanLPLExPHMjIL8kqa2Cb0Jr9D4UV3dbfKme300l3iG3NsK0wTK5/e5BMI27jldLz5bFIkvWr+NqOXl6fFDmBMds5LzNJMNlRKmhChyiMkvkEIqTeEcb3DKtxqwQQN5mA35alSmGm1a7RAV8DeYw264R3o78zBif5z4XYbiWN1lYma5uFcQ93/GicyTuIhm4E1MLsFRyVH8PC87QqKGNul6sQ3rn7EZrtEdREE0Q0Dpl4FIhKGUCPTt0n1GoYYR5TMFaBC8Y0rV4eUJnuhEQMT63/Z3fe7SZYd7YpssmG/u1U9ZyitgaErlZpmgk9dtIWix+t6O4++7O6hNbrqvEP7x+ubhtm33FXp0GMr1IwIaWfl5lUzpUZZSTqRPJFO2pOSUQAjU3ebncC1dxXE1F1Y1OgiQZTYYwhNbzAIsafkOpjAU/l3ZIP6dGV73bRyoyag677NfZzz+9+RnSNKwMwknb0J9dzXXMInJxKL+ENuW6fQsi7uUM1fbNkqvcH3YM4PWBzM3dDasCHhP8vZoIYQc94ggLpwezN/L2fNWkJFpPlP++H7E4rBQUtnADO4thB3RQ+Ox8URQb2/0rj0ZEzZjlROVC8NtteRUQ/IOch8kEb77PzJgS56mv3VtsdQx2ALVRFVyWAJoYVkRZ4L6wGKfqemstkPCg/04Bm1Ngi9jxCruLHmqEjRVNNjq0wFKU3wEekasTcmofocC63zfOMQN9F4p4ykiEzUIJ6sc0Ptf36npZSeYzCbz34HYcK6bWM41aG731ezhOzDzCrR05uGawmSfC/ttCD4GuJ+Qzdi146rjou6jotcB8m4BPQBxO/E4A/mNXR9kk2d3cNm5R31C8O/OEdyLCMQVqHxS5Y8d5Djcj2Vxr2TKKHiFMOvGfQOL64IMolCLly6TnPLsgi5x1jr9rGZQLLZv4kNjsH5CDrDgbLVbSfrd8zJJe9mEQoHfpvFqg8cuT7pWrixfL7bqZ7FoQac3RyNkBtMzdAadqPWh7J7BTBTxASHBZ2xLGXr/HTk3KANNtJfMlg7av4stQ6+7VqKTgSCKMVOq7FDLxKiVCtlSiua+3R4sDzECux76q6/Xs+ioUDm5O+yJvs9q7OTl83VlbEyySnDpDVpfo3+je8d2fDpBbYsYyO64TqDNqqJy/Z6T5HVKg9X9AyZDyqKcI+j5Hudsb5T9bJm0Ctb0KJGx21Ywx2sqc8UcPeptlRXkU5NqIuzXE7yJBSAt2zTaIRCbRATWV8fRIsAlYINrr5V3Goz96IRfUyS15e+WzpbANPhCZIq7KP0kYtf4AJMoHEf/lFCoECgL7N8stYTNphHgv5uzckYWVTsRENDtIzCWEsrHdhR0S89w58pNCwpYtaXaI27jK8OqR7yJT84KNTRthEWmJV2JjvmaPI82Brl0Wah3IhDC6d+XNQVdLhpt4gE202fDtYQbmtkmBDQUE/0Ty/1WG1FKlxEJO+FYgEL8LLGx26yjCgaA5bGABENsc2+pXWwsHusKhA14Y6THQrLa8dE2Hr0JmL3z/fR8DnZuCjtYZhnHDRv06eVx0Crml6oxp3EdMEh591WWX4CWGpZdOeNKHfYNDAkXIgbB/lossgoK50J0H4fHiAzqhMMXFyhLpemnFa+k2H1kmqtO8vD8eOIjxN+/MeTH2R5yvyXCwJf9pbZdmaTSqVw3lN9GWXOun26Ug1Oh7y7cLQgXSU2T3P57eHu+j7/R1Z6n/2fvVWOENYTRPFac1VDxs0owjjcuCOnWbWu395HnKNNvTjjHtKY6Hn6ePv36q/JYfQLez0w3Z+ShrGbEQ0y3l5hBVbpCNo5hIWDxdLGf9PVYCso/COmRLCYSJlT6WWj8S5U0zTz5KxNIlPKZPSV2klnoni26U3Z4ttY/Vuuqi0WjSC6anNEfD6gTq4TbclHtkh9zdLgz/uLu7c/1quA036kKE5kpz0b42lx3Rpf3+BdcthOVsCox0sJdCEUoxKGjOwqzvivLYzM+f495xS6dSA4Wl9qxP6bcrGvamAEKO42+g66eDsySfdwIhCIFsnv/yyg1FmvSHaeOGyseeadDFFgy5DKA21KfUOx/99baa1EV06lVRaiarG4JRjsck+fvB8f6tG8kh2bMIiWPAu3y/6eu23Gt2KiPFOMzwwi399CBOVsa4D3OYlZcRvFkNPW+yWEp3FdW1MEbVXJLt2xmleiFbIvtQ5qrz+5B6bY395OYorUagHNfllhUGdijnNAQ880+84O7cc6QoJgV7bYm7giiH/iuxpTkqcumYyX9fjBaHbACZtEpNKlwiKY3a7L43J2HWN0V5YObH9/4QUx2XquzYnqqPo2wY/tonw5VC6uOjOIiNT3NKkYX5B0IBSKdsu405Q2/3t87S9zxsFal91Fc26ma/JRTKCqHjopgdkv4KVdL0rfOEwDzsFELUC0cSLlVbplVmFCbCni0wi/e1v5GvCfvyNU9kXs5UOTL0KqA0Blks9wABX2CPPhCx6pwfdFxPa8DTrfXN8wn+8KvWrsy0sRW1oLO0AKgxSROOdluwKhtCFek1B6AAho0xQ8NX1C/PcikGpu2iH7cwz9cXwOJ47SDCWmmUj0eSzzGUpi771OjcpsxFTkmwHPZ5M50GPN/b3L1+5XScrp3pch6cczaQVqoQsqm/pNGqiYfwQgWabR2qJaZD2tQLKeJx4tZ1QttQ2mmbTJntyySlx4PTdtcyUU3Sr3X34Kg7mC/CvAm48TI76p6k+lkDuCHNuZNC7RGj8doAEq4NPPG1ADRIV9Ly37X69pCzhbujgzVdJK2cSdBtu4m8fEADRRT1JryRXpYW3zINXTe0xDx0KBRS0LHM9/byJvmQZCuK6yrpxq511iO98GXd0bN6mk5Dl2fLnDTfF2xM+NpHbVpJXD0rBRYFjM/1/FArRrLaw+OVSqo3SalXTeWBj2paH6jr+lv8a2k0wlWeNtW9aSXSBKZjThc81ttmWfdCO72jeKTiyflKXLW7NRkwqQB/2dQz96v9Clbe664I0TKrjqm67QFQAxSRmwLNDslPH0Na7aRG4/GpGNtDrAKNTodyNpjZPXErRoxqkd1+AeRYHN3SO/TVK6wwR1vg7SGl8aC164BloCe03aQRx91XbnczxZ/lA/qcOBK6PIZmWX5d3eTVibZXc1QQ+iyblcdmA7igSJVusQ4enTsVzhMpZWVvb3czJ+TjT3ddI2dG3ox0bMSdh/SVV2tnV27hFNJVt+SOJldyIg5yGqzstzGsXsG2PIQKZEUDTf6oXst0+1iwI9kzb3LNe7d4SzXd8afLUcoLOD2L2uaQAyCxtbKOZeu/V60MWjNAFVfsyZf3NBJTUN/NNe5wMUUogJPeCnpGTycnWN9mmZS25gLu9ykke584WpB9u1V3t15/cMTTw+5//jd+BPY4mr/kAI1IqB1ilIGww0klvHCAJdhN2KGWQhAbVYXph7S5re/N6QbCrTFymf/uS8hSA0bf+dL1T3JWZl7jLyZWc1pXEqJ1q1nUg2FPBnpoah5PbaFQNG5zUcdbeEdg8iwyGM/eExEK9EjEA79hVj5u4tWpTcySRF4gxymWz7lY4ze2zE89i4rJLnhaLWa311Z3zcPL064vaoulm7DRG69AuYnhVHDCdNt10XuTA0nfiDi6O7P6ShXDNbHrmrMk6fF8VxzygO1pjbLp7bUblairkll2eeclARhvrzCLRqzkY31FSZUB9yot+DKj8OCB5cb6y9P2o2RR5YCqDxYgZNoWlnBqtrjjkZIVRFpmhMtbfSVrW6wwhN2tnERkGLXOIXGI7VpTT5oA9Nybrk9yHaD0wu3LM1lENPx542pc/sPU9E4bZ0W+MocQpPEOjP0QfmxQIrEJqA1PS1mVV6C7CQ44ieMqH9EHPsgY5aAKYHUStHCqzavYjZNtzCJ9wVMN2asY5W4OPN50bCpNKDMFlmAsa68KpmwV1MZuG/bUEMdU5tX5aq2T2E6nC9U0tX19Lq3EyASE+TBTG4dx1ELv5jxmjr4ZLQ2Z0NQZYrPZukgwj5nGCasPQtTcmNuMWek26tM2BlW5NpcjjzYtqG5gXI56a0Wk2jci2b01R1Veg4gr4uCwNmcO54eOJid6knPRwGesHWzJwuyAcqlCBMvkJZJn0ZbdgL400LG5TVb+UA7lYBu7jswstTu0ZmG3r9ggfqzRZtF/ZgfxHZSGlebBal/ddrdDs/a8emXovsnpecpaBmgM1oft0ti6EsIogCzIBi9K8pVAUTRPjjy690KU5uIG4utowt+g+fHCBgMnBjFZhKnRLZ35pkIN00g162w4OobU+Vyq0MZg4zqL8cVXD31XHQGeRi8J1/2OADCghbTapvr1TcDA6LbPtboopHZ6hzdUX7bjWtdVkNYlw1l2F9kq4Lbykm8aCEsE7tHd0Ku/qMq7KrQRbIHSvBF/xsuO1vESxRamuiFsotmlPKXMfzwtfOsQg3ySskzPQDf2Cnj7QqczcYPgTlCwiv8Eej4YG8CiY7W0nZlrJ8B9C92CKvdJp/kH3xOvDVnFeBbsF9tLspnkSz3h5QEL/3D4V+dWbNslFXOiypZJlD4cVMqs0xbM1FUPA7oVBYnah2c2luKQFjTfU//YtugTG+3618VUzXT7nvfEv+J+R+vksUz3dbbuPvIrvdT/ehv+Efl9igmaESMxtEdGj0XvF+FcORN3cn53E94+/Nn7Fm42fJFDyhQTKk0R2a8mIJWoGYOajzzR5iteWWsAZBfGK0Ni9XxIX5Cgk50h6PDRciV3Zy2zrL8bwA8OHjnwhE0Y1rvd5RGSl0Cfo3U+4ZJiEjtmTINDCkuCIDJIWmv0lB6fEN3Y81j9MJ92k5Z7XPbJfaOmAQ2PojguvR648C49finPG1lsuDOXC07w/Z8PN1ZL53uqLxdKLMFpq+LCQs59Np2O+v5xdjuvluFDfz/dH0fTPKN5rH6Qv0eH5UKabMVUmKlCjlWXkJu/uvt5dvhEOptwzKSax+oH+a27zqa/F/YEieunxyGPwnRulTBrCreVfSmaTsVHIPJs7C2nQU531n8Mk3d8sBj6yE1H89acqx2oVAIGSz2x44NjcMjRZgISFyI896kz2YQ2R/ucpZjHyjbhWMLIjO9dZS2B2k8MW74yf7ocVVj50WykXx2HgvSEUMDsOV1Px+gKOTpoxo51YmegzzJZzLli33+I+9Pn08ONNmAiTMwZE54kq7r8lr7fiVq9Da9bOTFKMY/V939J75z1zOFQXeMQFlnGGb2qDjt2bc7j5MJx/bBSRGlZJOPdjhjjWK5T0rbrNWym68elZqQiGOQYWJneR1lL/AZC9fus8bhK04DHs7MddilKl8+PwZRCqbxCTPfeAc3hMonJ/VDv1HGOPaE1tUhmDc6lbK2mEWxeTLJsmyPjGyCdyC29gLrnk2rPpzvoV2l4XOti2o8ANru2mFyTtD0BctsmhldS7bEAfKXXdwe4J0YZOS5vMnin3GPHhre8st7bhmsxSC1kZzqt74hwokAvUL6o9kJ5gH4/Qmd4T6pIHHjjY21dr6Y3U9+iPJp4PxmtICTfOAZDcvtpD0DQprU3fmzqzG1ajiElNxVLhI49RqSsE01769TIQaelrD/PdjDvIt3OADf78xLTHRwX4XQAtDnE8Qqo/pUYClO22TmYMDpKcnHseMA3O0qqfZK3IVsav+PCCCMmMmXmr8H4u3EgLhChnTGV3E2DoHdZmXMGnOU1AqTqxSxiElkZvMNZ6ytIRPmg0i95uUmgwHtJuh6qQlasV8u+KshipGGaGh6jpKV/usi1rN44SMNDiocD2r7ycmT7zQRlyKYHWyoVvZErT1JaaoDVBlWGDIqwh4CbVtBbbMJATyufnJrN4cspwhSwa1OisK8mNQuDG1Xqk6tTihNvVXtnb3i2tUjFYK1N274MK4dtYIhUfy4S1twPmqWRzscx0S9xOiaGUbn5TspjN4HT6nwOfg9JUHKqkXseBpCFlq72hOEsmLVgkh87sVa8sNEt1TEE25c4tQsf4HEq00eqFC5GJpsjT1m/wzbTfKbKoqd/G/vOOw12t+0acx0i/Z80GwOOQlopEsbUbTpFp6Ej2E6TdZwn8kycwOgH9a2zIlvKE3zNxESFP4Zh0+G97859FsnMxr2ODSPgV/K/XL3ItNAzDHZ2d2ji5KXt3pmvbNZ6o8MrKb3qgG4L0CXNRugEEWoEffuL9KfyfvHUlKghOZufpSmJexXgG7MpLjHzxmDsfBkI5jl6lGVuwIrl0CGBnpot/mViK44ZvOp0JRVMziPNxzVKHPKk+EO7j3bk3nbuCC9/g+VZLYiuHSUzeC+9wajQ4GnxZ+3eILKS8KnZLuI6HPR0+YZ1ZS1w6cAdkCH3I232JFqkEDlJ9tJYhxpdTW9qe3qluvEbIHq8zFrUkkUUcPVaRWnkaaEooIswzkfsUK9IgcVj6WpPyG7P258l9vL0cyGk69DXB6+vFSUzrnSAN+LH9p9bL2Vda/M5c6ZFpoL22Pmu/SmCT4TqiHBBFOg+51bne+ZsfC8zDjFs82fsP7deyQYW53MW3wRBOGN4KNjQvJKobBXlfufwsFZDzTRUECsjSOBuB1hMIK7ExsD+4b0Whj8HMZ9++mhUAcDVpKEqQe/W6r33AXPBbmy8P+5COaKS0CyMcqvLC7Bl6Ybu7cR8ZZPlh2GNA2vL/rDhnLgx1cb7JOaD9vGPpdR3qeT77zsu9TEMCUJG7S2zj+Ig8ArabTgyIWR5hHQbBzT7mMLlCxrUJ/GsWQzHqvgBgNn6wyjAuHFTooMBGsIXBOgNtpOcb+EII9y/+ghReUqXV2/t8TgSi8unQJ/2UaCT/Cp+LIaDfqD0hTI0wU8hEPwOcdX7nBkWzwv1kuFMn+IDoGaZeLj38ZBcGNh3Fez3ZrLvqFhoaKJipMhVtSTwMPi/u7buMkRPW0UZjqI0vqi5jP6CP1CsaiQdDF9OKPH0yldJtbiQrNrLGD+qIzp5bbWZnS4QEXIzO1V6V6/hhiFgcvqbVM5hHKzkQY+d+TpD+FO/+YrGEFOmAfq33yNdGqWYo02nObW/hllVM0OlNVjrpra5VdloS98B5fVFjSvr6lxfaKA5TlFUzXWsW5XdlHX949BphaqSFPvZRmeRj37Cfasp7qQWqubo25KfLVrkvP26XVxXY4fSAXJfrHT0Exo8Vv+lrkrq6JGl5suqtIb+mUo4oWQMugDW6jiD/mw6B4sLkYXex9NTc7PPijzZzm4PfEj7JW1zgdojXAr3/JOFpI1K+UlTxtF7kaAZgdsWnGmXN74vqc4oe7URt8y1Nou2u9AJINiHLdH2JY5q8jIVaVckp0PXEIzybL/uajgxol7GyncJwhDPOt6Xad4rtUUqvxK2XVYxB1RXPIwg+HfPae6B8P8YWR4BgPKfguY5AEDreekVh56T3ZdbAJgn3e9H4DmEK0A9tQLIdZ8dfw60NWoBcwfnDPg9EVVQPBHhoBss4p3KZe0J11lhc2Ev6AG1p3T3yHr3uU9md99PZBvPa91BCCxWAD832tajpMlEpODXUHgM9HkK2buwAkSG8oDTq01iyEy5U0MKWaYRO8PYp5Oy04EAKLemAcq+lyU/87qLmvGjplfsC0PZnJ/pAMrEFBIEZhmcoWEQziXbakUtf6EmliQz/mhJAwhKw94DCuWK2LBNJStQdjm714w5Oh71PMT2sy9wMI5racZQFMgqt2KTGOvnvUTu7jF0Fz0PsD3mum5ebQHHUszGRGoaZaKcm726S9qEgHsR+2BbhCJWzDUH1Ged5W3ce3WezYuCGdPFxs0cuuFMM+VT8ZjpuSGEStQeNfDoXRwTMBstB2RzQDkNrDtLbUDB3qAVfJtblYfS8yxt4Po32KZ2UqezqZiaI2IshHquS/eNsF0SvFOGecHgNUEa01zDbxv3pZNOjZ6vuJ4ZtchEJGYag6B8eVZsxjzh3noBZ6HcJfxqsO0jzz0g/o2xMAGUvHIoFUhFUcGUipI6A2ZUQn6AIOn35HvpxZUtw/3HKUupR/PMC/ijQKVtn2NTNkpxTMMNqpN0AwGvoaIHuV6bXOyEY11nzo9MJ2JGlPsGvNH6LHD8MeudnvXhgbmuj5Uxn64JqxkfA9fvb8TDW+LRP5/d5nWZsS9UfMeD+oTXjtz92cgXtPro6xU2i58nVf26K6TcwhaLV8e4xkzNDWbSO673UyanMCJbaun5+lrNlLetpgV7PbMzZwsDdQTVuJmh1SsMwvrX4FCK10t0C0PJwz7VrzcfYA3rGWtNOmNaUh2KhcnZ9S80kUUK03H6RMFL6EhLerLDbB9S8txq0jWJOOx132QA31w0LBe8dvJ8DY+nacvQQnNprapi0Xgy0GrSrOHMTeE7BX5zyDcvMP8HjAIiNoP39Fw3hXKU6BkyadCC4PmWny2y1zNtzGNjX15xLTPl9bvOcm8avwNPTutyPb8Kk/SUjIqmQpWJs6j5WAhvnUiPA5k97phxVQTQlnX/XYutYL5G2A1g174AaJBvSkv3oE+D8URkE8yhAmP6q4JQLpdQu026W8EhyFFBGxi/giXJv4JLmsrPo/uqGo3LnQxou6ngG9yFCsHoJv/2hbyfDwTacAHIQ9tw9wok4LOgAhPu3FVB2HYur6CoPvcqODxeeQUt8o2sYHm/qyq4fN99FTzJu/ZWOBn6Dang03/nVAg2ybtXPtlC5gMBT7YkaVbuB4MPq49wfnp2BmtsGSPcUqHYkvakgNFDVVQS1nOiBSxDgBVPaAalTHokv4B64AxriQb30tmESjDiDFEMWgKlpOKLI/8FRvHc8bVIz9kFyeRBFEwx5o5Uo70sNLENUgxsIKDfCUPWDJOyGUXABOcyjxhAOopyVc1+93MJnAGfLoenEfW1Au4F2mBqWnrORphiOIIjNfzxk38oytmzM5aYGYJviDA+BEcMgGqTdNBTnm2hHgg8Ze4jfsjEmTZy9sg0HjN8ZxnJryiaYthTXwLq2eJUwsX/LoV0UUO7tX8Fho3tsAs8kGYMIiAx255hTL016KnaiCa5gdsZGpnQnDUGs/Tt5GSSe0EUCMat/k7Gm2IHp3LI4Ibtrr5aX62Ws/1uC7s13F6qqm22h+VmX1V3X7lreJYCAx4JpOXsGZAHk+eu86zkLMzQqYzyMlQ9MkiofaGCbVDfxZFIbdYAXxODJjtmmqopmt9wJoCQEznu2MFtVFHMGMBeiUZ6jusVo3Hs2wXRe9YOB3JS+HKrRaFkIqJvo3kGh0A9pgdB4MYmcWrzgehQvGKm3BajxqdbwFVHchzGGX4VyhqKxlE9qqfLqXQHjHQ8BVIg3EcpHZkmzhkwhqCuouSIjyMf3zsz3uCGImmtFi5mYkXJ2JMxRTqM0BJ0cgXIAxo8eU5C8/SyxtnI9DL6B96tJM3K/WDwYfURzk/P8vdhjS1jhFsqFFvSfgJ4Jh4qaMzPsZ4TLWAZujKkQbaM8urwSL2HC6gH9ri1REJD99LZhOHDMOIMUbxoHU4ppXa+uHj4EsiLS+74yG9uZxckvfMgPMyUi+WOlqpnP7E9m5R0fOe3Y/ptlCljYmhmEp0DJkJ2RAE+Kp1Mrmr2/1uKzRJkCJCSeWL+cX2N4uVjJpMnD/qIMGZyAJOEW2wMDzjENM5CHXHGy5hyypJ4VbK+4cgfmAST02PxBwqNSYHyS2TcR4qRQLJhRpwKESCS3OC7E2MkrChLvizsBbcSOLuzxenp7kVz87gdROKkPNR9RS7J6+CIB4aaeZSBTgEUIllLccic1xR6dJxDm8OMyXJTHR6uW/p2kkcTFhFnMgRWXHBypAgud4ROEg67Yburr9bFVsv7freFirU07LJqa+7CcrOvMu4cX9XwLAUG5HAJ0hatlHN3q1DzfHXOgrDoOHcZKyyX2p/ppKgfijzlUIOa6u0/zSqgTQZEletnqaSYYzRwY6K2yDHUNQ04CjwzeAoBn01JjyUOYAG8hxyTl9LQizxTj3osyuBLoFMo5TkToy+TGlzwO+qVViSakYhtnepqbtb+pDHCaKFtdX1QcreAK6oJQhO6GX7lsZxVdNaSDDVtRLImlVzypaNYSDwVhfqt0pFpKrrMWZuRlSrYECuD1/a9WE2ZMzZRAlLblIS9bCwLYCnH6pO6ste2aoSNUAFSzaxQr08Cgb6zylFh4FZyVtAoF8RtHb9QMprRFoCvaA8q0FhlfEaAy9sllMskBvmeiKf5xEx+8ztnMmGzqAV5UngU9DQO0dDdeMRCb+8CfobhR8lfgECBnqxrwZ1sY67A2GKrY7khPnwl1za77bLHWedgdIO5HtEzcsI3xzzhCI3tW9/h4Sjxl7+V+sOfihkiDySEHXlBgWBMPAqbee20z16jdLgtUhPxhlCAOl5xy1VfCM7kq9JpJ5xy0pcOOeNfAtE2y1ZE6LAX/vGSwn5fG8zLEUf9aEUolZYXpNzK0H6yOowFVoW10BohDBGvJvFpEr/m3z5/B1zw0adoBXIEWGRtjII91lVIoYWFoNp6i61TYYMqG+MW0ZCGNqzhohxCgkDRFefQPdCuXpwam9SKV2d4fQIeInzzCxFJeXdDodLoDCaLzeGKfGgMgTB33r15/yKWSLMkHplMrlCqIGmWrEGSRil+lmapVAddLLscsaNs3i9+FT3KzlRU6b0P7rkvTCJZG8xska710pfJqpKANwETqYSU8sLE4AgkCo3B5uPbND6XnAQiiZy7h59/i1QancFksTlcHl8gFIklUplcIQiW37dKlVqj1ekNRpPZYrXZHaJNOXYkBJUXdixXNwmMJiklLSMrJ68AikrKKqpq6hqaWto6urgnuh7hmfzvqNcbF+N+f/eAtsWkM4lET6RCs3Ht4yGMbRBaX9G5jvsFu/OtnTP1lF1TdCFiUhXhaoiwKNuWlIh2jkVCwSDYNrB41HXj5OMSDu4Evm83WwZpkokZsLrT+GTafQT3e7HkU3uKsoi+6HzIFboovrxfiT6bD7aY6hwL9JGEutg1ImaoMQd1CLMc0Qtng5OXqmu378KyFeoJcAzbOViSwJn+OkVdC+RW/pNzi+t25VnRe8pqnTqEHw6FM/jx4IcTRoVKd4JiqtCBMlQhAu1VNMeUTaUvDLHbBMj2ZjPuz1UbR3VMCat+yu6S1Az9yWWLMhmGCa7YnIDHxVyFVxlXwsVchQx8cnR1PeKDu3bfHGp1ExJ9fTZ/7YUoJ8x19HAb9wnCuFa3FjVkuGWkhP7k1rNOwjDDlgRxtB1FbCX+6CK23Klw29C4imFMMZjdHqpgJ/LXYjeUHFDKO2HRhWAZ9v5CR/uRYh90HO5tSmZ3zyKT1yfF9pA62RjVDt3GcVLHUmNoULTRgkZKnDbHSJyW0eGiOZSVUkwTmygJHk/MDNPYH/UEE5B71MlNiwzPFn1W2D3bsHN4cUfeyL6k3fHbC9MgOXTLNxLeplzePzo8XkgkjG3a7quzW5UMvbTspMjyRdyTDc/8wcsex/EcyB0Oj5wpRDO4r2UYQAoxpIiAtwEYGQADAoYTMIcIbJlBf+2vA+kAOoD214F0IB1AAfDasnZfcrlPLvv5cZKfzHKHKKKMKupZM7slQqSRRR5FlFFFnU2EGfUwElQWYBhACjGkiIC3ARgZAAMChhMwhwgptNchOrymzO+YdUAWDohDtkEctdfIbgPi0Foh3s42yEKEOLTXiLfp3iFD1K69/cvkm9cZqvB/opfaGb4fb5uOpKe0O/gaKTvd6p6WDkUiBhLSIpvqr5DJJHRXWrH4RHO1w5NVqfbNKyN3fNNasWuwa0OdgVDUfgFhc0niUyl83K9lIolcbxV/S8I4W5rQE8ZYtGordncY9x0VLyT+Ko77XvxFBMCS891fYR746n1Y7AxB8+7fXrHKndKdhG292QvN2y7f3oX3wE+lk7sKNsJvIlwEBFjsV5IRrCOT+fMC7Xh+2i8PO37/ATmWgfJfUP+d1Hrv+3vStN3kRaOYv2/YgJ2ynYQf9B3/bsULP1fBtVqbs30KDwE=)format("woff2")}@font-face{font-family:"Europa";font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,d09GMgABAAAAAHpEABEAAAABgkwAAHnjAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGhAbuXwcCgZgAI0OCIEYCZoWEQgKhMkkg9xbATYCJAOPIAuHUgAEIAWhZAeaUQyBI1sGR3ECve0HBbeDR/PW/fAjjNsXEqHnhlztbMViTLjD7lalSLBHVfb//ycnkzi223O3/SMKlUrlUwqigJA1oGUCwziMCWmpSZcEJUrzkiPUazQjinZbTblN02wVcndk9we2iNnkSJqeVax0j5LXUdfxDfVT6wOzuqRLuize62sUhlESBAqa/GSePCwSD0v3Zs93rNAWO2cuC4ZpF6Z2OzEzbMTBFB0P/jGYPPrBvhz2fKhQXzoykijcGsg2QgAtS4cNrjQ2OUPIy0VOpUtLygh3yUjnTFsLvz//L09NXf27i/KdPZrqeHE+q6Jk/vdmgW3DXjQ6eh5P2/p5u8uyICAiYuMDFbGxGvMUPa8wrjwRUTE5wIrLTvWi81/8aHg+ndb7AkTcALbBXtkZDJtCKjVz3RXtFdXx/zz7/f/m2udeRDxq9aSaiL+RPEPIlEIiWmNQAtnrC4V8B3i39ZvQjQiigCwZS5DHWMqQIQJOQMVRijtXaImrcmQ2bQ2vLK+sbNiY+Ctb07KlLcvG9OznrdbNf172B26mmS5xrIBUPK9PpY+31YBMpYzy8lLIytJV1DajNA6S1mLkUMghJODHxc/rDv7/1X1+gHogB47mht+TQ+SQHiU8w1JQHqpTpiiz3FVbDn6o+6hoqywwZPbgiaBoY+rWnW3tRxhyXT40QkpgIgcmCTePTt+WaoYjHMh8fZJ2f9d8r6GCatMS8MnCrV9Nf3e/Vlrf2RO3z6j/iKco+iaE8SAUukqNdrl3P3V2Uk8qBEWggUpw448lTFK60i3rrn0Z8A+2e85NF7JYhdysM00p/qQufbf8LtHtgBvi1q13ktUUACcgkC1/PmHJJEMAjaEi+YswzL2OzK22mxsupTMK4L8O/hMg4L8AAv5XZ/UlOwv/2wPvXXlFh0XFJbDAjpLRJAPeOS+DdKX1tgOsj4g9QFnOMRDEctUUdCDJigprp/oFHG7rnGM2mu0ICAv88/7c1yeAqGAhlBAQeqiiYuu5pU3dfaXX39/Z4zjXni+nVVUv/N+gyAhhJBCWU5QnJ3BPjLg1Afdt81kbT3u7z2FblnwzX7bQcueYtL6C1GyrAd6fqpyIVETIsujMplVjSh//pytcb5uwBSgxNi/LxxObGyVJJlPi4I+yKQ/VXmfvTdSXEfJkJEYh7Ye+0GVp9iaK0ixotdBlBpVBIRw4vCYFSQKYboCQYgB771yfJaFOug/KnhE/M9P2dUtH4JjkvTdJJml3m589ILAI2qEwJ9WH+S+d1bVKBW0JZnahuycFJuLN7j1ccIM96bQhnvr1afdw0w9VqqpfJVElgZFK2JaEg8ABSRgjcKgqCSgJ0SO7J9A5O09ICtiNwO0hdAp4UnTPxhAO933PvSfPbDzu6bynEO/nTRACQSQzUCQS+NhPRn+l/JDirt24tTHYpdWJ3ZAM1mATTIZmEn37MbUvadm1wsn3S/lJGQakCOxuVk7v5vT8f/c639ybdBqPkfkRqk4n6dr5VdSIataTyFeHxCIMB2HYalpBCpJAIn8/rdmjFnUeh1DoK6UIi5DX2udIsuVaaKVn60v25b+/u/l7oXRLV704BteERTeH0QxGIyRCSoRwEOQOKMIDoV5ay8IWBhyIBIkWVJNwOwmIiMJuLme+fikVHvDXLF9Q6RWPIsYrSyNGzNBsjNqD7dD7a7849lPfkWrXtnlm4UY8zmOEUL/e2szvp1JxpGO+S8dKE6OIA1AUlCli7n7vELeKILuHhD3Tf6SWCksqlNKkjcwk8O+XAQHgmRwQQP8cl1QQ9MZbOVpgUADg//+NN9Hnn5lrgbFrBJogHzMQsXqKNPuuhfYHAd3zTaV5N9MGiKSmoVWkglkbEg6oBPipF6l3EQrAA0tXswFwIPCYgUf3zIMf1R6FNJma3sJN39Lt3tF93z+HgIw+fTu7ncVn+XngufBsPs88Lz8fPV85vzv/dx1DP7ju0/Uu10dcT7u+8frRN0TfMHGj8iafpmXCKFJ/vCQVGZ+rsVKTZ3EGzxkoxMgpopTRXOQ6mGIq0KjB5w2RsvsqraWmTi5tXdtq7mFvTJJSNZZa61QVG4z95PHoc3/8mVa0to0fXceCIw+/IVUOyreqaHZhfwzkogP6wGS0CpYHQqftgpjdjQjALmFY5WODwdCMkZ3C4WKkdw+PO850Us4urnG3ibco3zM4Br9WZIW0DMsqLAsWSWYSS8Vr/bX4qGQ6mc2WXlnNglqSj7RtK8PvEkye3FN7qH5PYw9irAn3iEzETbJHuiYjp6CkoqahpaNnYGRiZmFlY+fg5OLm4eWPoIDate8cJiIGRyBdlZsuAASBIVAYHGE+rIymYVtz1KMyhoqeuQ/mhSWrGItPIbEQA6ELWahCFJqQhCKEVeXGZ+mqj7plXuUzAxdUGH8y+D7BB09eGRwwHcz26sJjy9kv/Pbw02D1sSB6sib5tdRaJgrz2gmNw1prCNP1rhlYMBKNDZteMtuycN8yufBrohPEh0nWpGTkFJRU1DS0dPQMjEzMLKxs7BycXNw8vM2XFkDIjr16XhgmIgZHIF25qbdp9+Wxi4KDB5JI4IlnXngtr+U34UCiUIEVQ5XClSNVolVj1eLVh0RT1tISRi0WqjQ6g8libWtf77F3+b6ADeoYv/Z5Pts2vWCW5TPxEQvUFn4B8AUClT+5oeepwRZKfhfRzVXmE0tW500f/2NqWzGYzEXzWLI6ytKQNeupcyTadBo9/+Rnenp6tlkO1obt7nPyQL0HTJCn814GJTQ91BgxkgzD7BlUiY9Y7pvLJK9qk/qkMUGSsaQtjFnOqmgiJiWjoKSmoaNnZGJhZefg4ublF4Tate8cJiIGRyBdlZsuAASBIVAYHGHe74t0UBnwCwucBTxIrooxxhhjjNf57dF7SS2cgb2n/NLvLQsqllQuEE4kE3lEFdFGDBFzxBZx3t31RIWhOJPWw0KncvkCioqWNBlRQ6Uxaq4gTV+m9DXGIjFklDT0TKwc3PyCULv2ncNExOAIpKty0wWAIDAECoMjkKrVhOiZ9+kf9jjjK3us4r5KkQ+OGQqFj4t70na437EYJ+XsUq4fKuT3Sn2lodDY0wzRsxjuWUX4FTEkZOSUVDS09AxMzKxsHJzcPPwRTALFrn3nMBExOALpqtzsBmQgCAyBwuAIpNDP4jI8FQJCCCGEELp5GT1lHJprh/YcNRyr2nJ6wxTlrL3GlsI311WF0dAiNrQODJqgtbwkDew8OLRRVvU2DiXC9p53o6CN2LLB04eqJWfl2M63tBSXhb3DBwzWAl1SNvTRhfKfUMcNoAPrO/3/vgBkrh4YFgkx+fcaPRgB0np7E5foNgxnPp87ALiwuk/U9sAxb3LIaYpLQ70npA78OnYDZfL3i2sADVzlUH7oFOhUrEfw0EQe/NfGKA0UsJ0UXBwgi76C56P/C7Yo7c3MU8OyEZ2zR+Q2qdDJa2RGmIAKrnL3TEQAy5eMs8VatenQaZTVfv8oFvD1ceYnULBwEaLFiBUnQRK1FKnSZciUJddAg+TJV2CwIYYapkijZodCe0p3/We7TUhMQkZOSUVDS8/AxMzKxsHJzS8ItWvfkRPnMBExOALpiheAv3IvPEzY8EVEihIvfoKEiRInSVp0McmSl1xKqaWVXkaZacopt/4NTFt+BQ1uaCMzZ8lafQ011lRrbbXXUWejIMFB42FnrIRgpz/qhNPO6XHRFdfd8hD4Y/BFEPgRlRSdrH4htW6uJsFSi7+xVvd4ODFZWuy0PEMi9od1omOOO+mUM846r1uvCy657KprbrjptjvuxShFfODwJ8tPmDhpMclLKS0Cgjnc4g011VYHgrfAaT0SXk+IEMg7J/VIbD2SUE9R17Ok1NNS69le1yNv61DuQhBhyOTlexEriJXEEYCKAhUDKg5UAqgkUMmgUkGlgyqAanA8lHgksLLE9cSNQNcatxN3ArtRuJOwIX6ZVRcAMuHIDjpD3AsSAAWAAcAFYEO8mhDhif8XLcAHYAuABYAGwMGdz8bg5JeOcDMTMT4bZHQWOAzJeISYnJcR4muG8BhoKlie/ywC4KfBMHkWiaVRaKCCIkqIkDFtBCETKQslF8tAtDxsQzCG4SiCTEQ5DjkFOQvphlyAXIZcg9yE3IE8QHiE8AThGcILhA9In5C+IP2C9B3pJ9JvSH8g/RXZAI2VmuPko4seyh2LcDzCiQirEU5BOA3hDIQzEdYwsMsRzkXYzMBkFW5AuImBU5twBxMrorm6JEDSRMhIwgodvbLlizCEiFspx0RISjlJyOiVcoaQMSzlPCEjWUovIeNZyiVCRrWUq4SMbSk3CBnhUm4TMs6l3CNktGHBggULFjQ0NDQ0NDR0aAEbNmzYsGHDhg17Z9d/DEwDlVuLcD7CBaxQ4wsKij8ExCPxUv1MTtEKLMwmrxBAtrpB1yhCPUPeAgCsBDs+Ac++E3/Je78gF9Tg7xMp+D8B8r/EAOYAAPTnjgLA+y5kthH31Hh1Q0L68+j+AMDxeyN/VwMQmx9VfzkChdHKwmqLnYTs8dVw5MSZC1du3El5wPJbOwftcwgHzY+/AIGCBFMJESqs1XBEimoxzfFpEtMkp69HqmW2ldhcaa2o9EmrxEwa2XL0lauf/ga0qmRt6ilMyw1Xr04DEWiHPJynPhZUdDYnHXNGr/MueeaTD+2CotkgDuIjWxSccFgvLuYUmVFRJZXabptiOuXGmmAWowqV5phtv7sl2WiXw44osdpa662zxiZVqq1yL50ULp4VNjA4AKBZC1uEo84Vl7ZMDiRalKhl+b7eY3MdtXeWXqMmk0yzwxjturCc9tkJX72Pi3hIgJh21EkF6Lmmp2t4bJhnqeUWWGiRxZZZYj7q1AJgvC709D9LgGBqxTpiIT6yCxm5qDRlV15Tnc3e0XXvwR4fc49Nx8nH1qQ/cI1dsBTLsQKrcCxOk0nNmoS3yiQyuUzritwc2R7ZPjmBvx1/l9xFLpX7yzPniucM5y4okhSGCxzybeT7fX57255MkmPkl1v6/w0AAFNJprMyGgmQKFSUOGnLqaJmH15+fvf2sNyy9DuO2Am7YdxjYp5hVdcrB7mhDsiaLmmWwMz0xZLs3MJEb02UihndfIy9+08B/utx7v7q/Yn7xD3v7uq/tR9/sSGeoUXub8e1W763LPOnfTN3fou/zUbjrJ5j9zMsoKvRA3jyPRoq+hPt46fo333Y87DN73xw7UHv/YcvrcoAY612OkAvzwOAuCOTnthy28SzM5gcNPHaMqYZbX150im1N+wVwks8OSVi93+Lv8Q1Au8FumyZEiblZheu0mxFLxktt01LtbFN5lSeYIzFbVCthZw35dDwoWXyu55676PPvsa8zK4GLwuSir0pyX7B3V99zY0zyzEnnXFer0vuefaBIxwH2TQqCrxKXR83FHuSQFHFTcv3gFoaX4crrrruhltuu++Bhx557oXHnvjhp1/95nd/+NNfvvmeMEhBQQsOFryQEE1DhsoqryJjlVVVXU211WX68IY/uNV11jWk0Y1pbBMaG9Le7HzL6rLdDmN58iHjRcG3u93qZrett9tUMzvX+brrqbcLXexSl7vS4Y50tGMd70QnO9XpzpjYYN2gyaabCC1TyjSnHQXEXz0ANWbNracPI6LnkdD5N60WzuYb7Cz62/MClPT3t+XuN9gl3Pl1DVKxc6yrRdwpQEBenCTp5R8Irl+St+8izx+ivMvb6vIi0vafGvIk0m/YeuUcMBik2rgHCqk5eBDAvu0hoE1x0sLTu/5W5HKyMSGL6CA1Lb6PzlzVFYr+8/+MU6dKRC83Rd8lFctQu8ktwWp+oeqrqKyok4I8SZqsE9yrmAsiNovcpS2SimzNyXOpQJaSAf3jVkoeEnIxB0rbTcHifCQkkBJCSE7QPRTMp3htlqiCjNBbqaod5smYTzaw7LZ0UF1idyIrqq43URLOYSHm+apdTNGSS0K9FNliJRcrejIPC7A56IEgSaA3H44EE+AZWlRtw1foRPawoWkOsuHGHw8l6h3m7ZyqvXmc3B2Dnj0OqZNw2dG+Fw70IHE5TIfMgFRcsybd1VIniCoVXOncyuVD1AT1wdTa8fC52HRVuNYjD65yGS4pHpQm1A9HbUU/3Mpcuuw8fBSiVfB7O/YIAHIJHl90BW/dEhLbW/RAmp/osYUQzocg9IJe5AeMHWZ1xUIgwTxCvFyOxetxOgv/zb567PByIb5cOqBU7oKxbyxCAVuu8Ls9PSwDu5ZAKtJQtp7p7SjcMWEIzMcyc1FcQ6dbOGa/7AxUllJVB5t7pdfjsoTCZtBtxvhCTd9R3h8FsLYxJEjskZOe/oE9dhRAFMuRXQmaMJTAQCA9KMPy5/5yJwhCSujOy6jnzyT/w7nkEaOA/cDjgCILLICVg6k8iAqwtAFbRQy0CUdbcLV9KOAQRvmadHKfmGrQ09GheNfjV+EO8e77uxv4eNRS7AAyLKG5lkfSMLUMLAd7gr3A3mAF2AesBEWNBEANhUyUCozN7LtGtklGagzTuWenP2uCQKARmD3BkGbSYNjau+YN068VK+QelVqLcYfgXFhxexJPYlC6jBBSUlRFQqFbUA8iDDugFCNcNrSRISsMkh9wP+jykd0todFBskMSDjWaTfbnEkht73oiUB9tPJHNQpAbTaeJQiGC5JxqzYDnMbHxeff/PhZ/q/j+MLcEJfQvRrR96LInGoAEYRPF9RHFRWk42OoeiNR0vLLEVHtV535B7YFWU4ri+SjUC/G7znbjqmdIu11SCCYYqvNseYA2zThdcVMWyJaMIgTzpkGy3awKiW1VivkkZto+uTUJKtlUkYJxD02RviIBF5u1kux06aeYixAsbZ9MGwBuEA3RCYAXaf40qROzPnliKeDlTlgp3s6au564w16YOn4KHBFqzhM/d1ASltxkaGOtxly1x12AAXXzr6RuZTxf2LHiUpo0qyUAdaInAYSbamrNrKzb8nKq7U6EqSYwdsoe43z1fvlDVpPqEhTFA09SzVdcrObHVvdLu/XtTh4SbaPFpAyJsQ4WtC0gUXpJGSjWBJknVV5ol5w+oElua2pU212O/dOGheloaDRSBnxGzGwWIoCnJ6UxD6S3jjaX4E1ypB8gekCBZWxdxQyc3bRRdCWWPuFwdE96uPGPHKwJz55M1m3WsAB6GhOxOtMMiXpF9meQTEy1ph2EdjbJGZrvmI9uH/Ud9s4BkPYmuYrQr45A+ie2FjCgAZBuA1GEQY4wLYnHeal7ACB5YPnLAkJBoFsrpAUGNwGQDaGAMDQQNowWeXh9kqpFXOQRkFwMga4BkCEliqCvI5DSVHCDT5JSKOPSyyFeAXEjxCshXgXxash9TeouiD15XquNdyZeFeskKZuOeBKivhqZuguVhzkhBUsJwbqEOIderyWiYUWiEY6kqb01mgWJFghalxDvytu0RLSvSHRApLO9NboEiVEQjF5CgisfoyVi7IrEOIiMb2+NCYLERMibSe8eDkX8pfpL8N/JGH6S1ydf34LvPCDoS5m8NHD0Y+6Y/CPLQ+f+ChL/Bsj9TR5Sg8J/UzU5eRin1DgtlAMFNBANRJcKskKVuv6KP3dqqaJVTh1bTCwfRrnAmnwzDKEwbFthLSK3WujW6gaDsbxfxlSk3A5pOtMaFWFLI8yiUUaRGBajUM7caYEb7lg0YDraBa3cIim1BmnU0/rCJRy9TN0JPBHYW853+uRe8kVBrf1+ujcKrjmebg4FTMBkoOeQ+4Bw4My5Ovj/0ijyqdlcM2/ADISCUjCZS2qr8cNW80mgOYdhgOpvGaJsBXXAYR0YYKqEgQ4eEiiZta7EmFWrxXbHiI7YiniTc52shxZybPTU57jKfuIGCy8M7jisREKO2XcuvVz+0JLO/qDUWP0pbvtxP37XInOpm0bzpLU7nHxhret6vaammBvXUteXEc4YxXMcTM3p75EZRJQ4MN6CmhVV1VG6o6CtXsQ4BlpKJNTXIsLvBdTvRVmB+hPbV5gFZL+giCKKqEIVqsBwW5n/oszZhwEd8gPvTiUqUan3e/Xld77da53FKtUEVh3gFUqMB93YamX4R+LQgzFxszpiEnnCrpHhnMTJOQuNPh3taOHTLqmOd1y3A8BuPqnPIpoINEXnFxRxKqQkNnOfgUhHhyI1DirhHmfAmm/it5CkMIotQpYE0p0D5lLoU0QRVahC+Em1g4S+476xZVSikogNMFj71jo4wt6gk7WCmqLYBy70oMtAxKBOowdmce0hBDkLkVB2mcCci5TCi5OkHKgA7voCeX2Gm9IUhkHKFDLX8rD3ZsOcoAfNNCktx22mwi3IIXWrWr7WwlSwDw6BaY/5fHwZZEXakyzDvNQ7h5cogOWaqF5febh1UBZ4P7n/ltzUqUOnjaR+F1UvDHNLy0s6hIKJ3IeJJwDIPE9MPs+v38cho8wbqd7RkJZiXwtYq7SdES3/7LrjljW39k518yvcl2mckOrMsL7Rfz/8HOpt8VtSbcBt6pn8Ua0nl4NZ1tNo1oM/J2/D8ympKmOvKthn468zCMyPGHIjIamuHtl5Sqogxv7zSRhUQc4J3rBIlcecFLSwTPCbmS84CK+TiHnsK0FcIVXqhSlyVfwqBiEzU3/CC0cUhVR/4P42BQi9MbBSrOfbfKvBTHbZknjwFkdVAQL1cosOw4osNy9pucbkDt08jmVTePJ5OT778TIx861Nv4G5zJReaHgGriD/1O9P7O6pglTueqUAqY+6MfEb45rochL+NaowS/TQTbgNqbbYfyP+SJnV69g1hFyEdppvweY3081vH/I+CWYEbsGwZFwIKtLYpEVgXfi5PW00NJNtvQcY8nM5BwQtwgZUIT8sYJ4a5hB+FntJyCQi7F6sQaqi8ir6NEnDwsr+kMi9LSo1nBn0fV4tQy6tZa+jve5hZw2dd2EpKWAfp6Sib5CL3oKlGBtCFZcljxPKjbYaglTNSOqxGCWT1KrceCpC8v0dk/O8+2RwqyE9DMkhR0WnQL8fuA7KbZYp0MACiz5BRgGXxAkQkCVjUfYzVJ84dlBt3w3EQ6Uaxircx0fJTG9lqAg8+VZth3jVCtOawJ3KPCmS+VyC9FXwnUc/SPGjcZsuwf7TiIlN16gy+X6UqGpvTaoZHPbFxrnqO8VCTQt/Q/IthHs865Jlyqm4mGcgt+gOjB0iCMRpz+smkwGScSyKhcnaDAeAWmjQXeEA5UOSJY6RUD8W69Ywx+zGwU0S9iZRtRrlRoGvaabeU++2fYP6v/h/80FfNriOgFlXR81ElvqrNchhTvIGJKMlqr+410KqwKpBOVmGUB/qdfU/7y7KHvzr8QzekU0PifwkbA9xK/FVnmjCA2GkBfmHWqV1/FSmEUtCCgj3AYajgkHOpuUz/WfGZe2M2hE+kmbKoCgULGkKVSLQUNMilvnZiTOrxvwV6GOhCdfYXxGE/HPQuWFuwjf0wXTHkhyA4iFq1UHc30Sq1LJv4ZRqg1K+Qxk9iGCjHTKXz8R4w60Q5CYFe7oBf1SOXz8s50o6LyBL+ce0S1eg2veMmxR+d0kxRkgB4qmCCZTEKZ9PbDnIKTAILsfG0PgETuaDHag9YHODoGTN1G8nIgDPhL9no+14XrL1RUpVeClzPXJpx/DstrIJ95EA19Q9fcfWci0UCpVeVi6f2k0IA9LtUrQIm8iRxNod4VxR+feluRoLdd9e1I6qGci9LTNqZfpLuThN7DuovY9BKAXYIp+zrJA8tUbFQvQ7iUHIcOduYoC2bqT1AW6nLTI0TZKashxTjJrH88h2rElhoExYnyGO7OFealNM8Qz54ecQmpgs+KIl50+SJD3u0WGupHvr7m3WSkkGcjIDS/wx54pTrl475WVfJjss4rkOHxRYZ6TysDDim6Fx0diAZchnYfJkL5uiRevRTrQQua/LPIVBLHwVpwjtxRdYdXfKHr1u80JZreni30ZLgOP6Hf5YrRCqzwtpAsY0DqRfiti9CC3AEFUKP0/Dcg4opu6ngzMQECDHCMeOaS3tDfHNaoG4o71+toGiS89whIHQOzYAWfVXLRBBSOEkt/a07jUkcTxUW4cnewLPcUSxbTRp1axVrUQkJCrg4R78/XS110n2TLLxy0vAckAcbMWkdYnLg1n6eWno8R3mQv6dPohp6Pm6IjCwxjGkioCOMfL76zjYAyM2USy7YIrmPYY6atY8xpiF/nPsez96VJXGPovjIfQxGfhCJf5JeroaT/XIxsVsD64UmTIUnZoXVBGSGq3IBIb1mfGK48mmLQO+BiE79qdTYng70jRS87vQ/IafsHfjBGr5gFyJprtTpoDY6uoARdm6nCAxXNwWLnxQEMw7512fqqD4sikL00Ovpu82rwsEglqgu5SMnJu6UH5UbsxklzdPhac3MLd1lmneJiJ2CiyFElFFUbo9Z+OGYNhLC9/HedbU/ekULdg5WwQ8jtyDUS8Lst1WU7IT82tor6SyUeMEqT7kqv0R72QZPVrjkgKVCXhCWHffIEOqq9wypzwgQ0YKDc0khcnuB5pSqEhaKwIeQ+ByV9EnGAQVG5Gy+1hxGmcZHcHMiwgaGwWqLlrbH5JjT+AdAi0LoYolxbsE/zg79nWq24a6/PnKrCY90xo7CU/CxgNEgQsdkpafQSgjKd5ArhUK9TGphoDSb2IxDkL4z4X0v0HGB5zz7PxbHoEFEiwDmU3MCZjOUK6q/H87xj70Sn7FP5JfKxkoiOBhfrPOyq1/V4TEfSbHfi6s/hFU2m6e9VzfR7/FMfpydTrywp+Ra48HTB+jZyKcGSp6GecaYhXuL5vVTbHgFotuQm9BonclEVW2c++3Pb0ixhdoOXH8Nx1mb0BAHV7TvxIEdb+WYyEJcWQiTYx6DAGyyaD9Cn8iifKiCjbb2kihdaEmjgijCs2JV3v+YvbgR7bXm1bUXDYg1R5p9S5haQVa4gj7BkmAK/0WWYaTOcxEb9vAm5U4xT4pdMDXUyqk8XHajt5gkW6c45tW6a0sKeCy4igCpxmNmUbd/AITT4K5C8Yp9EtYGABwP30CZCn4EQKnmwDVD9mc7LyQIAu8nhtr8hbhWcP6AmOoGml6+bHF67A/+iPSeRMtoWBfrVMeGj4MCyV14fsCFfeQ6CVCcJzO+OFxFVL/pwtjjGKx8wnGJO6hdAWuROMzPb6J5eRis3EH+z6Wh/C7n0MYXRgjXsn4pEgvGSOO5d+KlQgtl8qLnWPFRa6nZqpX2r8SjGjUMM8mJHaOC5w0L3mJYtxxRqcnK1BPtsZMg2lnYCc3+IJBkNYgGhkYolX3UBjwQjHceGk7Qo+U3KAwwL4YE+aeIn9YuME4l57/rpSCVwNSqD14a9UyXmFNXbxLRPGUZa8o3KLoO+4jZKUXplCKgYbJH1yt9SJgSK60pKc1HE4J8CMRNUO1T/QhUdfWr4ttZS81iAGATb+G8u5fN1PWAjSID7TbpxvkyJJyamjviux75j+d129f26AICXvu3nWaQ5Fz23RSpU9F3j78PFArGWfI3DRLRX9Kg6zm+XRA+oOKR8Yz1D+U3SG//1E3qiMgImdkWNZLaB2uTCZX0uDY5CAkeWbR7raHdjaRkZyuFwPRtM2TgAy26+amkPOTDMc7Dn/Az59yI9NNtfH6pg3UVeK4IweAoxZGLCczWWyoLCQMKHjCv2FQnjVTJaSRPj2SEWiZpFiy+t/oDNWubLkQ9s5mTQzZIbcglMe0Nsxw8T14lGGJZVBggjhsWosaI3zjFkszuXQFgom4cc0zwlJtrMvgz5KFg+bBgPmrfu3h+giYA+dkJb2HlRvBO1CNjbKxLuscwHak4ijKE5buad8il6bwd7Z6CaJ8P+lXr4/l4OoduKdHgBan47A9dwQonTUKs24ccwDQIuUA53VXPuKfsZx5RERfXXaZ7xwrJ9nQyiA51emJkpD/KrQjKBDJ2VYwF9UVSWIsl9Ua3vJC7WAvr9EXF93QHxJOUb/b4QaF5qtR0oZz5DU87MaylcnVb5vyhOsjdopTbxvebS7hk5A66LtOl+DvF1BenGkthpOqtkouSJrB66fI6Qy2VOL2sPOgCPrjl1gisEwBxyn6fXVldpRsuJTfXHZYoz+5ys+MHw80E3m6aScZyCOrLhPeGfbmLsZKSj8lofS/gUUF4iyGjEixRvq2ZoSNNPeIWjPOEihs7Al4Crg+pUxpGUoDSE1ReiJ+qIfgpy1DOPglETKKQsLoqpxq9b3F2cnbZT56iuYA1StCoSMfOHk0AuGXhpxlwcNHSAKcoe6k5jteA+I6yQ3rzQx9Nw9+k3UDzbgEKyeO4MbDhgWbKt1WeZgMMWcBCvhQ/ohHPokQ6dpuVqnw3iOxOLpaTLMo4isxaCiNZrr399B/xJDoFdqNQ1tsFbHSZ3X93xd8+FzCvq9f2UcaEpXwC2spt8/Mq00XMK2CFfHbizkIP5apULtgQOL9a14wZO3gM+q/ivSEhTa8Y2k37XEzDXQB9P948h0tOfglOToKubAJctwygtSbzZP9Avs6CaRLXLrswEtOa0fQEEf/sIo/1CEu2xYoypjy6LqyX7fH8T+v4PZiXM6+M467l0Z3FuNIvqoDHWMFhx+KPDu3IrkSW/ZTONZu3uxJsSuncctJi27+fXaHvPglLTAaP2Izgm3T0B4reuUGVdrb5lqI9X3tQCG7MHv/LqXlBS74fZqGUURwnIwrGEn62oj2AAJYKqrwQx3RGu7mGCPTegdkDi+ANRFxdGs332wOdnGMbm6jGRenbRh1ABIzGrMgQ45Fxra8td9pgN0AJm4rSQbUN3IWuBGFBP6MPNcqtVeUlFGNKm3A2NGrM+5mLTPNh1rHrE3qTARytkpC+cScY84kJHeS6F98Ui5AuVM3ZYrHrB2VM14KJZLqvBbGQfJzLsR5+s2RyHXoFpHx2TG4dSba+mla9ZmX92x6Cv3ykqsXJn1saOE1S9zn3bM20jZFnclhBzDYI//55HImM7pXsf1K7zc7qUjppcUUsgV4bjXxZMtJFQYqBKn7FXkwBcQkF0U6BMb8ZoH5egP7iYWNY2mwA7eCDoTwm0H7em4NjlvqaGURk47XSiGX41iC9sAp1C2YxHZF6z63mc4qmU6dTESz5EQYbyVDjBk7p61AmEASja2zaorKpRXuUqnFzmgKu4LspbCUTrvhJIHXcg8Bjio2GCi1+2RsrQbJ3YwYmjwk2C/YH7QEjIFGGZJHgkYX9g9J5H4JxSOyDEW9TIhMStSbhC0WzMmyIEnF6UYq5CForiUE+gxhJPstQpaMPaSQx3IVv4zT8hjBi/VoMbIuwTFZZBiRPIq+oaNt1ErncH6az8YG9LINew74kPBksdra2QWAhJ87Ag8GOedH8h2z7jjBuswpNe0Rgta7cJTwU/9OUBmkUe8MMihnAkJZZRQ3/S0quoyyiKJ2E9bKHd2UcxgoXMk5Cs6Qhtw5ZmAqd8Lgaxx3FHeqsty/yRJQwAJhAK2vFCD6Dwosf0gNEIevY2V7zJUIjhshxgh9E5op/w6uTtIElFqSueDPMYq/3DlvLkCiL+MiQTbs642pnFS+z9fNX96/y3PPm85CEnCl03nqSVnyXBTZCWB8/IRrXPDayZ4/0hCwcQW+Df98M/ma59TXS2FOmzO3mMSm1ikBLPx6jpvJjZMix87z55Bi8rmWTAL/t7VnEW7jVu1P0Y5OmHOTsj9y7ZbaVe3AnjOcs/ULWZm9jD0+HuPuu7NkWtRQaxATWm4j3/eDGoJf+3pAxto/2eMrsrL/91iXQpLAMH+QbuEaJlCbSjMBxtfnVJVpsV6ZM8uZFT63EjRjVvbCCusV+77KnjGmWZ2RdsLYld1bYSOUrk6nQdM6sxcmn/1m0v4/ywFIUhoLuua1zVrdsPVHWKEoNOslhiBoGimGVw6W8pwEh/YO+N25g2ZQGSBBqcJYR6i4jLUc7WrZaJ5yeoALGkwj8rZuj5Iv/SVJQxn+/ONqfqdWd0l9h5C3K0j9iIbNZQZVuRA73GNoK0oEH4zGx0ZNMaEU8nHIHXZ4VT9DysEbfshl/Mc9FBNiclwVk3qikOZVb2uQxTUiva/iemSZhU0f7ydr2uKw/tuMN81NVN0IKy7SaNKp/oxNh/qvo3AXG3b1IwpOqNZB8e/Lkt6Q4/qoK6Yj3nvwzcgl+l5ypn3DILQrBGep/+/s4sZr6xn1H/uvigOz+hYbi39dG0Zghf+XWk68f5QVgFEwQvsG1gQeglieFUIg7YtaOHkRxE/1b7P7XYsP8lL5/Hiz05sDa2vS52NepvmgH5T1CsxObwmsnT1QWx7I4qhZo+0Pbo6fe/aEybwJi91oNu/C4XaZzRux2E1m0wksfvKJJ0FiRH6FI2p/txhPzuHqcJNfAhN4gsiNQC4dpgx1Revi9ZQ1GXggN0wc3yqAQASt8fHVCoHwNwrxuibeH89VTdrZAoEU3z1/9mAJjtfSI0ZWyFfyKVUXr9kRd8zC4e1/j/hoN31qwOsvpczG1XEjfOD1SzKtHCFhujs0myQSFVDVZkqBWEQtUKsLaCJuXPBkV3PP1Ur0xLuXjngrHG7F5//xH+NNKgASAsLsH1p7PfvdcBOE2kgtiqFVltRVRCpiq9lOJ6tGqZitzoF5ALF5Burqrcnigsvn2YKVDYdn2dTJpTnWOkDLsYR/eCdT4MKcbzamypPoenIEUt7RoUVSqcN5nPPbfwQ1f4GcP3/WjGQIgdJ4btdbetA+vEaBDr8UXnvIiN24ZXF3cV+1XwTv/WJYYhz+5Akib/rUHkPkp+Hds99JGQnh16556KgxH4bDRlT5RGsYUBsfsmL/7U8/Y4bxOzY/leHuJ3LUs+XD2/H8oBMN5U332FQQ6cePXd+hYBjR16/jOGr0p7uHqeHrfjER8/ft85Mz+sc92Xcumz2+tk1NO8BEjO64eOtLHY0eX80egK24B1RUmgFUy7DZ5Muw/Qz5xjyQl6It7zIxCR9B1GMTGDeBw94HsV1phoccCuXXVx+kQSWbuvb4YfX1cjPvtqH/IJ3w9152yht/XOFBC7EsH7sPglrdbe/GsqdqfyLY7yreIfZd7lM+iWnW6YqffMTOVdhE0Em8SWF5+8+BCpWNpMMpy8vns0k6tZonUF9GiP0/B+OV0zbgQNXnqtKQFHXTtPcTwpn7hoJj8jzLSkljr38vjZWVSRX7kAl04ewTDeDu28/NN0nN2HUsQelkRzkbvHTnThk7BTX6SWZkxXTzyltH/gvLUQu901CAKi6X90WQK9wnOXPWX6jg0oD6YB6nglSXFz3d2X7EWGXc4Nhgr64MOODPRM9KUKLS0axqQ1IQ0yYsSeynSlQ6oVSn1kvVxNMPVp6wyxeJ0oJCWBbUDykpUyLwucbCrgQJ0kkvhzxMTCbONBlkJfH5nFpBk7IUJhUW7+t6PuPoMhpZblqitEX/LlMERKLEbAUAKNhiVGSAAtATnFMNNwu4GIYA0X758Wakjiyq4NFJv76EMDAJn38VyoRCtf76TEFGgkfanoHpJwkUVNwpl4Ll5XevotNX0Wj57xT6pi9f3jown7oUFro8TYO9nfgWIydPvkDg8HTyizHZIzuxlqxz7+6LXJlOkhf12aK3S7xxA/55KdNf7x5UxBHzumzcjESu4kCXUcnHL3Ye/wnNYYJktUZTCxPQb+wJ2TLRGcw3KJTcFfccQ+7B4XmR5AdeMJgXGg2G97wZi90sce81Z3veN05CylgSnjzu2566wJq9dQnp47PH86E7xtwxU01cHrqULO88KMXXOnsGILPCpC/PyLTPNRt0lAP7H0kw3tCoWLgmAFWAMM+q/kbrkiu9+hXHN8+b3qBq6zOW0N4PhfMjur3goRg0JntLdEIYM3+QHt8FjQpFKvbG2ypTSMaZO//FzbEFa/IULai4G6r1Kuaeod8lmMBQdC4Fe2tK+QlqOsnvcQuWVB5WzYN4VVs7b28eD3x5zYOMN22v71GuzVuzkvl72bzvlNfOjfsJBzgiGt2pp3RRDyy8HmoBK8xZH+Csk+2grFOsbhx6tziQqHOOF3epeAV88O0NvYr0CzsnVEy84dv3PPeoH0+WceOYjEXsor3z6LxPbPYn3vxTwvu2U4PKxASeIhePU+qbeV+Au2Y01oNxnRwVoS/M4Bf/Lymh+K0PHTCTXr6UWTkcXMb59ySPDETRnfr5wLNnIfP1+qh5zya6uPEvB8azOMkRd25LTWx2uPn20IAITtkj5uBWhB0xwLfvH9hlZ1MHt0DtUKZjYKudTLhr607btWZrFSwmMTsUHWNYwMNhBa1GA78N4tLGM1Skcnk3kxNh8hAanZtGcnOTZwAcQkZQUAaZq/jkdAw4mHRmHkbTcWlaK1TDSRirmFtXZVaLRthpOsdxPSpmaqoKO9j8b8w6SBpg2xokke5kx+gGxtPs20NPOMdHpFHlgOPBaM5UDxwDpKPO7BcvmwbKssdeUCni5uXRPJdJoM1oBFon0dFQDPOPDg0kA20uk/MjDEDuMdk4hDMAoBrdeZFH4nJ9L+7ojqGXhRk650SYBTvxFCez2TyQpxP5WGDOD8eT8uhvYcC3hKInNPc/rDXROXkmQ1pheqayto44/fyGmd/irhp9yVdwuKaqF3VjL7WLIp/nKBHpnG/CLJhPT3EiKym5Qhe0P2DpjmkCsONBnUTBBYB56kumD3F6nzOjs8qzwss04jQiRvP4kxYLZBoF07akJGf+1YcjH76Xh8gkU7muQ0p8+5q0TC1vWkZoVLlJw9ydoaee/kMZhTdRmbd0g/Zv9lPxDuRnp+O0iJiL59pI0dEqzMUTc0WnHQeMhgydTh9hI1IcIhxuPXn2wNl26OmQO773eNDhjtU9W3psm3vW9zQh6NM2TFv4wjicvHz5l6nfxt4cMF7Sial0BE/0tu0Rhm88hdAa50xdup1YrjP81n1KlbyelZPCq5ReWjvqg7tXLdGpyqxG4ClsWgiN1E+mJ/MWk/JqnW+UuGVh30+EZ6znIAgVd/H4mzPx83VfHTnd/2/2jEyNmPzmlcnjzY/cl8lBXpGKC+zzMZW1OwpyRZhwDzexVAJ3DUazZvza1pVgM6C2JiQKUxPKI7lZRDyObAUAciYOdz9UbsrHP1kpurgVaWFoWBBfhMK5BsHQXNfKmFq1k8SsvwrRrh81Ju+X60uDo/aMzaYLl/DJYgmRLI2S+60qjnltwU9+k1v5UAg4j5XsV8nlPAz9GZdxTwEV03jN1WFJmS/GZ375UvjX4eybkMGnUJyPmXgplAeMFNVY51X3YGiMrwcC8v8+vAuM+JxHrqgpq6lwVOREdbBfnS0DsPjtKb/AHo6pfDbbIFMLy9L1DLeTsZnBR0dlsbEKoZSw39y1Ja/fNiiTAQcsSkYj+jsPCR1TjkF2+B5clGS1W7W/oA2OUQdm1t+TUjL2b8ZqL/Qva+K3JlbJ+TVH0PScuJ30wfDdpzbffvr4z+V7b12tSPAdEGf/ItoveN2T/yI1yhHEaWaQJ/YcEn391Eer1Df+mqrQjAReXurYS8/KJMf7dEVu0c3kLnKy4XUWEYcjsspZChY/PG3cTNYJpOGiMqcWNae7QlBiYrpYnE4UoyCu19vJ2DOSeAV2KoIj3hFO4Z1xR8fZWiA9yDEuI9KmkJ490OhXrKlE8I4+/F7Zqnv9cDx15pHYO96RmM/b+I5Ru3rzw2p80oxuAncPmgKD+S7bcb9FnhLQpNaq8g25cY9/JgiyijdbkBFHYPDenf9bZMNeUoUfXdWTAGdlKWlQTSRsJHuZY1lnWecZGva/Nz7kHT23alc+Qvu/iey72cBlH/acN4j7B4v86doqaYG30zd3EZPbRxpdU9f87dtAl0Ujuv8Xfi/QrwHf6199WTBgbXJP6YEaWTZjZc7KRb+/2j41o3LbWLSOA1NYn+dS/Nkn3M+Pg9+8GrfV2mhtfp3KW9jIOvFPEuneyAfjWNXefQhGq4guI37hR1wH2UKJltEQpdIIrYR96oL9ucOnJSi/tw3T9eEPjnfno33f98eHKTfVZXiZZCYjeGJvXEZ8JkCzXUiRD8XiF6yxUDGqK70GdI9JZpBrZ/WRu9AvKIsHd5j/wbHCwVk+0eohTCqLVYt1J0aV6ZMmM6vA7VXEFB331hutf/uVQ78lJFIfP92bKssJ42id4IH9rZVFGxwx/jHjpKmzKzy4uV1T8I+DH5HQqMgCDm77/4sg7K2y/Z8cYEPPLusyZXdnyHcu+iYJCWw0JWS0hREIYXF7ZUp7mlrw3dWirllbH849QU9A3JvR/EZ1Oc+/9cWmFST1cdPNt01vb2qPk9WdEti9dEy5WWFROtgzCQJCwUh1sr/epll2R/saBwmaFvrG9HCZTaUnHftqlhf8agvDNqcqk+WYiiSTwcNX5AczWiD3phPKMpSZSkdiRzTcFP9nji9fW6FxckwaBdoLjTH56cs0ccJC1jRjMmWRNDl6JnZruhxZlWVKRaDNoAiCv9WemcGtokQPpbVx8FbITGvYKj9tbrw2ghH8gFH4aGoXQzKnQmfaIas3V9Sh1WjU7tbsUKkWfDkrkq5WWf9u0tSotfnpk1CjrYwCgKjQgy74HHaEy/mXUYAL46X8zFD8YG6KOAvb25adrF5fpdUnhCWQ4egURFjbx1k282f8z+RofX/uPrKSietrT0pW7VoJT9At7nvjnP9B8D9yTTps/omfkA/m3ANqwyG8Og+k4gKnHQNR172iK1m9njn01De6Ctp0unK7HkLPfUqzgJZXWJhHEwrz6WYz1Xbs1HwhP7LbaLOk5wtVZZeuLn3mmDpKpMaH7zkVrqVQavGdp3RoqsTePJQs5o96wli3bwfA3z67GpzqQcYaBwYMGBrNiLlxw8NIo2EM16/3xVLJgHU6sQaaXLxxowStBl4/giYAUKMlGwETWjkjDx2EhFXwotTSRv9ovq40COQvoEXBtNUNxUWpxNQiTFrMLPvxWceT7WmPyvfmVHlUYAc/7U6Xcs5ryCIUCAnN+oRiMOT8KMLAxfHQECM9DEGDtSIU+08AKP+/R/akw4uDId6wsWDoi+D/6J14h9m8EItd2JRD/7PFjNqIRv8zQFqwdDot1L1lrwZBpr5itOM112qgb/72mtP7Y2OOL7DPGBt9VmxHr1wdPcgdq2WdKDk2V9IhXQg3wS35vbodWM2SXDEHqIbGpysdtPJk7lLixdIF8FRq1yvDVftyJd+RRAsJj1mRp+ImCgc9Bssm4vqZrB+yMr7YnBo9FPPmqgM8PXLGm+hRqTlfxGcTvkaK8s3S0eg3MyLT4bCrbxKHolPNYn4Z7kcwsx+94KlI1mMC+8zYgJhFe4ezNx77SMdMbe53PmggM2/ax6d8BoDIW/YRDACTnaV/ldpLOvRP6ba/X/2O5JlAcjrFnjlrptUdRv+dD8zVij2Ikvp8gDsATwCxOKEGLd6zRwwlL8Qab9zIxtB5qoOO0R8AOuh6LIuL9XRQCAml2rgxFkliDxRa8i2FGlIsauNGVCwJ1Oys2sK2EFxcRvey2REWLYpE2SpHVVA+4fXISVN2c/UhDKXJ82FA/iOP7b7IOHqeo9RRFeHs/rJySnPOQrfiYVWat1ekZdnmdGF8QqNCQwPDpqG243HffQtyS3NL7VRd4hh18FpNGcHppdOrQijXmSbRW9AQhAIbeRhvfPXH+PvZBa8WMDa8VeY+rJbGgFGu01TWmBrVZZVmZTFX0qzfTm0xtGs4nC+lwC+D7NLsSlPPTl0IzVLRYtY5qKvyhC2RZi41t7vZIlkTB4fpDBlpeCiufDqyvtnR3FnaOZgtM8YMLSZuz6fcBztL9rOUWuyZVa5aQ96le9fZl0oBPR2fmlV+aVcjna0q1aj9ZQbJwjm41M+fKmkJoSNKSb7sN9dGrVXFkzcmSbS85uCqgLQ1MpE45vfs0ri/yBH4pv5IXh+AcSz3Wyae+TexvwoSA7bt7zXE7dkHSvqynZdzTAsavn9ogSK51lpnlSWDQtt3TpztfPObCVrgJD0YdWW6z3Mvi8QD7otkskXuAD4yktJZWwzW85AKz9ERSwFZbMDlXH8VKxY+ERLyz7c22l7/Cox2sNQHdPbrseci2G4EZFXP9PWhIpt/KIyNf5ppBZvrPneS8HsrG/2Q/w1qkuX7vOavIED95iq7BV6BssamGMHdQ/P69ZG1x39EfMwa7LlBWabEQr4Xxs+59lK67euyH/HzZ738LYsAvtXdxfkpEMw3JJNicy7Msrvbpf1yhiaVg7UMjQ0iAEAVGxvCFo6FESvvl577FTXrdfxck0Ew39+vg6MBDdlcftF01tI6RWplRdZiR7HJ7mq33ebRAmtc80l5km9iRDibnACivi4LvRW0Tz1nL8I2B5rBtfK4iXJbh58AVXhZYZ3PzyJBAiMyAWD0g7hmE/lCy/XpItFHTgSuf+1gx7Id2wFQ1kfl7Q32o1+H/zb9oH0TCDd+1gw9f+98a6W9v/IRCIENU228kY4kEXW4GzJFfvTe0OGIJDXyxsYwFZGY/RG2MD5+9KU8CPyjq8tzTj2c+vEJC14A83xiQ6Zc8ndd2gWv0SPIPh8DvX0zUn6q1uGoMZ6PAnNpzXk+yOfYja+z3JBBWJ7RxsgV2w+CkLexoK/d30q+VY1nVzkON0ztBDdmqtiG4rnksIQGSpupbTsv51MFQ7GKrSumPfxqvLy2qW07ZD+NOFh8ncqU2VXrn71epaqzozdoG8LD3+4bLcavY79j/2L74k9NnzpwMbc7bky0Hwk39uDrj04He/LYrtOO0werDp5wnDioINp7Wypaegt7GyoaensHCgfoeOa5qnOgw6Hmfa+wn6s4tyI5DlFRBRte9mo0vsWCGJv3V+w37D/6+FfV1aNFFdsj1JcrXJs+55TdKqzYFqG+VOHS9i/NSMl5XI6HGpYoPxd5kb61BGvlV4OXLSdgEH0f+ai/C/oBjoSz30yQtC/vWWEsFqGYmOOFTnuDIfKbF1oj07ux4eZF+t9HG3w7n50fay/QQXumaMmkqnt/u1J2C/x3/iVacqhqccufIMR9bB7vzXJv7aiL7mcLOJ336v4yuw5/oeZHCHdtjT6B4wI/Q6Z1Ifs0Mfimh99EhPRmw9fuXwPHma8XA0u8w3tWqBrLFjxenl1nMqkglDu2vwKe27l3Agw4LfOsGhswE5io8RwiUC12sINQCc91rRhKgceolKKVKB5vKY2iEJ5oOJYae0fjquZpS6TRkdfNNlNlZdpCmyMgZz0ckXQFTbiusio5Xuyi5Sz8/OZ0GkMr0HaKJEQrj0ETre6mS+L3nuMV80Tso67fx7NF81rZMjrQzyrfforoexKe6qpGZJ6tWaIzFHh+nZVSuMrNavbIU3LlhcvODFHgi6fkbx90N8x17Wdl1BT23zrj6YQj/FSIczQ+P2A/zvC+3itCySYKvou08PXh47e9eS6bnouKrRLgXajZd++HvZBfFqc2xBu5LgIvkm4eI9Pxiy8HZG9SBmjpV9PDlhTujFv63BN3tglnC/EcQU2RysX+HcD5W9+Y35z2qGrsDDQtb+lynjX9UmtuZUmWBkQnjL1IC5rtdJbCL4n3JUQXscXeVraarIJXtx3FyttOZK1lLE5nsI+YuNkBY060WMOLfk8rlVd9M+DOY8jPc3katz1+MlZEWxTPQfWJ8Nk4/TIMLsNz2x5Dgm1HkXm6dgeHRTHCpkMIvIbbhiKEhuD5x7/tu6S+QKXFTpHeBoDhtwq4ag+D43LBycOq9QsiK1iZZxgktzgIqFHUBIcmsDBJTqx281zrT0gMufbC2eWirMVWwsWzD3TwWsW1M7IkY35kGOTvoPRc1uO5YoIxjZJkIOhYuaUxxCI4LJMS6p4BwRMzuBMgkHsAeL5CuFI5urnYaxhRPJ4rSYO4xGBC+cBF4NsWXui8jQ1FLVgJsTy2cuWb61wljVfQZXlSfhK9mcu1bs7fXHAZRW/2j7VoYeTkVuMSll+q56lVR28X4F1qOvLLLCMILy/w5sy5ETD2xEPA+y/0ZatBSgvTzpha2VYJQBIcfgchw5IA5qyvWIjy/yOT4lVr5cg4kJUEHaeawglTHRmKkBUNi0mgHhkDc+NiISpjTWZU0inrBxMWan4oq69UBUpdAYpbSdWdPt6vep2ph5Y/G0Boz2lvipcvmjSv81NGpsBDnTGckjEUc5dWn9xwJWAdpUt237OnLQcq0euab+WfX+wrur4rFRjUH0rU/0W/lEDvPytNiWxPTEQc5m0a1+FtfkEX/rIOWgJ9U3PJDmh19+gVroQOT2CrFENEzm2BoI1YR+pJ/63lzh002ycINOkv8hLtOQVZ0er79xsemN0YD2lh/33SHvuHFHEbrJrjYGLDfw9xUcG2N6cxv9VtbG8sSsrOceTQ94t1+bpviB3fHk/9aKNn0iXTlicVOApW5q9cDHUCHnk86b8HCxz0JFHCTcctB8Uz1QwpqfeaXRLqCQX9VgzvcnRWUKwpUZvwgMFMiNrAvxO8bFcwVBoWnIXIjWZAadpcwFmUu7tKV1K3FHeGo63P69xV+qzU7q1ij1yRyCuR5WP0MKtuOfJchpd3an4GkxVIz7diKzl1+hqP4fnibGXqnJFSYfrLpfCMIKXm32h7p4Qqcs+vOO4YGGRMC9xuJEIPfgbtqL3fHnjfMer6ajb0ZvB4xM32SM0Pp0Lbi9aMEwrhztyoZmt4yLWuCxgHS2s5qmE8I8EtQADO6gnuSBZSzlbhTVwf/SW2g7H+BomAZIjS0DT3UxdFQCJqYohV475XYR3+dc2o49Tuk4d0D4h7zdJq8PCmxt+MOdUZHIk5o57YZf16NwZ+wTJ+aTvSdcus1S3bdh3/zjy2cGAVL7oJxwxLfvv50J73a8wrHMDutijl4759VPu2c8eJniGVlgUOigKIUlZb8xyezz3w0OLBUDzQykvbfhFgvMLxHcYqYJYXQuBMaDRAiAfz4ahcmjegFIPyeLb21HqNFcYZm6Jrp0/qTNEGnqAkCRmZQg9GTYms1vjw23QEc2jajZU9RRxgbxuMj25rRP3s5CH2PQJOBM451MvroloT0cuCe1ak93ogbjrHd7x743z7GgbHx8GK17TB8EKwI3WINzx8dfDYnNS1MicG3iid8+fa3MjxfHoaLemZmDxKJSbmpcB5lyznzpJ9x/so0qhVOcaJ825wnJErcrqttD1nLKrZkPZD52TI1clgdcoQp0Wfv5dUZ8tVyeCcL1ylYFZxQlG8yL9zuUFkWMoKQdXbhykKX99f/fdqRLBwst7YeOn+77d/kf+mdb1pCzF599VlhDfqQEcxdo3M67u2najzB/pQ0g/GM6Pya2/AnO8l88DBYuiwZEz6426OEOo78jHnNy/yeIo5KGCreZdW53vGLJRHkuMc75ErL99HpXmbtXFzgf8SD+bFx9frBvwnENdZ9cvhHJUSMTYkS2OxcJahF/cZR4Uyz6g6v0KSzxBS8hhirjXV2+CtEVxhLkMwLfv/gzScu1zck+6KQ4n4OWnWMTXgMyHlTJsIPDLYKzReN2MbwuGKYc+CF3tK5/a3oQgxj57uqWMuC+hr/Y3Q5rNQplAM7TljN1AY+2ajTpaa+wvl7OWt5YY6rgdqfmwyERYi1OkM/nf6RKN+X7MsRz3wLFCSRspUIyJCYPANGrn/xhTZhdjwVz3ns+GMiciFnr+dUBPTCiQIQC9fSKDOQkWfDwT3dF6syh4Ay3rMc+G5kR7dxAVrpclLwecJ6Fczo/m9jLSj3RlbTA4dh7/1XG0MIYo8oVpWr6QrgUUEqM1XpA5VslktTx1pqAp716qG/IY5jjkNdNhI6mTT0s6EzvzOAFxQzyM6N24ve+NT81MTUmMDx+U5fNQ9VL6O8/0qrKF056DCehqm9UKyocEnNGe/2I6zQYgFrHVUfsSJQUKQzISqKHlxluFNEC7wTVuY46jZkgPK1pKVXDn4vCSG94vP0l6MZlSBYvCyXtjuU730lo7n25LvJ9r3BkCZDAwcdAaOj8jx+hGWyQWXnFFQZZczOYtGv/HRdmT89bXp2WGtt0OjoKuzPcVsxPltPTneNywbq4g4vBjq/k+2XVaXl+8yna1kx5pDQDFxN6Fa0W+JYJybXuQji4vWzHwdh8PkH1ZfsVuUx/N5qSku0kx0edj5tpwYHrvbd0YPD3a3bMTIfwzk170pwKWbBDz8ezxGaK+x4mgrQ7jeNjFiPCkqxLa1zhjy1uhLfPyGLxUrzh9o8ubpJXQ6Dt0JYU4FPga64PGuwPO4zJlrp5CvFSsDFKwTF2ATRodE5M0TCTvzckaR04at14g4t9hUdjh6ydUE+XGE+RI+6vz6U/Ff93Vy8tI7Ts/fRXOscNP9zley85cuDWli9emr/JQNwV1R4NSqnsc/jbmCTF2P6B8KW/06MHVOR6WlTAloxUXFWqGCW27Z5jgdGBu8UCTqICi1NyIHv+YYs9axnGWqGa01njYlYGQ47PW60DnKspndrtOTwDHjNzcUArFL9mdjeYLmFQUylSkYly8oeBpY9ReBOibl6B3pAuteZ4+VluOySTx7VBP5z+AsIk/cnGaWSM2FYnGhWSoxp0nAo/frRh3KlmJ1BqjmKN5lpX3Dle68k73ZgZgrWNjL5zdGFNLu/5PuLSBpQo+dwCjI+OpBUCXzy8P3/tzQsfWFUbj4xMh2CT0p9K0XwcCRSr7Eu224EcyKMHh7a5HsWXEJbsgCnsW3kyw4T8uuoRXT6MvpoLSRBWW6Ct2l2kulJeUjXY8YpMUoZ6ShWLN0iW7oPEEps5MiiE6MDpdjEsRSHbGLvPyoI7rMq9UtONKE9lXL7SDvUvxnChkZK+4rE3n+6wRqn8yK8XOp+OEW0pcJbhkN1ec2hvkNTIGrcS49fCuNogFMuTErQlRqgVCl4nHVKqFAreaCLU+jiBPW1eZy+UQlKV+rszRmCCupa/jU/zvkMzxDxh/VFsOnk+rJGu4dA8+Tru3KYsIM+uv690+CGZhZu65lkwwhY1zuGOntQz4LBJ9DyDRvG9aLXwJ5XLFIbcSHAe/3Uwj8YrHP8sz0yfsAfCjg2EbMHA5HjgxTErjrCKrNdXzEvaNlfjFl/0YXa5lF5xPDwhKRYZ/WhVFd3bE7/flBB6wmPe8U3eeHKQSApBQ3BjZr1JuLhPOZZ76nanBkecHck9IsnxjuCowdwnkY1scSpJb04f4igWhYyNvaJ6d71RHv2CFfgHA+PIh/Eud1Iusj1ZriM5gO3uGUAB1/WnfrFvShMAFo+AipPTh9ad2AjvHSwQFH6gf0z6k68e7brYHxj6BIAchnyTrMcIa1uToe2VDzbSDLeXlRmFcBGebl15K8aX0bMeeKAlMiyESjMwUlCgw1yUtbXqj1Sjrv80lB+O7IN2XyBZ/SfEtcKvaTzj8Hq8sNuo8BcfYBtSx3AX1g7XyFwCnxNxYMQrKWnhIvb9EZApwc0PKWYFCuM74VmdOxtKu9GcefTNdSByjZuWtgV3nxjQ+XmA8/qNCpymhrfpBteWWRN6PA8Os/py1cuv7nhHnhfx7n3f1z4jxvybfotsDV5rqQqiiSFQKxkjicTBIEQrRyOMQvYPwJmMOxEiEQUiYH3H3Ry8JSCdAINCoCAJQotDKKw0OiiUG4FLQ31BkxELEy/Y9/X4RMXxy3mMD1/h9gB1aBprky2Xr3np43b2q2ifFbtvjXmr3xTlCb84fbdTuoueVUc11vXHiw2Q6/BwqY2Z5N5b83FTNlzdamLFhTWQBLC2pN62w1a6NtWasWzsDQv4fZhKcleYbEOZwPxQeT8ojppCRIX75RgoqNBbgo5Ee6vUr8mo/1kwSFUsX+MUHf7W7jnj0b1J7kgXcriaeleh7AwTI1W0FJ7QK3L2Et8fHs1js3OviGYyz0wvwFylCKPjG/l3kApq4sg/i68OO94tlyt1DnnkmB1HGMMOru+A8fRnj/OCv0Pax74Ls/ROvN2eUo7t/3N4O3R18TLfhZY7fNYnKsxjpShFwqwrCROWwTjfII/6aYm8faLwqPT0ae6wxspGkIPU+tdHre2I8h0ehFLbPwZSSQJbKHYheYdbMOPnlOFzKbdFkp3mGfx75hee44gt9+Z28e7/NzflrMnMxJo0C4H/deOj1u7J+cq5rJluqOxYC1iXrRJGEWyiD5Sl6Nd9rF+nVY9/go4pexCy7+1I/28ev99ejh6P7uRpztNNId8qAFM1/8+MR9h//+l6uDGZZOJmVLITyjxxgUH/TJkopRTVHPVHZMpdBq0CEY8HHuAn/7xV//+Puf/niYZoomeRl1CYu5/n6ilzT/U7+rIe2t38MiN4R2lVCSW6thGQd3cpNfIOMJ8XBXBV8/AC5eD8/bNdhMeOQWzWnvMGm1BLZ/pNQWuyCA0y6jfK4Hs3EV+EXU6MPGRobO0dniZJWrNbV4pJSdIzvNe2OYpzRs9KXGHACyBjyopDtqvqmMkCJkXuH0QN8ZZFpDTdNONRombmXouLldhtzohtb6wWQah4lA5UEvK4f3yaHYR+3Ck+Rtj/sX28YlB27QuXwj/v7ARn0QbBdhtYBsABLhu6v5OIL1gOog9VmV01hQzDci3n/bOOskvsG4FfwkVXilx24Z0mORwngZd32DmVanPcSAvMLUc0CHdiNmcURMN54dJWi/A3BsDxGMe+fq1qk5RNn6NnGcd2oX+RyKO+f9JcWhOG7ccHJrSbiF99ZBqQI1T/toMZ9WZeDlswxuvKVM4Iv1IHqXUU+ngIbnI/NbEfbjBSrNnja2cCBjMo1RarFPAxkKFeszJl1L9gHdSKdZrMj4z/GIi9VHf6bmaoYFIkBDSA+2lahhOuAwUpvukN+yrjUkLuliNCxjc+4yeOqSXlNtqUXSUkenRbc+gof5AERT/8KmiJPx3Byw/zC/O+zqcZmDOVULtfqgsSTwuVg6w637t/HXztKeOHEWTsu8nN4+wu9JU6UbFilXblSxVtEyYAia36ByVfbget7bSqFdGaexzyOfnvs9P27Xu8qvll4emEiXrI98HDgqHIoe1PDL6WIJQYgXpMf/0pIGboIqc7dvigLmTzQ3/7Rj3gxUfkPF6wTbfSy28rfwXeBIoH3NE1XuPnKZRo+Uuz8FBNHU08gohGsgQ65Q40KTOBtnCdJbPdPH8v8QOBwoMBHHNe1XqazOuKMac1haJZckvIT3iYJGpekRVNvYbjAY1gF3Onm0XcNhdlSOy/7zk8XiJ7//ye9+9Ysffv/bXy8+Lj5M2iU9ekAvybeAnmiH3FNVznViSCAObjByIjuRXVxKshLpAonYovwH7u7pFGO2yqJtsrzxiv9ZSalKNnwTAALCNQMMYH6/XxfF1z/5+sff/+6Hd8+PxX1xt17OJoMj7z0c9nMI3Ftj4JbIb1r2vGneueFqs5bCONqeDWFv3TYs1NLUHlsNuiTq1zvmiBFtQannDMr27/Gx1eB8C83Y1IRq5l9unnbBqs3/BHhEj4RnqwmCikkLhmst33wUKPVJpJb66ZV5lr7Hw36HkDY2pNsqBeX7MN22pDxO1udIE18xn9PeTDqe/TU7bFaTUZFJL+cXz1qyw6SxSILDmIFnrKZ8PHUJXlSlIaPsS3FnhCs2yKqONLmbNQA1r2lokTwNi6jwXRJYgWkELSU8YEwgOQ15jdTO//wuSO8SCFZp6jJrEELKulWXvrBBmn65D8xW+g/X3e4JO9xJ+fJLmAIQgRsyfI39QJHDF1HhylUsKGRQrvnj1LnYkwNtc687M1Cp8HbgUAm66zfrogiFX45gk426pEhX4jt6wIMY2mCu7z8WgzEUQ/RMV1oZbckdrmOFZ0QZRxSMYOvcylx9mqoiHeXGD+16QgtGiYtbnfR0opuVDiWIMTzYUNl83aEI5b8gRDNKS+fOdIkAuttkTCNQkK9dCdlTBJT1MafoECiZIYKRpVqoDMQafzFX09pu2jSogqkNYdlGBuCMEtubcQi6FOuN6necSJCz1QQVDjrbCMtq171zq0GTPccuVQg83NJ4Ua0mNeru+IPZsMhGwlhMIBxcNY6DsJ2GTqMMboCCM5xGgvKgLpkItI0dmIRWio4FAjrlU7XBbNQuM1BV6u/mAZ0cNhLsMvpzMojxgJJIrL0uwWVxxGPl91HuEXgoZgDlC7RDqdv3XEUQGe37p7abMDQACpGK3rWd3Oe+6C2Z6EjEZR0zeh4+IBidAzEnI0kA1WGyGFegZFZnVGsTj5v4qfcTg3cPOMchurXmiJZkC50oBKA6hzTvIMOObrOfEBI2Vv+kL5jY+Dwh2cGy9v21XtIJ9t6mFiSPMk1OmKmb5hdMfsL+Luv2AZcuIqwlC8Kq1G2uKRDnZ/SU1T/JqkRPhwrEorz2LVkVjyoEnhFSrS+APVYrIc0MGVvXMIovKaDcotZU/IxpTUmLxIWMZYhbhNQCCFTv32hrY/mFM8YDt26rZ4nS7OOBcJi6+LIQ0Ei+zFiIPAYEZjYndmBIQIVXYbqvkm3ud0noO82csocmo5aySIxl0u1t1gdijNGObKxB+A4xFYPeefwF+04SS3+oCAryVI8NcYGEFIl7Mim5aN95AC22BRwyL+VgUafeSvfEqKk7laU9yLhObr2DoJCqVmVusXL6qJ2bEw5xaZWghOM+YB5kdEFNi5h0IYknVBscwhw6NyhzkZAf6g2t0pRdA9fQnezDpC2w/sC1DtaA0DovREcb50kyO6XrMTYTuPNm/aVT2M0sXrlK8tBnZyuFwbljoFjtiAXE4X4ts7xPn13Ipb5o7TEsEEEe6xukOI+6ntTMPQd06c6K1c2eNO/em4ERIwOAo6bmAme7LnYucuDrBz0M09V4HkVPm5dAd0NwTNZZT4SGJmIA4lUAqnPbkCc6O2IYBgdbAqdzZyw4WdayzgK0aaV6qk7I0OrZn9BzBBmEymGPPW5nnI1jAXJo3YfbnvRZrfK/+OOpgKhIinMy5sPmYrxohOJCViWJRYAt6hIadZwjNgNJTC5um0f8rC7FOlOAtBVVDELgIUZZ4z7baU/pH1haouXwUbyjTY1ZzpUn5AJbacfHM/dOY91YLu4sgWOCTBruOzZMEpmqRgyhM2wtmzyaK+2rIs8aq3bb+WwU+AMba9IKx56nbxI06N4eGzrnIv4MZmkSOAMTq6h7YKtYeBoOuCj+LYOLOt4WgUej9hrODdbjCmqJZXK70BC0I9/G1NLRZbYKk1TnyKN5gTThvZo3thHgYBuKyiyRG52eIUnsMl3GdeeGrqGXsIoUudxsv90mDghNpF/Vec2UaOWLphqdJZ1FrmpOtWPqfNyHi8l4VGURMpDqSsLAY+gSAYx7WFMM0ycUajHCPHoACH4rBsCm4RpUQhYjPYw80yd6lI/qYhqmXawq/aLUhllYTRCH5QqRwFT+jqxE8bOmqJKhPc65htLHu5S37Zqk/2Teetxozou23b87ZEVmeT/c3X3v/nurEMXqrBCX8vN7foYlHu9znc9zsZbAiSbZAOrbHShwFSeB33Hj79XfzcpR6aY+PKwu5rr/UpXThw6nmTYRqSb+QuB4ndMYTfWmj1RkVIabAM2wGbw3Iww4Avdzskzb727Ou9v9LUI4KfKSyuyF+ET+SGoGOQuYPpSfoI2ZqFt3LlzzK8ybNW91+tL/9tMURvBO94PJrS9sCkE3LYkEkMS9A/ANUPTuOysBaCZ4AY2fhwODRBYAwb54meHmvHSPTkdDIbUibQt20W0sA7a7egfUsm6LJmquDL/9Ui7EBAFty4UDz1Y7uxUA+ZNnqsfdzvLYky8VrVMnX7bXgt0bGQSRdGf2J4BDbEK1LAhcut4mejsuGwEJD/oFBXi5/LeJVRT0dBMioWWq8j4j4FHkoWdrIvsDcqp3ogDsF+yZKEdm4L0I3bM1Yq5SOvTxHLkE85kSyKtKAzqPY5+kHC1pBVpTIaf6q9kcnrDH5HU8ctWm01r6WMjfBWE6wc9C3UuUsOzVOPJeFAYzzZkDIA4nLgzw38nHw3EQcrmof78chzLFe8uE1EY4pED1QZE71k0WUAQzo+Nh705WMNQAvQiaBY0u1hSbAWUw4QJ4D9B6uAjWNUp521aKvBWFDycZVcA07MmEkWwZEHUKKNl83qtEPwxJXC/MYeSk95a1dOzRcjGfTWtl3VXmWVSREvVvuq/TtdcY1+felkaNmBRoQIDqEtWz8zYlvnZSCinr+3AewKhsQ3VIsKLPZmuXy9Okga+sjJImIzT23WsY073AJfa97Ehom2uP5nQytvUAeA7F04l91dmnpYG3n4YKJRWEkyzj8LQnKMCpCLMHoBxilXpSlTTWz0DvdNFmj80Ay3nMd0zn/uwSCJSjeO6zasDCzRRUMhALuu75L0oCR6nShD4j6NCptNjW4MxDWpzpysvJ130byiSPSEHtI9i+0kxoSDuTDkMmD0WWP7VhOw9/bhjO3Kv+m/yQLJMXICcvU4GIw1f1QD5e2LxZEh/OP/ww6myzJmEARPxfb8GzlAJA/iTYFL0KRtSgXmQKMY+U7a1QHLFILCf0fyxx5yO8O3g3lHd6kPvYjped0+j4rVDRaRE2vKfn8ahIXX/zXjQ+DRcjvY2HTcy7tASg1+tz+aIkgEPVANRzmiEI7HJY+a3hoKnhJm5hqRNPfAVtPo4vAP9+uOQvXKdgYYfsxx3w35H8R9b94fIC1E4sOPrbHgcEzWEbVlGRynKFCuc1EqAgIW40NCwVxeHEq5ebx91S0QtSN9iMa0YDQh00bKYb67OYZHGO9UTL2o1Zc2ImBTzpGyrL2j3l2oGSBbNyEEuBgrmKWujroU0rdT5c4JS1y441bfP4AdjNNNM3ZneVzFwELpoZki3znd7nVMVvvmtbr3EfQ1jeg4OtN5LTKmzN6AtxEyi/hnYs9eCZq2jsKIj2z8tXq2LzKEvBd36Uu/lUeBtv7nJqXv0r+TUvWCIM7xqxtlTQHMkxHhns8DP6Bj13nL0yQ4x4uj1WqCqx7v2qDsu5+L68u2KsrnJEOky33/nb645xtSpSpxhZWwtb7OTphQTWJoDdEQ2JiTy6ItSHo3ek1reTAi9Z2b5yc3NdeYOsElMmzu5stX+hGWTTu7JS30ubJFbroncMBotyanzFDVuVQBIRInFTrbhl1uNjEDx+//F7H9///xmEe+pFgnGpbs/a633pLPW7PaDUUfSjja0CIx3srKgZUgQqmVvY9WVVHlr57m1H6Tm3ouyuSHwXOEh0Qtt46qIpqapwOhFy+nj68PRAjuRwJWKyICjGpJ8fS0/rNv22dpXrVO/1Bl2dA6YZA/pMv0m/4Fg9N72aUVdmq9yopNfB8S6Kp+zkDPf3nnf/3fvvvH/r3Xm3V4A8DM7z/6ymltbhS6seUliZxhbc0p9ek4NgH3fpiw0UFTcTmHmN41i7FLFPaVftGp2rklX0Mkr1QrGM7EKZiy7tcCDeNs61KgYeyRiWC4RcumWmPBH11Y2MI1XoPQcD5g6dsdtGOeRDWvkIONU6i5hYRqOlX1RmrmHXF1W5b+Xb19zRHFccPZmgKtpSZ5xl59Vql2zFbsmddY570XHOo6DSg/E45dwYJoY+KIqMbJQmMyDfVowOB4wBF5+Hdw93eI95tU2ZB55tnSLdS3jdnXKn9/JYtiFMbJG+TdFaxfmYhHkY0ASy54wJaHgaHNCsh4/5xRo6XlyE7is7U4+gc3bUkMouoT1AaRGyWPb9+M0CEQszMpK8UHfrm0JUOXt+bx/uwH/O6qyiQ6mn7bo9Zt0b9KaNCjtrqK1Sc1RV39Al11Raao11FTyjizH2R5uay3y4nucIcNTiSG8XJvmAoGOTp2B2iWJ9a29JpLlIfX4q0oDnz58+vn05PEa9ZQUbNI9zmlHSbwlDFg4k52NbpA+Bk2hc2aV5d8f9+AAz/Olau5A8qTRVwixW8wumcqw8bTGv1HDflxbl0x0PyyeYkWPrOy5PzMA0XvOLz9IxzVgY+9dtVkPeqjsck3+2tcnOJFbahjv7hkbt+npfC9TIroeBvbWeT9zxwvIPzilp+FM5JtB2Y43hexhmPmLjNr+oHu58EGGFcrNBq9XC2oZEhNsajFFrUuBpiZ4gZZARN8RIrs0a6Z9d6wiSbCsqrVrC2XAXQNeVdYrZ6A59Q2vE8syErzSAEjPmRrOunBsxjjUk3qg3Jifo76q4f8J1iigWzuWGOgRFe6XhJL+LFDZ2cVhn9Xy1LpSsIvSMNBGjyacC/UPjjy64VVmlJudYE2/zti49VKSDqboGMMtfzW3LWoTUHfZ2UReJ44C6PivYe3kqODuw8rFK3B4m2ITRd7zDEJgI2bW8MbYy9sY2ueBb73OY6VrhdbyCcZ56KbrHsvkwKYMdD4SZ4mjDo73WSrHufEyveiy+LW9gPGkpjtrqTEakx4bV1DVT6xo3CF01iyRTm9TofQnT7/6QQ22sgUfjG7lymamli5SSnJEdlfPSb/kI6Rk6yJ6g0gErsTN9ap68p5aruCG17iaJoXac0MqNwSdhTxhKE7Zu74QBbkIFsqINlbduPZTZtMRFq3ZT07x7Sfay1bTP/7UTk7EYZpMTpHvpt0sCi1C2MV3kpFrankZrWCbnG080bJwLY5w0AheyLNjtMAacPeSo7IS3eDOuktj3CpTR5eoK9udoNHS8eMxCx03dzSE1X3vt1J2zs++JWy06n5c/NScSTme4aYMGJNROIMU0bL/TIdF01yCdaIWKcg6hyZd5p0LgwVTrx6skg38ELwLKYFRHuZExC0Snpr3O94Dzx5S4OYMzTssJJQPiB8IeI2i7Ct4wsEOFN9thQN547cBz5Rux2fgq/EB9GybffOEqksgbjOsiD6mBmKMt1WmJN2GKX04/nsEpz8k6tfxENd42sG1IeBNzZNFdL2saggDmgXt8i5xU47DJsw3L04EuLNAs4YpPr7ijOeTBi8Zf0BViA/Y2lyxBQxM6uLGFbzVKTkDgcDKCfX6h7PecLqd1aGKIEqycxMuR+QQ2l08Z0mHH+EW1P2Q24P3x3c1+O6urYZYMrFO/P+w5hxW3KXdZdMDFuyEO6opX+yRj1lveLECWqntl+U+AIlPJ4AIrLSyAbe8fcFO2qHpP6a7MCdjbnLPEWrbNVV3AGXDsikctbAHU0+EaY5T0pEno3JgHLevUJjnVh4xxjxUFtpsrj+cSMYpzvRCXwOTrT1yFE3mNcfXCwIMLYo61TKflZcNknlTOTA/ayuC3urIg/ED0gOlgu8RsT8IDwgwWuuksMw6qfEjfcELGMDcqDdegf9ciN3TQopW+hajoe2SrFtKPZapVUPXW7ZWC3Tow1tFBWu0GHVriy6dNXoBlkHbcKiNO2uxn66aMNbR61K5Nl677hsvizKknHlIRemrD7te9w6VMsnrqPyTYYB65NW8hvM00xSjUSlCY7GYvdwuFBgVXAoeWzX1oUdeqTxfpV1GM8+vjYnjcFTswytIuTBrHDEXSMbfYhoisAvpqbz/FADzd0eqJZNqZ1XDlMB7IqYlj3MPJj7y1+0t2l8ZKUfmlOyv5hIiF0XIwFbcdTNbXfwMfxrCT0m2zKy93zyJFlBH7Qspnyqdz1VG4zHQ+QN+Rr3HSZVnTHJF5ND/HPo1dFgRsyZ3h5XoWtNn/S29bDgLtWGi13c52K2DK7gA/uzonODRb/VqPIfv7WtRwkm09xD4JmAeRDiqhUNTpxEqn2mygLNiDsmKYg+8ZPIESGIQii1xDHTl1qlV6MXVHoFJgRLwcxiVSP0sVYFj40w1OK4EDt0xg4jI6ZNKZ6ND/jO7BUxeGldEhkO9ymZZeA2HcrMiZOfa13QMIM7M4XCW4HTSMEZnuqtvRADjwTdY+0/Yyiv3WbaBglPVPLjfJtxV1z0qGs/j0uQrgNdSCX9KRjwDc1NtRi781k1I0u5m4PPCu+e1sGG3ghji3m2JC2EiMpbOa37r9xjuyYF0+7D+Oe4Sx5MwNA9igL7dx6YxhUXDCYOQl8obqUUcLv7NvfWjduODSLpYQVLkfyDJrx8Memy8SVJFpFXOJbpT/g9BzsjzgsIQAuUwfzl6W7DMBApWOm+qXyShdOKqUiSsvMqt4CtuYwSaGWrtWu1DLzobzW4Zy6F8Hq1MU7bUojaK0otN85tq9CeW1+d1MGG2QJuBQLROpZgyzY5SagZkstKu0RxyhoXqtbk+TKIvOL8Kac0otT+gk6gpAJTLHsKs1lvVrm4jVBtRR8QU2oAxblA35cV3rhWLq0DfUaRmCHr08SdSCVVAjSJ+TtknbWsteQIuD3tBhjVHViJPX7g4wQq6BjdlhjOWom1OdnSZFPpto11O4H5WYOYJnH5xZnr4q8kJMQzezUJ4d1UCa5LRjnznTnqegJU48sU4+eYsyrwUTNxVRwZteKijCBV+9cZZcr3c+TEnLFpzOgszMOdy6xMkmCDYfNx/ub1uKNHkDplk/JMUloWt1OiWIeWIX8rJ5vjlLa3nTFmnko8ROTUj9VD8edq5l0kjDB6aZW0kzjQxRvAu5qdl2LZzUyI/JhLNtzxWk4wMOZm0CqyOIJdTryBM4dvG1N82yaVYZGIY+Cpkm3muRo6ONvrC4hcLVstuaSekg7yhlK1HZ9wDDykYjcM89jV06QexJza1NmprYLlN5Iopm96Mtv2DF0qZhOoGGl8y12B8yvQmzhbh0dtvSHWjRhSVok6rOfxG3xhgDth7H97sNHuEqCvSDWHB1p9HlgHBMqhZV3eUyLE3PJFCnZc7LhV+PT+tllM2bFbPcsgWGLwetaahDqrL1eHy0rZJUMZpZXPBdUBeZuxT0V2l6Y4yrx2v/Wojes/rbrV9XsNzC6bc23gr48FPaVJneRYPcF70z2Td7n+/rGnB+gm/vb7WN3WCbrTXrptglW5Y9yIWcND0ll8kNxzZc7K6iTde9yVRdJLRbRIg4ovo60x1uIyPpI8OHOy7FbZhSWjpzHlEDZ8Bj6dKZofrq+LsmjjnaHjvetVIQTipIky7TNT3H9IlvSc9avY5btfsTTgDSVLtGhfLFHUflLkx1lBmGwHN7Ji9Z9OKx8m6FKstux9aQ0Cx/ZKYOJOdCLxEM2HrfJPvBjMmGLAgEXjiwUnGNl1LSL3e2mU48x9DI3PoMCPOKKTVS+9GCKTJqb13tfLfVpw3DZzfL1NPqsByvlryW/lZPndejerINPsela7Fl5f11hAxdh8+lD5g7yDwlWwZ/2aMGKw507oJAGC+6JjqIaO1qat5KdW/bvCbO4TA25zzIYR0GvkteGLQx2qL6MAQrRunA3PfcSK+0IWVEp6HLBJqQgnoaRUdeT5JXi1O6WlfpgvombyLNfTR83/jwmlncH349JbNkSy8Niomi6mSPqdTS0aB88ZqT8nCYYUnVf15t0d4FiAYyRroSVKVe6da+2t4xHsnwN25R28IO1MSxmWGs+CjYrRuiqfNxcMYT+2syIRIR1QAZz15dmDKfSKmHiGjG3N8D6c/pEaZ+vrynLnhuRZhUxQezr7gJ1u6odXld2pD2jCsCyCkHtn4HpU3SRI7y2PboGutBhZ749p9Pa5Du2ABIzcUN+JABNcNPO9VRyY4GcRN0kSwtdaE5j3cj1lfTxHe1hra2V7o29+qahTuKLIVinf7sLolySAO4tmdFxDa8hbbwKHfhvEboOwOBLmsF80yjDgP4JCb0U9NHY8ZxzWtCLlmIVBves7bylnUZpIiIHIqPabRuhjg0zBy7Qo7Gmh/tvzw+Jozbt3IRBx+pdPdlEM4LDR6r2+2aubQiyrE3e2/3Uy45pzhh8zZzl/OFTs9bimCP3bLQY4P62OC6eM2tKePeF4wpRUeAhmuPGr7EvJvfiXe0Ox3t6G73GnnNnaVaKGO56TEAMNpjUJLg0/xevJtkKgTZrzOQApLJHTkYvXGhdAlO86EQpu7NTHY6JSVEJ4aIrvc3UAbXD9U+c2wIY0qZon8euDbvQIbTASsbY0mFSBD1Bkjm+GGZ05Bz3NeutpNHiqh2u+kYJOxJ+xApHzWk8RAT3jU/jLa/YUxNg7Vw4qlszevssS6sbqTFJ+afSecG0jF7JmZfHLjFE09pzExdZLDit6Ptb5jTFAFbOBk6BIJwxmaYYTPdY+KKLffv7PbvrlsoDRfUpWznBzSkvMdCnsgp1fwFPpbO9P4h3GN6XHfVgPcOgd3AdlcntUKOc2oYPzk8F7nKg9yrkuqXDcNJ1A+T9Lo7j3MEnKfn5EO/d/WrJxKLGoLXCLjlg38xtHiTmVgmgJBRvcfMx1l8bC0/XYBsogY2ASnLtbjuIohKj7xB6HVu2DnFAlBE/wSYOKHfaCBZKixmQT/ztMtn+nuBMQbT7qI+UI+B2xCK6+jugbcgBP99gCBK2DCll6N2z700L/yYPnljp1/fA54aekwaoaz3k9oWF6sHA4IAHeAH8MZKOrjBBkql8fok+76AZv6AUuvkG+10ka42zSc2EcJD7hvLZRh3Kwc0+0gzAMcirg5MbJ3VbSticrFEGeA7BLq/w7uudfDZ1Aq1QktFLnSPMmlyNsZudZ3fOJp35jY9Z8UsvspzdsHLtyuMnvNfmd35ccmZ5xGlRrrOsYBGSMaw4vzUk2VQ93oal2IYfiik3OwEum9DtdKz/IyrThYw5rmlOPfsVmzzg3Kc+Yhkn7s+Mg3cJx9KlavKILJZk7McdssV8p4kxPSRj9SZvjpBGle/ktBsyTWD1mvYtsbC1/N7lvzSahG7nQ1uNqV9pwWjYkx6ecpCG0vh88tuGD9hv3tMmCZybgxfRVc6gdfu8BttT+/U7mveV4T9KsslkEDANxsiOKjpXDcNTmkUeI5NsK5a1ISCfSGKAG7iDoYI7HFjF/glmRXeWDQqd171/9popQIiJwMceujdzRGJ8f8DebwDAN2/JxfvAIDbjxU//H//hxVXsnUAwP6/MNAQ+Ke9bwTq00trjuyVUnRaQQl0tUJekUBWgPiWz66QnNh67oGhWmbHRfae8KXKODRT0xBekNjjnVLfiP0QKHOytJGsKX4CmN8fQFyjbIBwdMqJeS/5crcsqnH5zB+8Jl9HPY8YQiG7qGqnBvcjCk9QUilxO9HLpdla8u1CkEPbbuwl3wGKpFQ4DpCzrjf+pDlicexOAwPy8WlHSltkgwQNTrCdVG5AHHdRK8VbGWZ5pmJOFNPT9I2bqHMbLKZqwkULGHayRHyGS2iOJPNAc6SJX0QW5XBbNMCmZK3iGyetm8Q8i74hDgBqfBCOiemrIKGp+GZ0BhVov1wmkGycSDl5aE79EHoAVO3GOrw5pCaqgGRgoHsvFeUBmfUamgackKpBVA6XBq+UOA2Rg6AH+ztM2QrxcEDdBTyn/imVTKWckdO6ee0w4TTKP7IUraXN9EEgXXZRdBnUTSRISJy8FNCPXKhNFf3CNxegi5OYCwhwLIxTB3a56K0mOlSoQ8yfvqklXIYl3nmZe8Fps3SfDg3ntgN0hWg6es64+OWklHakFdWetLscWMKCFtEBtD3xsyGoX0j96Vzaj9WOQ5f4O3kT3IqWfIF1DRfwlgxtWzgVN5zB3nAeD7TB0S2gm+QaHQMXmtNCL9aOYabGJNEvJSqmgVZSLktdaoVfRIOX5JLXXivYbvhOeqGzZQrQzg9nl1RK3yeFfRE/LyDLdhvKCl0HbMfGN0Wc7xOZciUiL6Qx7utocrw7ugq0GyP7SCsVVqRsidz9inG4pYcukGJiuG6jmPRYA/QZ0J3ZpNpDFPsR6OLpJRqcwP1hXL2Vnq/1y4Yr98MezQT6L+WAJ7ME+TMhMEkr0fII/JBprOFo8PnzCRPaVchKaBXl6bjE5bBtKt0hdLDfaCQtxfH9McPwWIyfL6cROQ5Fk5yiIIO8v4NaTuNF43IED3lIXCmoFtJiMVWSVFVWakHVyS8bt4yE+wKOzyinNjeKjZfdLulkoTneET014P1D9BK3Wbg+50BRX1B0GAysjqfFdDbtOThzTeQHGIKXTuiPQ1O5mTwe9xX5vWYKesdO8BJhCpjjVol0SqtY0jv6oXV+KeKtyBCo9iN5dgrFuadY+P2G5jR3DLshcYjGwJWwGDac14DHY2vwl7DDZwH5aRIJnTgA5BtnUQQJvcGCILhhIlLGDfMLVZ+eYHG50R9NdSMFQ35jOg6vG+txtdy4nI3QmxB4Em+KX/xTy00iCaTdThBS3q75bYe5/Vj3DE0nXFYKD4NH+Pr4/IQR5oweFpTI5yQlCaC3kCUJDR66ht6g5xz0eBpBKJLcyb7BoeIIo+AV9qHQFoWgxg58UMgJhBoJNhmyL1AHywWvLy1H40IkC0FABX0sSGST51dqWauQFLQioP+NgKIRWmFV8oDNMPu9o4NQACqVHXfrTQ84Al4dgKUa5acBQgFTBKa75KgkKIk9GBLF4kf+OwlHy0Y5+CgR2BGC5JOwRwco2oYRhjtnxzhUBJYil178oW4kKBld4c6zgz6HmuyAvAq6fnD28+3D4t9AcEh/q40r8TVO2U2Es9CJJA5MoH9aPbE0+lUKdHrLqTaXnnfQKQ1jGVCpNn/e31t732h8UWdoogn1QVIM09TFmmq1PkxH3wzi7N7rFaxHsLhbs9XqDb3xLsuWX6UPcA0JKrwThHw2r4MsqAp/+CwLGXUdFBJqFaXUN7RCYHCRhLnT2Z3RkGin9MDRO+N1d5DaydvcVBoAITZkuGADC7WSX0mApRDVdD2kFPTKvuwXRmvZINw4k+LLoW6BFGkSYyvkF7NzVCI4cADOHQWjtwAEOf4OToXzpNT5am8wLaY8BH0H/xJFo4Su04liYXkEdkhJ6ttQ4wizBKE7UztzKSSDg24jZIjvzo7OPVFseEyezNU4LJJiS4pYkjXFG/SQE4xyEGQBFa587657btHgXLUnAcGAVHVMmpkZlatghSml8oWFUgl5eORYBp0SRjq1sBwG9QxqlTAwK38huKahFJZOzDwr62g1MzEIgiWrTq1YDLFsaQaW3v4GhmxoEEyrgrGmJ0OdWkDlBqlTxqqRrn15rIZOM6xWXS0pYfSYGZhE95Sqp+dHAlrCva1GZYw5vE600KtWJ76nFFaHQ7MyY9EsymDJ5ppoIyPrjVanXhws4c05Bk2agQUyaUSoWVkp2ozpmABpDXQEXN46ZTT1pMszMPwbnckwDR4dJK2UAfnlN6viotMHR5OOHlLOkViR4YwYQRL9XqeVLiOVPDUjC1GN9KyMhNp8hLSEa+U6rXca1eInOiGkkalDcRpYGgRFDPqlDZpROScTCrA2NCsDplEhwCBcw1KYpIYTSYWM9UWq2Yl1qpUaSL1Wrxp9T4ggqofkOHmyFchdGzimmS0JHGEAJB+fbEFhxRBGVKxBW2lkw9ZnGn7o/PSkRHfDFDZi3gamsVYmsYIfmEYSxJEjwGO1KqInIo3W1jJALakurlchVz9aWTKetFTJZbSfXPiFZFADWVq63CQZS9bHQOkPpC9jJi1ssDr1sAo6DFuxOiXWiu14/FbH1EoZ1z16VtXEkjLM46lxrBFxec4/Yq9H6umxVruebHKzM6nZ+eU8DWBvnL2ZKmzHJr6v06rOyxILD1m/WBA9BFjAGL74Md2NZmbww5gPwXtEV/qNanOdSE2nlGTOa2TXWaUnoGWPGVZvnxwZF5WVamK0+DUG5R4WU8SBMF0yZb3LccseXhCJFRYpWeIuCoPwniBYFtQURNO6nmbYSD1aLd6TW4o0HbNYA2VjmSnH+pJryCImnLKOqB+smUEDI4NGqxu21jiw2Ak6DYyeQbfc63iNZcFM+nDxGDxsmoB12hDqY6KzZVP/JOvtXi5xGowGQyE6qMP2UJcMVg3gorZ4uRT9R2SR4TI2aDC39f95CvdRdAXgk26xQGOc983W7wfgkFuNsoYdd1vYktIRSrHbHvbEgaPRB+Wlch7wayxEw8/YiIHf+vjBjzO8KfhQ8g3Oy0gH4eUhxgW2scaZnw3iwXrHjDfFZFMtszyeOckI7yRSs8FTpDjQSbPbZDMulrP2O+CcvfY5wyTxkQAmZgsng9zicyova5Lppkl1z/PwuJDHAT7qe99TD6wNgsu3SUsstNgi68y21CF8ycYY7TSBOb466BfYDBt4kJlrnm0qc9bLmItuVbnariY3Japzp1cbUCUBlwuEXCDmf/XIZlrpX/+ljOp/BErV5Rfdex8KiFlkrnDRSAYmPcwusBQcu6g4AXHDsgSD+mIamqUH4K6r6l1idVmDKxqDtST0yR9J1ndf8W1Lrd5ottqdbq8fvqVZRGMvHZyfzuYK6UNTLFfrjWGzhsy4Y84B7Yo0WmnVjTsmdyHMteu3qxthfiiHR9/9azvqGCbFAxruWXR/3xWaH/rsLCZdh8N8Zp57/oUXX3r5lVd9hF193RGH33jzrbe9cSIscjsuV5Lq3OL5JUuXLV+xctXqNKvVO3Xmd2wrb3e6vTVr163fsHHT5i1buynm4kOHxnxmu4Rf9Gdm5+YXFpeWV1bX1jc2i7La2t7Z3Yv7B4dHx+lnPR7fgZK839q6KkBdYbWMgyf64CrWD+68s+26tWIqbmlNwd2a3frFbUfqKKojdBBXZIlTOYNags5TCHToEtMGGSvGpmbtoCiGi/e/4reb0PnhoW5SoVpJPLLgbpuqvTHhrYnQ1Ws6StCINstq0jkazzZvvgP9P/w89cGVmKL1xNT6dhg3RvGx6k+iejVaTlGh2ro00XwRejlTR4Bz6LzHmVClSL85oYkoM6hfGbN+XQ9sErSWomjTvwxDg5wi2PmloeGEAtl4RtQq8w5UIPMIdCs7pKOisnFXkTbjR+SX3tiVz5VjQ86HgGW50GZS1auOi0mOXFSzHUyP8w54Xqupv2RMDddq6hn4ycF0NuBvM3Pvfe/LuSf8+WzyUzJRDBidt7A49Ttw83252JGuwOJIGndcLGySws0KrKrA25X1WBn/R+OxSa1wamoaZr4akq/U+l/IgLUJ/5quqxwr5LwJmGUatAK7eiF2ZwW7uczne0sTtdkfIy+mF8VhO0SdKx32nOl8WxxOUkNxROKRCUeTtqPjc2Q7Svnp9BhKJdXqeDKRdnB+YRZo57PzeActypzHyrTrAtcdZ12izdXC7+Y3N+ZX6dul636/MHIhVu3slzitQm3efMjs/jR40rS25tn81U3IB7MiZN484a5af+T/1OxJPb0Gyj37PcfsUSPZRmiREQNGMiNvIqJaRJARekbsmRCbgqpUJSQBCUhVQhKSgETSfy2HreTmftjsL0LVIqxsYdAZTBa6V0xQqDQ6g8mad8QSV/3TiFESwzQgIyGTBL8BWDWAQTCdYHsiGcXCo9OdIaaNj2OQmg6SUy4ll8VC6jcgOYO55DflUmqSJKdYSH5DfzsYkRDbzsMfocpGjlE4/QX6Fr1EX6MTdevLzRbeIcV9jzthM4PMHitikswPdR6AVTV2FBow20CTfp+zJEKutjZu0fexDoJtrb015KoIWfQPJWwriaQllXcmddYQ++RWovvKAU/Z+gYtaXhHp49T4Tte/kEPEgvjX4KdOVPySwF782N548xu8Fvt+PvVgeKA6AA5uP5C7+/L3Oe2bxB38//OP+ckvSOrBI6k+KgLv6RKnLtQWrkWJy5E3v72/TdV2274/62fP6E6XwO/LcftQprM5ffrA+UB8QFykv+gZhzUbyF+7dYR9b4Wxw==)format("woff2")}a:hover{text-decoration:underline;text-decoration-thickness:.25rem;text-underline-offset:.08em}p{word-wrap:break-word;overflow-wrap:break-word;word-break:break-word}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1rem;line-height:1.3;display:flex;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{width:100%;margin:0 8px 0 0;padding:0;display:inline;list-style:none;font-size:1rem}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}}.c-article-author-list__button svg{margin:1px 4px 0 0}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;line-height:1.3;font-size:1rem}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-author-affiliation__list,.c-article-author-institutional-author,.c-article-references{list-style:none;padding:0}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;padding-bottom:8px;margin:0}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-references p,.c-bibliographic-information__column button,.c-bibliographic-information__column p{margin-bottom:16px}.c-article-section{clear:both}.c-article-section__content{padding-top:8px;margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__pill-button{padding:8px 16px 8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:.875rem;line-height:1.4;font-weight:700;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-decoration:none;display:inline-flex;align-items:center}.c-article__pill-button:hover{background-color:#0067c5;color:#fff;text-decoration:none}.c-article__pill-button:focus{outline:0;box-shadow:0 0 0 3px #fece3e;text-decoration:none}.c-article__pill-button:active,.c-article__pill-button:hover{box-shadow:0 0 0 0}.c-article__pill-button svg{height:.8em;margin-left:2px}.c-article__sub-heading{font-size:1.125rem;font-weight:400;font-style:normal;line-height:1.3;color:#222;margin:24px 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading--small{font-size:1.125rem;font-weight:700}.c-article__sub-heading:first-child{margin-top:0}.c-article-references__item{display:flex;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item::before{content:attr(data-counter);font-size:1.5rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__item::before{font-size:1.125rem;line-height:inherit}}.c-article-references__item>p.c-article-references__text{flex:1;padding-left:8px}.c-article-references__links{display:flex;flex-basis:100%;justify-content:flex-end;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links a{padding-left:8px}.c-article-references__links a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-references__download svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-author-affiliation__list>li{margin-bottom:16px}.c-article-author-institutional-author{margin-top:0;margin-bottom:24px}.c-article-author-institutional-author__name{font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-subject-list{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;list-style:none;display:flex;flex-wrap:wrap;padding:0;margin:0 0 24px}.c-article-subject-list__subject{background-color:#e1e1e1;border-radius:20px;padding:4px 10px;font-weight:700;margin-right:15px;margin-bottom:16px;flex:0 1 auto}.c-bibliographic-information{display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1rem;display:block}.c-bibliographic-information__column:first-child{width:81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:flex;justify-content:flex-start;flex-wrap:wrap}.c-bibliographic-information__list-item{flex:0 0 33%;box-sizing:border-box;padding-right:8px;margin-bottom:16px;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{flex:0 0 100%}}.c-bibliographic-information__list-item p{margin-bottom:0}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:24px}.c-article-share-box__description{font-size:1rem}.c-article-share-box__additional-info{color:#626262;font-size:.813rem}.c-article-share-box__button{background:#fff;border:1px solid #0067c5;box-sizing:content-box;color:#0067c5;font-size:1rem;line-height:1.5;padding:8px 20px;text-align:center}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}@supports ((-webkit-backdrop-filter:blur(10px)) or (backdrop-filter:blur(10px))){.c-context-bar--sticky:after{background:linear-gradient(to top,rgba(255,255,255,.75) 50%,#fff);-webkit-backdrop-filter:blur(10px);backdrop-filter:blur(10px)}}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0;min-height:200px}.c-reading-companion__tabs{font-size:1rem;list-style:none;display:flex;flex-direction:row;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{color:#0067c5;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1.5;overflow:hidden;white-space:nowrap;text-overflow:ellipsis}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;color:#222}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-table{border:2px solid #d5d5d5;clear:both;padding:20px 10px;margin-bottom:24px}.c-article-table__figcaption{line-height:1.4;margin-bottom:16px;word-break:break-word}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1;padding:13px 24px}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:.875rem}}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0;aspect-ratio:var(--card--image-aspect-ratio,16/9)}}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}}.c-article-associated-content__container a{text-decoration:underline}.js .u-js-hide:first-child+*,.u-hide:first-child+*{-webkit-margin-before:0;margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media only screen and (min-width:1024px){.js .u-js-hide-at-lg:first-child+*,.u-hide-at-lg:first-child+*{-webkit-margin-before:0;margin-block-start:0}}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-style-bullet{list-style-type:disc}.u-list-reset{list-style:none;margin:0;padding:0}.u-sans-serif{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.u-text-right{text-align:right}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}.u-reset-margin a:hover{text-decoration:inherit}.c-article-associated-content__container a:hover{text-decoration-thickness:.3875rem;text-underline-offset:.08em}.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label{display:block}.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}</style>
<link rel=canonical href=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3>
<meta property=og:url content=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3>
<meta property=og:type content=article>
<meta property=og:site_name content="BioMed Central">
<meta property=og:title content="Current controversies in radiotherapy for breast cancer - Radiation Oncology">
<meta property=og:description content="Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).">
<meta property=og:image content=https://media.springernature.com/w200/springer-static/cover/journal/13014.jpg>
<script type=application/ld+json>{"mainEntity":{"headline":"Current controversies in radiotherapy for breast cancer","description":"Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).","datePublished":"2017-01-23","dateModified":"2017-01-23","pageStart":"1","pageEnd":"10","license":"http://creativecommons.org/publicdomain/zero/1.0/","sameAs":"https://doi.org/10.1186/s13014-017-0766-3","keywords":"Cancer Research,Oncology,Radiotherapy,Imaging / Radiology","image":"","isPartOf":{"name":"Radiation Oncology","issn":["1748-717X"],"volumeNumber":"12","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"David Krug","affiliation":[{"name":"University Hospital Heidelberg and National Center for Radiation Research in Oncology (NCRO)","address":{"name":"Department of Radiation Oncology, University Hospital Heidelberg and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany","@type":"PostalAddress"},"@type":"Organization"}],"email":"david.krug@med.uni-heidelberg.de","@type":"Person"},{"name":"René Baumann","affiliation":[{"name":"University Hospital Schleswig-Holstein","address":{"name":"University Hospital Schleswig-Holstein, Kiel, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wilfried Budach","affiliation":[{"name":"Heinrich-Heine-University","address":{"name":"Heinrich-Heine-University, Duesseldorf, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Jürgen Dunst","affiliation":[{"name":"University Hospital Schleswig-Holstein","address":{"name":"University Hospital Schleswig-Holstein, Kiel, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Petra Feyer","affiliation":[{"name":"Vivantes Hospital Neukoelln","address":{"name":"Vivantes Hospital Neukoelln, Berlin, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rainer Fietkau","affiliation":[{"name":"University Hospital Erlangen","address":{"name":"University Hospital Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wulf Haase","affiliation":[{"name":"Formerly St.-Vincentius-Hospital","address":{"name":"Formerly St.-Vincentius-Hospital, Karlsruhe, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wolfgang Harms","affiliation":[{"name":"St. Claraspital","address":{"name":"St. Claraspital, Basel, Switzerland","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Marc D. Piroth","affiliation":[{"name":"HELIOS-Hospital Wuppertal, Witten/Herdecke University","address":{"name":"HELIOS-Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Marie-Luise Sautter-Bihl","affiliation":[{"name":"Municipal Hospital","address":{"name":"Municipal Hospital, Karlsruhe, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Felix Sedlmayer","affiliation":[{"name":"Paracelsus Medical University Hospital","address":{"name":"Paracelsus Medical University Hospital, Salzburg, Austria","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rainer Souchon","affiliation":[{"name":"Formerly University Hospital Tuebingen","address":{"name":"Formerly University Hospital Tuebingen, Tuebingen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Frederik Wenz","affiliation":[{"name":"University Hospital Mannheim","address":{"name":"University Hospital Mannheim, Mannheim, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rolf Sauer","affiliation":[{"name":"University Hospital Erlangen","address":{"name":"University Hospital Erlangen, Erlangen, Germany","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>
<style>@keyframes fadeOutUp{from{opacity:1}to{margin-top:0;padding:0;height:0;min-height:0;opacity:0;transform:scaleY(0)}}sr-rd-crlbar.controlbar:hover{opacity:1}@media all and (max-height:620px){fab{zoom:.8}}@keyframes srFadeInUp{from{opacity:0;transform:translateY(100px)}to{opacity:1;transform:translateY(0)}}@keyframes srFadeInDown{from{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(100px)}}:root{--balloon-color:rgba(16,16,16,0.95);--balloon-font-size:12px;--balloon-move:4px}sr-rd-crlbar.controlbar{z-index:2147483647}sr-rd-crlbar fab{position:fixed;display:block;bottom:45px;right:24px;width:56px;height:56px;line-height:56px;text-align:center;color:#fff;background-color:rgb(76,175,80);border-radius:50%;cursor:pointer;box-shadow:0 2px 2px 0 rgba(0,0,0,0.14),0 1px 5px 0 rgba(0,0,0,0.12),0 3px 1px -2px rgba(0,0,0,0.2);transform:rotate(0deg);transition:all 450ms 0ms}sr-rd-crlbar fab.setting,sr-rd-crlbar fab.about{bottom:100px;right:33px;margin-bottom:10px;width:40px;height:40px;line-height:40px;font-size:10px;background-color:rgb(3,169,244);background-position:center;background-repeat:no-repeat;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAABvUlEQVRIS72WjVFCQQyENxVoB2oF2oFYiZYAFYgVaAlQidgBdoAdaAVxvptkjMffQxluhoF3L5fNZff2MB1huPuCNGY2cveppEdJd2a2sCPkVwCcSRpLeojP0QFuu2J3A7j7paT7smhuZquaxN1HkkhM1XRjJinn+L3a2qJY/FoStoo6gOw3028dBy30F4C7UwlVTySdS1oDiH4vzWwcu2SnL5IuJC0l8cyHHMsG4O4kuy4EQRaDhTmYIwG74JvnD9oWoDcFALAfDja0Y6i4nsxsulemsVXakwQB8BGkJRjvqay+W8BLtJZzMItiyTNjdz0Ha6Rl9qgypdgIHbJNi4UewZUgqqPXbbg7PU7iP6Pf+XpSYyswAJm8zq9JsgAdFH8SgHp4aBFEIkH63LcIvyH+q2vReGuL9p3Mf5McBKbvoIxUB76Dn1SZEsfId+xyk0xRW/OuPMkkrbYwRIHEDD5oyA8ZVi8iwXNBat4ShbwHT6tiFVhN9aJ1u44TCQgkDzU7RIFnXXVe1LzrtHbdKQpC2U2O5i1dTIqCOA5gXjjMz3deOENZDhVyNg67Mv8AAGd56XNpHf3S3/i35Rt5qiGSUhS/qAAAAABJRU5ErkJggg==);opacity:0;transition:opacity .5s ease}sr-rd-crlbar fab.about{bottom:150px;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAAeklEQVRIie3T0QmAIBDG8RuhEdwkR3CENmiE3KxRXKEN/r0oSJkvXaHgB/ckfD84OZFWAlhgTqNd7rnHDyAHXAFwakDfARZgu8wKTBrltrB7vU/+AzDA8RmQQf0f2gAeiw2wA6EAhPhm3gC1O0ix7QIR8bV5VT4iInICHxrcTgOet60AAAAASUVORK5CYII=)}@media (pointer:coarse){fab{opacity:1!important}@media only screen and (max-device-width:414px){sr-rd-crlbar.controlbar{z-index:2147483646!important}}}@media (pointer:coarse){@media only screen and (max-device-width:1024px){html{font-size:80%!important}}@media only screen and (max-device-width:414px){html{font-size:70%!important}}@media only screen and (max-device-width:320px){html{font-size:90%!important}}}/*!
 * Waves v0.7.5
 * http://fian.my.id/Waves
 * 
 * Copyright 2014-2016 Alfiana E. Sibuea and other contributors
 * Released under the MIT license
 * https://github.com/fians/Waves/blob/master/LICENSE
 */sr-rd-crlbar.controlbar{position:fixed;right:0;bottom:0;width:100px;height:100%;opacity:0;-webkit-transition:opacity .5s ease;transition:opacity .5s ease}sr-rd-crlbar.controlbar:hover{opacity:1}@media (max-height:620px){fab{zoom:.8}}@-webkit-keyframes srFadeInUp{0%{opacity:0;-webkit-transform:translateY(100px);transform:translateY(100px)}to{opacity:1;-webkit-transform:translateY(0);transform:translateY(0)}}@keyframes srFadeInUp{0%{opacity:0;-webkit-transform:translateY(100px);transform:translateY(100px)}to{opacity:1;-webkit-transform:translateY(0);transform:translateY(0)}}@-webkit-keyframes srFadeInDown{0%{opacity:1;-webkit-transform:translateY(0);transform:translateY(0)}to{opacity:0;-webkit-transform:translateY(100px);transform:translateY(100px)}}@keyframes srFadeInDown{0%{opacity:1;-webkit-transform:translateY(0);transform:translateY(0)}to{opacity:0;-webkit-transform:translateY(100px);transform:translateY(100px)}}@-webkit-keyframes fadeOutUp{0%{opacity:1}to{margin-top:0;padding:0;height:0;min-height:0;opacity:0;-webkit-transform:scaleY(0);transform:scaleY(0)}}@keyframes fadeOutUp{0%{opacity:1}to{margin-top:0;padding:0;height:0;min-height:0;opacity:0;-webkit-transform:scaleY(0);transform:scaleY(0)}}:root{--sr-annote-color-0:#b4d9fb;--sr-annote-color-1:#ffeb3b;--sr-annote-color-2:#a2e9f2;--sr-annote-color-3:#a1e0ff;--sr-annote-color-4:#a8ea68;--sr-annote-color-5:#ffb7da}@-webkit-keyframes sr-annote-slideInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0);visibility:visible}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@keyframes sr-annote-slideInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0);visibility:visible}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@-webkit-keyframes sr-annote-slideInDown{0%{opacity:1;visibility:visible}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}@keyframes sr-annote-slideInDown{0%{opacity:1;visibility:visible}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}@-webkit-keyframes fadeInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@keyframes fadeInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@-webkit-keyframes fadeOutDown{0%{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}@keyframes fadeOutDown{0%{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}@-webkit-keyframes scaleAnimation{0%{opacity:0;-webkit-transform:scale(1.5);transform:scale(1.5)}to{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}@keyframes scaleAnimation{0%{opacity:0;-webkit-transform:scale(1.5);transform:scale(1.5)}to{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}@-webkit-keyframes fadeOut{0%{opacity:1}to{opacity:0}}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}@-webkit-keyframes fadeIn{0%{opacity:0}to{opacity:1}}@keyframes fadeIn{0%{opacity:0}to{opacity:1}}@-webkit-keyframes swing{20%{-webkit-transform:rotate(15deg);transform:rotate(15deg)}40%{-webkit-transform:rotate(-10deg);transform:rotate(-10deg)}60%{-webkit-transform:rotate(5deg);transform:rotate(5deg)}80%{-webkit-transform:rotate(-5deg);transform:rotate(-5deg)}to{-webkit-transform:rotate(0deg);transform:rotate(0deg)}}@keyframes swing{20%{-webkit-transform:rotate(15deg);transform:rotate(15deg)}40%{-webkit-transform:rotate(-10deg);transform:rotate(-10deg)}60%{-webkit-transform:rotate(5deg);transform:rotate(5deg)}80%{-webkit-transform:rotate(-5deg);transform:rotate(-5deg)}to{-webkit-transform:rotate(0deg);transform:rotate(0deg)}}@-webkit-keyframes fadeInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@keyframes fadeInUp{0%{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}to{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}}@-webkit-keyframes fadeOutDown{0%{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}@keyframes fadeOutDown{0%{opacity:1;-webkit-transform:translateZ(0);transform:translateZ(0)}to{opacity:0;-webkit-transform:translate3d(0,100%,0);transform:translate3d(0,100%,0)}}.cc-banner{-webkit-box-sizing:border-box;box-sizing:border-box;background-color:#01324b;color:#fff;position:fixed;bottom:0;left:0;right:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;line-height:1.5;z-index:99999}.cc-banner *{color:inherit!important}.cc-banner:focus{outline:none}.cc-banner a{color:#fff;text-decoration:underline}.cc-banner a:focus{outline:none;-webkit-box-shadow:0 0 0 3px #fece3e;box-shadow:0 0 0 3px #fece3e}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{text-decoration:none;color:inherit}.cc-banner__content{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;margin:0 auto;max-width:1320px;max-height:90vh;padding:12px}@media (min-width:680px){.cc-banner__content{padding:16px}}@media (min-width:980px){.cc-banner__content{padding-top:60px;padding-bottom:60px}}.cc-banner__title{font-size:18px;margin:0 0 12px}@media (min-width:980px){.cc-banner__title{margin:0 0 16px;font-size:28px}}.cc-banner__body{-webkit-box-flex:1;-webkit-flex:1 1 auto;-ms-flex:1 1 auto;flex:1 1 auto;overflow-x:hidden;overflow-y:auto;padding:0 0 16px}@media (min-width:680px){.cc-banner__body{padding:0;margin:0 0 16px}}.cc-banner__copy{font-size:14px;margin:0}@media (min-width:980px){.cc-banner__copy{font-size:16px}}.cc-banner__footer{padding:12px;margin:0-12px -12px;background-color:#012132;border-top:1px solid rgba(0,0,0,.3);-webkit-box-shadow:0 0 5px 0 rgba(0,0,0,.8);box-shadow:0 0 5px 0 rgba(0,0,0,.8);position:relative}@media (min-width:380px){.cc-banner__footer{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;-webkit-box-align:center;-webkit-align-items:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between}}@media (min-width:680px){.cc-banner__footer{margin:0;padding:0;background-color:transparent;border-top:0;-webkit-box-shadow:none;box-shadow:none;-webkit-box-pack:start;-webkit-justify-content:flex-start;-ms-flex-pack:start;justify-content:flex-start}}.cc-banner__button{width:100%;white-space:nowrap}@media (min-width:380px){.cc-banner__button{width:auto}}@media (min-width:680px){.cc-banner__button{max-width:250px}}.cc-banner__button:not(:last-child){margin-bottom:4px}@media (min-width:680px){.cc-banner__button:not(:last-child){margin-right:8px;margin-bottom:0}}@media (min-width:980px){.cc-banner__button:not(:last-child){margin-right:16px}}@media (min-width:380px){.cc-banner__button-accept{width:100%}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-accept{width:100%}}@media (min-width:680px){.cc-banner__button-accept{max-width:240px}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{-webkit-box-flex:0;-webkit-flex:0 0 auto;-ms-flex:0 0 auto;flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}.cc-button{font-size:13px;font-weight:700;padding:.5em 1em;border:1px solid #183642;border-radius:3px;cursor:pointer;line-height:1.2}.cc-button:focus{outline:none;-webkit-box-shadow:0 0 0 3px #fece3e;box-shadow:0 0 0 3px #fece3e}.cc-button:hover{-webkit-box-shadow:0-2px 4px 0 rgba(60,64,67,.15),0 2px 4px 0 rgba(60,64,67,.15);box-shadow:0-2px 4px 0 rgba(60,64,67,.15),0 2px 4px 0 rgba(60,64,67,.15);text-decoration:underline}@media (min-width:680px){.cc-button{padding:.75em 1em;font-size:14px}}.cc-button--contrast{color:#000!important;border-color:#fff;background-color:#fff}.cc-button--link{color:inherit;text-decoration:underline;background-color:transparent;border-color:transparent}.cc-button--link:hover{text-decoration:none;-webkit-box-shadow:none;box-shadow:none}#MathJax_Message{position:fixed;left:1em;bottom:1.5em;background-color:#E6E6E6;border:1px solid #959595;margin:0px;padding:2px 8px;z-index:102;color:black;font-size:80%;width:auto;white-space:nowrap}</style><link rel=icon type=image/png sizes=32x32 href="data:image/png;base64,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"><style>.sf-hidden{display:none!important}</style><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:; object-src 'self' data:;"><style>img[src="data:,"],source[src="data:,"]{display:none!important}</style></head>
 <body class="journal journal-fulltext" data-new-gr-c-s-check-loaded=14.1110.0 data-gr-ext-installed data-new-gr-c-s-loaded=14.1110.0><div id=MathJax_Message style=display:none></div><section class=cc-banner data-cc-banner data-nosnippet aria-labelledby=cc-banner-label>
 <div class=cc-banner__content>
 <header class=cc-banner__header>
 <h2 class=cc-banner__title id=cc-banner-label>Your Privacy</h2>
 </header>
 <div class=cc-banner__body>
 <p class=cc-banner__copy>
 We use cookies to make sure that our website works properly, as well as some ‘optional’ cookies to personalise content and advertising, provide social media features and analyse how people use our site. By accepting some or all optional cookies you give consent to the processing of your personal data, including transfer to third parties, some in countries outside of the European Economic Area that do not offer the same data protection standards as the country where you live. You can decide which optional cookies to accept by clicking on ‘Manage Settings’, where you can also find more information about how your personal data is processed.
 Further information can be found in our <a href=https://www.biomedcentral.com/privacy-statement>privacy policy</a>.
 </p>
 </div>
 <div class=cc-banner__footer>
 <button data-cc-action=accept class="cc-button cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
 
 <button data-cc-action=preferences class="cc-button cc-button--link cc-banner__button cc-banner__button-preferences">Manage preferences</button>
 </div>
 </div>
 </section>
 
 
 
 
 <noscript>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ" height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
 
 
 
 <div class=u-visually-hidden aria-hidden=true>
 
 <svg xmlns=http://www.w3.org/2000/svg xmlns:xlink=http://www.w3.org/1999/xlink><defs><path id=a d="M0 .74h56.72v55.24H0z"></path></defs><symbol id=icon-access viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule=evenodd></path></symbol><symbol id=icon-account viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-alert viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-broad viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule=evenodd transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id=icon-arrow-down viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-left viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-right viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-sub viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-up viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path></symbol><symbol id=icon-article viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule=evenodd></path></symbol><symbol id=icon-audio viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule=evenodd></path></symbol><symbol id=icon-block viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule=evenodd></path></symbol><symbol id=icon-book viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-broad viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule=evenodd transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id=icon-calendar viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule=evenodd></path></symbol><symbol id=icon-cart viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id=icon-chevron-less viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id=icon-chevron-more viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id=icon-chevron-right viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id=icon-circle-fill viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-circle viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-citation viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-close viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule=evenodd></path></symbol><symbol id=icon-collections viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-compare viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule=evenodd></path></symbol><symbol id=icon-download-file viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule=evenodd></path></symbol><symbol id=icon-download viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule=evenodd></path></symbol><symbol id=icon-editors viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule=evenodd></path></symbol><symbol id=icon-email viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule=evenodd></path></symbol><symbol id=icon-error viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule=evenodd></path></symbol><symbol id=icon-ethics viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule=evenodd></path></symbol><symbol id=icon-expand><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule=evenodd></path></symbol><symbol id=icon-explore viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule=evenodd></path></symbol><symbol id=icon-filter viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id=icon-home viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule=evenodd></path></symbol><symbol id=icon-image viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule=evenodd></path></symbol><symbol id=icon-info viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path></symbol><symbol id=icon-institution viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule=evenodd></path></symbol><symbol id=icon-location viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule=evenodd></path></symbol><symbol id=icon-minus viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-newsletter viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule=evenodd></path></symbol><symbol id=icon-orcid viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule=evenodd></path></symbol><symbol id=icon-plus viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-print viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule=evenodd></path></symbol><symbol id=icon-search viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule=evenodd></path></symbol><symbol id=icon-social-facebook viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule=evenodd></path></symbol><symbol id=icon-social-twitter viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule=evenodd></path></symbol><symbol id=icon-social-youtube viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule=evenodd></path></symbol><symbol id=icon-subject-medicine viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-success viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule=evenodd></path></symbol><symbol id=icon-table viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule=evenodd></path></symbol><symbol id=icon-tick-circle viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule=evenodd></path></symbol><symbol id=icon-tick viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule=evenodd></path></symbol><symbol id=icon-update viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule=evenodd></path></symbol><symbol id=icon-upload viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule=evenodd></path></symbol><symbol id=icon-video viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule=evenodd></path></symbol><symbol id=icon-warning viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-facebook-bordered viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"></path><path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213
	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354
	L483.025,280.48L483.025,280.48z"></path></symbol><symbol id=icon-twitter-bordered viewBox="463.812 263.868 32 32"><g><path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502
		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71
		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361
		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656
		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883
		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215
		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"></path></g><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"></path></symbol><symbol id=icon-weibo-bordered viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"></path><g><path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588
		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63
		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021
		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027
		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493
		C485.697,280.594,484.689,279.911,483.782,279.63"></path><path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72
		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0
		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833
		"></path><path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621
		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0
		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"></path><path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389
		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301
		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393
		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396
		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"></path></g></symbol><symbol id=icon-arrow-left-bullet viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"></path></symbol><symbol id=icon-chevron-down viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 3)"></path></symbol><symbol id=icon-download-rounded><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"></path></symbol><symbol id=icon-ext-link viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"></path><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"></path><path d="M9.7 0L16 6.2V0z"></path></symbol><symbol id=icon-remove viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"></path><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"></path></symbol><symbol id=icon-rss viewBox="0 0 18 18"><path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule=evenodd></path></symbol><symbol id=icon-springer-arrow-left><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id=icon-springer-arrow-right><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id=icon-springer-collections viewBox="3 3 32 32"><path fill-rule=evenodd d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"></path></symbol><symbol id=icon-springer-download viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"></path></symbol><symbol id=icon-springer-info viewBox="0 0 24 24"><g id=V&amp;I stroke=none stroke-width=1 fill-rule=evenodd><g id=info fill-rule=nonzero><path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id=Combined-Shape></path></g></g></symbol><symbol id=icon-springer-tick-circle viewBox="0 0 24 24"><g id=Page-1 stroke=none stroke-width=1 fill-rule=evenodd><g id=springer-tick-circle fill-rule=nonzero><path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id=path-1></path></g></g></symbol><symbol id=icon-updates viewBox="0 0 18 18"><g fill-rule=nonzero><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"></path><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"></path></g></symbol><symbol id=icon-checklist-banner viewBox="0 0 56.69 56.69"><path style=fill:none d="M0 0h56.69v56.69H0z"></path><clippath id=b><use xlink:href=#a style=overflow:visible></use></clippath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style=clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style=clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round></path></symbol><symbol id=icon-submit-closed viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-3.03756612 2.46243388-5.5 5.5-5.5zm0 1c-2.4852814 0-4.5 2.0147186-4.5 4.5s2.0147186 4.5 4.5 4.5 4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5zm2.3087379 2.1912621c.2550161.2550162.2550161.668479 0 .9234952l-1.3859024 1.3845831 1.3859024 1.3859023c.2550161.2550162.2550161.668479 0 .9234952-.2550162.2550161-.668479.2550161-.9234952 0l-1.3859023-1.3859024-1.3845831 1.3859024c-.2550162.2550161-.668479.2550161-.9234952 0-.25501614-.2550162-.25501614-.668479 0-.9234952l1.3845831-1.3859023-1.3845831-1.3845831c-.25501614-.2550162-.25501614-.668479 0-.9234952.2550162-.25501614.668479-.25501614.9234952 0l1.3845831 1.3845831 1.3859023-1.3845831c.2550162-.25501614.668479-.25501614.9234952 0zm-9.8087379-8.7782621-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"></path></symbol><symbol id=icon-submit-open viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z"></path></symbol><symbol id=icon-submit-upcoming viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-1.6607442.73606908-3.14957021 1.89976608-4.15803695l-1.51549374.02214397c-.27613212.00263356-.49998143-.22483432-.49998143-.49020681 0-.24299316.17766103-.44509007.40961587-.48700057l.08928713-.00797472h2.66407569c.2449213 0 .4486219.17766776.490865.40963137l.008038.08929051v2.6642143c0 .275547-.2296028.4989219-.4949753.4989219-.24299317 0-.44342617-.1744719-.4830969-.4093269l-.00710993-.0906783.01983146-1.46576707c-.96740882.82538117-1.58082193 2.05345007-1.58082193 3.42478927 0 2.4852814 2.0147186 4.5 4.5 4.5s4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5c-.7684937 0-.7684937-1 0-1zm0 2.85c.3263501 0 .5965265.2405082.6429523.5539478l.0070477.0960522v1.731l.8096194.8093806c.2284567.2284567.2513024.5846637.068537.8386705l-.068537.0805683c-.2284567.2284567-.5846637.2513024-.8386705.068537l-.0805683-.068537-.9707107-.9707107c-.1125218-.1125218-.1855975-.257116-.2103268-.412296l-.0093431-.1180341v-1.9585786c0-.3589851.2910149-.65.65-.65zm-7.5-8.437-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"></path></symbol></svg>
</div>
 
 
 <div class=u-vh-full>
 <a class=c-skip-link href=#main-content>Skip to main content</a>
 
 
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 
 <aside class="adsbox c-ad c-ad--728x90 sf-hidden" data-component-mpu>
 <div class="c-ad__inner sf-hidden">
 
 <div id=div-gpt-ad-LB1 data-ad-type=LB1 data-test=LB1-ad data-pa11y-ignore data-gpt data-gpt-unitpath=/270604982/bmc/ro-journal/articles data-gpt-sizes=728x90,970x90 data-gpt-targeting="pos=LB1;doi=10.1186/s13014-017-0766-3;type=article;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation;pmc=B11001,H33160,H29056,H29005;" class=sf-hidden>
 <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/ro-journal/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s13014-017-0766-3&amp;type=article&amp;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation&amp;pmc=B11001,H33160,H29056,H29005&amp;">
                        <img data-test="gpt-advert-fallback-img" src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/ro-journal/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s13014-017-0766-3&amp;type=article&amp;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation&amp;pmc=B11001,H33160,H29056,H29005&amp;" alt="Advertisement" width="728" height="90">
                    </a>
                </noscript>
 </div>
 </div>
 </aside>
 
 
 
 
 <div id=membership-message-loader-desktop class=placeholder data-placeholder=/placeholder/v1/membership/message></div>
 
 
 <div id=top class=u-position-relative>
 <header class=c-header data-test=publisher-header>
 <div class=c-header__container>
 <div class="c-header__brand u-mr-48" itemscope itemtype=http://schema.org/Organization data-test=navbar-logo-header>
 <div class=c-logo>
 <a href=https://www.biomedcentral.com/ itemprop=url>
 <img alt=BMC itemprop=logo width=76 height=18 role=img src=data:image/svg+xml;base64,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>
 <div class=c-logo__strapline>
 <img alt="Part of Springer Nature" width=173 height=16 role=img src=data:image/svg+xml;base64,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>
 </div>
 </a>
</div>
 </div>
 <div class=c-header__navigation>
 <button type=button class="c-header__link u-button-reset u-mr-24" data-expander data-expander-target=#publisher-header-search data-expander-autofocus=firstTabbable data-test=header-search-button aria-controls=publisher-header-search aria-expanded=false aria-haspopup=true>
 <span class="u-display-flex u-align-items-center">
 <span>Search</span>
 <svg class="u-icon u-flex-static u-ml-8" aria-hidden=true focusable=false>
 <use xlink:href=#icon-search></use>
 </svg>
 </span>
 </button>
 <nav>
 <ul class="c-header__menu u-hide-at-lt-lg" data-enhanced-menu data-test=publisher-navigation>
 
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/journals>
 Explore journals
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/getpublished>
 Get published
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/about>
 About BMC
 </a>
 </li>
 
 
 <li class=c-header__item>
 <a href=https://ro-journal.biomedcentral.com/login class=c-header__link>Login</a>
 </li>
 </ul><div class="c-dropdown u-hide-at-lg sf-hidden"></div>
 </nav>
 </div>
 </div>
 </header>
 <div class="c-popup-search u-js-hide sf-hidden" id=publisher-header-search hidden>
 
 </div>
</div>
 
 
 <header class="c-journal-header c-journal-header--radiation-oncology ctx-journal-header">
 <div class=u-container>
 <div class=c-journal-header__inner>
 
 <div class=c-journal-title id=journalTitle>
 <a href=https://ro-journal.biomedcentral.com/>
 
 
 
 <span class=c-journal-title__text>Radiation Oncology</span>
 
</a>
 </div>
 
 </div>
 </div>
 <div class="c-navbar c-navbar--with-submit-button">
 <div class=c-navbar__container>
 
 <div class=c-navbar__content>
 <nav class=c-navbar__nav>
 <ul class="c-navbar__nav c-navbar__nav--journal" role=menu data-test=site-navigation>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=Home data-track-action="Clicked journal navigation link" href=https://ro-journal.biomedcentral.com/>Home</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=About data-track-action="Clicked journal navigation link" href=https://ro-journal.biomedcentral.com/about>About</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class="c-navbar__link c-navbar__link--is-shown" data-track=click data-track-category=Articles data-track-action="Clicked journal navigation link" href=https://ro-journal.biomedcentral.com/articles>Articles</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href=https://ro-journal.biomedcentral.com/submission-guidelines>Submission Guidelines</a>
 </li>
 
 
 
 <li class=c-navbar__item role=menuitem data-test=journal-header-submit-button>
 
 
 
 <div>
 
 <a class="u-button u-button--tertiary u-button--alt-colour-on-mobile" href=https://submission.nature.com/new-submission/13014/3 data-track=click data-track-action="manuscript submission" data-track-category=article data-track-label="button in journal nav" data-track-external data-test=submit-manuscript-button>Submit manuscript<svg class=u-ml-8 width=15 height=16 aria-hidden=true focusable=false><use xlink:href=#icon-submit-open></use></svg></a>
 
 </div>
 
 </li>
 
 
 </ul>
 </nav>
 </div>
 
 </div>
 </div>
 <div class="c-journal-header__identity c-journal-header__identity--sky-dark-blue">
 
 </div>
 </header>
 
 
 <div class="u-container u-mt-32 u-mb-32 u-clearfix" id=main-content data-component=article-container>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 <div class="c-context-bar u-hide sf-hidden" data-test=context-bar data-context-bar aria-hidden=true>
 
 </div>
 <div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile sf-hidden">
 
 </div>
 <article lang=en>
 <div class=c-article-header>
 
 
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Review</li>
 
 
 <li class=c-article-identifiers__item>
 <a href=https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research data-track=click data-track-action="open access" data-track-label=link class=u-color-open-access data-test=open-access>Open Access</a>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2017-01-23>23 January 2017</time></a></li>
 </ul>
 <h1 class=c-article-title data-test=article-title data-article-title>Current controversies in radiotherapy for breast cancer</h1>
 <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test=authors-list data-component-authors-activator=authors-list><li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-David-Krug data-author-popup=auth-David-Krug data-corresp-id=c1>David Krug<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-email></use></svg></a><sup class="u-js-hide sf-hidden"></sup>, <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Ren_-Baumann data-author-popup=auth-Ren_-Baumann>René Baumann</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Wilfried-Budach data-author-popup=auth-Wilfried-Budach>Wilfried Budach</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-J_rgen-Dunst data-author-popup=auth-J_rgen-Dunst>Jürgen Dunst</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Petra-Feyer data-author-popup=auth-Petra-Feyer>Petra Feyer</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Rainer-Fietkau data-author-popup=auth-Rainer-Fietkau>Rainer Fietkau</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Wulf-Haase data-author-popup=auth-Wulf-Haase>Wulf Haase</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Wolfgang-Harms data-author-popup=auth-Wolfgang-Harms>Wolfgang Harms</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Marc_D_-Piroth data-author-popup=auth-Marc_D_-Piroth>Marc D. Piroth</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Marie_Luise-Sautter_Bihl data-author-popup=auth-Marie_Luise-Sautter_Bihl>Marie-Luise Sautter-Bihl</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Felix-Sedlmayer data-author-popup=auth-Felix-Sedlmayer>Felix Sedlmayer</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Rainer-Souchon data-author-popup=auth-Rainer-Souchon>Rainer Souchon</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Frederik-Wenz data-author-popup=auth-Frederik-Wenz>Frederik Wenz</a><sup class="u-js-hide sf-hidden"></sup>, <li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Rolf-Sauer data-author-popup=auth-Rolf-Sauer>Rolf Sauer</a><sup class="u-js-hide sf-hidden"></sup> &amp; <li class=c-article-author-list__item><a data-test=author-name data-author-popup=group-1 href=#group-1>Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO)</a></ul><button aria-expanded=false class="c-article-author-list__button sf-hidden"><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-plus></use></svg></button>
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://ro-journal.biomedcentral.com/ data-track=click data-track-action="journal homepage" data-track-category="article body" data-track-label=link><i data-test=journal-title>Radiation Oncology</i></a>
 <b data-test=journal-volume><span class=u-visually-hidden>volume</span>&nbsp;12</b>, Article&nbsp;number:&nbsp;<span data-test=article-number>25</span> (<span data-test=article-publication-year>2017</span>)
 <a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>10k <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>31 <span class=c-article-metrics-bar__label>Citations</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
 
 
 
 
 
 
 </div>
 <section aria-labelledby=Abs1 data-title=Abstract lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><p>Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).</p></div></div></section>
 
 
 <section data-title=Background><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Background</h2><div class=c-article-section__content id=Sec1-content><p>Since 2005, the breast cancer expert panel of the German Society for Radiation Oncology (DEGRO) has published and updated evidence-based practical guidelines for the treatment of breast cancer using radiotherapy for the most important clinical situations [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Budach W, Matuschek C, Bölke E, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol. 2015;191:623–33." href=#ref-CR1 id=ref-link-section-d10423035e955>1</a>–<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 6" title="Wenz F, Sperk E, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol. 2014;190:705–14." href=#ref-CR6 id=ref-link-section-d10423035e958>6</a>].<p>Interdisciplinary efforts to pursue risk-adapted treatment strategies have improved outcome for breast cancer patients in the last decade. Subsequently, several long-standing paradigms regarding the role of different modalities have been scrutinized.<p>The most striking example for such a controversy in the radiation oncology community was the introduction of accelerated partial breast irradiation (APBI) for invasive breast cancer, especially intraoperative radiotherapy and the results of the TARGIT A-trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Zietman A. Letters Regarding the TARGIT-A Trial: The Editor’s Introduction. Int J Radiat Oncol Biol Phys. 2015;92:951–2." href=#ref-CR7 id=ref-link-section-d10423035e967>7</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Vaidya JS, Bulsara M, Wenz F, Joseph D, Saunders C, Massarut S, et al. Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2015;92:491–7." href=#ref-CR8 id=ref-link-section-d10423035e970>8</a>]. Another issue of dispute is the role of regional nodal irradiation (RNI) in early stage breast cancer recently highlighted by several randomized studies [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015;373:317–27." href=#ref-CR9 id=ref-link-section-d10423035e973>9</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015;373:307–16." href=#ref-CR10 id=ref-link-section-d10423035e976>10</a>]. Contrary to the results of trials which led to the established role of sentinel lymph-node biopsy, these trials consistently showed a benefit of intensified locoregional treatment, i.e. radiotherapy to the regional lymphatic pathways.<p>Last but not least, debate continues about the optimal risk-adapted treatment of ductal carcinoma in situ (DCIS). Substantial effort has been dedicated to the establishment of prognostic factors justifying the omission of adjuvant radiotherapy after breast-conserving surgery. Furthermore, some researchers suggest a change in the attitude towards low grade DCIS arguing that it should be regarded as a risk factor for a subsequent breast cancer rather than a malignant disease by itself.<p>The goal of this article is to provide an update on the DEGRO practical guidelines for APBI, RNI and DCIS with respect to recent data from randomised studies and to discuss their possible impact on future developments.<h3 class=c-article__sub-heading id=Sec2>Accelerated partial breast irradiation (APBI)</h3><p>Mostly in order to shorten duration of treatment, APBI is carried out with a variety of techniques for RT delivery. Its feasibility has been proven in randomized controlled trials (RCT) for “anticipated” or postoperative boost radiotherapy in addition to external beam whole breast irradiation (WBI) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="Sedlmayer F, Reitsamer R, Fussl C, Ziegler I, Zehentmayr F, Deutschmann H, et al. Boost IORT in Breast Cancer: Body of Evidence. Int J Breast Cancer. 2014;2014:472516." href=#ref-CR11 id=ref-link-section-d10423035e993>11</a>].<p>Moreover, APBI has been administered as sole RT modality applying different dose and fractionation schemes using various target volume definitions [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, et al. Accelerated Partial Breast Irradiation in Clinical Practice. Breast Care. 2015;10:247–52." href=#ref-CR12 id=ref-link-section-d10423035e999>12</a>]. Summarizing results of these trials, equieffectiveness of the various techniques is unclear and the differences in patient characteristics as well as dosimetric characteristics render the optimal selection of the treatment regimen as well as technique for individual patients difficult.<p>Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a> summarizes the results and patient characteristics of the recent randomized controlled trials of ABPI versus WBI followed by a boost to the tumor bed.<div class=c-article-table data-test=inline-table data-container-section=table id=table-1><figure><figcaption class=c-article-table__figcaption><b id=Tab1 data-test=table-caption>Table 1 Recent randomized phase III trials studying accelerated partial breast irradiation in breast cancer</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3/tables/1 aria-label="Full size table 1"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-chevron-right></use></svg></a></div></figure></div>
 <h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec3>Multicatheter brachytherapy</h4><p>Multicatheter brachytherapy is the technique with the longest experience for APBI and the only technique for which 10&nbsp;year-data from a randomized controlled trial are available [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Polgár C, Fodor J, Major T, Sulyok Z, Kásler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108:197–202." href=#ref-CR13 id=ref-link-section-d10423035e1533>13</a>]. The Budapest trial did show similar results with APBI using multicatheter brachytherapy and WBI with a tumor bed boost, however this mono-institutional trial was closed early due to poor enrollment and the study was hence not adequately powered to show non-inferiority of APBI [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Polgár C, Fodor J, Major T, Sulyok Z, Kásler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108:197–202." href=#ref-CR13 id=ref-link-section-d10423035e1536>13</a>].<p>Results from the randomized phase III noninferiority-trial on interstitial multicatheter brachytherapy conducted by the GEC-ESTRO group have been published recently [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387:229–38." href=#ref-CR14 id=ref-link-section-d10423035e1542>14</a>]. Between 2004 and 2009, 1184 patients were randomized to APBI with with multicatheter brachytherapy or percutaneous WBI of 50&nbsp;Gy in 2&nbsp;Gy fractions with a sequential boost of 10&nbsp;Gy. The primary endpoint was ipsilateral local recurrence. The non-inferiority-margin was set at a difference of 3% at 5&nbsp;years. At the time of analysis 14 patients had developed a local recurrence at the 5&nbsp;year-follow up. This corresponded to a 5-year local recurrence rate of 0.9% for EBRT and 1.4% for APBI as sole RT modality (<i>p</i> = 0.42). Overall survival was 95.6% for EBRT and 97.3% for APBI (<i>p</i> = 0.11). Adverse events occurred less frequently in the APBI-arm, however statistical significance was only reached for breast pain, which occurred in 3.2% after EBRT and 1.1% after APBI (<i>p</i> = 0.04). Detailed results on late effects and cosmetic outcome were not yet reported.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec4>Intraoperative radiotherapy (IORT)</h4><p>The TARGIT A-trial tested the approach of intraoperative radiotherapy to the lumpectomy cavity using a 50&nbsp;kV-device with a spherical applicator [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13." href=#ref-CR15 id=ref-link-section-d10423035e1563>15</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91–102." href=#ref-CR16 id=ref-link-section-d10423035e1566>16</a>]. Patients were randomized to WBI with or without a tumor bed boost according to local standards or to IORT with a dose of 20&nbsp;Gy. However, additional WBI was mandated in the case of additional risk factors identified in the pathologic work-up of the surgical specimen which was the case for about 15% of patients in the IORT-arm. TARGIT A was planned as a non-inferiority-trial with a margin of 2.5% at 5&nbsp;years. After the first results were published in 2010 with the planned trial cohort size of 2232 patients, recruitment was continued until 2012 with a total size of 3451 patients. The trial protocol was amended in 2004 to allow inclusion of patients in which IORT was administered during a second surgical procedure by reopening the wound (post-pathology-stratum).<p>The most recent results were published in 2014 with a median follow up of 29&nbsp;months [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13." href=#ref-CR15 id=ref-link-section-d10423035e1572>15</a>]. 1222 of the patients included in this analysis had a median follow up of 5&nbsp;years. Results showed an estimated 5-year local recurrence rate of 3.3% with IORT and 1.3% with WBI (<i>p</i> = 0.043). This difference was not statistically significant due to adjustment for multiple testing. Furthermore, non-inferiority was established for the whole cohort, but not for the post-pathology stratum which showed a 5-year local recurrence rate of 5.4% with IORT and 1.7% with WBI (<i>p</i> = 0.067). The 5-year non-breast cancer-related mortality was higher in the WBI-group (3.5% vs. 1.4%, <i>p</i> = 0.089). A recently published report provided further details on subgroup analyses and other endpoints [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Saunders C, et al. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). Health Technol Assess. 2016;20:1–188." href=#ref-CR17 id=ref-link-section-d10423035e1584>17</a>]. Tumors without expression of the progesterone receptor had a significantly increased risk of local recurrence in the overall cohort and in the IORT-arm. A multivariate analysis showed that non-inferiority could not be established in the absence of estrogen and/or progesterone receptor expression. The risk of recurrence outside of the index quadrant or the axilla was not elevated in patients in the IORT-arm as compared to patients in the EBRT-arm.<p>The publication of this trial evoked an unprecedented discussion around the results of this trial in the Lancet and in the Red Journal with criticism circling mainly around the short overall follow up and the statistical design [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Zietman A. Letters Regarding the TARGIT-A Trial: The Editor’s Introduction. Int J Radiat Oncol Biol Phys. 2015;92:951–2." href=#ref-CR7 id=ref-link-section-d10423035e1590>7</a>].<p>The second randomized phase III-trial on intraoperative radiotherapy was the ELIOT-study, a single-institutional trial using electrons (IOERT) instead of KV-x-rays [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77." href=#ref-CR18 id=ref-link-section-d10423035e1596>18</a>]. From 2000 to 2007, 1307 patients were enrolled at the European Institute of Oncology in Milan, Italy. The study was designed as an equivalence trial assuming a 5-year local recurrence rate of 3% in the WBI group with an accepted non-inferiority margin of 4.5%. The 5-year ipsilateral breast tumor recurrence rate, although within the prespecified equivalence margin, was significantly higher in the IOERT-arm with 4.4% compared to 0.4% in the WBI-arm (<i>p</i> &lt; 0.001). The risk of recurrence was not only elevated in other breast quadrants but also within the index quadrant and regional lymph nodes. There was no difference in distant recurrence or survival. The ELIOT trial provided detailed information about risk factors for local tumor recurrence in the IOERT group. Pathologic tumor size, grading, estrogen receptor status, Ki-67 and molecular subtype were significant predictors of an increased local recurrence rate. In the absence of adverse prognostic factors, the local recurrence rate was 1.1% in patients treated with IOERT. Adverse events occurred less frequently with IOERT with the exception of fat necrosis.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec5>External-beam radiotherapy</h4><p>Interim results from the phase III randomized RAPID-trial suggested that APBI with 3D-conformal EBRT might be associated with inferior cosmesis and an elevated risk of grade 1–2 adverse events [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Olivotto IA, Whelan TJ, Parpia S, Kim D-H, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31:4038–45." href=#ref-CR19 id=ref-link-section-d10423035e1610>19</a>]. While an interrelation with dosimetric parameters as well as the fractionation scheme of 38.5&nbsp;Gy in 10 fractions over one week was suspected, a follow up-publication failed to identify treatment-associated predictors of adverse cosmesis in the APBI-group [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Peterson D, Truong PT, Parpia S, Olivotto IA, Berrang T, Kim D-H, et al. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis. Int J Radiat Oncol Biol Phys. 2015;91:968–76." href=#ref-CR20 id=ref-link-section-d10423035e1613>20</a>].<p>Livi et al. conducted a randomized phase III-trial using intensity-modulated radiotherapy (IMRT) for APBI at the University of Florence [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63." href=#ref-CR21 id=ref-link-section-d10423035e1619>21</a>]. The trial was designed to detect an 2%-increase in the local recurrence-rate at 5&nbsp;years from 3% in the standard arm to 5% in the APBI arm. From 2005 to 2013, 520 women were enrolled and randomized to 50&nbsp;Gy of WBI followed by a boost of 10&nbsp;Gy or to 30&nbsp;Gy of APBI in 6 fractions over 2&nbsp;weeks delivered as IMRT. The clinical target volume for APBI contained the surgical clip as determined by at least 4 clips placed during surgery and an additional margin of 1&nbsp;cm. The 5&nbsp;year-local recurrence rate was 1.5% in patients receiving APBI and 1.4% in patients receiving standard treatment (<i>p</i> = 0.86). Toxicity and cosmesis were significantly in favor of the APBI-arm.<p>At the 10<sup>th</sup> European Breast Cancer Conference held in Amsterdam in April 2016, preliminary results from the IMPORT LOW-trial were presented [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Coles C, Agrawal R, Ah-See ML, Algurafi H. Partial breast radiotherapy for women with early breast cancer: First results of local recurrence data for IMPORT LOW (CRUK/06/003). Eur J Cancer. 2016;57 Supplement 2:S1–S8." href=#ref-CR22 id=ref-link-section-d10423035e1630>22</a>]. This 3-arm randomized phase III trial compared hypofractionated WBI (40.05&nbsp;Gy in 15 fractions, arm A) to hypofractionated WBI with a lower dose to the breast tissue outside of the tumor bed (40.05&nbsp;Gy to the tumor bed delivered as a simultaneous integrated boost, 36&nbsp;Gy to the remaining breast tissue in 15 fractions, arm B) and APBI to the tumor bed (40.05&nbsp;Gy in 15 fractions, arm C). 2018 patients were recruited. 5-year local recurrence rates were 1.1% for arm A, 0.2% for arm B and 0.5% for arm C. Non-inferiority was demonstrated for the experimental arms B and C (pre-defined threshold 2.5%, one-sided alpha 2.5%).<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec6>Conclusions of the <b>DEGRO</b> expert panel</h4>
 <ul class=u-list-style-bullet>
 <li>
 <p>APBI is feasible and provides excellent results regarding toxicity and local control in selected low risk-patients.</p>
 </li>
 <li>
 <p>Although non-inferiority was established in the TARGIT A- and ELIOT-trial, there are some methodologic issues in the design of those trials including the additional use of EBRT, different timing in the IORT application and the choice of the non-inferiority margin.</p>
 </li>
 <li>
 <p>APBI using EBRT should be applied with caution until the results of phase III trials such as NSABP B-39/RTOG 0413, RAPID and IMPORT LOW are published.</p>
 </li>
 <li>
 <p>Multicatheter brachytherapy remains the only modality for which 10-year data are available.</p>
 </li>
 <li>
 <p>A meta-analysis including 4.489 patients from several of the above mentioned trials demonstrated that overall mortality is not increased with APBI [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 23" title="Vaidya JS, Bulsara M, Wenz F, Coombs N, Singer J, Ebbs S, et al. Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65." href=#ref-CR23 id=ref-link-section-d10423035e1675>23</a>].</p>
 </li>
 <li>
 <p>Long term follow up is needed to determine the impact of APBI on survival, the risk of late recurrences, adverse events as well as cosmetic results.</p>
 </li>
 </ul>
 <h3 class=c-article__sub-heading id=Sec7>Radiotherapy of the lymphatic pathways in early stage breast cancer</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec8>Sentinel lymph node metastases</h4><p>Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node dissection (ALND) as the standard of care for surgical staging of the axilla in patients with clinically unsuspicious lymph nodes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365–83." href=#ref-CR24 id=ref-link-section-d10423035e1701>24</a>].<p>Controversy exists regarding the optimal treatment of alleged low risk patients with 1–2 positive sentinel lymph nodes. The ACOSOG Z0011 trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 25" title="Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32." href=#ref-CR25 id=ref-link-section-d10423035e1707>25</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 26" title="Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75." href=#ref-CR26 id=ref-link-section-d10423035e1710>26</a>] randomly assigned 891 patients with T1-2 breast cancer with sentinel lymph node metastases after breast-conserving surgery to ALND or no further axillary surgery. All patients were supposed to undergo standard tangential WBI without irradiation of the supra-/infraclavicular region (SCN). The trial was designed as a non-inferiority trial but was closed early due to slow recruitment and low event rates. Overall, 40% patients had micrometastases and 27% of patients in the ALND-arm had additional non-sentinel lymph node metastases. The 10-year results were recently presented at the 2016 ASCO annual meeting and published [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 27" title="Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264:413–20." href=#ref-CR27 id=ref-link-section-d10423035e1713>27</a>]. Regional nodal recurrence rates were low at 0.5% and 1.5% in the ALND- and SLNB-arms, respectively (<i>p</i> = 0.28). There were no significant differences in disease-free or overall survival. However, a retrospective analysis of the available radiation treatment records revealed that there was a significant number of protocol violations regarding radiotherapy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 28" title="Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol. 2014;32:3600–6." href=#ref-CR28 id=ref-link-section-d10423035e1719>28</a>]. 18.9% of the reviewed patients received radiotherapy to the SCN and more than half of the patients were treated using high tangents known to be associated with a higher radiation dose exposure to axillary lymph node levels I and II compared to conventional tangential irradiation. Protocol violations were equally distributed between the two treatment arms, but it cannot be excluded that RNI contributed to the favorable outcome in the SLNB-arm [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 29" title="Nitsche M, Temme N, Förster M, Reible M, Hermann RM. Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study. Strahlenther Onkol. 2014;190:715–21." href=#ref-CR29 id=ref-link-section-d10423035e1723>29</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 30" title="Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. How nescience may obscure evidence. Strahlenther Onkol. 2014;190:861–3." href=#ref-CR30 id=ref-link-section-d10423035e1726>30</a>].<p>The AMAROS-trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 31" title="Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–10." href=#ref-CR31 id=ref-link-section-d10423035e1732>31</a>] conducted by the EORTC addressed a similar patient group as Z0011 (cT1-2 cN0 with sentinel lymph node metastases), however patients with mastectomy were also eligible. 1425 patients were randomly assigned to ALND or radiotherapy to axillary lymph node levels I-III and the SCN. As the event rate was lower than expected, the non-inferiority test for the primary endpoint, the axillary recurrence rate, was underpowered. Yet, axillary recurrence rates at 5&nbsp;years were low at 0.4% and 1.2% without any differences in disease-free and overall survival. Axillary morbidity was significantly higher in the ALND-arm with lymphedema rates being almost twice as high as in patients treated without ALND.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec61>Conclusions of the <b>DEGRO</b> expert panel</h4>
 <ul class=u-list-style-bullet>
 <li>
 <p>There is no clear standard for the treatment of patients with 1–2 sentinel lymph node metastases. It remains uncertain in which patients ALND and RNI including the axilla can safely be omitted.</p>
 </li>
 <li>
 <p>Since radiotherapy to the axilla and the SCN yields similar regional recurrence rate and survival compared to axillary dissection while the associated morbidity is reduced, it should always be considered when treatment of the axilla seems indicated.</p>
 </li>
 </ul>
 <h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec9>Recent results on radiotherapy of the lymphatic pathways</h4><p>Several trials on RNI in early stage breast cancer were recently published [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 32" title="Sautter-Bihl M-L, Sedlmayer F. Radiotherapy of the Lymphatic Pathways in Early Breast Cancer. Breast Care. 2015;10:254–8." href=#ref-CR32 id=ref-link-section-d10423035e1770>32</a>]. Design and results of those trials are summarized in Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>.<div class=c-article-table data-test=inline-table data-container-section=table id=table-2><figure><figcaption class=c-article-table__figcaption><b id=Tab2 data-test=table-caption>Table 2 Recent clinical trials studying regional nodal irradiation in breast cancer</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://ro-journal.biomedcentral.com/articles/10.1186/s13014-017-0766-3/tables/2 aria-label="Full size table 2"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-chevron-right></use></svg></a></div></figure></div>
 <p>Generally, two types of trials can be distinguished, those comparing the addition of RNI including the SCN and the internal mammary lymph nodes (IMN) to whole breast or chest wall irradiation to either one alone or those trials addressing treatment of the whole breast or chest wall and the SCN with or without irradiation of the IMN.<p>The MA.20-[<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015;373:307–16." href=#ref-CR10 id=ref-link-section-d10423035e2243>10</a>] and the EORTC 22922/10925-[<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015;373:317–27." href=#ref-CR9 id=ref-link-section-d10423035e2246>9</a>] trials belong to the first category. Both trials enrolled mostly patients with 0–3 involved lymph nodes. However, there were several notable differences in the inclusion criteria. While the MA.20-trial only recruited patients after breast-conserving surgery, 24% of patients in the EORTC-trial had undergone mastectomy. Node negative patients were included in both trials, however the EORTC-trial defined medial/central tumor location as a prerequisite for eligibility in these patients whereas the MA.20-trial used a combination of tumor size, number of removed lymph nodes and other risk factors. Hence, the MA.20-trial included only 10% node negative patients while 44% of the study population in the EORTC-trial did not have nodal involvement. Furthermore, there were differences in the radiation technique [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol. 2014;190:342–51." href=#ref-CR3 id=ref-link-section-d10423035e2249>3</a>]. Both trials did show significant improvements in locoregional control, distant-metastasis-free survival and disease-free survival. Interestingly, the improvement in distant metastasis-free survival exceeded the improvement in locoregional control, suggesting that RNI could prevent distant spread [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol. 2014;190:342–51." href=#ref-CR3 id=ref-link-section-d10423035e2252>3</a>]. Concerning the primary endpoint overall survival, the EORTC-trial was of significance after adjustment for stratification factors (hazard ratio (HR) 0.87, <i>p</i> = 0.0496) whereas the MA.20-investigators concluded that there was no significant improvement in overall survival.<p>While a meta-analysis of both trials [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 33" title="Budach W, Kammers K, Boelke E, Matuschek C. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials. Radiat Oncol. 2013;8:267." href=#ref-CR33 id=ref-link-section-d10423035e2261>33</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 34" title="Budach W, Bölke E, Kammers K, Gerber PA, Nestle-Krämling C, Matuschek C. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta- analysis of randomized trials- an update. Radiat Oncol. 2015;10:1–7." href=#ref-CR34 id=ref-link-section-d10423035e2264>34</a>] showed a significant improvement in overall survival (HR 0.88, <i>p</i> = 0.034), subgroup analyses did not yield consistent results on which patient subgroup might benefit most from RNI. In MA.20, the overall survival benefit was most pronounced in estrogen receptor-negative patients (HR 0.69, <i>p</i> = 0.05) whereas in the EORTC-trial, this was true for patients who did receive both endocrine and chemotherapy (HR 0.72). These discrepancies might be related to the differences in inclusion criteria regarding type of surgery and node-negative patients (see Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a>).<p>The DBCG-IMN [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 35" title="Thorsen LBJ, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016;34:314–20." href=#ref-CR35 id=ref-link-section-d10423035e2280>35</a>] and the French trial by Hennequin et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois J-B, Datchary J, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86:860–6." href=#ref-CR36 id=ref-link-section-d10423035e2283>36</a>] belong to the second category of clinical trials in RNI that specifically addressed the benefit of targeting the IMN-area in RNI. The study of Hennequin et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 36" title="Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois J-B, Datchary J, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86:860–6." href=#ref-CR36 id=ref-link-section-d10423035e2286>36</a>] is the oldest one of the four mentioned trials. It was designed to detect a 10% benefit in overall survival in the patients treated with RNI including IMN and was thus underpowered to show a difference between the two treatment arms. The DBCG-IMN trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 35" title="Thorsen LBJ, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016;34:314–20." href=#ref-CR35 id=ref-link-section-d10423035e2289>35</a>] is a prospective cohort study, but was meticiously planned and executed. In patients with right sided breast cancer, the internal mammary region was included into the radiotherapy target volume, whereas in left sided breast cancer patients this region was not treated due to concerns regarding cardiac toxicity. The 8-year overall survival rates were 75.9% with IMN-RT versus 72.2% without IMN-RT (HR 0.82, <i>p</i> = 0.005). Subgroup analyses suggested that patients with 1–3 involved lymph nodes in the case of medial/central tumor location and patients with 4 or more involved lymph nodes irrespective of the tumor location did derive the largest benefit [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 35" title="Thorsen LBJ, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016;34:314–20." href=#ref-CR35 id=ref-link-section-d10423035e2296>35</a>].<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec10>Conclusions of the <b>DEGRO</b> expert panel</h4>
 <ul class=u-list-style-bullet>
 <li>
 <p>RNI improves the outcome of patients with early stage breast cancer with locoregional lymph node involvement.</p>
 </li>
 <li>
 <p>In patients with 1–3 involved lymph nodes, RNI should be strongly considered, especially in the presence of further risk factors such as negative estrogen or progesterone receptor, poorly differentiated tumors, medial tumor location and premenopausal status.</p>
 </li>
 <li>
 <p>In patients with &gt;3 involved lymph nodes, RNI should be regarded as mandatory.</p>
 </li>
 <li>
 <p>Irradiation of the IMN should be strongly considered in all patients in whom RNI is performed.</p>
 </li>
 <li>
 <p>Currently, due to the differing inclusion criteria for node negative patients in the MA.20- and the EORTC-trials, the optimal selection criteria for RNI in this subgroup remain unclear. However, it can be discussed on a case by case-basis in patients with the above-mentioned risk factors.</p>
 </li>
 <li>
 <p>Additional toxicity associated with RNI was mild and none of the mentioned trials showed an increase in cardiac morbidity or mortality, although further follow-up is necessary regarding this endpoint.</p>
 </li>
 </ul>
 <h3 class=c-article__sub-heading id=Sec11>Ductal carcinoma in situ (DCIS)</h3><p>The effect of adjuvant radiotherapy on local recurrence of DCIS after breast-conserving surgery has been established by 4 randomized controlled phase III trials and a meta-analysis of those trials by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 37" title="Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast. JNCI Monographs. 2010;2010:162–77." href=#ref-CR37 id=ref-link-section-d10423035e2360>37</a>].<p>Several recent publications have shed light on the prognosis and treatment of patients with DCIS. Using data from the Surveillance, Epidemiology and End Results (SEER) registry, Narod et al. investigated the prognosis of more than 108000 women with DCIS diagnosed between 1988 and 2011 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1:888–9." href=#ref-CR38 id=ref-link-section-d10423035e2366>38</a>]. The 20&nbsp;year-breast cancer-specific mortality was 3.3% overall, but increased to 7.8% for women diagnosed before age 35&nbsp;years. For women with an ipsilateral invasive recurrence, the relative risk for dying of breast cancer was elevated 18-fold. Radiotherapy did significantly reduce ipsilateral invasive and non-invasive recurrences, but 10-year breast cancer-specific mortality was similar with and without adjuvant radiotherapy.<p>Another study from the SEER-registry by Sagara et al. used the patient prognostic score developed by Smith et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 39" title="Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2006;65:1397–403." href=#ref-CR39 id=ref-link-section-d10423035e2372>39</a>] to assess the benefit of adjuvant radiotherapy according to different clinical and pathologic factors [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 40" title="Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, et al. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study. J Clin Oncol. 2016;34:1190–6." href=#ref-CR40 id=ref-link-section-d10423035e2375>40</a>]. Using the patient age (&lt;40&nbsp;years, 40–60 years, &gt;60&nbsp;years), tumor size (&lt;16&nbsp;mm, 16–40&nbsp;mm, &gt; 40&nbsp;mm) and grading (low, intermediate, high), more than 32000 patients were assigned a score from 0 to 6. The investigators used propensity score-corrections to account for imbalances in baseline characteristics. Although breast cancer-specific mortality was similar to the analysis by Narod et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 38" title="Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1:888–9." href=#ref-CR38 id=ref-link-section-d10423035e2378>38</a>], Sagara et al. could show a small but statistically significant benefit in the 10&nbsp;year breast cancer-specific mortality for patients who received adjuvant radiotherapy. The benefit in terms of breast cancer-specific mortality and overall mortality was highly dependent on the patient prognostic score. Patients with higher scores derived the largest benefit from radiotherapy with absolute improvements in 10&nbsp;year-breast cancer-specific mortality of 1.9% and 4% in patients with a score of 4 and 5, respectively. While these results suggest that it might be possible to use the patient prognostic score to guide the decision making-process for adjuvant radiotherapy, caution is advised because information on several important factors such as margin status, endocrine therapy and comorbidities were lacking.<p>Due to the advances in diagnosis and treatment of DCIS as well as declining rates of local recurrence [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 41" title="Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol. 2015;22:3273–81." href=#ref-CR41 id=ref-link-section-d10423035e2384>41</a>], the role of adjuvant radiotherapy has been questioned. Several groups have tried to establish a definition of a low risk-group of patients in which adjuvant radiotherapy after breast-conserving surgery could safely be omitted using clinical, pathological and molecular parameters. However there is no consensus on which factors should be used (for review see [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 42" title="Krug D, Souchon R. Radiotherapy of Ductal Carcinoma In Situ. Breast Care. 2015;10:259–64." href=#ref-CR42 id=ref-link-section-d10423035e2387>42</a>]).<p>The ECOG-ACRIN E5194-trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 43" title="Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, et al. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study. J Clin Oncol. 2015;33:3938–44." href=#ref-CR43 id=ref-link-section-d10423035e2394>43</a>] prospectively assessed the outcome of patients with DCIS after breast-conserving surgery without adjuvant radiotherapy. Patients were eligible if they had well or moderately differentiated DCIS ≤ 2.5&nbsp;cm (cohort 1) or poorly differentiated DCIS ≤ 1&nbsp;cm (cohort 2) with clear margins (≥3&nbsp;mm). Although median tumor size was only 6&nbsp;mm and 7&nbsp;mm in the two cohorts with wide negative margins for most patients, the 12&nbsp;year-local recurrence rates were 14.4% and 24.6%, respectively. The 12&nbsp;year-invasive recurrence rates reached 7.5% and 13.4%, respectively.<p>The only randomized phase III trial specifically studying the benefit of adjuvant radiotherapy in a prospectively defined „low risk“&nbsp;population is the RTOG 9804-trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 44" title="McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15." href=#ref-CR44 id=ref-link-section-d10423035e2400>44</a>]. Women with well or moderately differentiated DCIS with a tumor size of ≤ 2.5&nbsp;cm were randomly assigned to adjuvant WBI or no radiotherapy after lumpectomy with clear margins. The 7-year local recurrence rate was 0.9% with and 6.7% without adjuvant radiotherapy (<i>p</i> &lt; 0.001, HR 0.11). 42% of local failures in the observation arm were invasive recurrences. The rate of contralateral invasive breast cancer (4% at 7&nbsp;years) was considerably lower than the rate of ipsilateral local failure after radiotherapy, suggesting that radiotherapy could prevent secondary tumors [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 45" title="Pahl R, Dunst J. Adjuvant radiotherapy significantly also reduces local recurrence rate for prognostically favorable DCIS. Strahlenther Onkol. 2015;191:997–1000." href=#ref-CR45 id=ref-link-section-d10423035e2406>45</a>]. Toxicity associated with radiotherapy was generally low.<p>There are several ongoing clinical trials addressing active surveillance [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 46" title="Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer. 2015;51:1497–510." href=#ref-CR46 id=ref-link-section-d10423035e2412>46</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 47" title="Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303." href=#ref-CR47 id=ref-link-section-d10423035e2415>47</a>] or chemoprevention (e.g. CALGB 40903, ClinicalTrials.gov number, NCT01439711) strategies in screening-detected biopsy-proven low or intermediate DCIS. However, this is an experimental approach and should not be chosen outside of clinical trials [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 48" title="Merrill AL, Esserman L, Morrow MCLINICALDECISIONS. Ductal Carcinoma In Situ. N Engl J Med. 2016;374:390–2." href=#ref-CR48 id=ref-link-section-d10423035e2418>48</a>]. A recent retrospective cohort study showed that 20% of patients matching the inclusion criteria for the LORIS-trial [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 47" title="Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303." href=#ref-CR47 id=ref-link-section-d10423035e2421>47</a>] after biopsy had invasive carcinoma on final pathology after surgery and 18% of those patients received a recommendation for adjuvant chemotherapy [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 49" title="Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow M. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? Ann Surg Oncol. 2016;23:3487–93." href=#ref-CR49 id=ref-link-section-d10423035e2424>49</a>].<p>A systematic review and meta-analysis by Nilsson et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 50" title="Nilsson C, Valachis A. The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies. Radiother Oncol. 2015;114:50–5." href=#ref-CR50 id=ref-link-section-d10423035e2430>50</a>] summarizes the current evidence on hypofractionation and boost radiotherapy for DCIS. Results suggested that moderately hypofractionated radiotherapy (40–42&nbsp;Gy in 15–16 fractions) is safe with a non-significant trend towards an improvement in local control compared to conventionally fractionated radiotherapy (odds ratio 0.78, <i>p</i> = 0.08). There was a benefit of a tumor bed boost in patients with positive margins (odds ratio 0.56, <i>p</i> = 0.01). The evidence was mostly limited to small single-institutional retrospective studies with a suboptimal quality of evidence.<p>A recent multicenter retrospective study presented at the 2016 annual meeting of the American Society for Radiation Oncology included 4131 patients with DCIS [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 51" title="Moran MS, Zhao S, Ma S, Kirova YM. Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions. Int J Radiat Oncol Biol Phys. 2016;96:S144." href=#ref-CR51 id=ref-link-section-d10423035e2442>51</a>].<p>Two thousand six hundred sixty-one patients received a boost to the tumor bed with a median dose of 14&nbsp;Gy. Local control at 15&nbsp;years was significantly better in patients receiving a boost (91.6% vs. 88.0%, <i>p</i> = 0.013). Patients with positive margins had no significant benefit, however the subgroup was small with limited statistical power.<p>Two randomized controlled trials, the TROG 07.01 trial (NCT00470236) and the Bonbis trial (NCT00907868), studying the role of a boost irradiation in patients with DCIS have finished patient recruitment. The TROG 07.01 trial additionally addresses hypofractionation compared to standard fractionation in a 2x2 trial design.<p>A discussion of adjuvant radiotherapy in patients with DCIS should always include consideration of possible late effects of radiotherapy. Cardiotoxicity of adjuvant radiotherapy has been shown to be of relevance especially in patients with left-sided tumor location [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 52" title="Duma MN, Molls M, Trott KR. From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy. Strahlenther Onkol. 2014;190:5–7." href=#ref-CR52 id=ref-link-section-d10423035e2458>52</a>]. There is a clear dose–response relationship [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 53" title="Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. N Engl J Med. 2013;368:987–98." href=#ref-CR53 id=ref-link-section-d10423035e2461>53</a>]. Thus, modern radiotherapy techniques to reduce cardiac radiation doses such as deep inspiration breath hold [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 54" title="Hepp R, Ammerpohl M, Morgenstern C, Nielinger L, Erichsen P, Abdallah A, et al. Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients. Strahlenther Onkol. 2015;191:710–6." href=#ref-CR54 id=ref-link-section-d10423035e2464>54</a>] are of great importance to reduce long term morbidity. Other possible severe late sequelae of radiotherapy include secondary malignancies. Although rare, the risk of secondary malignancies is significantly elevated after radiotherapy for breast cancer. This includes the risk for subsequent lung cancer, esophageal cancer and sarcoma [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 55" title="Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114:56–65." href=#ref-CR55 id=ref-link-section-d10423035e2467>55</a>]. Smokers should be counseled regarding their elevated risk for both cardiac events and secondary lung cancer after radiotherapy.<h4 class="c-article__sub-heading c-article__sub-heading--small" id=Sec12>Conclusions of the <b>DEGRO</b> expert panel</h4>
 <ul class=u-list-style-bullet>
 <li>
 <p>Clinical and pathological factors can help to select patients at lower risk of local recurrence, however there is no uniform definition of a low risk-phenotype.</p>
 </li>
 <li>
 <p>Local recurrence rates show no plateau after 10&nbsp;years of follow up in patients not undergoing radiotherapy.</p>
 </li>
 <li>
 <p>Radiotherapy significantly lowers ipsilateral invasive and non-invasive recurrences of DCIS after breast-conserving surgery.</p>
 </li>
 <li>
 <p>Patients with high-risk DCIS derive the highest absolute benefit from adjuvant radiotherapy.</p>
 </li>
 <li>
 <p>Although both invasive and non-invasive recurrences are significantly reduced by radiotherapy, there is no survival benefit.</p>
 </li>
 <li>
 <p>Patients should be informed about the beneficial effects and low toxicity of radiotherapy with optimal local control even in screening-detected DCIS.</p>
 </li>
 <li>
 <p>The rate of contralateral invasive breast cancer is considerably lower than the rate of ipsilateral local failure after radiotherapy, suggesting that radiotherapy could prevent secondary tumors.</p>
 </li>
 <li>
 <p>The role of boost radiotherapy and hypofractionation is currently unclear, however results from two prospective randomized controlled trials are pending.</p>
 </li>
 <li>
 <p>In clinical practice, individual risk factors as well as patient preferences, comorbidities and potential side effects should be carefully weighed against each other in the decision-making process concerning adjuvant radiotherapy.</p>
 </li>
 </ul>
 <h3 class=c-article__sub-heading id=Sec13>Conclusions and future challenges</h3><p>The treatment of breast cancer is a poster child of how multidisciplinary management can improve the outcome of an oncologic disease. Using data from the National Vital Statistics Reports and the SEER-database, Smith et al. could show that from 1990 to 2007, the breast cancer death rate decreased about 2% per year [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 56" title="Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, et al. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol. 2011;29:4647–53." href=#ref-CR56 id=ref-link-section-d10423035e2548>56</a>]. The 10&nbsp;year-breast cancer specific death rate decreased from 29.6% to 20.1% for women treated from 1980–1984 compared to women treated from 1995–1997 (<i>p</i> &lt; 0.001) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 56" title="Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, et al. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol. 2011;29:4647–53." href=#ref-CR56 id=ref-link-section-d10423035e2554>56</a>].<p>With improving outcomes, better risk stratification and patient selection for specific treatment approaches, the benefit achieved by individual treatment modalities tends to decrease. Thus, an individual treatment might provide a high relative benefit, but with decreasing absolute benefit and increasing number needed to treat, effects on morbidity and non-breast cancer related mortality gain increasing importance.<p>The basic goal to optimize treatment outcome may involve different approaches and goals depending on the specific risk-constellation of the disease. While in DCIS and low risk-early stage breast cancer, it may be justified to attempt de-escalation of treatment in order to limit morbidity and preserve quality of life, the contrary i.e. escalation of locoregional (radio-) therapy is indicated in node-positive breast cancer bearing a significant risk of breast cancer-related mortality. Finding the optimal combination of treatment approaches for achieving cure while simultaneously balancing effectiveness against morbidity requires individualization according to the individual risk, comorbidities and personal preferences of the patient. These purposes are most likely achieved by a multidisciplinary approach based on best available evidence.</p></div></div></section>
 <section data-title=Abbreviations><div class=c-article-section id=abbreviations-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=abbreviations>Abbreviations</h2><div class=c-article-section__content id=abbreviations-content><dl class=c-abbreviation_list><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>APBI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>accelerated partial breast irradiation</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>CI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>confidence interval</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>DCIS:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>ductal carcinoma in situ</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>DEGRO:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>German Society of Radiation Oncology</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>EBCTCG:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Early Breast Cancer Trialists’ Collaborative Group</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>EBRT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>external beam radiotherapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>ECOG-ACRIN:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Eastern Cooperative Oncology Group (ECOG) and American College of Radiology Imaging Network</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>GEC-ESTRO:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Groupe Européen de Curiethérapie and European Society for Radiotherapy &amp; Oncology</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>HDR:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>High dose rate</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>HR:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Hazard ratio</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>IDC:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Invasive ductal carcinoma</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>ILC:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Invasive lobular carcinoma</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>IMN:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Internal mammary lymph nodes</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>IOERT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Intraoperative electron radiotherapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>IORT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Intraoperative radiotherapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>PDR:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Pulsed dose rate</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>RTOG:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Radiation Therapy Oncology Group</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>SCV:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Supra-/infraclavicular region</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>SEER:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Surveillance, Epidemiology and End Results</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>TARGIT:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Targeted intraoperative radiotherapy</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>TROG:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Trans Tasman Radiation Oncology Group</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>TWI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Thoracic wall irradiation</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style=min-width:50px><dfn>WBI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Whole-breast irradiation</p>
 </dl></div></div></section><div id=MagazineFulltextArticleBodySuffix><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references data-track-component="outbound reference"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=1.><p class=c-article-references__text id=ref-CR1>Budach W, Matuschek C, Bölke E, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol. 2015;191:623–33.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-015-0843-1 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-015-0843-1 aria-label="Article reference 1" data-doi=10.1007/s00066-015-0843-1>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25963557" aria-label="PubMed reference 1">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516860 aria-label="PubMed Central reference 1">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%20for%20radiotherapy%20of%20breast%20cancer%20V%3A%20Therapy%20for%20locally%20advanced%20and%20inflammatory%20breast%20cancer%2C%20as%20well%20as%20local%20therapy%20in%20cases%20with%20synchronous%20distant%20metastases&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-015-0843-1&amp;volume=191&amp;pages=623-33&amp;publication_year=2015&amp;author=Budach%2CW&amp;author=Matuschek%2CC&amp;author=B%C3%B6lke%2CE&amp;author=Dunst%2CJ&amp;author=Feyer%2CP&amp;author=Fietkau%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=2.><p class=c-article-references__text id=ref-CR2>Harms W, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol. 2016;192:199–208.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-015-0939-7 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-015-0939-7 aria-label="Article reference 2" data-doi=10.1007/s00066-015-0939-7>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26931319" aria-label="PubMed reference 2">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833793 aria-label="PubMed Central reference 2">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%20for%20radiotherapy%20of%20breast%20cancer%20VI%3A%20therapy%20of%20locoregional%20breast%20cancer%20recurrences&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-015-0939-7&amp;volume=192&amp;pages=199-208&amp;publication_year=2016&amp;author=Harms%2CW&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Feyer%2CP&amp;author=Fietkau%2CR&amp;author=Haase%2CW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=3.><p class=c-article-references__text id=ref-CR3>Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol. 2014;190:342–51.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-013-0543-7 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-013-0543-7 aria-label="Article reference 3" data-doi=10.1007/s00066-013-0543-7>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24638236" aria-label="PubMed reference 3">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%3A%20radiotherapy%20of%20breast%20cancer%20III%E2%80%94radiotherapy%20of%20the%20lymphatic%20pathways&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-013-0543-7&amp;volume=190&amp;pages=342-51&amp;publication_year=2014&amp;author=Sautter-Bihl%2CML&amp;author=Sedlmayer%2CF&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Feyer%2CP&amp;author=Fietkau%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=4.><p class=c-article-references__text id=ref-CR4>Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P, et al. DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol. 2013;189:825–33.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-013-0437-8 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-013-0437-8 aria-label="Article reference 4" data-doi=10.1007/s00066-013-0437-8>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BC3sbltVerug%3D%3D aria-label="CAS reference 4">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24002382" aria-label="PubMed reference 4">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825416 aria-label="PubMed Central reference 4">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%3A%20radiotherapy%20of%20breast%20cancer%20I%3A%20radiotherapy%20following%20breast%20conserving%20therapy%20for%20invasive%20breast%20cancer&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-013-0437-8&amp;volume=189&amp;pages=825-33&amp;publication_year=2013&amp;author=Sedlmayer%2CF&amp;author=Sautter-Bihl%2CML&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Fastner%2CG&amp;author=Feyer%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=5.><p class=c-article-references__text id=ref-CR5>Souchon R, Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, et al. DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast. Strahlenther Onkol. 2014;190:8–16.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-013-0502-3 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-013-0502-3 aria-label="Article reference 5" data-doi=10.1007/s00066-013-0502-3>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BC2c3js1Chuw%3D%3D aria-label="CAS reference 5">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24306068" aria-label="PubMed reference 5">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%3A%20radiotherapy%20of%20breast%20cancer%20II%3A%20radiotherapy%20of%20non-invasive%20neoplasia%20of%20the%20breast&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-013-0502-3&amp;volume=190&amp;pages=8-16&amp;publication_year=2014&amp;author=Souchon%2CR&amp;author=Sautter-Bihl%2CML&amp;author=Sedlmayer%2CF&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Feyer%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=6.><p class=c-article-references__text id=ref-CR6>Wenz F, Sperk E, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol. 2014;190:705–14.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-014-0687-0 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-014-0687-0 aria-label="Article reference 6" data-doi=10.1007/s00066-014-0687-0>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24888511" aria-label="PubMed reference 6">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=DEGRO%20practical%20guidelines%20for%20radiotherapy%20of%20breast%20cancer%20IV%3A%20radiotherapy%20following%20mastectomy%20for%20invasive%20breast%20cancer&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-014-0687-0&amp;volume=190&amp;pages=705-14&amp;publication_year=2014&amp;author=Wenz%2CF&amp;author=Sperk%2CE&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Feyer%2CP&amp;author=Fietkau%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=7.><p class=c-article-references__text id=ref-CR7>Zietman A. Letters Regarding the TARGIT-A Trial: The Editor’s Introduction. Int J Radiat Oncol Biol Phys. 2015;92:951–2.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2015.05.048 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2015.05.048 aria-label="Article reference 7" data-doi=10.1016/j.ijrobp.2015.05.048>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26194661" aria-label="PubMed reference 7">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Letters%20Regarding%20the%20TARGIT-A%20Trial%3A%20The%20Editor%E2%80%99s%20Introduction&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2015.05.048&amp;volume=92&amp;pages=951-2&amp;publication_year=2015&amp;author=Zietman%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=8.><p class=c-article-references__text id=ref-CR8>Vaidya JS, Bulsara M, Wenz F, Joseph D, Saunders C, Massarut S, et al. Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2015;92:491–7.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2015.03.022 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2015.03.022 aria-label="Article reference 8" data-doi=10.1016/j.ijrobp.2015.03.022>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26068479" aria-label="PubMed reference 8">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464618 aria-label="PubMed Central reference 8">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Pride%2C%20Prejudice%2C%20or%20Science%3A%20Attitudes%20Towards%20the%20Results%20of%20the%20TARGIT-A%20Trial%20of%20Targeted%20Intraoperative%20Radiation%20Therapy%20for%20Breast%20Cancer&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2015.03.022&amp;volume=92&amp;pages=491-7&amp;publication_year=2015&amp;author=Vaidya%2CJS&amp;author=Bulsara%2CM&amp;author=Wenz%2CF&amp;author=Joseph%2CD&amp;author=Saunders%2CC&amp;author=Massarut%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=9.><p class=c-article-references__text id=ref-CR9>Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015;373:317–27.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMoa1415369 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMoa1415369 aria-label="Article reference 9" data-doi=10.1056/NEJMoa1415369>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlKrtbvL aria-label="CAS reference 9">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26200978" aria-label="PubMed reference 9">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Internal%20Mammary%20and%20Medial%20Supraclavicular%20Irradiation%20in%20Breast%20Cancer&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2FNEJMoa1415369&amp;volume=373&amp;pages=317-27&amp;publication_year=2015&amp;author=Poortmans%2CPM&amp;author=Collette%2CS&amp;author=Kirkove%2CC&amp;author=Limbergen%2CE&amp;author=Budach%2CV&amp;author=Struikmans%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=10.><p class=c-article-references__text id=ref-CR10>Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015;373:307–16.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMoa1415340 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMoa1415340 aria-label="Article reference 10" data-doi=10.1056/NEJMoa1415340>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlKrtbbI aria-label="CAS reference 10">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26200977" aria-label="PubMed reference 10">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556358 aria-label="PubMed Central reference 10">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Regional%20Nodal%20Irradiation%20in%20Early-Stage%20Breast%20Cancer&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2FNEJMoa1415340&amp;volume=373&amp;pages=307-16&amp;publication_year=2015&amp;author=Whelan%2CTJ&amp;author=Olivotto%2CIA&amp;author=Parulekar%2CWR&amp;author=Ackerman%2CI&amp;author=Chua%2CBH&amp;author=Nabid%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=11.><p class=c-article-references__text id=ref-CR11>Sedlmayer F, Reitsamer R, Fussl C, Ziegler I, Zehentmayr F, Deutschmann H, et al. Boost IORT in Breast Cancer: Body of Evidence. Int J Breast Cancer. 2014;2014:472516.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1155/2014/472516 data-track-action="article reference" href=https://doi.org/10.1155%2F2014%2F472516 aria-label="Article reference 11" data-doi=10.1155/2014/472516>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25258684" aria-label="PubMed reference 11">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167210 aria-label="PubMed Central reference 11">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Boost%20IORT%20in%20Breast%20Cancer%3A%20Body%20of%20Evidence&amp;journal=Int%20J%20Breast%20Cancer&amp;doi=10.1155%2F2014%2F472516&amp;volume=2014&amp;publication_year=2014&amp;author=Sedlmayer%2CF&amp;author=Reitsamer%2CR&amp;author=Fussl%2CC&amp;author=Ziegler%2CI&amp;author=Zehentmayr%2CF&amp;author=Deutschmann%2CH">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=12.><p class=c-article-references__text id=ref-CR12>Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, et al. Accelerated Partial Breast Irradiation in Clinical Practice. Breast Care. 2015;10:247–52.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1159/000437194 data-track-action="article reference" href=https://doi.org/10.1159%2F000437194 aria-label="Article reference 12" data-doi=10.1159/000437194>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26600760" aria-label="PubMed reference 12">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608660 aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Accelerated%20Partial%20Breast%20Irradiation%20in%20Clinical%20Practice&amp;journal=Breast%20Care&amp;doi=10.1159%2F000437194&amp;volume=10&amp;pages=247-52&amp;publication_year=2015&amp;author=Wenz%2CF&amp;author=Sedlmayer%2CF&amp;author=Herskind%2CC&amp;author=Welzel%2CG&amp;author=Sperk%2CE&amp;author=Neumaier%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=13.><p class=c-article-references__text id=ref-CR13>Polgár C, Fodor J, Major T, Sulyok Z, Kásler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108:197–202.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.radonc.2013.05.008 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.radonc.2013.05.008 aria-label="Article reference 13" data-doi=10.1016/j.radonc.2013.05.008>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23742961" aria-label="PubMed reference 13">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Breast-conserving%20therapy%20with%20partial%20or%20whole%20breast%20irradiation%3A%20ten-year%20results%20of%20the%20Budapest%20randomized%20trial&amp;journal=Radiother%20Oncol&amp;doi=10.1016%2Fj.radonc.2013.05.008&amp;volume=108&amp;pages=197-202&amp;publication_year=2013&amp;author=Polg%C3%A1r%2CC&amp;author=Fodor%2CJ&amp;author=Major%2CT&amp;author=Sulyok%2CZ&amp;author=K%C3%A1sler%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=14.><p class=c-article-references__text id=ref-CR14>Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387:229–38.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S0140-6736(15)00471-7 data-track-action="article reference" href=https://doi.org/10.1016%2FS0140-6736%2815%2900471-7 aria-label="Article reference 14" data-doi=10.1016/S0140-6736(15)00471-7>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26494415" aria-label="PubMed reference 14">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=5-year%20results%20of%20accelerated%20partial%20breast%20irradiation%20using%20sole%20interstitial%20multicatheter%20brachytherapy%20versus%20whole-breast%20irradiation%20with%20boost%20after%20breast-conserving%20surgery%20for%20low-risk%20invasive%20and%20in-situ%20carcinoma%20of%20the%20female%20breast%3A%20a%20randomised%2C%20phase%203%2C%20non-inferiority%20trial&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2815%2900471-7&amp;volume=387&amp;pages=229-38&amp;publication_year=2016&amp;author=Strnad%2CV&amp;author=Ott%2COJ&amp;author=Hildebrandt%2CG&amp;author=Kauer-Dorner%2CD&amp;author=Knauerhase%2CH&amp;author=Major%2CT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=15.><p class=c-article-references__text id=ref-CR15>Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S0140-6736(13)61950-9 data-track-action="article reference" href=https://doi.org/10.1016%2FS0140-6736%2813%2961950-9 aria-label="Article reference 15" data-doi=10.1016/S0140-6736(13)61950-9>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24224997" aria-label="PubMed reference 15">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Risk-adapted%20targeted%20intraoperative%20radiotherapy%20versus%20whole-breast%20radiotherapy%20for%20breast%20cancer%3A%205-year%20results%20for%20local%20control%20and%20overall%20survival%20from%20the%20TARGIT-A%20randomised%20trial&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2813%2961950-9&amp;volume=383&amp;pages=603-13&amp;publication_year=2014&amp;author=Vaidya%2CJS&amp;author=Wenz%2CF&amp;author=Bulsara%2CM&amp;author=Tobias%2CJS&amp;author=Joseph%2CDJ&amp;author=Keshtgar%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=16.><p class=c-article-references__text id=ref-CR16>Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91–102.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S0140-6736(10)60837-9 data-track-action="article reference" href=https://doi.org/10.1016%2FS0140-6736%2810%2960837-9 aria-label="Article reference 16" data-doi=10.1016/S0140-6736(10)60837-9>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20570343" aria-label="PubMed reference 16">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeted%20intraoperative%20radiotherapy%20versus%20whole%20breast%20radiotherapy%20for%20breast%20cancer%20%28TARGIT-A%20trial%29%3A%20an%20international%2C%20prospective%2C%20randomised%2C%20non-inferiority%20phase%203%20trial&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2810%2960837-9&amp;volume=376&amp;pages=91-102&amp;publication_year=2010&amp;author=Vaidya%2CJS&amp;author=Joseph%2CDJ&amp;author=Tobias%2CJS&amp;author=Bulsara%2CM&amp;author=Wenz%2CF&amp;author=Saunders%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=17.><p class=c-article-references__text id=ref-CR17>Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Saunders C, et al. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). Health Technol Assess. 2016;20:1–188.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.3310/hta20730 data-track-action="article reference" href=https://doi.org/10.3310%2Fhta20730 aria-label="Article reference 17" data-doi=10.3310/hta20730>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27689969" aria-label="PubMed reference 17">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056335 aria-label="PubMed Central reference 17">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20international%20randomised%20controlled%20trial%20to%20compare%20TARGeted%20Intraoperative%20radioTherapy%20%28TARGIT%29%20with%20conventional%20postoperative%20radiotherapy%20after%20breast-conserving%20surgery%20for%20women%20with%20early-stage%20breast%20cancer%20%28the%20TARGIT-A%20trial%29&amp;journal=Health%20Technol%20Assess&amp;doi=10.3310%2Fhta20730&amp;volume=20&amp;pages=1-188&amp;publication_year=2016&amp;author=Vaidya%2CJS&amp;author=Wenz%2CF&amp;author=Bulsara%2CM&amp;author=Tobias%2CJS&amp;author=Joseph%2CDJ&amp;author=Saunders%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=18.><p class=c-article-references__text id=ref-CR18>Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S1470-2045(13)70497-2 data-track-action="article reference" href=https://doi.org/10.1016%2FS1470-2045%2813%2970497-2 aria-label="Article reference 18" data-doi=10.1016/S1470-2045(13)70497-2>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24225155" aria-label="PubMed reference 18">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Intraoperative%20radiotherapy%20versus%20external%20radiotherapy%20for%20early%20breast%20cancer%20%28ELIOT%29%3A%20a%20randomised%20controlled%20equivalence%20trial&amp;journal=Lancet%20Oncol&amp;doi=10.1016%2FS1470-2045%2813%2970497-2&amp;volume=14&amp;pages=1269-77&amp;publication_year=2013&amp;author=Veronesi%2CU&amp;author=Orecchia%2CR&amp;author=Maisonneuve%2CP&amp;author=Viale%2CG&amp;author=Rotmensz%2CN&amp;author=Sangalli%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=19.><p class=c-article-references__text id=ref-CR19>Olivotto IA, Whelan TJ, Parpia S, Kim D-H, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31:4038–45.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2013.50.5511 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2013.50.5511 aria-label="Article reference 19" data-doi=10.1200/JCO.2013.50.5511>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23835717" aria-label="PubMed reference 19">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Interim%20cosmetic%20and%20toxicity%20results%20from%20RAPID%3A%20a%20randomized%20trial%20of%20accelerated%20partial%20breast%20irradiation%20using%20three-dimensional%20conformal%20external%20beam%20radiation%20therapy&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2013.50.5511&amp;volume=31&amp;pages=4038-45&amp;publication_year=2013&amp;author=Olivotto%2CIA&amp;author=Whelan%2CTJ&amp;author=Parpia%2CS&amp;author=Kim%2CD-H&amp;author=Berrang%2CT&amp;author=Truong%2CPT">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=20.><p class=c-article-references__text id=ref-CR20>Peterson D, Truong PT, Parpia S, Olivotto IA, Berrang T, Kim D-H, et al. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis. Int J Radiat Oncol Biol Phys. 2015;91:968–76.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2014.12.040 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2014.12.040 aria-label="Article reference 20" data-doi=10.1016/j.ijrobp.2014.12.040>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25832689" aria-label="PubMed reference 20">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Predictors%20of%20adverse%20cosmetic%20outcome%20in%20the%20RAPID%20trial%3A%20an%20exploratory%20analysis&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2014.12.040&amp;volume=91&amp;pages=968-76&amp;publication_year=2015&amp;author=Peterson%2CD&amp;author=Truong%2CPT&amp;author=Parpia%2CS&amp;author=Olivotto%2CIA&amp;author=Berrang%2CT&amp;author=Kim%2CD-H">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=21.><p class=c-article-references__text id=ref-CR21>Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ejca.2014.12.013 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ejca.2014.12.013 aria-label="Article reference 21" data-doi=10.1016/j.ejca.2014.12.013>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25605582" aria-label="PubMed reference 21">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Accelerated%20partial%20breast%20irradiation%20using%20intensity-modulated%20radiotherapy%20versus%20whole%20breast%20irradiation%3A%205-year%20survival%20analysis%20of%20a%20phase%203%20randomised%20controlled%20trial&amp;journal=Eur%20J%20Cancer&amp;doi=10.1016%2Fj.ejca.2014.12.013&amp;volume=51&amp;pages=451-63&amp;publication_year=2015&amp;author=Livi%2CL&amp;author=Meattini%2CI&amp;author=Marrazzo%2CL&amp;author=Simontacchi%2CG&amp;author=Pallotta%2CS&amp;author=Saieva%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=22.><p class=c-article-references__text id=ref-CR22>Coles C, Agrawal R, Ah-See ML, Algurafi H. Partial breast radiotherapy for women with early breast cancer: First results of local recurrence data for IMPORT LOW (CRUK/06/003). Eur J Cancer. 2016;57 Supplement 2:S1–S8.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=23.><p class=c-article-references__text id=ref-CR23>Vaidya JS, Bulsara M, Wenz F, Coombs N, Singer J, Ebbs S, et al. Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2016.05.008 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2016.05.008 aria-label="Article reference 23" data-doi=10.1016/j.ijrobp.2016.05.008>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27478165" aria-label="PubMed reference 23">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Reduced%20Mortality%20With%20Partial-Breast%20Irradiation%20for%20Early%20Breast%20Cancer%3A%20A%20Meta-Analysis%20of%20Randomized%20Trials&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2016.05.008&amp;volume=96&amp;pages=259-65&amp;publication_year=2016&amp;author=Vaidya%2CJS&amp;author=Bulsara%2CM&amp;author=Wenz%2CF&amp;author=Coombs%2CN&amp;author=Singer%2CJ&amp;author=Ebbs%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=24.><p class=c-article-references__text id=ref-CR24>Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365–83.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2013.54.1177 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2013.54.1177 aria-label="Article reference 24" data-doi=10.1200/JCO.2013.54.1177>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24663048" aria-label="PubMed reference 24">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Sentinel%20lymph%20node%20biopsy%20for%20patients%20with%20early-stage%20breast%20cancer%3A%20American%20Society%20of%20Clinical%20Oncology%20clinical%20practice%20guideline%20update&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2013.54.1177&amp;volume=32&amp;pages=1365-83&amp;publication_year=2014&amp;author=Lyman%2CGH&amp;author=Temin%2CS&amp;author=Edge%2CSB&amp;author=Newman%2CLA&amp;author=Turner%2CRR&amp;author=Weaver%2CDL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=25.><p class=c-article-references__text id=ref-CR25>Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20739842" aria-label="PubMed reference 25">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Locoregional%20recurrence%20after%20sentinel%20lymph%20node%20dissection%20with%20or%20without%20axillary%20dissection%20in%20patients%20with%20sentinel%20lymph%20node%20metastases%3A%20the%20American%20College%20of%20Surgeons%20Oncology%20Group%20Z0011%20randomized%20trial&amp;journal=Ann%20Surg&amp;volume=252&amp;pages=426-32&amp;publication_year=2010&amp;author=Giuliano%2CAE&amp;author=McCall%2CL&amp;author=Beitsch%2CP&amp;author=Whitworth%2CPW&amp;author=Blumencranz%2CP&amp;author=Leitch%2CAM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=26.><p class=c-article-references__text id=ref-CR26>Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1001/jama.2011.90 data-track-action="article reference" href=https://doi.org/10.1001%2Fjama.2011.90 aria-label="Article reference 26" data-doi=10.1001/jama.2011.90>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXhvVymtrg%3D aria-label="CAS reference 26">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21304082" aria-label="PubMed reference 26">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Axillary%20dissection%20vs%20no%20axillary%20dissection%20in%20women%20with%20invasive%20breast%20cancer%20and%20sentinel%20node%20metastasis%3A%20a%20randomized%20clinical%20trial&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2011.90&amp;volume=305&amp;pages=569-75&amp;publication_year=2011&amp;author=Giuliano%2CAE&amp;author=Hunt%2CKK&amp;author=Ballman%2CKV&amp;author=Beitsch%2CPD&amp;author=Whitworth%2CPW&amp;author=Blumencranz%2CPW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=27.><p class=c-article-references__text id=ref-CR27>Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264:413–20.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1097/SLA.0000000000001863 data-track-action="article reference" href=https://doi.org/10.1097%2FSLA.0000000000001863 aria-label="Article reference 27" data-doi=10.1097/SLA.0000000000001863>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27513155" aria-label="PubMed reference 27">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Locoregional%20Recurrence%20After%20Sentinel%20Lymph%20Node%20Dissection%20With%20or%20Without%20Axillary%20Dissection%20in%20Patients%20With%20Sentinel%20Lymph%20Node%20Metastases%3A%20Long-term%20Follow-up%20From%20the%20American%20College%20of%20Surgeons%20Oncology%20Group%20%28Alliance%29%20ACOSOG%20Z0011%20Randomized%20Trial&amp;journal=Ann%20Surg&amp;doi=10.1097%2FSLA.0000000000001863&amp;volume=264&amp;pages=413-20&amp;publication_year=2016&amp;author=Giuliano%2CAE&amp;author=Ballman%2CK&amp;author=McCall%2CL&amp;author=Beitsch%2CP&amp;author=Whitworth%2CPW&amp;author=Blumencranz%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=28.><p class=c-article-references__text id=ref-CR28>Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol. 2014;32:3600–6.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2014.56.5838 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2014.56.5838 aria-label="Article reference 28" data-doi=10.1200/JCO.2014.56.5838>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25135994" aria-label="PubMed reference 28">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220042 aria-label="PubMed Central reference 28">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Radiation%20field%20design%20in%20the%20ACOSOG%20Z0011%20%28Alliance%29%20Trial&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2014.56.5838&amp;volume=32&amp;pages=3600-6&amp;publication_year=2014&amp;author=Jagsi%2CR&amp;author=Chadha%2CM&amp;author=Moni%2CJ&amp;author=Ballman%2CK&amp;author=Laurie%2CF&amp;author=Buchholz%2CTA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=29.><p class=c-article-references__text id=ref-CR29>Nitsche M, Temme N, Förster M, Reible M, Hermann RM. Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study. Strahlenther Onkol. 2014;190:715–21.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-014-0681-6 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-014-0681-6 aria-label="Article reference 29" data-doi=10.1007/s00066-014-0681-6>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24838410" aria-label="PubMed reference 29">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Tangential%20vs.%20defined%20radiotherapy%20in%20early%20breast%20cancer%20treatment%20without%20axillary%20lymph%20node%20dissection%3A%20a%20comparative%20study&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-014-0681-6&amp;volume=190&amp;pages=715-21&amp;publication_year=2014&amp;author=Nitsche%2CM&amp;author=Temme%2CN&amp;author=F%C3%B6rster%2CM&amp;author=Reible%2CM&amp;author=Hermann%2CRM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=30.><p class=c-article-references__text id=ref-CR30>Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. How nescience may obscure evidence. Strahlenther Onkol. 2014;190:861–3.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-014-0755-5 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-014-0755-5 aria-label="Article reference 30" data-doi=10.1007/s00066-014-0755-5>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25238991" aria-label="PubMed reference 30">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=How%20nescience%20may%20obscure%20evidence&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-014-0755-5&amp;volume=190&amp;pages=861-3&amp;publication_year=2014&amp;author=Sautter-Bihl%2CML&amp;author=Sedlmayer%2CF&amp;author=Budach%2CW&amp;author=Dunst%2CJ&amp;author=Feyer%2CP&amp;author=Fietkau%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=31.><p class=c-article-references__text id=ref-CR31>Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–10.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S1470-2045(14)70460-7 data-track-action="article reference" href=https://doi.org/10.1016%2FS1470-2045%2814%2970460-7 aria-label="Article reference 31" data-doi=10.1016/S1470-2045(14)70460-7>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25439688" aria-label="PubMed reference 31">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291166 aria-label="PubMed Central reference 31">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Radiotherapy%20or%20surgery%20of%20the%20axilla%20after%20a%20positive%20sentinel%20node%20in%20breast%20cancer%20%28EORTC%2010981%E2%80%9322023%20AMAROS%29%3A%20a%20randomised%2C%20multicentre%2C%20open-label%2C%20phase%203%20non-inferiority%20trial&amp;journal=Lancet%20Oncol&amp;doi=10.1016%2FS1470-2045%2814%2970460-7&amp;volume=15&amp;pages=1303-10&amp;publication_year=2014&amp;author=Donker%2CM&amp;author=Tienhoven%2CG&amp;author=Straver%2CME&amp;author=Meijnen%2CP&amp;author=Velde%2CCJH&amp;author=Mansel%2CRE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=32.><p class=c-article-references__text id=ref-CR32>Sautter-Bihl M-L, Sedlmayer F. Radiotherapy of the Lymphatic Pathways in Early Breast Cancer. Breast Care. 2015;10:254–8.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1159/000438662 data-track-action="article reference" href=https://doi.org/10.1159%2F000438662 aria-label="Article reference 32" data-doi=10.1159/000438662>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26600761" aria-label="PubMed reference 32">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608631 aria-label="PubMed Central reference 32">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Radiotherapy%20of%20the%20Lymphatic%20Pathways%20in%20Early%20Breast%20Cancer&amp;journal=Breast%20Care&amp;doi=10.1159%2F000438662&amp;volume=10&amp;pages=254-8&amp;publication_year=2015&amp;author=Sautter-Bihl%2CM-L&amp;author=Sedlmayer%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=33.><p class=c-article-references__text id=ref-CR33>Budach W, Kammers K, Boelke E, Matuschek C. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials. Radiat Oncol. 2013;8:267.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/1748-717X-8-267 data-track-action="article reference" href=https://doi.org/10.1186%2F1748-717X-8-267 aria-label="Article reference 33" data-doi=10.1186/1748-717X-8-267>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24225206" aria-label="PubMed reference 33">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842771 aria-label="PubMed Central reference 33">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Adjuvant%20radiotherapy%20of%20regional%20lymph%20nodes%20in%20breast%20cancer%20-%20a%20meta-analysis%20of%20randomized%20trials&amp;journal=Radiat%20Oncol&amp;doi=10.1186%2F1748-717X-8-267&amp;volume=8&amp;publication_year=2013&amp;author=Budach%2CW&amp;author=Kammers%2CK&amp;author=Boelke%2CE&amp;author=Matuschek%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=34.><p class=c-article-references__text id=ref-CR34>Budach W, Bölke E, Kammers K, Gerber PA, Nestle-Krämling C, Matuschek C. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta- analysis of randomized trials- an update. Radiat Oncol. 2015;10:1–7.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/s13014-015-0568-4 data-track-action="article reference" href=https://doi.org/10.1186%2Fs13014-015-0568-4 aria-label="Article reference 34" data-doi=10.1186/s13014-015-0568-4>Article</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Adjuvant%20radiation%20therapy%20of%20regional%20lymph%20nodes%20in%20breast%20cancer%20-%20a%20meta-%20analysis%20of%20randomized%20trials-%20an%20update&amp;journal=Radiat%20Oncol&amp;doi=10.1186%2Fs13014-015-0568-4&amp;volume=10&amp;pages=1-7&amp;publication_year=2015&amp;author=Budach%2CW&amp;author=B%C3%B6lke%2CE&amp;author=Kammers%2CK&amp;author=Gerber%2CPA&amp;author=Nestle-Kr%C3%A4mling%2CC&amp;author=Matuschek%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=35.><p class=c-article-references__text id=ref-CR35>Thorsen LBJ, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016;34:314–20.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2015.63.6456 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2015.63.6456 aria-label="Article reference 35" data-doi=10.1200/JCO.2015.63.6456>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26598752" aria-label="PubMed reference 35">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=DBCG-IMN%3A%20A%20Population-Based%20Cohort%20Study%20on%20the%20Effect%20of%20Internal%20Mammary%20Node%20Irradiation%20in%20Early%20Node-Positive%20Breast%20Cancer&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2015.63.6456&amp;volume=34&amp;pages=314-20&amp;publication_year=2016&amp;author=Thorsen%2CLBJ&amp;author=Offersen%2CBV&amp;author=Dan%C3%B8%2CH&amp;author=Berg%2CM&amp;author=Jensen%2CI&amp;author=Pedersen%2CAN">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=36.><p class=c-article-references__text id=ref-CR36>Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois J-B, Datchary J, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86:860–6.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2013.03.021 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2013.03.021 aria-label="Article reference 36" data-doi=10.1016/j.ijrobp.2013.03.021>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23664327" aria-label="PubMed reference 36">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Ten-year%20survival%20results%20of%20a%20randomized%20trial%20of%20irradiation%20of%20internal%20mammary%20nodes%20after%20mastectomy&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2013.03.021&amp;volume=86&amp;pages=860-6&amp;publication_year=2013&amp;author=Hennequin%2CC&amp;author=Bossard%2CN&amp;author=Servagi-Vernat%2CS&amp;author=Maingon%2CP&amp;author=Dubois%2CJ-B&amp;author=Datchary%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=37.><p class=c-article-references__text id=ref-CR37>Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast. JNCI Monographs. 2010;2010:162–77.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1093/jncimonographs/lgq039 data-track-action="article reference" href=https://doi.org/10.1093%2Fjncimonographs%2Flgq039 aria-label="Article reference 37" data-doi=10.1093/jncimonographs/lgq039>Article</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Overview%20of%20the%20Randomized%20Trials%20of%20Radiotherapy%20in%20Ductal%20Carcinoma%20In%20Situ%20of%20the%20Breast&amp;journal=JNCI%20Monographs&amp;doi=10.1093%2Fjncimonographs%2Flgq039&amp;volume=2010&amp;pages=162-77&amp;publication_year=2010">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=38.><p class=c-article-references__text id=ref-CR38>Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1:888–9.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1001/jamaoncol.2015.2510 data-track-action="article reference" href=https://doi.org/10.1001%2Fjamaoncol.2015.2510 aria-label="Article reference 38" data-doi=10.1001/jamaoncol.2015.2510>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26291673" aria-label="PubMed reference 38">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Breast%20Cancer%20Mortality%20After%20a%20Diagnosis%20of%20Ductal%20Carcinoma%20In%20Situ&amp;journal=JAMA%20Oncol&amp;doi=10.1001%2Fjamaoncol.2015.2510&amp;volume=1&amp;pages=888-9&amp;publication_year=2015&amp;author=Narod%2CSA&amp;author=Iqbal%2CJ&amp;author=Giannakeas%2CV&amp;author=Sopik%2CV&amp;author=Sun%2CP">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=39.><p class=c-article-references__text id=ref-CR39>Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2006;65:1397–403.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2006.03.009 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2006.03.009 aria-label="Article reference 39" data-doi=10.1016/j.ijrobp.2006.03.009>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16750316" aria-label="PubMed reference 39">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Rationalization%20and%20regionalization%20of%20treatment%20for%20ductal%20carcinoma%20in%20situ%20of%20the%20breast&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2006.03.009&amp;volume=65&amp;pages=1397-403&amp;publication_year=2006&amp;author=Smith%2CGL&amp;author=Smith%2CBD&amp;author=Haffty%2CBG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=40.><p class=c-article-references__text id=ref-CR40>Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, et al. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study. J Clin Oncol. 2016;34:1190–6.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2015.65.1869 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2015.65.1869 aria-label="Article reference 40" data-doi=10.1200/JCO.2015.65.1869>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXnvF2nsA%3D%3D aria-label="CAS reference 40">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26834064" aria-label="PubMed reference 40">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Patient%20Prognostic%20Score%20and%20Associations%20With%20Survival%20Improvement%20Offered%20by%20Radiotherapy%20After%20Breast-Conserving%20Surgery%20for%20Ductal%20Carcinoma%20In%20Situ%3A%20A%20Population-Based%20Longitudinal%20Cohort%20Study&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2015.65.1869&amp;volume=34&amp;pages=1190-6&amp;publication_year=2016&amp;author=Sagara%2CY&amp;author=Freedman%2CRA&amp;author=Vaz-Luis%2CI&amp;author=Mallory%2CMA&amp;author=Wong%2CSM&amp;author=Aydogan%2CF">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=41.><p class=c-article-references__text id=ref-CR41>Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol. 2015;22:3273–81.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1245/s10434-015-4740-8 data-track-action="article reference" href=https://doi.org/10.1245%2Fs10434-015-4740-8 aria-label="Article reference 41" data-doi=10.1245/s10434-015-4740-8>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26215193" aria-label="PubMed reference 41">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694562 aria-label="PubMed Central reference 41">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Decreasing%20Recurrence%20Rates%20for%20Ductal%20Carcinoma%20In%20Situ%3A%20Analysis%20of%202996%20Women%20Treated%20with%20Breast-Conserving%20Surgery%20Over%2030%20Years&amp;journal=Ann%20Surg%20Oncol&amp;doi=10.1245%2Fs10434-015-4740-8&amp;volume=22&amp;pages=3273-81&amp;publication_year=2015&amp;author=Subhedar%2CP&amp;author=Olcese%2CC&amp;author=Patil%2CS&amp;author=Morrow%2CM&amp;author=Zee%2CKJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=42.><p class=c-article-references__text id=ref-CR42>Krug D, Souchon R. Radiotherapy of Ductal Carcinoma In Situ. Breast Care. 2015;10:259–64.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1159/000437452 data-track-action="article reference" href=https://doi.org/10.1159%2F000437452 aria-label="Article reference 42" data-doi=10.1159/000437452>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26600762" aria-label="PubMed reference 42">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608608 aria-label="PubMed Central reference 42">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Radiotherapy%20of%20Ductal%20Carcinoma%20In%20Situ&amp;journal=Breast%20Care&amp;doi=10.1159%2F000437452&amp;volume=10&amp;pages=259-64&amp;publication_year=2015&amp;author=Krug%2CD&amp;author=Souchon%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=43.><p class=c-article-references__text id=ref-CR43>Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, et al. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study. J Clin Oncol. 2015;33:3938–44.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2015.60.8588 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2015.60.8588 aria-label="Article reference 43" data-doi=10.1200/JCO.2015.60.8588>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26371148" aria-label="PubMed reference 43">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652014 aria-label="PubMed Central reference 43">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Surgical%20Excision%20Without%20Radiation%20for%20Ductal%20Carcinoma%20in%20Situ%20of%20the%20Breast%3A%2012-Year%20Results%20From%20the%20ECOG-ACRIN%20E5194%20Study&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2015.60.8588&amp;volume=33&amp;pages=3938-44&amp;publication_year=2015&amp;author=Solin%2CLJ&amp;author=Gray%2CR&amp;author=Hughes%2CLL&amp;author=Wood%2CWC&amp;author=Lowen%2CMA&amp;author=Badve%2CSS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=44.><p class=c-article-references__text id=ref-CR44>McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2014.57.9029 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2014.57.9029 aria-label="Article reference 44" data-doi=10.1200/JCO.2014.57.9029>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtVWgsrvM aria-label="CAS reference 44">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25605856" aria-label="PubMed reference 44">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334775 aria-label="PubMed Central reference 44">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=RTOG%209804%3A%20a%20prospective%20randomized%20trial%20for%20good-risk%20ductal%20carcinoma%20in%20situ%20comparing%20radiotherapy%20with%20observation&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2014.57.9029&amp;volume=33&amp;pages=709-15&amp;publication_year=2015&amp;author=McCormick%2CB&amp;author=Winter%2CK&amp;author=Hudis%2CC&amp;author=Kuerer%2CHM&amp;author=Rakovitch%2CE&amp;author=Smith%2CBL">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=45.><p class=c-article-references__text id=ref-CR45>Pahl R, Dunst J. Adjuvant radiotherapy significantly also reduces local recurrence rate for prognostically favorable DCIS. Strahlenther Onkol. 2015;191:997–1000.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-015-0906-3 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-015-0906-3 aria-label="Article reference 45" data-doi=10.1007/s00066-015-0906-3>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26497497" aria-label="PubMed reference 45">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Adjuvant%20radiotherapy%20significantly%20also%20reduces%20local%20recurrence%20rate%20for%20prognostically%20favorable%20DCIS&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-015-0906-3&amp;volume=191&amp;pages=997-1000&amp;publication_year=2015&amp;author=Pahl%2CR&amp;author=Dunst%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=46.><p class=c-article-references__text id=ref-CR46>Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer. 2015;51:1497–510.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ejca.2015.05.008 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ejca.2015.05.008 aria-label="Article reference 46" data-doi=10.1016/j.ejca.2015.05.008>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26025767" aria-label="PubMed reference 46">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Feasibility%20of%20a%20prospective%2C%20randomised%2C%20open-label%2C%20international%20multicentre%2C%20phase%20III%2C%20non-inferiority%20trial%20to%20assess%20the%20safety%20of%20active%20surveillance%20for%20low%20risk%20ductal%20carcinoma%20in%20situ%20-%20The%20LORD%20study&amp;journal=Eur%20J%20Cancer&amp;doi=10.1016%2Fj.ejca.2015.05.008&amp;volume=51&amp;pages=1497-510&amp;publication_year=2015&amp;author=Elshof%2CLE&amp;author=Tryfonidis%2CK&amp;author=Slaets%2CL&amp;author=Leeuwen-Stok%2CAE&amp;author=Skinner%2CVP&amp;author=Dif%2CN">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=47.><p class=c-article-references__text id=ref-CR47>Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ejca.2015.07.017 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ejca.2015.07.017 aria-label="Article reference 47" data-doi=10.1016/j.ejca.2015.07.017>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26296293" aria-label="PubMed reference 47">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Addressing%20overtreatment%20of%20screen%20detected%20DCIS%3B%20the%20LORIS%20trial&amp;journal=Eur%20J%20Cancer&amp;doi=10.1016%2Fj.ejca.2015.07.017&amp;volume=51&amp;pages=2296-303&amp;publication_year=2015&amp;author=Francis%2CA&amp;author=Thomas%2CJ&amp;author=Fallowfield%2CL&amp;author=Wallis%2CM&amp;author=Bartlett%2CJMS&amp;author=Brookes%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=48.><p class=c-article-references__text id=ref-CR48>Merrill AL, Esserman L, Morrow MCLINICALDECISIONS. Ductal Carcinoma In Situ. N Engl J Med. 2016;374:390–2.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMclde1512213 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMclde1512213 aria-label="Article reference 48" data-doi=10.1056/NEJMclde1512213>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26816018" aria-label="PubMed reference 48">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Ductal%20Carcinoma%20In%20Situ&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2FNEJMclde1512213&amp;volume=374&amp;pages=390-2&amp;publication_year=2016&amp;author=Merrill%2CAL&amp;author=Esserman%2CL&amp;author=Morrow%2CMCLINICALDECISIONS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=49.><p class=c-article-references__text id=ref-CR49>Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow M. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? Ann Surg Oncol. 2016;23:3487–93.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1245/s10434-016-5268-2 data-track-action="article reference" href=https://doi.org/10.1245%2Fs10434-016-5268-2 aria-label="Article reference 49" data-doi=10.1245/s10434-016-5268-2>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27172775" aria-label="PubMed reference 49">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Do%20LORIS%20Trial%20Eligibility%20Criteria%20Identify%20a%20Ductal%20Carcinoma%20In%20Situ%20Patient%20Population%20at%20Low%20Risk%20of%20Upgrade%20to%20Invasive%20Carcinoma%3F&amp;journal=Ann%20Surg%20Oncol&amp;doi=10.1245%2Fs10434-016-5268-2&amp;volume=23&amp;pages=3487-93&amp;publication_year=2016&amp;author=Pilewskie%2CM&amp;author=Stempel%2CM&amp;author=Rosenfeld%2CH&amp;author=Eaton%2CA&amp;author=Zee%2CKJ&amp;author=Morrow%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=50.><p class=c-article-references__text id=ref-CR50>Nilsson C, Valachis A. The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies. Radiother Oncol. 2015;114:50–5.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.radonc.2015.01.001 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.radonc.2015.01.001 aria-label="Article reference 50" data-doi=10.1016/j.radonc.2015.01.001>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25596912" aria-label="PubMed reference 50">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20boost%20and%20hypofractionation%20as%20adjuvant%20radiotherapy%20in%20patients%20with%20DCIS%3A%20a%20meta-analysis%20of%20observational%20studies&amp;journal=Radiother%20Oncol&amp;doi=10.1016%2Fj.radonc.2015.01.001&amp;volume=114&amp;pages=50-5&amp;publication_year=2015&amp;author=Nilsson%2CC&amp;author=Valachis%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=51.><p class=c-article-references__text id=ref-CR51>Moran MS, Zhao S, Ma S, Kirova YM. Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions. Int J Radiat Oncol Biol Phys. 2016;96:S144.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.ijrobp.2016.06.349 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.ijrobp.2016.06.349 aria-label="Article reference 51" data-doi=10.1016/j.ijrobp.2016.06.349>Article</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Radiation%20Boost%20for%20Ductal%20Carcinoma%20In%20Situ%20After%20Whole-Breast%20Radiation%20Therapy%20%28WBRT%29%20Improves%20Local%20Control%3A%20Analysis%20From%2010%20Pooled%20Academic%20Institutions&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;doi=10.1016%2Fj.ijrobp.2016.06.349&amp;volume=96&amp;publication_year=2016&amp;author=Moran%2CMS&amp;author=Zhao%2CS&amp;author=Ma%2CS&amp;author=Kirova%2CYM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=52.><p class=c-article-references__text id=ref-CR52>Duma MN, Molls M, Trott KR. From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy. Strahlenther Onkol. 2014;190:5–7.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-013-0465-4 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-013-0465-4 aria-label="Article reference 52" data-doi=10.1007/s00066-013-0465-4>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BC2c7os12isA%3D%3D aria-label="CAS reference 52">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24253182" aria-label="PubMed reference 52">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=From%20heart%20to%20heart%20for%20breast%20cancer%20patients%20-%20cardiovascular%20toxicities%20in%20breast%20cancer%20radiotherapy&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-013-0465-4&amp;volume=190&amp;pages=5-7&amp;publication_year=2014&amp;author=Duma%2CMN&amp;author=Molls%2CM&amp;author=Trott%2CKR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=53.><p class=c-article-references__text id=ref-CR53>Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. N Engl J Med. 2013;368:987–98.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMoa1209825 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMoa1209825 aria-label="Article reference 53" data-doi=10.1056/NEJMoa1209825>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://ro-journal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXktlemtrk%3D aria-label="CAS reference 53">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23484825" aria-label="PubMed reference 53">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Risk%20of%20Ischemic%20Heart%20Disease%20in%20Women%20after%20Radiotherapy%20for%20Breast%20Cancer&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2FNEJMoa1209825&amp;volume=368&amp;pages=987-98&amp;publication_year=2013&amp;author=Darby%2CSC&amp;author=Ewertz%2CM&amp;author=McGale%2CP&amp;author=Bennet%2CAM&amp;author=Blom-Goldman%2CU&amp;author=Br%C3%B8nnum%2CD">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=54.><p class=c-article-references__text id=ref-CR54>Hepp R, Ammerpohl M, Morgenstern C, Nielinger L, Erichsen P, Abdallah A, et al. Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients. Strahlenther Onkol. 2015;191:710–6.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00066-015-0838-y data-track-action="article reference" href=https://doi.org/10.1007%2Fs00066-015-0838-y aria-label="Article reference 54" data-doi=10.1007/s00066-015-0838-y>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25893323" aria-label="PubMed reference 54">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=Deep%20inspiration%20breath-hold%20%28DIBH%29%20radiotherapy%20in%20left-sided%20breast%20cancer%3A%20Dosimetrical%20comparison%20and%20clinical%20feasibility%20in%2020%20patients&amp;journal=Strahlenther%20Onkol&amp;doi=10.1007%2Fs00066-015-0838-y&amp;volume=191&amp;pages=710-6&amp;publication_year=2015&amp;author=Hepp%2CR&amp;author=Ammerpohl%2CM&amp;author=Morgenstern%2CC&amp;author=Nielinger%2CL&amp;author=Erichsen%2CP&amp;author=Abdallah%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=55.><p class=c-article-references__text id=ref-CR55>Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114:56–65.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.radonc.2014.10.004 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.radonc.2014.10.004 aria-label="Article reference 55" data-doi=10.1016/j.radonc.2014.10.004>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25454172" aria-label="PubMed reference 55">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Risk%20of%20second%20non-breast%20cancer%20after%20radiotherapy%20for%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis%20of%20762%2C468%20patients&amp;journal=Radiother%20Oncol&amp;doi=10.1016%2Fj.radonc.2014.10.004&amp;volume=114&amp;pages=56-65&amp;publication_year=2015&amp;author=Grantzau%2CT&amp;author=Overgaard%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=56.><p class=c-article-references__text id=ref-CR56>Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, et al. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol. 2011;29:4647–53.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1200/JCO.2011.35.8408 data-track-action="article reference" href=https://doi.org/10.1200%2FJCO.2011.35.8408 aria-label="Article reference 56" data-doi=10.1200/JCO.2011.35.8408>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22067407" aria-label="PubMed reference 56">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Improvement%20in%20breast%20cancer%20outcomes%20over%20time%3A%20are%20older%20women%20missing%20out%3F&amp;journal=J%20Clin%20Oncol&amp;doi=10.1200%2FJCO.2011.35.8408&amp;volume=29&amp;pages=4647-53&amp;publication_year=2011&amp;author=Smith%2CBD&amp;author=Jiang%2CJ&amp;author=McLaughlin%2CSS&amp;author=Hurria%2CA&amp;author=Smith%2CGL&amp;author=Giordano%2CSH">
 Google Scholar</a>&nbsp;
 </p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link rel=nofollow href="https://citation-needed.springer.com/v2/references/10.1186/s13014-017-0766-3?format=refman&amp;flavour=references">Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-download></use></svg></a></p></div></div></div></section></div><section data-title=Acknowledgements><div class=c-article-section id=Ack1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Ack1>Acknowledgements</h2><div class=c-article-section__content id=Ack1-content><p>Not applicable.</p>
 <h3 class=c-article__sub-heading id=FPar1>Funding</h3>
 <p>Not applicable.</p>
 
 <h3 class=c-article__sub-heading id=FPar2>Availability of data and material</h3>
 <p>Not applicable.</p>
 
 <h3 class=c-article__sub-heading id=FPar3>Authors’ contributions</h3>
 <p>DK reviewed the literature and drafted the manuscript. RaS and MLSB reviewed the literature and contributed to the writing of the manuscript. RB, WB, JD, PF, RF, WoH, WuH MDP, FS, FW and RoS critically revised the manuscript. All of the authors read and approved the final manuscript.</p>
 
 <h3 class=c-article__sub-heading id=FPar4>Competing interests</h3>
 <p>The authors declare that there are no conflicts of interest.</p>
 
 <h3 class=c-article__sub-heading id=FPar5>Consent for publication</h3>
 <p>Not applicable.</p>
 
 <h3 class=c-article__sub-heading id=FPar6>Ethics approval and consent to participate</h3>
 <p>Not applicable.</p>
 </div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><h3 class=c-article__sub-heading id=affiliations>Authors and Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>Department of Radiation Oncology, University Hospital Heidelberg and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany<p class=c-article-author-affiliation__authors-list>David Krug</p><li id=Aff2><p class=c-article-author-affiliation__address>University Hospital Schleswig-Holstein, Kiel, Germany<p class=c-article-author-affiliation__authors-list>René Baumann&nbsp;&amp;&nbsp;Jürgen Dunst</p><li id=Aff3><p class=c-article-author-affiliation__address>Heinrich-Heine-University, Duesseldorf, Germany<p class=c-article-author-affiliation__authors-list>Wilfried Budach</p><li id=Aff4><p class=c-article-author-affiliation__address>Vivantes Hospital Neukoelln, Berlin, Germany<p class=c-article-author-affiliation__authors-list>Petra Feyer</p><li id=Aff5><p class=c-article-author-affiliation__address>University Hospital Erlangen, Erlangen, Germany<p class=c-article-author-affiliation__authors-list>Rainer Fietkau&nbsp;&amp;&nbsp;Rolf Sauer</p><li id=Aff6><p class=c-article-author-affiliation__address>Formerly St.-Vincentius-Hospital, Karlsruhe, Germany<p class=c-article-author-affiliation__authors-list>Wulf Haase</p><li id=Aff7><p class=c-article-author-affiliation__address>St. Claraspital, Basel, Switzerland<p class=c-article-author-affiliation__authors-list>Wolfgang Harms</p><li id=Aff8><p class=c-article-author-affiliation__address>HELIOS-Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany<p class=c-article-author-affiliation__authors-list>Marc D. Piroth</p><li id=Aff9><p class=c-article-author-affiliation__address>Municipal Hospital, Karlsruhe, Germany<p class=c-article-author-affiliation__authors-list>Marie-Luise Sautter-Bihl</p><li id=Aff10><p class=c-article-author-affiliation__address>Paracelsus Medical University Hospital, Salzburg, Austria<p class=c-article-author-affiliation__authors-list>Felix Sedlmayer</p><li id=Aff11><p class=c-article-author-affiliation__address>Formerly University Hospital Tuebingen, Tuebingen, Germany<p class=c-article-author-affiliation__authors-list>Rainer Souchon</p><li id=Aff12><p class=c-article-author-affiliation__address>University Hospital Mannheim, Mannheim, Germany<p class=c-article-author-affiliation__authors-list>Frederik Wenz</p></ol><div class="u-js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=groups>Consortia</h3><div class=c-article-author-institutional-author id=group-1><h3 class="c-article-author-institutional-author__name u-h3">Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO)</h3></div><h3 class=c-article__sub-heading id=corresponding-author>Corresponding author</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 href=mailto:david.krug@med.uni-heidelberg.de>David Krug</a>.</p></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p>
 <b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href=http://creativecommons.org/licenses/by/4.0/ rel=license>http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href=http://creativecommons.org/publicdomain/zero/1.0/ rel=license>http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=Current%20controversies%20in%20radiotherapy%20for%20breast%20cancer&amp;author=David%20Krug%20et%20al&amp;contentID=10.1186%2Fs13014-017-0766-3&amp;copyright=The%20Author%28s%29.&amp;publication=1748-717X&amp;publicationDate=2017-01-23&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1186/s13014-017-0766-3 target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1186/s13014-017-0766-3" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img width=57 height=81 alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>Krug, D., Baumann, R., Budach, W. <i>et al.</i> Current controversies in radiotherapy for breast cancer.
 <i>Radiat Oncol</i> <b>12</b>, 25 (2017). https://doi.org/10.1186/s13014-017-0766-3<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external rel=nofollow href="https://citation-needed.springer.com/v2/references/10.1186/s13014-017-0766-3?format=refman&amp;flavour=citation">Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2016-11-09>09 November 2016</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2017-01-11>11 January 2017</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2017-01-23>23 January 2017</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value>https://doi.org/10.1186/s13014-017-0766-3</span></p></ul><div data-component=share-box><div class="c-article-share-box u-display-block"><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type=button id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
 Provided by the Springer Nature SharedIt content-sharing initiative
 </p></div></div><h3 class=c-article__sub-heading>Keywords</h3><ul class=c-article-subject-list><li class=c-article-subject-list__subject><span>Breast cancer</span><li class=c-article-subject-list__subject><span>Accelerated partial breast irradiation</span><li class=c-article-subject-list__subject><span>Ductal carcinoma in situ</span><li class=c-article-subject-list__subject><span>Regional nodal irradiation</span></ul><div data-component=article-info-list></div></div></div></div></div></section>
 
 </article>
 </main>
 <div class="c-article-extras u-text-sm u-hide-print" data-container-type=reading-companion data-track-component="reading companion">
 <aside>
 <div data-test=download-article-link-wrapper class=js-context-bar-sticky-point-desktop>
 
 <div class="c-pdf-download u-clear-both">
 <a href=https://ro-journal.biomedcentral.com/counter/pdf/10.1186/s13014-017-0766-3.pdf class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf=true data-readcube-pdf-url=true data-test=pdf-link data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=link data-track-external download>
 <span class=c-pdf-download__text>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#icon-download></use></svg>
 </a>
 </div>
 
 </div>
 
 
 <div class=c-article-associated-content__container>
 <section>
 <h2 class="c-article-associated-content__title u-mb-24 sf-hidden">Associated Content</h2>
 
 <div class="c-article-associated-content__collection section u-mb-24">
 <section>
 <p class="c-article-associated-content__collection-label u-sans-serif u-text-bold u-mb-8">Section</p>
 <h3 class="c-article-associated-content__collection-title u-h3 u-mb-8">
 <a href=https://ro-journal.biomedcentral.com/articles/sections/clinical-radiation-oncology class=u-link-inherit data-track=click data-track-action="view section" data-track-category="associated content" data-track-label=section data-test=collection-link>Clinical Radiation Oncology</a>
 </h3>
 </section>
 </div>
 
 
 </section>
 </div>
 
 
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:40px>
 <ul class=c-reading-companion__tabs role=tablist><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections role=tabpanel><div class=c-reading-companion__scroll-pane style=max-height:none><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Background>Background</a><li id=rc-sec-abbreviations class=c-reading-companion__section-item><a href=#abbreviations data-track=click data-track-action="section anchor" data-track-label=link:Abbreviations>Abbreviations</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Ack1 class=c-reading-companion__section-item><a href=#Ack1 data-track=click data-track-action="section anchor" data-track-label=link:Acknowledgements>Acknowledgements</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a></ul></div>
 <div class="js-ad u-lazy-ad-wrapper u-mt-16 u-show sf-hidden" data-component-mpu>
 
 
 <aside class="adsbox c-ad c-ad--300x250 u-mt-16 sf-hidden" data-component-mpu>
 <div class="c-ad__inner sf-hidden">
 
 <div id=div-gpt-ad-MPU1 data-ad-type=MPU1 data-test=MPU1-ad data-pa11y-ignore data-gpt data-gpt-unitpath=/270604982/bmc/ro-journal/articles data-gpt-sizes=300x250 data-gpt-targeting="pos=MPU1;doi=10.1186/s13014-017-0766-3;type=article;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation;pmc=B11001,H33160,H29056,H29005;" class=sf-hidden>
 <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/ro-journal/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s13014-017-0766-3&amp;type=article&amp;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation&amp;pmc=B11001,H33160,H29056,H29005&amp;">
                        <img data-test="gpt-advert-fallback-img" src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/ro-journal/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s13014-017-0766-3&amp;type=article&amp;kwrd=Breast cancer,Accelerated partial breast irradiation,Ductal carcinoma in situ,Regional nodal irradiation&amp;pmc=B11001,H33160,H29056,H29005&amp;" alt="Advertisement" width="300" height="250">
                    </a>
                </noscript>
 </div>
 </div>
 </aside>
 </div>
 </div>
 
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references role=tabpanel></div>
 </div>
 </div>
 </aside>
 </div>
 </div>
 
 <div class=c-journal-footer>
 <div class=c-journal-footer__inner>
 <div class=c-journal-footer__summary>
 <h4 class="c-journal-title c-journal-title--footer">
 
 <span class=c-journal-title__text>Radiation Oncology</span>
 </h4>
 <p class=c-journal-footer__issn>ISSN: 1748-717X</p>
 </div>
 
 <div class=c-journal-footer__contact>
 <h4 class=c-journal-footer__contact-title>Contact us</h4>
 <ul class=c-journal-footer__contact-list>
 
 <li class=c-journal-footer__contact-item>Submission enquiries: <a href=mailto:marjoshua.jemina@springernature.com>marjoshua.jemina@springernature.com</a></li>
 
 
 <li class=c-journal-footer__contact-item>General enquiries: <a href=mailto:info@biomedcentral.com>info@biomedcentral.com</a></li>
 
 </ul>
 </div>
 
 </div>
 </div>
 
 
 <img rel=nofollow class=tracker style=display:none src=data:, alt>
 
 <footer>
 
 <div class="c-publisher-footer u-color-inherit" data-test=publisher-footer>
 <div class=u-container>
 <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test=publisher-footer-menu>
 <div class=u-display-flex>
 
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://blogs.biomedcentral.com/>Read more on our blogs</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/login>Receive BMC newsletters</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/account>Manage article alerts</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href="https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022">Language editing for authors</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href="https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022">Scientific editing for authors</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/policies>Policies</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/accessibility>Accessibility</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/press-centre>Press center</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://support.biomedcentral.com/support/home>Support and Contact</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://biomedcentral.typeform.com/to/VLXboo>Leave feedback</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/jobs>Careers</a>
 </li>
 
 </ul>
 
 
 </div>
 <div class=u-mb-24>
 <h3 id=social-menu class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
 <ul class="u-display-flex u-list-reset" data-test=footer-social-links>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://twitter.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Twitter" class=u-gray-link>
 <span class=u-visually-hidden>BMC Twitter page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-twitter-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://www.facebook.com/BioMedCentral data-track=click data-track-category=Social data-track-action="Clicked BMC Facebook" class=u-gray-link>
 <span class=u-visually-hidden>BMC Facebook page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-facebook-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=http://www.weibo.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Weibo" class=u-gray-link>
 <span class=u-visually-hidden>BMC Weibo page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-weibo-bordered></use>
 </svg>
 </a>
 </li>
 
 </ul>
 </div>
 </div>
 <p class=u-reset-margin>
 By using this website, you agree to our
 <a class=u-gray-link href=https://www.biomedcentral.com/terms-and-conditions>Terms and Conditions</a>,
 <a class=u-gray-link href=https://www.springernature.com/ccpa>California Privacy Statement</a>,
 <a class=u-gray-link href=https://www.biomedcentral.com/privacy-statement>Privacy
 statement</a> and
 <a class=u-gray-link href=https://www.biomedcentral.com/cookies data-test=cookie-link>Cookies</a> policy.
 
 <a class="optanon-toggle-display u-gray-link" data-cc-action=preferences>Manage cookies/Do not sell my data</a> we use in the preference centre.
 
 </p>
 </div>
</div>
 
 <div class=c-corporate-footer>
 <div class=u-container>
 <img src=data:image/svg+xml;base64,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 class=c-corporate-footer__logo alt="Springer Nature" itemprop=logo role=img>
 <p class=c-corporate-footer__legal data-test=copyright> © 2023 BioMed Central Ltd unless otherwise stated. Part of
 <a class=c-corporate-footer__link href=https://www.springernature.com/ itemscope itemtype=http://schema.org/Organization itemid=#parentOrganization>Springer Nature</a>.
 </p>
 </div>
</div>
 </footer>
 </div>
 <div class=u-visually-hidden aria-hidden=true>
 
 <svg xmlns=http://www.w3.org/2000/svg xmlns:xlink=http://www.w3.org/1999/xlink><defs><path id=a d="M0 .74h56.72v55.24H0z"></path></defs><symbol id=icon-access viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule=evenodd></path></symbol><symbol id=icon-account viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-alert viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-broad viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule=evenodd transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id=icon-arrow-down viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-left viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-right viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-sub viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-up viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path></symbol><symbol id=icon-article viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule=evenodd></path></symbol><symbol id=icon-audio viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule=evenodd></path></symbol><symbol id=icon-block viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule=evenodd></path></symbol><symbol id=icon-book viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-broad viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule=evenodd transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id=icon-calendar viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule=evenodd></path></symbol><symbol id=icon-cart viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id=icon-chevron-less viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id=icon-chevron-more viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id=icon-chevron-right viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id=icon-circle-fill viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-circle viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-citation viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-close viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule=evenodd></path></symbol><symbol id=icon-collections viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-compare viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule=evenodd></path></symbol><symbol id=icon-download-file viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule=evenodd></path></symbol><symbol id=icon-download viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule=evenodd></path></symbol><symbol id=icon-editors viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule=evenodd></path></symbol><symbol id=icon-email viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule=evenodd></path></symbol><symbol id=icon-error viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule=evenodd></path></symbol><symbol id=icon-ethics viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule=evenodd></path></symbol><symbol id=icon-expand><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule=evenodd></path></symbol><symbol id=icon-explore viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule=evenodd></path></symbol><symbol id=icon-filter viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id=icon-home viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule=evenodd></path></symbol><symbol id=icon-image viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule=evenodd></path></symbol><symbol id=icon-info viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path></symbol><symbol id=icon-institution viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule=evenodd></path></symbol><symbol id=icon-location viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule=evenodd></path></symbol><symbol id=icon-minus viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-newsletter viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule=evenodd></path></symbol><symbol id=icon-orcid viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule=evenodd></path></symbol><symbol id=icon-plus viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-print viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule=evenodd></path></symbol><symbol id=icon-search viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule=evenodd></path></symbol><symbol id=icon-social-facebook viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule=evenodd></path></symbol><symbol id=icon-social-twitter viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule=evenodd></path></symbol><symbol id=icon-social-youtube viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule=evenodd></path></symbol><symbol id=icon-subject-medicine viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-success viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule=evenodd></path></symbol><symbol id=icon-table viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule=evenodd></path></symbol><symbol id=icon-tick-circle viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule=evenodd></path></symbol><symbol id=icon-tick viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule=evenodd></path></symbol><symbol id=icon-update viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule=evenodd></path></symbol><symbol id=icon-upload viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule=evenodd></path></symbol><symbol id=icon-video viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule=evenodd></path></symbol><symbol id=icon-warning viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-account-header viewBox="0 0 24 24"><path fill-rule=nonzero d="M12 12c5.498 0 10 4.001 10 9a1 1 0 0 1-2 0c0-3.838-3.557-7-8-7s-8 3.162-8 7a1 1 0 0 1-2 0c0-4.999 4.502-9 10-9Zm0-11a5 5 0 1 0 0 10 5 5 0 0 0 0-10Zm0 2a3 3 0 1 1 0 6 3 3 0 0 1 0-6Z"></path></symbol><symbol id=icon-checklist-banner viewBox="0 0 56.69 56.69"><path style=fill:none d="M0 0h56.69v56.69H0z"></path><clippath id=b><use xlink:href=#a style=overflow:visible></use></clippath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style=clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style=clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round></path></symbol><symbol id=icon-chevron-down viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id=icon-eds-search viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z" fill-rule=nonzero></path></symbol><symbol id=icon-expand-image viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule=evenodd></path></symbol><symbol id=icon-github viewBox="0 0 100 100"><path fill-rule=evenodd clip-rule=evenodd d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id=icon-menu viewBox="0 0 24 24"><path d="M21.09 5c.503 0 .91.448.91 1s-.407 1-.91 1H2.91C2.406 7 2 6.552 2 6s.407-1 .91-1h18.18Zm-3.817 6c.401 0 .727.448.727 1s-.326 1-.727 1H2.727C2.326 13 2 12.552 2 12s.326-1 .727-1h14.546Zm3.818 6c.502 0 .909.448.909 1s-.407 1-.91 1H2.91c-.503 0-.91-.448-.91-1s.407-1 .91-1h18.18Z" fill-rule=nonzero></path></symbol><symbol id=icon-search-filter viewBox="0 0 29 29"><path d="M28 9H11a1 1 0 0 1 0-2h17a1 1 0 0 1 0 2ZM7 9H4a1 1 0 0 1 0-2h3a1 1 0 0 1 0 2Zm14 8H4a1 1 0 0 1 0-2h17a1 1 0 0 1 0 2Zm-10 8H4a1 1 0 0 1 0-2h7a1 1 0 0 1 0 2Z"></path><path d="M9 11a3 3 0 1 1 3-3 3 3 0 0 1-3 3Zm0-4a1 1 0 1 0 1 1 1 1 0 0 0-1-1Zm14 12a3 3 0 1 1 3-3 3 3 0 0 1-3 3Zm0-4a1 1 0 1 0 1 1 1 1 0 0 0-1-1ZM13 27a3 3 0 1 1 3-3 3 3 0 0 1-3 3Zm0-4a1 1 0 1 0 1 1 1 1 0 0 0-1-1Z"></path><path d="M28 17h-3a1 1 0 0 1 0-2h3a1 1 0 0 1 0 2Zm0 8H15a1 1 0 0 1 0-2h13a1 1 0 0 1 0 2Z"></path><path d="M0 0h32v32H0z" style=fill:none></path></symbol><symbol id=icon-springer-arrow-left><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id=icon-springer-arrow-right><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id=icon-submit-open viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule=nonzero></path></symbol></svg>
</div>
 
<sr-rd-crlbar class="controlbar draggable" data-x=146.30915451049805 data-y=-13.983770370483398 style=transform:translate(146.309px,-13.9838px)><fab class=about></fab><fab class=setting></fab><fab style=font-size:12px!important>简 悦</fab></sr-rd-crlbar><div id=volume-booster-visusalizer class=sf-hidden>
 
 
 </div><div data-cc-ghost style=height:327px></div>
<grammarly-desktop-integration data-grammarly-shadow-root=true><template shadowroot=open><style class=sf-hidden>div.grammarly-desktop-integration{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);white-space:nowrap;border:0;-moz-user-select:none;-webkit-user-select:none;-ms-user-select:none;user-select:none}div.grammarly-desktop-integration:before{content:attr(data-content)}</style><div aria-label=grammarly-integration role=group tabindex=-1 class=grammarly-desktop-integration data-content='{"mode":"full","isActive":true,"isUserDisabled":false}'></div></template></grammarly-desktop-integration><script data-template-shadow-root>(()=>{document.currentScript.remove();processNode(document);function processNode(node){node.querySelectorAll("template[shadowroot]").forEach(element=>{let shadowRoot = element.parentElement.shadowRoot;if (!shadowRoot) {try {shadowRoot=element.parentElement.attachShadow({mode:element.getAttribute("shadowroot")});shadowRoot.innerHTML=element.innerHTML;element.remove()} catch (error) {} if (shadowRoot) {processNode(shadowRoot)}}})}})()</script>